1	Cancer	NNP	O	Cancer	nn	2	SENT_1	[p1l845t82r930b103],
2	Epidemiology	NNP	O	Epidemiology	_	0	SENT_1	[p1l941t81r1113b108],
3	34	CD	NUMBER	34	number	4	SENT_1	[p1l1124t82r1155b103],
4	(	CD	NUMBER	(	dep	2	SENT_1	[p1l1166t81r1248b108],
5	2010	CD	DATE	2010	dep	4	SENT_1	[p1l1166t81r1248b108],
6	)	CD	NUMBER	)	num	7	SENT_1	[p1l1166t81r1248b108],
7	634-638	CD	NUMBER	634-638	dep	2	SENT_1	[p1l1259t82r1369b103],

1	Contents	NNS	O	contents	_	0	SENT_2	[p1l779t188r915b213],
2	lists	NNS	O	list	dep	1	SENT_2	[p1l929t188r988b213],
3	available	JJ	O	available	amod	2	SENT_2	[p1l1001t188r1137b213],
4	at	IN	O	at	_	0	SENT_2	[p1l1151t191r1178b213],
5	ScienceDirect	NNP	O	ScienceDirect	prep_at	3	SENT_2	[p1l1191t188r1400b213],

1	ITC	NNP	ORGANIZATION	ITC	_	0	SENT_3	[p1l2016t196r2135b216],
2	=	JJ	O	=	dep	1	SENT_3	[p1l2016t196r2135b216],
3	'	''	O	'	_	0	SENT_3	[p1l2016t196r2135b216],
4	1i	JJ	O	1i	amod	5	SENT_3	[p1l2016t196r2135b216],
5	‘	NN	O	‘	dep	2	SENT_3	[p1l2016t196r2135b216],
6	;	:	O	;	_	0	SENT_3	[p1l2016t196r2135b216],
7	i	LS	O	i	dep	2	SENT_3	[p1l2016t196r2135b216],
8	:	:	O	:	_	0	SENT_3	[p1l2016t196r2135b216],
9	:1	CD	NUMBER	:1	num	10	SENT_3	[p1l2016t196r2135b216],
10	l	NN	O	l	dep	7	SENT_3	[p1l2016t196r2135b216],
11	:	:	O	:	_	0	SENT_3	[p1l2016t196r2135b216],
12	f	FW	O	f	dep	2	SENT_3	[p1l2016t196r2135b216],
13	~	FW	O	~	nn	14	SENT_3	[p1l2016t196r2135b216],
14	(	FW	O	(	amod	12	SENT_3	[p1l2016t196r2135b216],

1	,	,	O	,	_	0	SENT_4	[p1l25t315r28b318],
2	‘	CD	NUMBER	‘	num	3	SENT_4	[p1l95t318r100b321],
3	Cancer	NN	O	cancer	_	0	SENT_4	[p1l809t265r988b309],
4	Epidemiology	NN	O	epidemiology	dep	3	SENT_4	[p1l1009t262r1370b320],
5	.	.	O	.	_	0	SENT_4	[p1l2111t288r2129b304],

1	.	.	O	.	_	0	SENT_5	[p1l56t352r86b382],

1	.	.	O	.	_	0	SENT_6	[p1l56t352r86b382],

1	T	NN	O	t	nn	4	SENT_7	[p1l97t375r105b379],
2	’	CD	NUMBER	’	num	4	SENT_7	[p1l97t375r105b379],
3	pE	NN	O	pe	nn	4	SENT_7	[p1l112t329r155b389],
4	l	NN	O	l	_	0	SENT_7	[p1l112t329r155b389],
5	+	CC	O	+	_	0	SENT_7	[p1l112t329r155b389],
6	H	NN	O	h	nn	7	SENT_7	[p1l200t376r206b382],
7	K	NN	O	k	conj_+	4	SENT_7	[p1l229t372r248b385],
8	The	DT	O	the	det	10	SENT_7	[p1l429t336r490b366],
9	International	NNP	O	International	nn	10	SENT_7	[p1l505t336r724b366],
10	Journal	NNP	O	Journal	dep	4	SENT_7	[p1l735t336r859b373],
11	of	IN	O	of	_	0	SENT_7	[p1l874t336r909b366],
12	Cancer	NNP	O	Cancer	nn	13	SENT_7	[p1l920t338r1035b366],
13	Epidemiology	NNP	O	Epidemiology	prep_of	10	SENT_7	[p1l1049t336r1288b373],
14	.	.	O	.	_	0	SENT_7	[p1l1049t336r1288b373],

1	Detection	NN	O	detection	_	0	SENT_8	[p1l1303t337r1474b371],
2	,	,	O	,	_	0	SENT_8	[p1l1303t337r1474b371],
3	and	CC	O	and	_	0	SENT_8	[p1l1489t336r1550b366],
4	Prevention	NNP	O	Prevention	conj_and	1	SENT_8	[p1l1565t337r1747b366],
5	»	CD	NUMBER	»	num	6	SENT_8	[p1l2047t340r2084b356],
6	l	NN	O	l	dep	4	SENT_8	[p1l15t417r249b453],
7	+	CC	O	+	_	0	SENT_8	[p1l15t417r249b453],
8	journal	NN	O	journal	nn	9	SENT_8	[p1l618t418r750b449],
9	homepage	NN	O	homepage	conj_+	6	SENT_8	[p1l770t418r973b449],
10	:	:	O	:	_	0	SENT_8	[p1l770t418r973b449],
11	www	NN	O	www	dep	1	SENT_8	[p1l991t418r1558b449],
12	.	.	O	.	_	0	SENT_8	[p1l991t418r1558b449],

1	cancerepidemio	NN	O	cancerepidemio	_	0	SENT_9	[p1l991t418r1558b449],
2	|	CD	NUMBER	|	num	3	SENT_9	[p1l991t418r1558b449],
3	ogy.net	NN	O	ogy.net	dep	1	SENT_9	[p1l991t418r1558b449],

1	Distribution	NN	O	distribution	_	0	SENT_10	[p1l6t565r327b610],
2	of	IN	O	of	_	0	SENT_10	[p1l351t565r405b610],
3	TYMS	NN	O	tym	nn	11	SENT_10	[p1l420t567r585b617],
4	,	,	O	,	_	0	SENT_10	[p1l420t567r585b617],
5	MTHFR	NN	LOCATION	mthfr	nn	11	SENT_10	[p1l609t568r814b617],
6	,	,	O	,	_	0	SENT_10	[p1l609t568r814b617],
7	p53	NN	O	p53	nn	11	SENT_10	[p1l839t567r934b621],
8	and	CC	O	and	_	0	SENT_10	[p1l960t565r1056b610],
9	MDR1	NN	O	mdr1	nn	11	SENT_10	[p1l1081t568r1235b610],
10	gene	NN	O	gene	nn	11	SENT_10	[p1l1265t578r1389b621],
11	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_10	[p1l1413t565r1829b621],
12	in	IN	O	in	_	0	SENT_10	[p1l1854t566r1903b610],
13	patients	NNS	O	patient	prep_in	1	SENT_10	[p1l6t637r219b692],
14	with	IN	O	with	dep	1	SENT_10	[p1l242t636r364b681],
15	breast	NN	O	breast	nn	16	SENT_10	[p1l386t636r551b681],
16	cancer	NN	O	cancer	pobj	14	SENT_10	[p1l573t649r746b681],
17	treated	VBN	O	treat	partmod	16	SENT_10	[p1l768t636r956b681],
18	with	IN	O	with	_	0	SENT_10	[p1l979t636r1101b681],
19	neoadjuvant	JJ	O	neoadjuvant	amod	20	SENT_10	[p1l1125t636r1457b692],
20	chemotherapy	NN	O	chemotherapy	prep_with	17	SENT_10	[p1l1479t636r1865b692],

1	Luis	NNP	PERSON	Luis	nn	3	SENT_11	[p1l8t742r88b777],
2	Alberto	NNP	PERSON	Alberto	nn	3	SENT_11	[p1l106t742r260b777],
3	Henriquez	NNP	PERSON	Henriquez	_	0	SENT_11	[p1l279t740r742b786],
4	.	.	O	.	_	0	SENT_11	[p1l279t740r742b786],

1	—	NN	O	—	_	0	SENT_12	[p1l279t740r742b786],
2	.	.	O	.	_	0	SENT_12	[p1l279t740r742b786],

1	Hernéndez	NNP	O	Hernéndez	_	0	SENT_13	[p1l279t740r742b786],
2	“	CD	NUMBER	“	num	1	SENT_13	[p1l753t734r833b783],
3	"	``	O	"	punct	4	SENT_13	[p1l753t734r833b783],
4	"	``	O	"	dep	1	SENT_13	[p1l753t734r833b783],
5	'	''	O	'	_	0	SENT_13	[p1l753t734r833b783],
6	*	CD	NUMBER	*	dep	1	SENT_13	[p1l753t734r833b783],
7	,	,	O	,	_	0	SENT_13	[p1l753t734r833b783],
8	Adolfo	NNP	PERSON	Adolfo	nn	9	SENT_13	[p1l850t742r986b777],
9	Murias	NNP	PERSON	Murias	appos	6	SENT_13	[p1l1005t742r1323b777],
10	.	.	O	.	_	0	SENT_13	[p1l1005t742r1323b777],

1	—	NN	O	—	_	0	SENT_14	[p1l1005t742r1323b777],
2	.	.	O	.	_	0	SENT_14	[p1l1005t742r1323b777],

1	Rosales	NNP	PERSON	Rosales	_	0	SENT_15	[p1l1005t742r1323b777],
2	'	POS	O	'	_	0	SENT_15	[p1l1333t734r1385b783],
3	3	CD	NUMBER	3	num	1	SENT_15	[p1l1333t734r1385b783],
4	"	``	O	"	punct	1	SENT_15	[p1l1333t734r1385b783],
5	,	,	O	,	_	0	SENT_15	[p1l1333t734r1385b783],
6	Ana	NNP	PERSON	Ana	nn	7	SENT_15	[p1l1402t743r1482b777],
7	Gonzalez-Hernandez	NNP	PERSON	Gonzalez-Hernandez	poss	14	SENT_15	[p1l1501t740r1938b777],
8	'	POS	O	'	_	0	SENT_15	[p1l1949t734r2005b783],
9	°	JJ	O	°	amod	14	SENT_15	[p1l1949t734r2005b783],
10	"	``	O	"	punct	14	SENT_15	[p1l1949t734r2005b783],
11	'	''	O	'	_	0	SENT_15	[p1l1949t734r2005b783],
12	,	,	O	,	_	0	SENT_15	[p1l1949t734r2005b783],
13	Antonio	NNP	PERSON	Antonio	dep	14	SENT_15	[p1l6t795r172b831],
14	Cabrera	NNP	PERSON	Cabrera	dep	26	SENT_15	[p1l191t795r350b831],
15	de	IN	PERSON	de	_	0	SENT_15	[p1l369t795r416b831],
16	Leon	NNP	PERSON	Leon	nn	17	SENT_15	[p1l435t793r532b831],
17	b-d	NNP	O	b-d	prep_de	14	SENT_15	[p1l542t787r598b836],
18	,	,	O	,	_	0	SENT_15	[p1l542t787r598b836],
19	Nicolas	NNP	PERSON	Nicolas	nn	21	SENT_15	[p1l616t793r766b831],
20	Diaz-Chico	NNP	PERSON	Diaz-Chico	nn	21	SENT_15	[p1l785t793r1010b831],
21	“	NN	O	“	appos	17	SENT_15	[p1l1020t787r1074b836],
22	'	''	O	'	_	0	SENT_15	[p1l1020t787r1074b836],
23	9	CD	NUMBER	9	dep	21	SENT_15	[p1l1020t787r1074b836],
24	,	,	O	,	_	0	SENT_15	[p1l1020t787r1074b836],
25	Leandro	NNP	PERSON	Leandro	nn	26	SENT_15	[p1l1093t795r1259b831],
26	Fernandez-Pérez	NNP	PERSON	Fernandez-Pérez	dep	1	SENT_15	[p1l1278t793r1626b831],
27	3	CD	NUMBER	3	number	28	SENT_15	[p1l1636t787r1679b814],
28	”’	NN	O	”’	amod	26	SENT_15	[p1l1636t787r1679b814],
29	3	CD	NUMBER	3	dep	26	SENT_15	[p1l6t870r15b880],
30	Clinical	JJ	ORGANIZATION	clinical	amod	37	SENT_15	[p1l22t871r110b893],
31	Science	NNP	ORGANIZATION	Science	nn	37	SENT_15	[p1l119t871r207b893],
32	Department	NNP	ORGANIZATION	Department	nn	37	SENT_15	[p1l217t872r367b898],
33	,	,	O	,	_	0	SENT_15	[p1l217t872r367b898],
34	Universidad	NNP	ORGANIZATION	Universidad	appos	37	SENT_15	[p1l380t871r523b893],
35	de	IN	ORGANIZATION	de	amod	37	SENT_15	[p1l533t871r560b893],
36	Las	NNP	ORGANIZATION	Las	nn	37	SENT_15	[p1l570t872r609b893],
37	Palmas	NNP	ORGANIZATION	Palmas	dep	1	SENT_15	[p1l619t871r705b893],
38	de	IN	ORGANIZATION	de	_	0	SENT_15	[p1l715t871r743b893],
39	Gran	NNP	ORGANIZATION	Gran	nn	40	SENT_15	[p1l753t872r811b893],
40	Canaria	NNP	ORGANIZATION	Canaria	prep_de	37	SENT_15	[p1l822t871r920b896],
41	,	,	O	,	_	0	SENT_15	[p1l822t871r920b896],
42	C/Dr	NNP	O	C/Dr	appos	40	SENT_15	[p1l932t871r990b898],
43	.	.	O	.	_	0	SENT_15	[p1l932t871r990b898],

1	Pasteur	NNP	O	Pasteur	nn	2	SENT_16	[p1l1001t872r1093b893],
2	s/n	NNP	O	s/n	nsubj	16	SENT_16	[p1l1101t871r1141b898],
3	,	,	O	,	_	0	SENT_16	[p1l1101t871r1141b898],
4	CP	NNP	O	CP	appos	2	SENT_16	[p1l1153t872r1184b893],
5	35016	CD	NUMBER	35016	num	4	SENT_16	[p1l1192t872r1272b896],
6	,	,	O	,	_	0	SENT_16	[p1l1192t872r1272b896],
7	Las	NNP	LOCATION	Las	nn	11	SENT_16	[p1l1284t872r1322b893],
8	Palmas	NNP	LOCATION	Palmas	nn	11	SENT_16	[p1l1332t871r1418b893],
9	de	IN	LOCATION	de	amod	11	SENT_16	[p1l1429t871r1456b893],
10	Gran	NNP	LOCATION	Gran	nn	11	SENT_16	[p1l1467t872r1524b893],
11	Canaria	NNP	LOCATION	Canaria	appos	2	SENT_16	[p1l1536t871r1633b896],
12	,	,	O	,	_	0	SENT_16	[p1l1536t871r1633b896],
13	Spain	NNP	LOCATION	Spain	nn	15	SENT_16	[p1l1644t871r1710b898],
14	blnstituto	NNP	O	blnstituto	nn	15	SENT_16	[p1l6t902r124b928],
15	Canaria	NNP	LOCATION	Canaria	appos	2	SENT_16	[p1l135t907r228b928],
16	cle	VBP	O	cle	_	0	SENT_16	[p1l239t907r266b928],
17	lm/estigaci	JJ	O	lm/estigaci	amod	23	SENT_16	[p1l276t905r434b934],
18	én	NN	O	én	nn	23	SENT_16	[p1l276t905r434b934],
19	clel	NN	O	clel	nn	23	SENT_16	[p1l445t907r480b928],
20	Cancer	NN	O	cancer	nn	23	SENT_16	[p1l491t905r574b928],
21	(	CD	NUMBER	(	num	23	SENT_16	[p1l583t907r655b934],
22	ICIC	NN	ORGANIZATION	icic	nn	23	SENT_16	[p1l583t907r655b934],
23	)	NN	O	)	dobj	16	SENT_16	[p1l583t907r655b934],
24	,	,	O	,	_	0	SENT_16	[p1l583t907r655b934],
25	Spain	NNP	LOCATION	Spain	nn	29	SENT_16	[p1l666t907r732b934],
26	‘	NNP	O	‘	nn	29	SENT_16	[p1l6t941r115b964],
27	Medical	NNP	ORGANIZATION	Medical	nn	29	SENT_16	[p1l6t941r115b964],
28	Oncology	NNP	ORGANIZATION	Oncology	nn	29	SENT_16	[p1l126t942r236b969],
29	Service	NNP	ORGANIZATION	Service	appos	23	SENT_16	[p1l246t942r335b967],
30	,	,	O	,	_	0	SENT_16	[p1l246t942r335b967],
31	Hospital	NNP	ORGANIZATION	Hospital	nn	36	SENT_16	[p1l347t942r447b969],
32	Universitario	NNP	ORGANIZATION	Universitario	nn	36	SENT_16	[p1l458t942r613b964],
33	Insular	NNP	ORGANIZATION	Insular	nn	36	SENT_16	[p1l624t942r709b964],
34	de	IN	ORGANIZATION	de	amod	36	SENT_16	[p1l718t942r745b964],
35	Gran	NNP	ORGANIZATION	Gran	nn	36	SENT_16	[p1l756t943r813b964],
36	Canaria	NNP	ORGANIZATION	Canaria	appos	23	SENT_16	[p1l825t942r922b967],
37	,	,	O	,	_	0	SENT_16	[p1l825t942r922b967],
38	Avda	NNP	O	Avda	appos	23	SENT_16	[p1l932t942r999b964],
39	.	.	O	.	_	0	SENT_16	[p1l932t942r999b964],

1	Maritima	FW	PERSON	maritima	nn	4	SENT_17	[p1l1010t942r1123b964],
2	del	FW	PERSON	del	nn	4	SENT_17	[p1l1134t942r1169b964],
3	Sur	FW	PERSON	sur	nn	4	SENT_17	[p1l1178t943r1219b964],
4	s/n	FW	O	s/n	dep	33	SENT_17	[p1l1228t942r1268b969],
5	,	,	O	,	_	0	SENT_17	[p1l1228t942r1268b969],
6	2nd	JJ	ORDINAL	2nd	amod	7	SENT_17	[p1l1278t942r1325b964],
7	floor	NN	O	floor	appos	4	SENT_17	[p1l1331t942r1394b969],
8	,	,	O	,	_	0	SENT_17	[p1l1331t942r1394b969],
9	CP	NN	O	cp	appos	4	SENT_17	[p1l1407t943r1438b964],
10	35016	CD	NUMBER	35016	num	9	SENT_17	[p1l1446t943r1526b967],
11	,	,	O	,	_	0	SENT_17	[p1l1446t943r1526b967],
12	Las	NNP	LOCATION	Las	nn	16	SENT_17	[p1l1538t943r1576b964],
13	Palmas	NNP	LOCATION	Palmas	nn	16	SENT_17	[p1l1586t942r1672b964],
14	de	IN	LOCATION	de	amod	16	SENT_17	[p1l1683t942r1710b964],
15	Gran	NNP	LOCATION	Gran	nn	16	SENT_17	[p1l1721t943r1778b964],
16	Canaria	NNP	LOCATION	Canaria	appos	4	SENT_17	[p1l1789t942r1887b967],
17	,	,	O	,	_	0	SENT_17	[p1l1789t942r1887b967],
18	Spain	NNP	LOCATION	Spain	nn	21	SENT_17	[p1l1898t942r1964b969],
19	“	NNP	O	“	nn	21	SENT_17	[p1l6t972r128b999],
20	Research	NNP	ORGANIZATION	Research	nn	21	SENT_17	[p1l6t972r128b999],
21	Unit	NNP	ORGANIZATION	Unit	appos	4	SENT_17	[p1l141t977r195b1002],
22	,	,	O	,	_	0	SENT_17	[p1l141t977r195b1002],
23	Hospital	NNP	ORGANIZATION	Hospital	nn	27	SENT_17	[p1l207t977r307b1004],
24	Universitario	NNP	ORGANIZATION	Universitario	nn	27	SENT_17	[p1l319t977r473b999],
25	de	IN	ORGANIZATION	de	amod	27	SENT_17	[p1l484t977r512b999],
26	La	NNP	ORGANIZATION	La	nn	27	SENT_17	[p1l522t978r548b999],
27	Candelaria	NNP	ORGANIZATION	Candelaria	appos	4	SENT_17	[p1l560t977r693b1002],
28	,	,	O	,	_	0	SENT_17	[p1l560t977r693b1002],
29	Carretera	NNP	ORGANIZATION	Carretera	nn	32	SENT_17	[p1l705t978r818b999],
30	de	IN	ORGANIZATION	de	amod	32	SENT_17	[p1l829t977r856b999],
31	El	NNP	ORGANIZATION	El	nn	32	SENT_17	[p1l866t977r888b999],
32	Rosario	NNP	ORGANIZATION	Rosario	appos	4	SENT_17	[p1l897t977r986b999],
33	45	CD	NUMBER	45	_	0	SENT_17	[p1l996t978r1031b1002],
34	,	,	O	,	_	0	SENT_17	[p1l996t978r1031b1002],
35	Hospital	NNP	ORGANIZATION	Hospital	nn	38	SENT_17	[p1l1043t977r1143b1004],
36	de	IN	ORGANIZATION	de	amod	38	SENT_17	[p1l1153t977r1180b999],
37	La	NNP	ORGANIZATION	La	nn	38	SENT_17	[p1l1190t978r1217b999],
38	Candelaria	NNP	ORGANIZATION	Candelaria	appos	33	SENT_17	[p1l1228t977r1361b1002],
39	,	,	O	,	_	0	SENT_17	[p1l1228t977r1361b1002],
40	CP	NNP	O	CP	appos	33	SENT_17	[p1l1374t978r1404b999],
41	38010	CD	NUMBER	38010	num	40	SENT_17	[p1l1412t978r1493b1002],
42	,	,	O	,	_	0	SENT_17	[p1l1412t978r1493b1002],
43	Santa	NNP	ORGANIZATION	Santa	nn	46	SENT_17	[p1l1504t978r1572b999],
44	Cruz	NNP	ORGANIZATION	Cruz	nn	46	SENT_17	[p1l1583t978r1637b999],
45	de	IN	ORGANIZATION	de	amod	46	SENT_17	[p1l1647t977r1674b999],
46	Tenerife	NNP	ORGANIZATION	Tenerife	appos	33	SENT_17	[p1l1685t977r1785b1004],
47	,	,	O	,	_	0	SENT_17	[p1l1685t977r1785b1004],
48	Spain	NNP	LOCATION	Spain	nn	50	SENT_17	[p1l1796t977r1862b1004],
49	“	NNP	O	“	nn	50	SENT_17	[p1l6t1012r154b1040],
50	Physiology	NNP	O	Physiology	appos	33	SENT_17	[p1l6t1012r154b1040],
51	,	,	O	,	_	0	SENT_17	[p1l6t1012r154b1040],
52	Biochemistry	NNP	O	Biochemistry	nn	60	SENT_17	[p1l166t1012r322b1040],
53	and	CC	O	and	_	0	SENT_17	[p1l333t1012r377b1034],
54	Molecular	JJ	ORGANIZATION	molecular	nn	60	SENT_17	[p1l387t1012r509b1034],
55	Biology	NNP	ORGANIZATION	Biology	nn	60	SENT_17	[p1l517t1013r606b1040],
56	Department	NNP	ORGANIZATION	Department	nn	60	SENT_17	[p1l616t1014r766b1040],
57	,	,	O	,	_	0	SENT_17	[p1l616t1014r766b1040],
58	Universiclucl	NNP	ORGANIZATION	Universiclucl	appos	60	SENT_17	[p1l779t1013r922b1034],
59	de	IN	ORGANIZATION	de	amod	60	SENT_17	[p1l932t1012r959b1034],
60	Las	NNP	ORGANIZATION	Las	appos	33	SENT_17	[p1l969t1014r1007b1034],
61	Palmas	NNP	ORGANIZATION	Palmas	nn	64	SENT_17	[p1l1017t1012r1104b1034],
62	de	IN	ORGANIZATION	de	amod	64	SENT_17	[p1l1114t1012r1141b1034],
63	Gran	NNP	ORGANIZATION	Gran	nn	64	SENT_17	[p1l1152t1014r1209b1034],
64	Canaria	NNP	ORGANIZATION	Canaria	dep	60	SENT_17	[p1l1221t1013r1318b1038],
65	,	,	O	,	_	0	SENT_17	[p1l1221t1013r1318b1038],
66	C/Dr	NNP	O	C/Dr	appos	33	SENT_17	[p1l1331t1013r1388b1040],
67	.	.	O	.	_	0	SENT_17	[p1l1331t1013r1388b1040],

1	Pasteur	NNP	O	Pasteur	nn	2	SENT_18	[p1l1400t1014r1491b1034],
2	s/n	NNP	O	s/n	nsubj	9	SENT_18	[p1l1499t1013r1540b1040],
3	,	,	O	,	_	0	SENT_18	[p1l1499t1013r1540b1040],
4	CP	NNP	O	CP	appos	2	SENT_18	[p1l1552t1014r1583b1034],
5	35016	CD	NUMBER	35016	num	4	SENT_18	[p1l1591t1014r1671b1038],
6	,	,	O	,	_	0	SENT_18	[p1l1591t1014r1671b1038],
7	Las	NNP	LOCATION	Las	nn	8	SENT_18	[p1l1683t1014r1721b1034],
8	Palmas	NNP	LOCATION	Palmas	appos	4	SENT_18	[p1l1731t1013r1817b1034],
9	cle	VBP	LOCATION	cle	_	0	SENT_18	[p1l1828t1013r1855b1034],
10	Gran	NNP	LOCATION	Gran	nn	11	SENT_18	[p1l1866t1014r1923b1034],
11	Canaria	NNP	LOCATION	Canaria	dobj	9	SENT_18	[p1l1935t1013r2032b1038],
12	,	,	O	,	_	0	SENT_18	[p1l1935t1013r2032b1038],
13	Spain	NNP	LOCATION	Spain	appos	11	SENT_18	[p1l2043t1013r2109b1040],

1	ARTICLEINFO	NNP	O	ARTICLEINFO	_	0	SENT_19	[p1l6t1152r308b1172],
2	ABSTRACT	NN	O	abstract	dep	1	SENT_19	[p1l698t1152r915b1172],

1	A1TiCl	NN	O	a1ticl	_	0	SENT_20	[p1l6t1227r82b1248],
2	€	CD	NUMBER	€	num	1	SENT_20	[p1l6t1227r82b1248],
3	h1	NN	O	h1	nn	5	SENT_20	[p1l99t1227r186b1254],
4	'	''	O	'	_	0	SENT_20	[p1l99t1227r186b1254],
5	Sf0T	NN	O	sf0t	dep	1	SENT_20	[p1l99t1227r186b1254],
6	.	.	O	.	_	0	SENT_20	[p1l99t1227r186b1254],

1	V	NN	O	v	_	0	SENT_21	[p1l99t1227r186b1254],
2	-	:	O	-	_	0	SENT_21	[p1l99t1227r186b1254],
3	'	''	O	'	_	0	SENT_21	[p1l99t1227r186b1254],
4	Purpose	NN	O	purpose	dep	1	SENT_21	[p1l713t1230r821b1258],
5	To	TO	O	to	aux	6	SENT_21	[p1l838t1230r873b1252],
6	investigate	VB	O	investigate	infmod	4	SENT_21	[p1l892t1229r1048b1258],
7	the	DT	O	the	det	8	SENT_21	[p1l1067t1228r1112b1252],
8	role	NN	O	role	dobj	6	SENT_21	[p1l1132t1228r1185b1252],
9	of	IN	O	of	_	0	SENT_21	[p1l1205t1228r1234b1252],
10	TSER	NN	O	tser	prep_of	8	SENT_21	[p1l1248t1229r1319b1252],
11	(	CD	NUMBER	(	num	13	SENT_21	[p1l1338t1228r1448b1258],
12	TYMS	NN	O	tym	nn	13	SENT_21	[p1l1338t1228r1448b1258],
13	)	NN	O	)	dep	34	SENT_21	[p1l1338t1228r1448b1258],
14	,	,	O	,	_	0	SENT_21	[p1l1338t1228r1448b1258],
15	C677T	NN	O	c677t	nn	18	SENT_21	[p1l1468t1229r1557b1252],
16	(	CD	NUMBER	(	num	18	SENT_21	[p1l1575t1228r1709b1258],
17	MTHFR	NN	O	mthfr	nn	18	SENT_21	[p1l1575t1228r1709b1258],
18	)	NN	O	)	dep	34	SENT_21	[p1l1575t1228r1709b1258],
19	,	,	O	,	_	0	SENT_21	[p1l1575t1228r1709b1258],
20	Arg72Pro	NN	O	arg72pro	nn	23	SENT_21	[p1l1727t1229r1860b1258],
21	(	CD	NUMBER	(	num	23	SENT_21	[p1l1880t1228r1955b1258],
22	p53	NN	O	p53	nn	23	SENT_21	[p1l1880t1228r1955b1258],
23	)	NN	O	)	dep	34	SENT_21	[p1l1880t1228r1955b1258],
24	and	CC	O	and	_	0	SENT_21	[p1l1975t1228r2026b1252],
25	C3435T	NN	O	c3435t	dep	34	SENT_21	[p1l2046t1229r2154b1252],
26	(	CD	NUMBER	(	num	25	SENT_21	[p1l6t1268r101b1298],
27	MDR1	NN	O	mdr1	dep	34	SENT_21	[p1l6t1268r101b1298],
28	)	CD	NUMBER	)	num	27	SENT_21	[p1l124t1268r131b1298],
29	Accepted	JJ	O	accepted	amod	34	SENT_21	[p1l158t1262r273b1289],
30	20	CD	DATE	20	num	34	SENT_21	[p1l300t1263r330b1284],
31	June	NNP	DATE	June	nn	34	SENT_21	[p1l354t1263r411b1289],
32	2010	CD	DATE	2010	num	34	SENT_21	[p1l438t1263r500b1284],
33	gene	NN	O	gene	nn	34	SENT_21	[p1l913t1275r979b1294],
34	Dolvm_orDhi_sms	NNS	O	dolvm_ordhi_sms	dep	8	SENT_21	[p1l1004t1268r1226b1306],
35	in	IN	O	in	_	0	SENT_21	[p1l1251t1268r1277b1292],
36	‘	JJ	O	‘	amod	39	SENT_21	[p1l1295t1268r1389b1306],
37	breast	NN	O	breast	nn	39	SENT_21	[p1l1295t1268r1389b1306],
38	cancer	NN	O	cancer	nn	39	SENT_21	[p1l1413t1275r1506b1292],
39	patients	NNS	O	patient	prep_in	34	SENT_21	[p1l1529t1268r1651b1306],
40	treated	VBN	O	treat	partmod	8	SENT_21	[p1l1668t1268r1769b1292],
41	with	IN	O	with	_	0	SENT_21	[p1l1792t1268r1858b1292],
42	5	CD	NUMBER	5	number	43	SENT_21	[p1l1883t1267r2078b1292],
43	—	CD	NUMBER	—	num	44	SENT_21	[p1l1883t1267r2078b1292],
44	ﬂuorouracil	NN	O	ﬂuorouracil	prep_with	40	SENT_21	[p1l1883t1267r2078b1292],
45	and	CC	O	and	_	0	SENT_21	[p1l2103t1267r2154b1292],
46	cvc1o	NN	O	cvc1o	nn	49	SENT_21	[p1l6t1316r368b1356],
47	¥	NN	O	¥	nn	49	SENT_21	[p1l6t1316r368b1356],
48	DhosDhar_nide	NN	O	dhosdhar_nide	nn	49	SENT_21	[p1l6t1316r368b1356],
49	—	NN	O	—	dobj	6	SENT_21	[p1l6t1316r368b1356],
50	based	VBN	O	base	partmod	49	SENT_21	[p1l6t1316r368b1356],
51	Avaﬂable	JJ	O	avaﬂable	amod	53	SENT_21	[p1l388t1306r500b1328],
52	°	NN	O	°	nn	53	SENT_21	[p1l514t1306r589b1328],
53	“	NN	O	“	dobj	50	SENT_21	[p1l514t1306r589b1328],
54	1	CD	NUMBER	1	num	55	SENT_21	[p1l514t1306r589b1328],
55	‘“	NN	O	‘“	dep	53	SENT_21	[p1l514t1306r589b1328],
56	e	SYM	O	e	dep	58	SENT_21	[p1l514t1306r589b1328],
57	17J	CD	NUMBER	17j	number	58	SENT_21	[p1l605t1306r689b1333],
58	“	CD	NUMBER	“	dep	63	SENT_21	[p1l605t1306r689b1333],
59	l3	NN	O	l3	prep	58	SENT_21	[p1l605t1306r689b1333],
60	’	CD	NUMBER	’	num	61	SENT_21	[p1l605t1306r689b1333],
61	2010	CD	DATE	2010	dep	59	SENT_21	[p1l703t1307r762b1328],
62	neoadjuvant	JJ	O	neoadjuvant	amod	63	SENT_21	[p1l1095t1316r1273b1346],
63	chemotherapy	NN	O	chemotherapy	dep	53	SENT_21	[p1l1292t1316r1504b1346],
64	.	.	O	.	_	0	SENT_21	[p1l1292t1316r1504b1346],

1	Results	NNS	O	result	nsubj	2	SENT_22	[p1l1523t1316r1618b1340],
2	Observed	VBD	O	observe	_	0	SENT_22	[p1l1638t1316r1770b1340],
3	allelic	JJ	O	allelic	amod	4	SENT_22	[p1l1790t1316r1873b1340],
4	frequencies	NNS	O	frequency	nsubj	5	SENT_22	[p1l1893t1316r2056b1346],
5	were	VBD	O	be	ccomp	2	SENT_22	[p1l2075t1323r2154b1340],
6	:	:	O	:	_	0	SENT_22	[p1l2075t1323r2154b1340],
7	TSER	NN	O	tser	dobj	5	SENT_22	[p1l6t1367r82b1394],
8	,	,	O	,	_	0	SENT_22	[p1l6t1367r82b1394],
9	(	NN	O	(	conj_and	7	SENT_22	[p1l101t1366r140b1396],
10	2	CD	NUMBER	2	number	11	SENT_22	[p1l101t1366r140b1396],
11	)	CD	NUMBER	)	num	12	SENT_22	[p1l101t1366r140b1396],
12	0.54	CD	NUMBER	0.54	dep	9	SENT_22	[p1l157t1367r217b1390],
13	and	CC	O	and	_	0	SENT_22	[p1l234t1366r286b1390],
14	(	CD	NUMBER	(	number	15	SENT_22	[p1l303t1366r343b1396],
15	3	CD	NUMBER	3	conj_and	7	SENT_22	[p1l303t1366r343b1396],
16	)	NN	O	)	dep	15	SENT_22	[p1l303t1366r343b1396],
17	0.46	CD	NUMBER	0.46	num	16	SENT_22	[p1l360t1367r428b1394],
18	;	:	O	;	_	0	SENT_22	[p1l360t1367r428b1394],
19	MTHFR	NNP	O	MTHFR	nn	20	SENT_22	[p1l1134t1367r1237b1390],
20	C677T	NNP	O	C677T	dep	15	SENT_22	[p1l1246t1367r1342b1393],
21	,	,	O	,	_	0	SENT_22	[p1l1246t1367r1342b1393],
22	(	CD	NUMBER	(	num	23	SENT_22	[p1l1352t1366r1392b1396],
23	C	NN	O	c	appos	20	SENT_22	[p1l1352t1366r1392b1396],
24	)	CD	NUMBER	)	num	25	SENT_22	[p1l1352t1366r1392b1396],
25	0.59	CD	NUMBER	0.59	dep	23	SENT_22	[p1l1401t1367r1460b1390],
26	and	CC	O	and	_	0	SENT_22	[p1l1471t1366r1522b1390],
27	(	CD	NUMBER	(	num	28	SENT_22	[p1l1532t1366r1570b1396],
28	T	NN	O	t	conj_and	23	SENT_22	[p1l1532t1366r1570b1396],
29	)	CD	NUMBER	)	number	30	SENT_22	[p1l1532t1366r1570b1396],
30	0.41	CD	NUMBER	0.41	dep	28	SENT_22	[p1l1580t1367r1650b1393],
31	;	:	O	;	_	0	SENT_22	[p1l1580t1367r1650b1393],
32	p53	NN	O	p53	nn	33	SENT_22	[p1l1662t1367r1713b1396],
33	Arg72Pro	NN	O	arg72pro	dep	15	SENT_22	[p1l1724t1367r1863b1396],
34	,	,	O	,	_	0	SENT_22	[p1l1724t1367r1863b1396],
35	(	CD	NUMBER	(	num	36	SENT_22	[p1l1874t1366r1944b1396],
36	Arg	NN	O	arg	appos	33	SENT_22	[p1l1874t1366r1944b1396],
37	)	CD	NUMBER	)	num	38	SENT_22	[p1l1874t1366r1944b1396],
38	0.73	CD	NUMBER	0.73	dep	36	SENT_22	[p1l1955t1367r2012b1390],
39	and	CC	O	and	_	0	SENT_22	[p1l2024t1366r2075b1390],
40	(	CD	NUMBER	(	conj_and	36	SENT_22	[p1l2086t1366r2154b1396],
41	Pro	FW	O	pro	nn	42	SENT_22	[p1l2086t1366r2154b1396],
42	)	FW	O	)	dep	40	SENT_22	[p1l2086t1366r2154b1396],
43	0.27	CD	NUMBER	0.27	dep	40	SENT_22	[p1l6t1406r74b1433],
44	;	:	O	;	_	0	SENT_22	[p1l6t1406r74b1433],
45	MDR1	NN	O	mdr1	nn	46	SENT_22	[p1l85t1406r168b1429],
46	c3435r	NN	O	c3435r	dep	15	SENT_22	[p1l180t1406r294b1433],
47	,	,	O	,	_	0	SENT_22	[p1l180t1406r294b1433],
48	(	NN	O	(	nn	49	SENT_22	[p1l303t1405r342b1435],
49	c	NN	O	c	dep	15	SENT_22	[p1l303t1405r342b1435],
50	)	CD	NUMBER	)	number	51	SENT_22	[p1l303t1405r342b1435],
51	0.52	CD	NUMBER	0.52	dep	49	SENT_22	[p1l351t1406r409b1429],
52	and	CC	O	and	_	0	SENT_22	[p1l419t1405r470b1429],
53	Keywords	NNPS	O	Keywords	dep	15	SENT_22	[p1l6t1439r132b1466],
54	:	:	O	:	_	0	SENT_22	[p1l6t1439r132b1466],
55	Breast	NN	O	breast	nn	56	SENT_22	[p1l7t1476r85b1496],
56	cancer	NN	O	cancer	dep	15	SENT_22	[p1l96t1481r178b1496],
57	Neoadjuvant	JJ	O	neoadjuvant	amod	59	SENT_22	[p1l7t1510r168b1537],
58	chemotherapy	NN	O	chemotherapy	nn	59	SENT_22	[p1l179t1510r362b1537],
59	Toxicity	NN	O	toxicity	dep	56	SENT_22	[p1l6t1546r107b1573],
60	Adverse	JJ	O	adverse	amod	64	SENT_22	[p1l6t1582r107b1604],
61	reaction	NN	O	reaction	nn	64	SENT_22	[p1l119t1582r221b1604],
62	Polymorphism	NN	O	polymorphism	nn	64	SENT_22	[p1l7t1618r192b1645],
63	MTHFR	NN	O	mthfr	nn	64	SENT_22	[p1l7t1655r100b1675],
64	p53	NN	O	p53	dep	56	SENT_22	[p1l7t1690r52b1716],

1	(	NN	O	(	nn	2	SENT_23	[p1l8t1774r46b1804],
2	T	NN	O	t	_	0	SENT_23	[p1l8t1774r46b1804],
3	)	CD	NUMBER	)	number	4	SENT_23	[p1l8t1774r46b1804],
4	0.48	CD	NUMBER	0.48	num	2	SENT_23	[p1l57t1775r123b1798],
5	.	.	O	.	_	0	SENT_23	[p1l57t1775r123b1798],

1	MTHFR	NN	O	mthfr	nn	3	SENT_24	[p1l134t1775r238b1798],
2	allele	NN	O	allele	nn	3	SENT_24	[p1l247t1774r321b1798],
3	T	NN	O	t	_	0	SENT_24	[p1l331t1775r348b1798],
4	and	CC	O	and	_	0	SENT_24	[p1l357t1774r409b1798],
5	p53	NN	O	p53	nn	6	SENT_24	[p1l419t1775r470b1804],
6	allele	NN	O	allele	conj_and	3	SENT_24	[p1l482t1774r556b1798],
7	Pro	FW	O	pro	nsubjpass	10	SENT_24	[p1l567t1775r612b1798],
8	were	VBD	O	be	auxpass	10	SENT_24	[p1l622t1781r692b1798],
9	strongly	RB	O	strongly	advmod	10	SENT_24	[p1l702t1774r818b1804],
10	associated	VBN	O	associate	rcmod	3	SENT_24	[p1l828t1774r975b1798],
11	with	IN	O	with	_	0	SENT_24	[p1l984t1774r1049b1798],
12	toxicity	NN	O	toxicity	prep_with	10	SENT_24	[p1l1059t1774r1167b1804],
13	due	JJ	O	due	_	0	SENT_24	[p1l1176t1774r1228b1798],
14	to	TO	O	to	_	0	SENT_24	[p1l1238t1778r1265b1798],
15	chemotherapy	NN	O	chemotherapy	nn	18	SENT_24	[p1l1275t1774r1481b1804],
16	(	CD	NUMBER	(	num	18	SENT_24	[p1l8t1814r86b1844],
17	odds	NNS	O	odds	nn	18	SENT_24	[p1l8t1814r86b1844],
18	ratio	NN	O	ratio	prep_due_to	3	SENT_24	[p1l95t1814r167b1842],
19	,	,	O	,	_	0	SENT_24	[p1l95t1814r167b1842],
20	7.1	CD	PERCENT	7.1	number	21	SENT_24	[p1l177t1815r214b1838],
21	(	CD	PERCENT	(	conj_and	3	SENT_24	[p1l226t1814r292b1844],
22	95	CD	PERCENT	95	num	25	SENT_24	[p1l226t1814r292b1844],
23	%	NN	PERCENT	%	nn	25	SENT_24	[p1l226t1814r292b1844],
24	conﬁdence	NN	O	conﬁdence	nn	25	SENT_24	[p1l301t1814r454b1838],
25	interval	NN	O	interval	dep	21	SENT_24	[p1l463t1814r579b1842],
26	,	,	O	,	_	0	SENT_24	[p1l463t1814r579b1842],
27	1.4	CD	NUMBER	1.4	number	28	SENT_24	[p1l589t1815r718b1842],
28	—	CD	NUMBER	—	conj_and	3	SENT_24	[p1l589t1815r718b1842],
29	36.1	CD	NUMBER	36.1	dep	28	SENT_24	[p1l589t1815r718b1842],
30	;	:	O	;	_	0	SENT_24	[p1l589t1815r718b1842],
31	p	NN	O	p	conj_and	3	SENT_24	[p1l728t1821r745b1844],
32	=	JJ	O	=	amod	34	SENT_24	[p1l754t1824r769b1832],
33	0.018	CD	NUMBER	0.018	tmod	32	SENT_24	[p1l779t1814r867b1844],
34	)	NN	O	)	dep	31	SENT_24	[p1l779t1814r867b1844],
35	and	CC	O	and	_	0	SENT_24	[p1l877t1814r928b1838],
36	7.0	CD	PERCENT	7.0	num	37	SENT_24	[p1l937t1815r978b1839],
37	(	CD	PERCENT	(	conj_and	3	SENT_24	[p1l987t1814r1052b1844],
38	95	CD	PERCENT	95	number	39	SENT_24	[p1l987t1814r1052b1844],
39	%	NN	PERCENT	%	amod	41	SENT_24	[p1l987t1814r1052b1844],
40	conﬁdence	NN	O	conﬁdence	nn	41	SENT_24	[p1l1061t1814r1214b1838],
41	interval	NN	O	interval	dep	37	SENT_24	[p1l1223t1814r1339b1842],
42	,	,	O	,	_	0	SENT_24	[p1l1223t1814r1339b1842],
43	1.2-40	CD	NUMBER	1.2-40	num	44	SENT_24	[p1l1350t1815r1478b1842],
44	.5	CD	NUMBER	.5	appos	37	SENT_24	[p1l1350t1815r1478b1842],
45	;	:	O	;	_	0	SENT_24	[p1l1350t1815r1478b1842],
46	p	NN	O	p	dep	3	SENT_24	[p1l6t1861r23b1884],
47	=	JJ	O	=	amod	49	SENT_24	[p1l33t1864r48b1872],
48	0.029	CD	NUMBER	0.029	tmod	47	SENT_24	[p1l57t1854r153b1884],
49	)	NN	O	)	dep	46	SENT_24	[p1l57t1854r153b1884],
50	,	,	O	,	_	0	SENT_24	[p1l57t1854r153b1884],
51	respectively	RB	O	respectively	advmod	52	SENT_24	[p1l162t1854r352b1884],
52	)	CD	NUMBER	)	rcmod	46	SENT_24	[p1l162t1854r352b1884],
53	.	.	O	.	_	0	SENT_24	[p1l162t1854r352b1884],

1	Conclusion	NN	O	conclusion	nsubj	6	SENT_25	[p1l361t1854r507b1878],
2	We	PRP	O	we	nsubj	3	SENT_25	[p1l515t1855r563b1878],
3	introduced	VBD	O	introduce	rcmod	1	SENT_25	[p1l572t1854r726b1878],
4	new	JJ	O	new	amod	5	SENT_25	[p1l736t1861r795b1878],
5	data	NNS	O	datum	dobj	3	SENT_25	[p1l804t1854r864b1878],
6	related	VBN	O	relate	_	0	SENT_25	[p1l873t1854r971b1878],
7	to	TO	O	to	_	0	SENT_25	[p1l980t1858r1008b1878],
8	the	DT	O	the	det	9	SENT_25	[p1l1016t1854r1061b1878],
9	contribution	NN	O	contribution	prep_to	6	SENT_25	[p1l1070t1854r1247b1878],
10	of	IN	O	of	_	0	SENT_25	[p1l1256t1854r1285b1878],
11	p53	NN	O	p53	nn	12	SENT_25	[p1l1291t1855r1342b1884],
12	codon	NN	O	codon	prep_of	9	SENT_25	[p1l1353t1854r1438b1878],
13	72	CD	NUMBER	72	num	12	SENT_25	[p1l1447t1855r1480b1878],
14	to	TO	O	to	_	0	SENT_25	[p1l8t1898r35b1918],
15	toxicity	NN	O	toxicity	prep_to	6	SENT_25	[p1l47t1894r155b1924],
16	due	JJ	O	due	_	0	SENT_25	[p1l167t1894r219b1918],
17	to	TO	O	to	_	0	SENT_25	[p1l231t1898r258b1918],
18	5-ﬂuorouracil	NN	O	5-ﬂuorouracil	nn	22	SENT_25	[p1l272t1894r467b1918],
19	and	CC	O	and	_	0	SENT_25	[p1l480t1894r531b1918],
20	cyclophosphamide-based	JJ	O	cyclophosphamide-based	nn	22	SENT_25	[p1l544t1894r906b1924],
21	neoadjuvant	JJ	O	neoadjuvant	amod	22	SENT_25	[p1l920t1894r1097b1924],
22	chemotherapy	NN	O	chemotherapy	prep_due_to	6	SENT_25	[p1l1109t1894r1315b1924],
23	in	IN	O	in	_	0	SENT_25	[p1l1328t1894r1354b1918],
24	patients	NNS	O	patient	prep_in	22	SENT_25	[p1l1366t1894r1480b1924],
25	with	IN	O	with	_	0	SENT_25	[p1l7t1934r73b1958],
26	breast	NN	O	breast	nn	27	SENT_25	[p1l85t1934r172b1958],
27	cancer	NN	O	cancer	prep_with	24	SENT_25	[p1l184t1941r283b1958],
28	.	.	O	.	_	0	SENT_25	[p1l184t1941r283b1958],

1	©	RB	O	©	advmod	2	SENT_26	[p1l904t1977r926b1998],
2	2010	CD	DATE	2010	_	0	SENT_26	[p1l940t1975r1010b1998],
3	Elsevier	NNP	ORGANIZATION	Elsevier	nn	4	SENT_26	[p1l1023t1974r1134b1998],
4	Ltd.	NNP	ORGANIZATION	Ltd.	dep	2	SENT_26	[p1l1145t1974r1195b1998],
5	.	.	O	.	_	0	SENT_26	[p1l1145t1974r1195b1998],

1	All	DT	O	all	det	2	SENT_27	[p1l1208t1974r1245b1998],
2	rights	NNS	O	rights	nsubj	3	SENT_27	[p1l1259t1974r1339b2004],
3	reserved	VBN	O	reserve	_	0	SENT_27	[p1l1352t1974r1480b1998],
4	.	.	O	.	_	0	SENT_27	[p1l1352t1974r1480b1998],

1	1	LS	NUMBER	1	_	0	SENT_28	[p1l14t2197r67b2249],
2	.	.	O	.	_	0	SENT_28	[p1l14t2197r67b2249],

1	Introduction	NN	O	introduction	_	0	SENT_29	[p1l106t2194r541b2248],

1	Breast	NN	O	breast	nn	2	SENT_30	[p1l114t2375r313b2426],
2	cancer	NN	O	cancer	nsubj	13	SENT_30	[p1l342t2387r551b2426],
3	(	CD	NUMBER	(	num	5	SENT_30	[p1l578t2372r711b2439],
4	BC	NN	O	bc	nn	5	SENT_30	[p1l578t2372r711b2439],
5	)	NN	O	)	nsubj	10	SENT_30	[p1l578t2372r711b2439],
6	is	VBZ	O	be	cop	10	SENT_30	[p1l741t2372r787b2426],
7	the	DT	O	the	det	10	SENT_30	[p1l817t2372r919b2426],
8	most	RBS	O	most	advmod	9	SENT_30	[p1l948t2380r1108b2426],
9	common	JJ	O	common	amod	10	SENT_30	[p1l1136t2387r1418b2426],
10	cancer	NN	O	cancer	rcmod	2	SENT_30	[p1l1447t2387r1657b2426],
11	in	IN	O	in	_	0	SENT_30	[p1l1684t2372r1743b2425],
12	women	NNS	O	woman	prep_in	10	SENT_30	[p1l1770t2387r2012b2426],
13	[	VBP	O	[	_	0	SENT_30	[p1l2044t2371r2144b2439],
14	1	CD	NUMBER	1	number	15	SENT_30	[p1l2044t2371r2144b2439],
15	]	CD	NUMBER	]	dobj	13	SENT_30	[p1l2044t2371r2144b2439],
16	.	.	O	.	_	0	SENT_30	[p1l2044t2371r2144b2439],

1	Gran	NNP	LOCATION	Gran	nn	6	SENT_31	[p1l13t2461r166b2513],
2	Canaria	NNP	LOCATION	Canaria	nn	6	SENT_31	[p1l191t2459r431b2513],
3	Island	NNP	LOCATION	Island	nn	6	SENT_31	[p1l456t2459r646b2513],
4	(	NNP	O	(	nn	6	SENT_31	[p1l671t2459r921b2526],
5	Canary	NNP	LOCATION	Canary	nn	6	SENT_31	[p1l671t2459r921b2526],
6	Islands	NNP	LOCATION	Islands	nsubj	10	SENT_31	[p1l945t2459r1182b2521],
7	,	,	O	,	_	0	SENT_31	[p1l945t2459r1182b2521],
8	Spain	NNP	LOCATION	Spain	nn	9	SENT_31	[p1l1208t2459r1407b2526],
9	)	NNP	O	)	nsubj	10	SENT_31	[p1l1208t2459r1407b2526],
10	has	VBZ	O	have	_	0	SENT_31	[p1l1433t2459r1537b2513],
11	one	CD	NUMBER	one	dobj	10	SENT_31	[p1l1563t2474r1678b2513],
12	of	IN	O	of	_	0	SENT_31	[p1l1702t2458r1769b2513],
13	the	DT	O	the	det	15	SENT_31	[p1l1785t2459r1886b2513],
14	highest	JJS	O	highest	amod	15	SENT_31	[p1l1912t2459r2147b2526],
15	rates	NNS	O	rate	prep_of	11	SENT_31	[p1l13t2553r166b2599],
16	of	IN	O	of	_	0	SENT_31	[p1l188t2545r254b2599],
17	the	DT	O	the	det	18	SENT_31	[p1l266t2545r368b2599],
18	disease	NN	O	disease	prep_of	15	SENT_31	[p1l388t2545r619b2599],
19	compared	VBN	O	compare	_	0	SENT_31	[p1l640t2545r959b2613],
20	with	IN	O	with	prepc_compared_with	18	SENT_31	[p1l979t2545r1126b2599],
21	the	DT	O	the	det	22	SENT_31	[p1l1145t2545r1247b2599],
22	rest	NN	O	rest	pobj	18	SENT_31	[p1l1268t2553r1387b2599],
23	of	IN	O	of	_	0	SENT_31	[p1l1407t2545r1473b2599],
24	the	DT	O	the	det	26	SENT_31	[p1l1484t2545r1586b2599],
25	Spanish	JJ	LOCATION	spanish	amod	26	SENT_31	[p1l1607t2545r1856b2613],
26	territory	NN	O	territory	prep_of	22	SENT_31	[p1l1875t2546r2147b2612],
27	(	CD	NUMBER	(	num	29	SENT_31	[p1l12t2633r2071b2700],
28	http://www.gobiernodecanarias.org/sanidad/scs/3/3_6/cancer/	NN	O	http://www.gobiernodecanarias.org/sanidad/scs/3/3_6/cancer/	nn	29	SENT_31	[p1l12t2633r2071b2700],
29	ppal	NN	O	ppal	dep	26	SENT_31	[p1l13t2719r302b2787],
30	.	.	O	.	_	0	SENT_31	[p1l13t2719r302b2787],

1	jsp	NN	O	jsp	_	0	SENT_32	[p1l13t2719r302b2787],
2	)	NN	O	)	dep	1	SENT_32	[p1l13t2719r302b2787],
3	.	.	O	.	_	0	SENT_32	[p1l13t2719r302b2787],

1	Primary	JJ	O	primary	amod	3	SENT_33	[p1l329t2720r584b2787],
2	systemic	JJ	O	systemic	amod	3	SENT_33	[p1l608t2720r888b2787],
3	therapy	NN	O	therapy	nsubjpass	12	SENT_33	[p1l910t2719r1160b2787],
4	(	CD	NUMBER	(	num	5	SENT_33	[p1l1182t2719r1346b2786],
5	PST	NNP	O	PST	dep	3	SENT_33	[p1l1182t2719r1346b2786],
6	)	CD	NUMBER	)	num	5	SENT_33	[p1l1182t2719r1346b2786],
7	or	CC	O	or	_	0	SENT_33	[p1l1370t2735r1436b2773],
8	neoadjuvant	JJ	O	neoadjuvant	amod	9	SENT_33	[p1l1458t2719r1860b2787],
9	therapy	NN	O	therapy	nsubjpass	12	SENT_33	[p1l1882t2719r2145b2787],
10	,	,	O	,	_	0	SENT_33	[p1l1882t2719r2145b2787],
11	is	VBZ	O	be	auxpass	12	SENT_33	[p1l13t2807r59b2860],
12	used	VBN	O	use	_	0	SENT_33	[p1l93t2806r240b2860],
13	in	IN	O	in	_	0	SENT_33	[p1l273t2807r332b2860],
14	nonmetastatic	JJ	O	nonmetastatic	amod	16	SENT_33	[p1l364t2807r826b2860],
15	breast	NN	O	breast	nn	16	SENT_33	[p1l857t2806r1055b2860],
16	cancer	NN	O	cancer	prep_in	12	SENT_33	[p1l1086t2822r1296b2860],
17	to	TO	O	to	aux	18	SENT_33	[p1l1325t2814r1387b2860],
18	treat	VB	O	treat	xcomp	12	SENT_33	[p1l1418t2814r1570b2860],
19	systemic	JJ	O	systemic	amod	20	SENT_33	[p1l1602t2807r1882b2874],
20	disease	NN	O	disease	dobj	18	SENT_33	[p1l1914t2806r2145b2860],
21	earlier	RBR	O	earlier	advmod	18	SENT_33	[p1l12t2894r233b2956],
22	,	,	O	,	_	0	SENT_33	[p1l12t2894r233b2956],
23	decrease	VB	O	decrease	xcomp	12	SENT_33	[p1l266t2894r544b2948],
24	tumour	NN	O	tumour	nn	25	SENT_33	[p1l575t2902r819b2948],
25	bulk	NN	O	bulk	dobj	23	SENT_33	[p1l848t2894r990b2948],
26	ideally	RB	O	ideally	advmod	23	SENT_33	[p1l1020t2894r1234b2961],
27	to	TO	O	to	_	0	SENT_33	[p1l1264t2902r1326b2948],
28	a	DT	O	a	det	31	SENT_33	[p1l1358t2909r1390b2948],
29	complete	JJ	O	complete	amod	31	SENT_33	[p1l1422t2894r1719b2961],
30	pathological	JJ	O	pathological	amod	31	SENT_33	[p1l1751t2894r2145b2961],
31	response	NN	O	response	prep_to	23	SENT_33	[p1l13t2996r312b3048],
32	,	,	O	,	_	0	SENT_33	[p1l13t2996r312b3048],
33	and	CC	O	and	_	0	SENT_33	[p1l354t2981r470b3035],
34	reduce	VB	O	reduce	xcomp	12	SENT_33	[p1l512t2981r726b3035],
35	the	DT	O	the	det	36	SENT_33	[p1l767t2981r868b3035],
36	extent	NN	O	extent	dobj	34	SENT_33	[p1l909t2989r1113b3035],
37	of	IN	O	of	_	0	SENT_33	[p1l1153t2980r1219b3035],
38	surgery	NN	O	surgery	prep_of	36	SENT_33	[p1l1252t2996r1493b3048],
39	[	CD	NUMBER	[	num	38	SENT_33	[p1l1537t2980r1693b3048],
40	2,3	CD	NUMBER	2,3	num	41	SENT_33	[p1l1537t2980r1693b3048],
41	]	NN	O	]	dep	38	SENT_33	[p1l1537t2980r1693b3048],
42	.	.	O	.	_	0	SENT_33	[p1l1537t2980r1693b3048],

1	Neoadjuvant	JJ	O	neoadjuvant	amod	2	SENT_34	[p1l1736t2981r2147b3048],
2	chemotherapy	NN	O	chemotherapy	nsubj	3	SENT_34	[p1l12t3067r479b3135],
3	allows	VBZ	O	allow	_	0	SENT_34	[p1l503t3067r707b3121],
4	observing	VBG	O	observe	xcomp	3	SENT_34	[p1l734t3067r1049b3135],
5	the	DT	O	the	det	6	SENT_34	[p1l1072t3067r1173b3121],
6	response	NN	O	response	dobj	4	SENT_34	[p1l1199t3083r1483b3135],
7	of	IN	O	of	_	0	SENT_34	[p1l1508t3067r1575b3121],
8	primary	JJ	O	primary	amod	9	SENT_34	[p1l1592t3068r1850b3135],
9	tumours	NNS	O	tumour	prep_of	6	SENT_34	[p1l1873t3075r2145b3121],
10	to	TO	O	to	_	0	SENT_34	[p1l12t3163r73b3209],
11	the	DT	O	the	det	12	SENT_34	[p1l94t3155r196b3209],
12	treatment	NN	O	treatment	prep_to	4	SENT_34	[p1l216t3163r553b3217],
13	,	,	O	,	_	0	SENT_34	[p1l216t3163r553b3217],
14	providing	VBG	O	provide	xcomp	3	SENT_34	[p1l575t3155r885b3222],
15	an	DT	O	a	det	17	SENT_34	[p1l904t3171r979b3209],
16	ideal	JJ	O	ideal	amod	17	SENT_34	[p1l1000t3155r1152b3209],
17	platform	NN	O	platform	dobj	14	SENT_34	[p1l1174t3155r1452b3222],
18	to	TO	O	to	aux	19	SENT_34	[p1l1472t3163r1534b3209],
19	identify	VB	O	identify	xcomp	14	SENT_34	[p1l1556t3155r1805b3222],
20	predictive	JJ	O	predictive	amod	21	SENT_34	[p1l1824t3155r2146b3222],
21	markers	NNS	O	marker	dobj	19	SENT_34	[p1l13t3241r289b3296],
22	.	.	O	.	_	0	SENT_34	[p1l13t3241r289b3296],

1	Thymidylate	NNP	O	Thymidylate	nsubj	6	SENT_35	[p1l308t3241r716b3309],
2	synthase	NN	O	synthase	nn	5	SENT_35	[p1l736t3241r1017b3309],
3	(	CD	NUMBER	(	num	5	SENT_35	[p1l1037t3241r1270b3308],
4	TYMS	NN	O	tym	nn	5	SENT_35	[p1l1037t3241r1270b3308],
5	)	NN	O	)	dep	1	SENT_35	[p1l1037t3241r1270b3308],
6	catalyses	VBZ	O	catalys	_	0	SENT_35	[p1l1289t3241r1577b3309],
7	the	DT	O	the	det	8	SENT_35	[p1l1597t3241r1698b3295],
8	conversion	NN	O	conversion	dobj	6	SENT_35	[p1l1718t3242r2068b3295],
9	of	IN	O	of	prep	8	SENT_35	[p1l2087t3241r2153b3295],

1	Abbreviations	NNS	O	abbreviation	_	0	SENT_36	[p2l7t20r365b64],
2	:	:	O	:	_	0	SENT_36	[p2l7t20r365b64],
3	5	CD	NUMBER	5	dep	1	SENT_36	[p2l399t23r532b70],
4	.	.	O	.	_	0	SENT_36	[p2l399t23r532b70],

1	—	NN	O	—	_	0	SENT_37	[p2l399t23r532b70],
2	.	.	O	.	_	0	SENT_37	[p2l399t23r532b70],

1	FU	NNP	O	FU	_	0	SENT_38	[p2l399t23r532b70],
2	,	,	O	,	_	0	SENT_38	[p2l399t23r532b70],
3	5-ﬂuorouracil	NN	O	5-ﬂuorouracil	appos	1	SENT_38	[p2l573t20r943b70],
4	;	:	O	;	_	0	SENT_38	[p2l573t20r943b70],
5	BC	NNP	O	BC	dep	1	SENT_38	[p2l987t22r1063b70],
6	,	,	O	,	_	0	SENT_38	[p2l987t22r1063b70],
7	breast	NN	O	breast	nn	8	SENT_38	[p2l1102t20r1261b63],
8	cancer	NN	O	cancer	appos	5	SENT_38	[p2l1299t32r1481b70],
9	;	:	O	;	_	0	SENT_38	[p2l1299t32r1481b70],
10	dTMP	NN	O	dtmp	dep	5	SENT_38	[p2l1525t20r1683b70],
11	,	,	O	,	_	0	SENT_38	[p2l1525t20r1683b70],
12	deoxythymidine	NN	O	deoxythymidine	nn	13	SENT_38	[p2l1723t20r2146b74],
13	monophosphate	NN	O	monophosphate	appos	10	SENT_38	[p2l12t92r446b147],
14	;	:	O	;	_	0	SENT_38	[p2l12t92r446b147],
15	dUMP	NN	O	dump	dep	5	SENT_38	[p2l480t92r648b142],
16	,	,	O	,	_	0	SENT_38	[p2l480t92r648b142],
17	deoxyuridine	NN	O	deoxyuridine	nn	18	SENT_38	[p2l678t92r1019b146],
18	monophosphate	NN	O	monophosphate	appos	15	SENT_38	[p2l1050t92r1484b147],
19	;	:	O	;	_	0	SENT_38	[p2l1050t92r1484b147],
20	MDR1	NN	O	mdr1	dep	5	SENT_38	[p2l1518t95r1687b142],
21	,	,	O	,	_	0	SENT_38	[p2l1518t95r1687b142],
22	multidrug	JJ	O	multidrug	amod	24	SENT_38	[p2l1718t92r1978b146],
23	resistance	NN	O	resistance	nn	24	SENT_38	[p2l2007t93r2145b136, p2l11t170r149b207],
24	gene	NN	O	gene	appos	20	SENT_38	[p2l184t176r304b218],
25	1	CD	NUMBER	1	dep	24	SENT_38	[p2l342t166r384b214],
26	;	:	O	;	_	0	SENT_38	[p2l342t166r384b214],
27	MTHFR	NNP	LOCATION	MTHFR	dep	5	SENT_38	[p2l424t166r622b214],
28	,	,	O	,	_	0	SENT_38	[p2l424t166r622b214],
29	methylene-tetrahydrofolate	JJ	O	methylene-tetrahydrofolate	amod	30	SENT_38	[p2l659t164r1381b218],
30	reductase	NN	O	reductase	appos	27	SENT_38	[p2l1416t164r1680b214],
31	;	:	O	;	_	0	SENT_38	[p2l1416t164r1680b214],
32	Pgp	NNP	O	Pgp	dep	5	SENT_38	[p2l1720t166r1824b218],
33	,	,	O	,	_	0	SENT_38	[p2l1720t166r1824b218],
34	product	NN	O	product	nn	35	SENT_38	[p2l1860t164r2061b218],
35	Pglycoprotein	NN	O	pglycoprotein	appos	32	SENT_38	[p2l2096t166r2146b207, p2l11t236r351b290],
36	;	:	O	;	_	0	SENT_38	[p2l2096t166r2146b207, p2l11t236r351b290],
37	TYMS	NNS	O	tym	dep	5	SENT_38	[p2l376t238r535b286],
38	,	,	O	,	_	0	SENT_38	[p2l376t238r535b286],
39	thymidylate	NN	O	thymidylate	nn	40	SENT_38	[p2l558t236r872b290],
40	synthase	NN	O	synthase	appos	37	SENT_38	[p2l895t236r1133b290],
41	.	.	O	.	_	0	SENT_38	[p2l895t236r1133b290],

1	*	NN	O	*	_	0	SENT_39	[p2l58t307r77b326],
2	Corresponding	VBG	O	correspond	partmod	1	SENT_39	[p2l111t308r489b362],
3	author	NN	O	author	dobj	2	SENT_39	[p2l522t307r694b351],
4	at	IN	O	at	prep	2	SENT_39	[p2l725t314r788b351],
5	:	:	O	:	_	0	SENT_39	[p2l725t314r788b351],
6	Clinical	JJ	O	clinical	amod	13	SENT_39	[p2l827t308r1015b351],
7	Science	NNP	O	Science	nn	13	SENT_39	[p2l1050t308r1239b351],
8	Department	NNP	O	Department	nn	13	SENT_39	[p2l1274t310r1595b362],
9	,	,	O	,	_	0	SENT_39	[p2l1274t310r1595b362],
10	Universidad	NNP	ORGANIZATION	Universidad	appos	13	SENT_39	[p2l1630t307r1940b351],
11	de	IN	ORGANIZATION	de	amod	13	SENT_39	[p2l1974t307r2033b351],
12	Las	NNP	ORGANIZATION	Las	nn	13	SENT_39	[p2l2067t310r2145b351],
13	Palmas	NNP	ORGANIZATION	Palmas	dep	1	SENT_39	[p2l12t380r192b424],
14	de	IN	ORGANIZATION	de	_	0	SENT_39	[p2l214t380r274b424],
15	Gran	NNP	ORGANIZATION	Gran	nn	16	SENT_39	[p2l295t383r418b424],
16	Canaria	NNP	ORGANIZATION	Canaria	prep_de	13	SENT_39	[p2l439t381r644b430],
17	,	,	O	,	_	0	SENT_39	[p2l439t381r644b430],
18	C/Dr	NNP	O	C/Dr	appos	16	SENT_39	[p2l666t380r792b435],
19	.	.	O	.	_	0	SENT_39	[p2l666t380r792b435],

1	Pasteur	NNP	O	Pasteur	nn	2	SENT_40	[p2l814t383r1006b424],
2	s/n	NNP	O	s/n	_	0	SENT_40	[p2l1026t380r1113b435],
3	,	,	O	,	_	0	SENT_40	[p2l1026t380r1113b435],
4	CP	NNP	O	CP	appos	2	SENT_40	[p2l1136t383r1199b424],
5	35016	CD	NUMBER	35016	num	4	SENT_40	[p2l1218t382r1391b430],
6	,	,	O	,	_	0	SENT_40	[p2l1218t382r1391b430],
7	Las	NNP	LOCATION	Las	nn	11	SENT_40	[p2l1414t383r1491b424],
8	Palmas	NNP	LOCATION	Palmas	nn	11	SENT_40	[p2l1514t380r1694b424],
9	de	IN	LOCATION	de	amod	11	SENT_40	[p2l1716t380r1775b424],
10	Gran	NNP	LOCATION	Gran	nn	11	SENT_40	[p2l1796t383r1919b424],
11	Canaria	NNP	LOCATION	Canaria	appos	2	SENT_40	[p2l1940t381r2145b430],
12	,	,	O	,	_	0	SENT_40	[p2l1940t381r2145b430],
13	Spain	NNP	LOCATION	Spain	appos	2	SENT_40	[p2l12t452r164b506],
14	.	.	O	.	_	0	SENT_40	[p2l12t452r164b506],

1	Tel.	NNP	O	Tel.	_	0	SENT_41	[p2l186t452r291b496],
2	:	:	O	:	_	0	SENT_41	[p2l186t452r291b496],
3	+34 928449940	CD	NUMBER	+34 928449940	dep	1	SENT_41	[p2l434t454r742b502],[p2l318t454r412b495],
4	;	:	O	;	_	0	SENT_41	[p2l434t454r742b502],
5	fax	NN	O	fax	dep	1	SENT_41	[p2l769t452r860b496],
6	:	:	O	:	_	0	SENT_41	[p2l769t452r860b496],
7	+34 928451461	CD	NUMBER	+34 928451461	dep	5	SENT_41	[p2l1002t454r1307b496],[p2l887t454r980b495],
8	.	.	O	.	_	0	SENT_41	[p2l1002t454r1307b496],

1	E-mail	NN	O	e-mail	nn	2	SENT_42	[p2l112t524r275b567],
2	addresses	NNS	O	address	_	0	SENT_42	[p2l296t524r546b568],
3	:	:	O	:	_	0	SENT_42	[p2l296t524r546b568],
4	lhenriquez@dcc.ulpgc.es	NNS	O	lhenriquez@dcc.ulpgc.es	dep	2	SENT_42	[p2l570t524r1200b578],
5	(	CD	NUMBER	(	num	4	SENT_42	[p2l1224t524r1332b578],
6	L.A.	NNP	LOCATION	L.A.	nn	8	SENT_42	[p2l1224t524r1332b578],
7	Henriquez-Hernandez	NNP	O	Henriquez-Hernandez	nn	8	SENT_42	[p2l1356t521r1961b578],
8	)	NNP	O	)	dep	4	SENT_42	[p2l1356t521r1961b578],
9	,	,	O	,	_	0	SENT_42	[p2l1356t521r1961b578],

1	amuriasrosales@gmail.com	NNP	O	amuriasrosales@gmail.com	nn	5	SENT_43	[p2l12t596r714b650],
2	(	NNP	O	(	nn	5	SENT_43	[p2l737t596r804b650],
3	A.	NN	PERSON	a.	nn	5	SENT_43	[p2l737t596r804b650],
4	Murias-Rosales	NNP	PERSON	Murias-Rosales	nn	5	SENT_43	[p2l828t596r1254b650],
5	)	NNP	O	)	nsubj	26	SENT_43	[p2l828t596r1254b650],
6	,	,	O	,	_	0	SENT_43	[p2l828t596r1254b650],
7	anagonzalezy@yahoo.es	VBZ	O	anagonzalezy@yahoo.es	parataxis	26	SENT_43	[p2l1277t596r1896b650],
8	(	CD	NUMBER	(	num	9	SENT_43	[p2l30t668r97b722],
9	A.	NN	PERSON	a.	dobj	7	SENT_43	[p2l30t668r97b722],
10	Gonzalez-Hernandez	NNP	PERSON	Gonzalez-Hernandez	nn	11	SENT_43	[p2l121t665r695b722],
11	)	NNP	O	)	nsubj	20	SENT_43	[p2l121t665r695b722],
12	,	,	O	,	_	0	SENT_43	[p2l121t665r695b722],
13	acableo@gobiernodecanarias.org	NN	O	acableo@gobiernodecanarias.org	appos	11	SENT_43	[p2l718t668r1563b722],
14	(	CD	NUMBER	(	num	18	SENT_43	[p2l1585t668r1699b722],
15	A.C.	NNP	PERSON	A.C.	nn	18	SENT_43	[p2l1585t668r1699b722],
16	de	IN	PERSON	de	amod	18	SENT_43	[p2l1723t668r1781b711],
17	Leon	NNP	PERSON	Leon	nn	18	SENT_43	[p2l1804t665r1957b722],
18	)	NNP	O	)	dep	13	SENT_43	[p2l1804t665r1957b722],
19	,	,	O	,	_	0	SENT_43	[p2l1804t665r1957b722],
20	bdiaz@dbbf.ulpgc.es	VBZ	O	bdiaz@dbbf.ulpgc.es	rcmod	9	SENT_43	[p2l11t740r534b794],
21	(	CD	NUMBER	(	dobj	20	SENT_43	[p2l550t740r621b794],
22	N.	NNP	PERSON	N.	nn	24	SENT_43	[p2l550t740r621b794],
23	Diaz-Chico	NNP	PERSON	Diaz-Chico	nn	24	SENT_43	[p2l637t738r949b794],
24	)	NNP	O	)	nsubj	7	SENT_43	[p2l637t738r949b794],
25	,	,	O	,	_	0	SENT_43	[p2l637t738r949b794],
26	lfernandez@dcc.ulpgc.es	VBZ	O	lfernandez@dcc.ulpgc.es	_	0	SENT_43	[p2l964t740r1592b794],
27	(	NNP	O	(	nn	29	SENT_43	[p2l1607t740r1665b794],
28	L.	NNP	PERSON	L.	nn	29	SENT_43	[p2l1607t740r1665b794],
29	Fernéndez	NNP	PERSON	Fernéndez	dobj	26	SENT_43	[p2l1682t738r2145b794],
30	.	.	O	.	_	0	SENT_43	[p2l1682t738r2145b794],

1	—	NN	O	—	_	0	SENT_44	[p2l1682t738r2145b794],
2	.	.	O	.	_	0	SENT_44	[p2l1682t738r2145b794],

1	Pérez	NNP	PERSON	Pérez	nn	2	SENT_45	[p2l1682t738r2145b794],
2	)	NNP	O	)	_	0	SENT_45	[p2l1682t738r2145b794],
3	.	.	O	.	_	0	SENT_45	[p2l1682t738r2145b794],

1	1877-7821	CD	DURATION	1877-7821	_	0	SENT_46	[p2l14t893r343b949],
2	/	:	O	/	punct	1	SENT_46	[p2l14t893r343b949],
3	$	$	MONEY	$	nsubj	5	SENT_46	[p2l14t893r343b949],
4	—	CD	MONEY	—	num	3	SENT_46	[p2l367t920r394b925],
5	see	VBP	O	see	dep	1	SENT_46	[p2l419t907r498b938],
6	front	JJ	O	front	amod	7	SENT_46	[p2l522t894r647b938],
7	matter	NN	O	matter	dobj	5	SENT_46	[p2l669t901r843b938],
8	©	CD	NUMBER	©	num	11	SENT_46	[p2l866t901r905b938],
9	2010	CD	DATE	2010	num	11	SENT_46	[p2l931t897r1057b938],
10	Elsevier	NNP	ORGANIZATION	Elsevier	nn	11	SENT_46	[p2l1080t894r1281b938],
11	Ltd.	NNP	ORGANIZATION	Ltd.	dep	7	SENT_46	[p2l1302t894r1393b938],
12	.	.	O	.	_	0	SENT_46	[p2l1302t894r1393b938],

1	All	DT	O	all	det	2	SENT_47	[p2l1415t894r1484b937],
2	rights	NNS	O	rights	nsubj	3	SENT_47	[p2l1507t894r1653b948],
3	reserved	VBN	O	reserve	_	0	SENT_47	[p2l1677t894r1909b938],
4	.	.	O	.	_	0	SENT_47	[p2l1677t894r1909b938],

1	doi	FW	O	doi	_	0	SENT_48	[p2l12t965r855b1020],
2	:10.1016	CD	NUMBER	:10.1016	dep	1	SENT_48	[p2l12t965r855b1020],
3	/	:	O	/	punct	25	SENT_48	[p2l12t965r855b1020],
4	j.	NN	O	j.	nn	5	SENT_48	[p2l12t965r855b1020],
5	canep	NN	O	canep	dep	10	SENT_48	[p2l12t965r855b1020],
6	.2010.06.013	CD	NUMBER	.2010.06.013	num	7	SENT_48	[p2l12t965r855b1020],
7	deoxyuridine	NN	O	deoxyuridine	dep	5	SENT_48	[p2l10t1043r438b1112],
8	monophosphate	NN	O	monophosphate	dep	10	SENT_48	[p2l466t1043r989b1112],
9	(	CD	NUMBER	(	num	8	SENT_48	[p2l1017t1043r1263b1111],
10	dUMP	NN	O	dump	dep	17	SENT_48	[p2l1017t1043r1263b1111],
11	)	CD	NUMBER	)	num	10	SENT_48	[p2l1017t1043r1263b1111],
12	to	TO	O	to	_	0	SENT_48	[p2l1290t1051r1352b1098],
13	deoxythymidine	JJ	O	deoxythymidine	amod	14	SENT_48	[p2l1380t1043r1910b1112],
14	monophosphate	NN	O	monophosphate	prep_to	10	SENT_48	[p2l1938t1059r2149b1098, p2l10t1132r346b1201],
15	(	CD	NUMBER	(	num	17	SENT_48	[p2l382t1132r617b1200],
16	dTMP	NN	O	dtmp	nn	17	SENT_48	[p2l382t1132r617b1200],
17	)	NN	O	)	dep	25	SENT_48	[p2l382t1132r617b1200],
18	in	IN	O	in	_	0	SENT_48	[p2l653t1133r713b1187],
19	the	DT	O	the	det	20	SENT_48	[p2l747t1132r849b1187],
20	process	NN	O	process	prep_in	17	SENT_48	[p2l885t1148r1123b1201],
21	of	IN	O	of	_	0	SENT_48	[p2l1161t1132r1227b1187],
22	DNA	NN	MISC	dna	nn	23	SENT_48	[p2l1255t1135r1402b1187],
23	synthesis	NN	O	synthesis	prep_of	20	SENT_48	[p2l1436t1132r1733b1201],
24	[	CD	NUMBER	[	num	25	SENT_48	[p2l1774t1132r1873b1201],
25	4	CD	NUMBER	4	dep	2	SENT_48	[p2l1774t1132r1873b1201],
26	]	NN	O	]	dep	2	SENT_48	[p2l1774t1132r1873b1201],
27	.	.	O	.	_	0	SENT_48	[p2l1774t1132r1873b1201],

1	It	PRP	O	it	nsubj	5	SENT_49	[p2l1911t1136r1956b1187],
2	is	VBZ	O	be	cop	5	SENT_49	[p2l1991t1133r2037b1187],
3	an	DT	O	a	det	5	SENT_49	[p2l2074t1148r2149b1187],
4	important	JJ	O	important	amod	5	SENT_49	[p2l10t1222r336b1290],
5	target	NN	O	target	_	0	SENT_49	[p2l366t1230r557b1290],
6	for	IN	O	for	_	0	SENT_49	[p2l587t1221r676b1277],
7	drugs	NNS	O	drug	prep_for	5	SENT_49	[p2l705t1222r882b1290],
8	such	JJ	O	such	_	0	SENT_49	[p2l915t1222r1061b1277],
9	as	IN	O	as	_	0	SENT_49	[p2l1092t1237r1154b1277],
10	5	CD	NUMBER	5	number	11	SENT_49	[p2l1188t1221r1631b1277],
11	—	CD	NUMBER	—	num	13	SENT_49	[p2l1188t1221r1631b1277],
12	ﬂuorouracil	NN	O	ﬂuorouracil	nn	13	SENT_49	[p2l1188t1221r1631b1277],
13	(	NN	O	(	prep_such_as	7	SENT_49	[p2l1662t1222r1882b1290],
14	5	CD	NUMBER	5	amod	13	SENT_49	[p2l1662t1222r1882b1290],
15	.	.	O	.	_	0	SENT_49	[p2l1662t1222r1882b1290],

1	—	NN	O	—	_	0	SENT_50	[p2l1662t1222r1882b1290],
2	.	.	O	.	_	0	SENT_50	[p2l1662t1222r1882b1290],

1	FU	NN	O	fu	nn	2	SENT_51	[p2l1662t1222r1882b1290],
2	)	NN	O	)	_	0	SENT_51	[p2l1662t1222r1882b1290],
3	,	,	O	,	_	0	SENT_51	[p2l1662t1222r1882b1290],
4	methotrexate	NN	O	methotrexate	nn	7	SENT_51	[p2l1915t1222r2149b1277, p2l9t1319r236b1365],
5	(	CD	NUMBER	(	num	7	SENT_51	[p2l271t1311r487b1379],
6	MTX	NN	O	mtx	nn	7	SENT_51	[p2l271t1311r487b1379],
7	)	NN	O	)	appos	2	SENT_51	[p2l271t1311r487b1379],
8	,	,	O	,	_	0	SENT_51	[p2l271t1311r487b1379],
9	oral	JJ	O	oral	amod	10	SENT_51	[p2l522t1310r643b1365],
10	5	CD	NUMBER	5	appos	7	SENT_51	[p2l679t1314r831b1365],
11	.	.	O	.	_	0	SENT_51	[p2l679t1314r831b1365],

1	—	NN	O	—	_	0	SENT_52	[p2l679t1314r831b1365],
2	.	.	O	.	_	0	SENT_52	[p2l679t1314r831b1365],

1	FU	NN	O	fu	nn	2	SENT_53	[p2l679t1314r831b1365],
2	prodrugs	NNS	O	prodrug	nsubj	10	SENT_53	[p2l866t1310r1153b1379],
3	and	CC	O	and	_	0	SENT_53	[p2l1188t1310r1305b1365],
4	other	JJ	O	other	amod	7	SENT_53	[p2l1339t1310r1512b1365],
5	novel	JJ	O	novel	amod	7	SENT_53	[p2l1544t1310r1717b1365],
6	folate	NN	O	folate	nn	7	SENT_53	[p2l1752t1310r2149b1365],
7	—	NN	O	—	nsubj	10	SENT_53	[p2l1752t1310r2149b1365],
8	based	VBN	O	base	partmod	7	SENT_53	[p2l1752t1310r2149b1365],
9	drugs	NNS	O	drug	dobj	8	SENT_53	[p2l10t1400r187b1468],
10	[	VBP	O	[	_	0	SENT_53	[p2l221t1400r321b1468],
11	5	CD	NUMBER	5	number	12	SENT_53	[p2l221t1400r321b1468],
12	]	CD	NUMBER	]	dobj	10	SENT_53	[p2l221t1400r321b1468],
13	.	.	O	.	_	0	SENT_53	[p2l221t1400r321b1468],

1	A	DT	O	a	det	4	SENT_54	[p2l349t1402r396b1454],
2	tandem	JJ	O	tandem	amod	4	SENT_54	[p2l422t1400r669b1455],
3	repeat	NN	O	repeat	nn	4	SENT_54	[p2l699t1408r902b1468],
4	polymorphism	NN	O	polymorphism	nsubjpass	7	SENT_54	[p2l931t1400r1405b1468],
5	has	VBZ	O	have	aux	7	SENT_54	[p2l1434t1400r1539b1455],
6	been	VBN	O	be	auxpass	7	SENT_54	[p2l1569t1400r1723b1455],
7	identiﬁed	VBN	O	identiﬁed	_	0	SENT_54	[p2l1752t1400r2061b1455],
8	in	IN	O	in	_	0	SENT_54	[p2l2090t1401r2149b1454],
9	the	DT	O	the	det	11	SENT_54	[p2l9t1489r111b1544],
10	5	CD	NUMBER	5	num	11	SENT_54	[p2l141t1491r360b1544],
11	’	NN	O	’	prep_in	7	SENT_54	[p2l141t1491r360b1544],
12	.	.	O	.	_	0	SENT_54	[p2l141t1491r360b1544],

1	—	NN	O	—	_	0	SENT_55	[p2l141t1491r360b1544],
2	.	.	O	.	_	0	SENT_55	[p2l141t1491r360b1544],

1	UTR	NN	O	utr	nn	3	SENT_56	[p2l141t1491r360b1544],
2	enhancer	NN	O	enhancer	nn	3	SENT_56	[p2l386t1489r685b1544],
3	region	NN	O	region	_	0	SENT_56	[p2l711t1490r914b1557],
4	of	IN	O	of	_	0	SENT_56	[p2l942t1489r1008b1544],
5	the	DT	O	the	det	10	SENT_56	[p2l1029t1489r1130b1544],
6	TYMS	NN	O	tym	nn	10	SENT_56	[p2l1156t1492r1340b1544],
7	promoter	NN	O	promoter	nn	10	SENT_56	[p2l1370t1497r1675b1557],
8	(	CD	NUMBER	(	num	10	SENT_56	[p2l1701t1489r1924b1557],
9	TSER	NN	O	tser	nn	10	SENT_56	[p2l1701t1489r1924b1557],
10	)	NN	O	)	prep_of	3	SENT_56	[p2l1701t1489r1924b1557],
11	,	,	O	,	_	0	SENT_56	[p2l1701t1489r1924b1557],
12	which	WDT	O	which	nsubj	13	SENT_56	[p2l1951t1489r2150b1544],
13	contains	VBZ	O	contain	rcmod	10	SENT_56	[p2l10t1578r279b1632],
14	triple	JJ	O	triple	advmod	13	SENT_56	[p2l310t1577r482b1646],
15	(	CD	NUMBER	(	num	17	SENT_56	[p2l511t1577r696b1645],
16	TSER	NN	O	tser	nn	17	SENT_56	[p2l511t1577r696b1645],
17	3R	NN	O	3r	dep	14	SENT_56	[p2l721t1577r828b1645],
18	)	CD	NUMBER	)	dobj	13	SENT_56	[p2l721t1577r828b1645],
19	or	CC	O	or	_	0	SENT_56	[p2l858t1593r923b1632],
20	double	JJ	O	double	amod	23	SENT_56	[p2l951t1577r1170b1632],
21	(	JJ	O	(	amod	23	SENT_56	[p2l1200t1577r1384b1645],
22	TSER	NN	O	tser	nn	23	SENT_56	[p2l1200t1577r1384b1645],
23	2R	NN	O	2r	dobj	13	SENT_56	[p2l1411t1577r1516b1645],
24	)	CD	NUMBER	)	num	25	SENT_56	[p2l1411t1577r1516b1645],
25	repeats	NNS	O	repeat	dep	3	SENT_56	[p2l1547t1585r1779b1646],
26	of	IN	O	of	_	0	SENT_56	[p2l1810t1577r1876b1632],
27	a	DT	O	a	det	31	SENT_56	[p2l1898t1593r1930b1632],
28	28	CD	NUMBER	28	number	29	SENT_56	[p2l1960t1577r2149b1646],
29	—	CD	NUMBER	—	num	31	SENT_56	[p2l1960t1577r2149b1646],
30	bp	NN	O	bp	nn	31	SENT_56	[p2l1960t1577r2149b1646],
31	sequence	NN	O	sequence	prep_of	25	SENT_56	[p2l11t1682r308b1735],
32	as	RB	O	as	_	0	SENT_56	[p2l329t1682r392b1721],
33	well	RB	O	well	_	0	SENT_56	[p2l414t1666r549b1721],
34	as	IN	O	as	_	0	SENT_56	[p2l572t1682r634b1721],
35	several	JJ	O	several	amod	37	SENT_56	[p2l658t1666r882b1721],
36	rare	JJ	O	rare	amod	37	SENT_56	[p2l905t1682r1031b1721],
37	alleles	NNS	O	allele	dep	3	SENT_56	[p2l1052t1666r1253b1721],
38	containing	VBG	O	contain	partmod	37	SENT_56	[p2l1276t1667r1618b1735],
39	4	CD	NUMBER	4	dobj	38	SENT_56	[p2l1637t1669r1691b1730],
40	,	,	O	,	_	0	SENT_56	[p2l1637t1669r1691b1730],
41	5	CD	NUMBER	5	conj_or	39	SENT_56	[p2l1714t1670r1747b1721],
42	or	CC	O	or	_	0	SENT_56	[p2l1772t1682r1838b1721],
43	9	CD	NUMBER	9	num	44	SENT_56	[p2l1857t1669r1892b1721],
44	repeats	NNS	O	repeat	conj_or	39	SENT_56	[p2l1915t1674r2148b1735],
45	[	CD	NUMBER	[	number	46	SENT_56	[p2l13t1755r114b1824],
46	6	CD	NUMBER	6	num	47	SENT_56	[p2l13t1755r114b1824],
47	]	NN	O	]	dep	44	SENT_56	[p2l13t1755r114b1824],
48	.	.	O	.	_	0	SENT_56	[p2l13t1755r114b1824],

1	In	FW	O	in	nn	2	SENT_57	[p2l139t1759r199b1810],
2	vitro	FW	O	vitro	dep	6	SENT_57	[p2l220t1757r372b1811],
3	and	CC	O	and	_	0	SENT_57	[p2l395t1756r512b1811],
4	in	FW	O	in	conj_and	2	SENT_57	[p2l537t1756r596b1810],
5	vivo	FW	O	vivo	pobj	4	SENT_57	[p2l617t1756r752b1811],
6	studies	NNS	O	study	nsubj	7	SENT_57	[p2l776t1756r1002b1811],
7	showed	VBD	O	show	_	0	SENT_57	[p2l1028t1756r1275b1811],
8	that	IN	O	that	complm	11	SENT_57	[p2l1299t1756r1428b1811],
9	TYMS	NN	O	tym	nn	10	SENT_57	[p2l1448t1758r1632b1811],
10	expression	NN	O	expression	nsubj	11	SENT_57	[p2l1656t1756r2002b1824],
11	was	VBD	O	be	ccomp	7	SENT_57	[p2l2024t1771r2148b1811],
12	TSER	NNP	O	TSER	nn	14	SENT_57	[p2l7t1847r168b1899],
13	genotype	NN	O	genotype	nn	14	SENT_57	[p2l184t1844r860b1913],
14	—	NN	O	—	nsubj	15	SENT_57	[p2l184t1844r860b1913],
15	dependent	JJ	O	dependent	xcomp	11	SENT_57	[p2l184t1844r860b1913],
16	and	CC	O	and	_	0	SENT_57	[p2l879t1844r996b1899],
17	that	IN	O	that	complm	21	SENT_57	[p2l1016t1844r1146b1899],
18	3R	NN	O	3r	nn	19	SENT_57	[p2l1163t1847r1247b1899],
19	allele	NN	O	allele	nsubjpass	21	SENT_57	[p2l1264t1844r1434b1899],
20	was	VBD	O	be	auxpass	21	SENT_57	[p2l1453t1860r1577b1899],
21	associated	VBN	O	associate	ccomp	7	SENT_57	[p2l1598t1844r1930b1899],
22	with	IN	O	with	_	0	SENT_57	[p2l1949t1844r2098b1899],
23	a	DT	O	a	det	27	SENT_57	[p2l2117t1860r2150b1899],
24	higher	JJR	O	higher	amod	27	SENT_57	[p2l10t1934r218b2002],
25	TYMS	NN	O	tym	nn	27	SENT_57	[p2l236t1937r420b1989],
26	expression	NN	O	expression	nn	27	SENT_57	[p2l444t1935r790b2002],
27	level	NN	O	level	prep_with	21	SENT_57	[p2l813t1934r961b1989],
28	[	CD	NUMBER	[	number	29	SENT_57	[p2l990t1934r1089b2002],
29	6	CD	NUMBER	6	num	30	SENT_57	[p2l990t1934r1089b2002],
30	]	NN	O	]	dep	21	SENT_57	[p2l990t1934r1089b2002],
31	.	.	O	.	_	0	SENT_57	[p2l990t1934r1089b2002],

1	The	DT	O	the	det	2	SENT_58	[p2l1111t1934r1228b1989],
2	role	NN	O	role	nsubjpass	17	SENT_58	[p2l1252t1934r1373b1989],
3	of	IN	O	of	_	0	SENT_58	[p2l1397t1934r1463b1989],
4	TSER	NN	O	tser	prep_of	2	SENT_58	[p2l1476t1937r1637b1989],
5	in	IN	O	in	_	0	SENT_58	[p2l1658t1935r1717b1988],
6	the	DT	O	the	det	7	SENT_58	[p2l1739t1934r1841b1989],
7	response	NN	O	response	prep_in	4	SENT_58	[p2l1864t1950r2149b2002],
8	to	TO	O	to	_	0	SENT_58	[p2l9t2031r71b2078],
9	ﬂuoropyrimidine	NN	O	ﬂuoropyrimidine	nn	10	SENT_58	[p2l104t2023r870b2091],
10	—	NN	O	—	prep_to	7	SENT_58	[p2l104t2023r870b2091],
11	based	VBN	O	base	partmod	10	SENT_58	[p2l104t2023r870b2091],
12	chemotherapy	NN	O	chemotherapy	dobj	11	SENT_58	[p2l903t2023r1371b2091],
13	has	VBZ	O	have	aux	15	SENT_58	[p2l1402t2023r1507b2078],
14	been	VBN	O	be	auxpass	15	SENT_58	[p2l1539t2023r1693b2078],
15	reported	VBN	O	report	_	0	SENT_58	[p2l1725t2023r2001b2091],
16	and	CC	O	and	_	0	SENT_58	[p2l2033t2023r2149b2078],
17	accepted	VBN	O	accept	conj_and	15	SENT_58	[p2l10t2111r293b2180],
18	[	NN	O	[	nn	20	SENT_58	[p2l322t2111r422b2180],
19	7	CD	NUMBER	7	num	20	SENT_58	[p2l322t2111r422b2180],
20	]	NN	O	]	dobj	15	SENT_58	[p2l322t2111r422b2180],
21	.	.	O	.	_	0	SENT_58	[p2l322t2111r422b2180],

1	TSER	NN	O	tser	nsubj	7	SENT_59	[p2l445t2114r606b2166],
2	was	VBD	O	be	auxpass	3	SENT_59	[p2l626t2127r750b2166],
3	included	VBN	O	include	rcmod	1	SENT_59	[p2l776t2111r1054b2166],
4	in	IN	O	in	_	0	SENT_59	[p2l1079t2112r1138b2166],
5	genotype	NN	O	genotype	nn	6	SENT_59	[p2l1161t2111r1710b2180],
6	—	NN	O	—	prep_in	3	SENT_59	[p2l1161t2111r1710b2180],
7	guided	VBD	O	guide	_	0	SENT_59	[p2l1161t2111r1710b2180],
8	clinical	JJ	O	clinical	amod	9	SENT_59	[p2l1736t2111r1963b2166],
9	trials	NNS	O	trial	nsubjpass	21	SENT_59	[p2l1987t2111r2148b2166],
10	for	IN	O	for	_	0	SENT_59	[p2l10t2200r99b2255],
11	patients	NNS	O	patient	prep_for	9	SENT_59	[p2l121t2201r379b2269],
12	with	IN	O	with	_	0	SENT_59	[p2l402t2200r551b2255],
13	rectal	JJ	O	rectal	amod	15	SENT_59	[p2l575t2200r752b2255],
14	cancer	NN	O	cancer	nn	15	SENT_59	[p2l777t2216r987b2255],
15	[	NN	O	[	prep_with	11	SENT_59	[p2l1011t2200r1092b2269],
16	8	CD	NUMBER	8	num	17	SENT_59	[p2l1011t2200r1092b2269],
17	]	NN	O	]	dep	11	SENT_59	[p2l1011t2200r1092b2269],
18	but	CC	O	but	_	0	SENT_59	[p2l1120t2200r1227b2255],
19	less	JJR	O	less	dep	11	SENT_59	[p2l1250t2200r1365b2255],
20	is	VBZ	O	be	auxpass	21	SENT_59	[p2l1390t2201r1437b2255],
21	known	VBN	O	know	ccomp	7	SENT_59	[p2l1462t2200r1682b2255],
22	related	JJ	O	related	acomp	21	SENT_59	[p2l1706t2200r1929b2255],
23	to	TO	O	to	_	0	SENT_59	[p2l1952t2208r2014b2255],
24	PST	NNP	O	PST	prep_to	22	SENT_59	[p2l2038t2203r2151b2255],
25	in	IN	O	in	_	0	SENT_59	[p2l10t2290r70b2344],
26	BC	NNP	O	BC	prep_in	21	SENT_59	[p2l111t2292r207b2345],
27	.	.	O	.	_	0	SENT_59	[p2l111t2292r207b2345],

1	Methylene	NNP	O	Methylene	dep	3	SENT_60	[p2l250t2289r1155b2358],
2	—	CD	NUMBER	—	num	1	SENT_60	[p2l250t2289r1155b2358],
3	tetrahydrofolate	JJ	O	tetrahydrofolate	amod	7	SENT_60	[p2l250t2289r1155b2358],
4	reductase	NN	O	reductase	nn	7	SENT_60	[p2l1197t2290r1507b2345],
5	(	CD	NUMBER	(	num	7	SENT_60	[p2l1548t2290r1835b2358],
6	MTHFR	NN	O	mthfr	nn	7	SENT_60	[p2l1548t2290r1835b2358],
7	)	NN	O	)	nsubj	11	SENT_60	[p2l1548t2290r1835b2358],
8	is	VBZ	O	be	cop	11	SENT_60	[p2l1877t2291r1924b2345],
9	a	DT	O	a	det	11	SENT_60	[p2l1966t2305r1998b2345],
10	key	JJ	O	key	amod	11	SENT_60	[p2l2039t2290r2150b2358],
11	enzyme	NN	O	enzyme	_	0	SENT_60	[p2l10t2394r261b2447],
12	that	WDT	O	that	nsubj	13	SENT_60	[p2l286t2378r416b2433],
13	forms	VBZ	O	form	rcmod	11	SENT_60	[p2l440t2378r623b2433],
14	the	DT	O	the	det	17	SENT_60	[p2l649t2378r751b2433],
15	reduced	VBN	O	reduce	amod	17	SENT_60	[p2l777t2378r1034b2433],
16	folate	NN	O	folate	nn	17	SENT_60	[p2l1060t2378r1240b2433],
17	cofactor	NN	O	cofactor	nsubj	18	SENT_60	[p2l1265t2378r1526b2433],
18	essential	JJ	O	essential	xcomp	13	SENT_60	[p2l1549t2378r1829b2433],
19	for	IN	O	for	_	0	SENT_60	[p2l1856t2378r1945b2433],
20	TYMS	NN	O	tym	nn	21	SENT_60	[p2l1965t2381r2149b2433],
21	inhibition	NN	O	inhibition	prep_for	18	SENT_60	[p2l10t2468r327b2523],
22	by	IN	O	by	_	0	SENT_60	[p2l355t2468r433b2536],
23	5	CD	NUMBER	5	prep_by	21	SENT_60	[p2l462t2471r629b2523],
24	.	.	O	.	_	0	SENT_60	[p2l462t2471r629b2523],

1	—	NN	O	—	_	0	SENT_61	[p2l462t2471r629b2523],
2	.	.	O	.	_	0	SENT_61	[p2l462t2471r629b2523],

1	FU	NNP	O	FU	_	0	SENT_62	[p2l462t2471r629b2523],
2	.	.	O	.	_	0	SENT_62	[p2l462t2471r629b2523],

1	Two	CD	NUMBER	two	nsubjpass	13	SENT_63	[p2l657t2471r794b2523],
2	linked	VBN	O	link	partmod	1	SENT_63	[p2l825t2468r1023b2523],
3	no	DT	O	no	det	5	SENT_63	[p2l1053t2484r1130b2523],
4	synonymous	JJ	O	synonymous	amod	5	SENT_63	[p2l1161t2484r1569b2536],
5	SNPs	NNS	O	snp	dobj	2	SENT_63	[p2l1600t2471r1771b2531],
6	,	,	O	,	_	0	SENT_63	[p2l1600t2471r1771b2531],
7	C677T	NN	O	c677t	conj_and	5	SENT_63	[p2l1801t2471r2005b2523],
8	and	CC	O	and	_	0	SENT_63	[p2l2033t2468r2149b2523],
9	A1298C	NN	O	a1298c	conj_and	5	SENT_63	[p2l7t2559r275b2620],
10	,	,	O	,	_	0	SENT_63	[p2l7t2559r275b2620],
11	have	VBP	O	have	aux	13	SENT_63	[p2l298t2557r447b2612],
12	been	VBN	O	be	auxpass	13	SENT_63	[p2l468t2557r622b2612],
13	shown	VBN	O	show	_	0	SENT_63	[p2l644t2557r856b2612],
14	to	TO	O	to	aux	15	SENT_63	[p2l877t2565r938b2612],
15	alter	VB	O	alter	xcomp	13	SENT_63	[p2l960t2557r1108b2612],
16	enzyme	NN	O	enzyme	nn	17	SENT_63	[p2l1127t2573r1379b2625],
17	activity	NN	O	activity	dobj	15	SENT_63	[p2l1400t2558r1641b2625],
18	and	CC	O	and	cc	17	SENT_63	[p2l1661t2557r1777b2612],
19	possibly	RB	O	possibly	advmod	17	SENT_63	[p2l1800t2557r2064b2625],
20	5FU	NN	O	5fu	nn	21	SENT_63	[p2l2085t2560r2149b2612, p2l10t2649r92b2700],
21	sensitivity	NN	O	sensitivity	dep	17	SENT_63	[p2l146t2646r480b2714],
22	[	CD	NUMBER	[	number	23	SENT_63	[p2l534t2645r733b2714],
23	9,10	CD	NUMBER	9,10	num	24	SENT_63	[p2l534t2645r733b2714],
24	]	NN	O	]	dep	21	SENT_63	[p2l534t2645r733b2714],
25	.	.	O	.	_	0	SENT_63	[p2l534t2645r733b2714],

1	MTHFR	NN	O	mthfr	nn	2	SENT_64	[p2l788t2649r1024b2700],
2	C677T	NN	O	c677t	nsubjpass	5	SENT_64	[p2l1074t2648r1278b2700],
3	has	VBZ	O	have	aux	5	SENT_64	[p2l1329t2645r1434b2700],
4	been	VBN	O	be	auxpass	5	SENT_64	[p2l1488t2645r1642b2700],
5	implicated	VBN	O	implicate	_	0	SENT_64	[p2l1695t2645r2036b2714],
6	in	IN	O	in	_	0	SENT_64	[p2l2090t2646r2149b2700],
7	different	JJ	O	different	amod	9	SENT_64	[p2l10t2734r288b2789],
8	adverse	JJ	O	adverse	amod	9	SENT_64	[p2l315t2734r562b2789],
9	reactions	NNS	O	reaction	prep_in	5	SENT_64	[p2l591t2735r883b2789],
10	[	VBP	O	[	dep	9	SENT_64	[p2l915t2734r1057b2803],
11	11	CD	NUMBER	11	num	12	SENT_64	[p2l915t2734r1057b2803],
12	]	CD	NUMBER	]	dobj	10	SENT_64	[p2l915t2734r1057b2803],
13	.	.	O	.	_	0	SENT_64	[p2l915t2734r1057b2803],

1	Severe	JJ	O	severe	amod	2	SENT_65	[p2l1087t2737r1296b2789],
2	toxicity	NN	O	toxicity	nsubjpass	7	SENT_65	[p2l1324t2735r1569b2802],
3	to	TO	O	to	_	0	SENT_65	[p2l1594t2742r1656b2789],
4	MTX	NNP	O	MTX	prep_to	2	SENT_65	[p2l1685t2737r1836b2788],
5	has	VBZ	O	have	aux	7	SENT_65	[p2l1863t2734r1967b2789],
6	been	VBN	O	be	auxpass	7	SENT_65	[p2l1996t2734r2150b2789],
7	reported	VBN	O	report	_	0	SENT_65	[p2l10t2823r286b2892],
8	with	IN	O	with	_	0	SENT_65	[p2l337t2823r486b2878],
9	the	DT	O	the	det	10	SENT_65	[p2l536t2823r638b2878],
10	implication	NN	O	implication	prep_with	7	SENT_65	[p2l690t2823r1058b2892],
11	of	IN	O	of	_	0	SENT_65	[p2l1110t2823r1176b2878],
12	those	DT	O	those	det	13	SENT_65	[p2l1220t2823r1393b2878],
13	polymorphisms	NNS	O	polymorphism	prep_of	10	SENT_65	[p2l1446t2823r1950b2892],
14	[	VBP	O	[	dep	13	SENT_65	[p2l2007t2823r2148b2892],
15	12	CD	NUMBER	12	num	16	SENT_65	[p2l2007t2823r2148b2892],
16	]	CD	NUMBER	]	dobj	14	SENT_65	[p2l2007t2823r2148b2892],
17	.	.	O	.	_	0	SENT_65	[p2l2007t2823r2148b2892],

1	MTHFR	NN	O	mthfr	nn	3	SENT_66	[p2l10t2916r247b2967],
2	gene	NN	O	gene	nn	3	SENT_66	[p2l267t2928r418b2981],
3	variants	NNS	O	variant	nsubj	4	SENT_66	[p2l441t2913r700b2967],
4	seem	VBP	O	seem	_	0	SENT_66	[p2l726t2928r892b2967],
5	to	TO	O	to	aux	6	SENT_66	[p2l916t2921r978b2967],
6	play	VB	O	play	xcomp	4	SENT_66	[p2l1003t2913r1138b2981],
7	a	DT	O	a	det	9	SENT_66	[p2l1162t2928r1194b2967],
8	critical	JJ	O	critical	amod	9	SENT_66	[p2l1218t2912r1437b2967],
9	role	NN	O	role	dobj	6	SENT_66	[p2l1462t2912r1584b2967],
10	in	IN	O	in	_	0	SENT_66	[p2l1609t2913r1668b2967],
11	non	JJ	O	non	prep_in	6	SENT_66	[p2l1693t2910r2148b2981],
12	.	.	O	.	_	0	SENT_66	[p2l1693t2910r2148b2981],

1	—	NN	O	—	_	0	SENT_67	[p2l1693t2910r2148b2981],
2	.	.	O	.	_	0	SENT_67	[p2l1693t2910r2148b2981],

1	Hodgkir	NNP	PERSON	Hodgkir	_	0	SENT_68	[p2l1693t2910r2148b2981],
2	’	CD	NUMBER	’	num	5	SENT_68	[p2l1693t2910r2148b2981],
3	1s	NNS	O	1	nn	5	SENT_68	[p2l1693t2910r2148b2981],
4	lymphoma	NN	O	lymphoma	nn	5	SENT_68	[p2l10t3002r358b3070],
5	outcome	NN	O	outcome	dep	1	SENT_68	[p2l376t3010r672b3065],
6	,	,	O	,	_	0	SENT_68	[p2l376t3010r672b3065],
7	possibly	RB	O	possibly	amod	24	SENT_68	[p2l691t3002r955b3070],
8	by	IN	O	by	_	0	SENT_68	[p2l971t3002r1049b3070],
9	interfering	VBG	O	interfere	prepc_by	7	SENT_68	[p2l1066t3002r1410b3070],
10	with	IN	O	with	_	0	SENT_68	[p2l1424t3002r1573b3057],
11	the	DT	O	the	det	12	SENT_68	[p2l1590t3002r1692b3057],
12	action	NN	O	action	prep_with	9	SENT_68	[p2l1710t3003r1906b3057],
13	of	IN	O	of	_	0	SENT_68	[p2l1924t3002r1990b3057],
14	MTX	NN	O	mtx	prep_of	12	SENT_68	[p2l2001t3005r2151b3056],
15	with	IN	O	with	_	0	SENT_68	[p2l8t3091r157b3146],
16	signiﬁcant	JJ	O	signiﬁcant	amod	17	SENT_68	[p2l182t3091r517b3159],
17	effects	NNS	O	effect	prep_with	14	SENT_68	[p2l541t3091r747b3146],
18	on	IN	O	on	_	0	SENT_68	[p2l773t3107r852b3146],
19	toxicity	NN	O	toxicity	prep_on	17	SENT_68	[p2l876t3092r1120b3159],
20	and	CC	O	and	_	0	SENT_68	[p2l1143t3091r1260b3146],
21	survival	NN	O	survival	prep_on	17	SENT_68	[p2l1286t3091r1539b3146],
22	[	CD	NUMBER	[	num	23	SENT_68	[p2l1568t3091r1709b3159],
23	13	CD	NUMBER	13	dobj	9	SENT_68	[p2l1568t3091r1709b3159],
24	]	NN	O	]	appos	1	SENT_68	[p2l1568t3091r1709b3159],
25	.	.	O	.	_	0	SENT_68	[p2l1568t3091r1709b3159],

1	Mutations	NNS	O	mutation	nsubj	11	SENT_69	[p2l1736t3092r2064b3146],
2	in	IN	O	in	_	0	SENT_69	[p2l2090t3092r2150b3145],
3	the	DT	O	the	det	5	SENT_69	[p2l9t3179r111b3234],
4	p53	NN	O	p53	nn	5	SENT_69	[p2l138t3182r254b3248],
5	gene	NN	O	gene	prep_in	1	SENT_69	[p2l283t3195r434b3248],
6	are	VBP	O	be	cop	11	SENT_69	[p2l461t3195r559b3234],
7	the	DT	O	the	det	11	SENT_69	[p2l585t3179r687b3234],
8	most	RBS	O	most	advmod	9	SENT_69	[p2l714t3187r873b3234],
9	common	JJ	O	common	amod	11	SENT_69	[p2l899t3195r1182b3234],
10	genetic	JJ	O	genetic	amod	11	SENT_69	[p2l1207t3180r1441b3248],
11	alterations	NNS	O	alteration	_	0	SENT_69	[p2l1466t3179r1810b3234],
12	in	IN	O	in	_	0	SENT_69	[p2l1838t3180r1897b3234],
13	human	JJ	O	human	prep_in	11	SENT_69	[p2l1924t3179r2150b3234],

1	L.A.	NNP	LOCATION	L.A.	nn	2	SENT_70	[p2l312t3325r352b3346],
2	Henr1	NN	O	henr1	_	0	SENT_70	[p2l364t3323r630b3351],
3	’	CD	NUMBER	’	num	4	SENT_70	[p2l364t3323r630b3351],
4	quez	NN	O	quez	dep	2	SENT_70	[p2l364t3323r630b3351],
5	.	.	O	.	_	0	SENT_70	[p2l364t3323r630b3351],

1	—	NN	O	—	_	0	SENT_71	[p2l364t3323r630b3351],
2	.	.	O	.	_	0	SENT_71	[p2l364t3323r630b3351],

1	Hemcindez	NNP	O	Hemcindez	_	0	SENT_72	[p2l364t3323r630b3351],
2	et	FW	O	et	nn	3	SENT_72	[p2l640t3327r663b3346],
3	al.	FW	O	al.	dep	1	SENT_72	[p2l672t3324r801b3351],
4	/	:	O	/	punct	1	SENT_72	[p2l672t3324r801b3351],
5	Cancer	NNP	O	Cancer	nn	6	SENT_72	[p2l672t3324r801b3351],
6	Epidemiology	NNP	O	Epidemiology	dep	1	SENT_72	[p2l810t3324r973b3351],
7	34	CD	NUMBER	34	number	8	SENT_72	[p2l982t3325r1012b3346],
8	(	CD	NUMBER	(	num	9	SENT_72	[p2l1023t3324r1103b3351],
9	2010	CD	DATE	2010	dep	6	SENT_72	[p2l1023t3324r1103b3351],
10	)	CD	NUMBER	)	number	11	SENT_72	[p2l1023t3324r1103b3351],
11	634-638 635	CD	NUMBER	634-638 635	num	9	SENT_72	[p2l1804t3325r1848b3346],[p2l1114t3325r1220b3346],

1	cancer	NN	O	cancer	_	0	SENT_73	[p3l10t77r220b116],
2	[	CD	NUMBER	[	num	1	SENT_73	[p3l280t61r421b129],
3	14	CD	NUMBER	14	num	4	SENT_73	[p3l280t61r421b129],
4	]	NN	O	]	dep	1	SENT_73	[p3l280t61r421b129],
5	.	.	O	.	_	0	SENT_73	[p3l280t61r421b129],

1	Some	DT	O	some	det	2	SENT_74	[p3l482t64r656b116],
2	polymorphisms	NNS	O	polymorphism	nsubjpass	8	SENT_74	[p3l715t61r1220b129],
3	in	IN	O	in	_	0	SENT_74	[p3l1280t62r1339b115],
4	p53	NN	O	p53	nn	5	SENT_74	[p3l1398t64r1514b129],
5	gene	NN	O	gene	prep_in	2	SENT_74	[p3l1575t77r1726b129],
6	have	VBP	O	have	aux	8	SENT_74	[p3l1785t61r1934b116],
7	been	VBN	O	be	auxpass	8	SENT_74	[p3l1993t61r2147b116],
8	suggested	VBN	O	suggest	_	0	SENT_74	[p3l11t149r329b218],
9	to	TO	O	to	aux	10	SENT_74	[p3l364t157r426b204],
10	play	VB	O	play	xcomp	8	SENT_74	[p3l462t149r597b218],
11	a	DT	O	a	det	12	SENT_74	[p3l631t165r663b204],
12	role	NN	O	role	dobj	10	SENT_74	[p3l699t149r820b204],
13	in	IN	O	in	_	0	SENT_74	[p3l856t150r915b204],
14	BC	NNP	O	BC	prep_in	12	SENT_74	[p3l951t152r1032b204],
15	[	CD	NUMBER	[	num	14	SENT_74	[p3l1070t149r1211b218],
16	15	CD	NUMBER	15	num	17	SENT_74	[p3l1070t149r1211b218],
17	]	NN	O	]	dep	12	SENT_74	[p3l1070t149r1211b218],
18	,	,	O	,	_	0	SENT_74	[p3l1070t149r1211b218],
19	and	CC	O	and	_	0	SENT_74	[p3l1246t149r1363b204],
20	as	IN	O	as	mark	23	SENT_74	[p3l1399t165r1461b204],
21	such	JJ	O	such	nsubj	23	SENT_74	[p3l1499t149r1644b204],
22	may	MD	O	may	aux	23	SENT_74	[p3l1680t165r1817b218],
23	inﬂuence	VB	O	inﬂuence	dep	12	SENT_74	[p3l1851t149r2146b204],
24	the	DT	O	the	det	25	SENT_74	[p3l9t238r111b293],
25	response	NN	O	response	dobj	23	SENT_74	[p3l141t254r425b307],
26	to	TO	O	to	_	0	SENT_74	[p3l454t246r516b293],
27	chemotherapy	NN	O	chemotherapy	prep_to	23	SENT_74	[p3l545t238r1027b307],
28	.	.	O	.	_	0	SENT_74	[p3l545t238r1027b307],

1	Codon	NNP	ORGANIZATION	Codon	nsubj	6	SENT_75	[p3l1058t238r1260b293],
2	72	CD	NUMBER	72	num	1	SENT_75	[p3l1290t241r1364b292],
3	is	VBZ	O	be	cop	6	SENT_75	[p3l1397t239r1443b293],
4	a	DT	O	a	det	6	SENT_75	[p3l1474t254r1506b293],
5	common	JJ	O	common	amod	6	SENT_75	[p3l1535t254r1818b293],
6	polymorphism	NN	O	polymorphism	dep	10	SENT_75	[p3l1847t238r2146b307, p3l10t327r208b396],
7	in	IN	O	in	_	0	SENT_75	[p3l237t328r296b382],
8	p53	NN	O	p53	nn	9	SENT_75	[p3l325t330r440b396],
9	gene	NN	O	gene	prep_in	6	SENT_75	[p3l471t343r622b396],
10	encodes	VBZ	O	encode	_	0	SENT_75	[p3l651t327r908b382],
11	either	CC	O	either	prep	10	SENT_75	[p3l938t327r1128b382],
12	an	DT	O	a	det	13	SENT_75	[p3l1154t343r1229b382],
13	arginine	NN	O	arginine	dep	11	SENT_75	[p3l1257t328r1521b396],
14	or	CC	O	or	_	0	SENT_75	[p3l1549t343r1615b382],
15	a	DT	O	a	det	16	SENT_75	[p3l1641t343r1673b382],
16	proline	NN	O	proline	dep	11	SENT_75	[p3l1703t327r1930b396],
17	at	IN	O	at	_	0	SENT_75	[p3l1957t336r2018b382],
18	the	DT	O	the	det	20	SENT_75	[p3l2044t327r2146b382],
19	codon	NN	O	codon	nn	20	SENT_75	[p3l10t416r204b471],
20	position	NN	O	position	prep_at	16	SENT_75	[p3l241t417r501b485],
21	72	CD	NUMBER	72	dobj	10	SENT_75	[p3l541t419r614b471],
22	in	IN	O	in	_	0	SENT_75	[p3l655t417r714b471],
23	the	DT	O	the	det	26	SENT_75	[p3l752t416r854b471],
24	proline	NN	O	proline	nn	26	SENT_75	[p3l892t416r1119b485],
25	rich	JJ	O	rich	amod	26	SENT_75	[p3l1158t416r1280b471],
26	domain	NN	O	domain	prep_in	21	SENT_75	[p3l1318t416r1576b480],
27	,	,	O	,	_	0	SENT_75	[p3l1318t416r1576b480],
28	which	WDT	O	which	nsubjpass	31	SENT_75	[p3l1613t416r1811b471],
29	has	VBZ	O	have	aux	31	SENT_75	[p3l1850t416r1954b471],
30	been	VBN	O	be	auxpass	31	SENT_75	[p3l1993t416r2147b471],
31	shown	VBN	O	show	rcmod	26	SENT_75	[p3l11t506r223b561],
32	to	TO	O	to	aux	36	SENT_75	[p3l245t514r307b561],
33	be	VB	O	be	cop	36	SENT_75	[p3l330t506r403b561],
34	an	DT	O	a	det	36	SENT_75	[p3l427t522r502b561],
35	important	JJ	O	important	amod	36	SENT_75	[p3l527t507r852b574],
36	component	NN	O	component	xcomp	31	SENT_75	[p3l874t514r1240b574],
37	in	IN	O	in	_	0	SENT_75	[p3l1262t507r1321b560],
38	the	DT	O	the	det	40	SENT_75	[p3l1344t506r1445b561],
39	apoptotic	JJ	O	apoptotic	amod	40	SENT_75	[p3l1469t507r1773b574],
40	function	NN	O	function	prep_in	36	SENT_75	[p3l1796t506r2064b561],
41	of	IN	O	of	_	0	SENT_75	[p3l2088t506r2154b561],
42	p53	NN	O	p53	prep_of	40	SENT_75	[p3l10t598r126b663],
43	[	CD	NUMBER	[	num	42	SENT_75	[p3l153t595r294b663],
44	16	CD	NUMBER	16	num	45	SENT_75	[p3l153t595r294b663],
45	]	NN	O	]	nsubj	10	SENT_75	[p3l153t595r294b663],
46	.	.	O	.	_	0	SENT_75	[p3l153t595r294b663],

1	Few	JJ	O	few	amod	2	SENT_76	[p3l316t598r446b650],
2	studies	NNS	O	study	nsubj	4	SENT_76	[p3l465t595r690b650],
3	have	VBP	O	have	aux	4	SENT_76	[p3l712t595r862b650],
4	investigated	VBN	O	investigate	_	0	SENT_76	[p3l882t595r1275b663],
5	the	DT	O	the	det	7	SENT_76	[p3l1295t595r1397b650],
6	predictive	JJ	O	predictive	amod	7	SENT_76	[p3l1417t595r1739b663],
7	value	NN	O	value	dobj	4	SENT_76	[p3l1757t595r1930b650],
8	of	IN	O	of	_	0	SENT_76	[p3l1950t595r2016b650],
9	this	DT	O	this	det	10	SENT_76	[p3l2028t595r2145b650],
10	polymorphism	NN	O	polymorphism	prep_of	7	SENT_76	[p3l10t683r484b752],
11	for	IN	O	for	_	0	SENT_76	[p3l535t683r624b738],
12	response	NN	O	response	prep_for	10	SENT_76	[p3l672t699r957b752],
13	to	TO	O	to	_	0	SENT_76	[p3l1007t691r1068b738],
14	neoadjuvant	JJ	O	neoadjuvant	amod	15	SENT_76	[p3l1119t683r1522b752],
15	chemotherapy	NN	O	chemotherapy	prep_to	4	SENT_76	[p3l1571t683r2038b752],
16	in	IN	O	in	_	0	SENT_76	[p3l2087t684r2146b738],
17	cancer	NN	O	cancer	nn	18	SENT_76	[p3l10t788r220b827],
18	patients	NNS	O	patient	prep_in	4	SENT_76	[p3l239t773r514b841],
19	.	.	O	.	_	0	SENT_76	[p3l239t773r514b841],

1	In	IN	O	in	_	0	SENT_77	[p3l536t775r596b826],
2	that	DT	O	that	det	3	SENT_77	[p3l617t772r746b827],
3	way	NN	O	way	prep_in	9	SENT_77	[p3l764t788r912b841],
4	,	,	O	,	_	0	SENT_77	[p3l764t788r912b841],
5	the	DT	O	the	det	7	SENT_77	[p3l934t772r1036b827],
6	Pro/Pro	NNP	O	Pro/Pro	nn	7	SENT_77	[p3l1057t772r1293b841],
7	variant	NN	O	variant	nsubj	9	SENT_77	[p3l1312t773r1541b827],
8	has	VBZ	O	have	aux	9	SENT_77	[p3l1562t772r1666b827],
9	seen	VBN	O	see	_	0	SENT_77	[p3l1689t788r1832b827],
10	to	TO	O	to	aux	13	SENT_77	[p3l1852t780r1914b827],
11	be	VB	O	be	cop	13	SENT_77	[p3l1934t772r2008b827],
12	less	RBR	O	less	advmod	13	SENT_77	[p3l2030t772r2145b827],
13	sensitive	JJ	O	sensitive	xcomp	9	SENT_77	[p3l11t862r292b916],
14	to	TO	O	to	_	0	SENT_77	[p3l316t870r378b916],
15	cyclophosphamide-based	JJ	O	cyclophosphamide-based	amod	16	SENT_77	[p3l404t861r1225b930],
16	PST	NNP	O	PST	prep_to	13	SENT_77	[p3l1251t864r1364b916],
17	in	IN	O	in	_	0	SENT_77	[p3l1387t862r1446b916],
18	BC	NNP	O	BC	nn	19	SENT_77	[p3l1472t864r1552b916],
19	patients	NNS	O	patient	prep_in	13	SENT_77	[p3l1577t862r1835b930],
20	[	CD	NUMBER	[	number	21	SENT_77	[p3l1864t861r2005b930],
21	17	CD	NUMBER	17	num	22	SENT_77	[p3l1864t861r2005b930],
22	]	NN	O	]	dep	13	SENT_77	[p3l1864t861r2005b930],
23	.	.	O	.	_	0	SENT_77	[p3l1864t861r2005b930],

1	The	DT	O	the	det	4	SENT_78	[p3l2029t861r2146b916],
2	multidrug	JJ	O	multidrug	amod	4	SENT_78	[p3l10t950r336b1019],
3	resistance	NN	O	resistance	nn	4	SENT_78	[p3l358t951r679b1005],
4	gene	NN	O	gene	_	0	SENT_78	[p3l702t966r852b1019],
5	1	CD	NUMBER	1	number	6	SENT_78	[p3l879t953r904b1005],
6	(	CD	NUMBER	(	num	10	SENT_78	[p3l936t951r1185b1019],
7	MDR1	NN	O	mdr1	nn	10	SENT_78	[p3l936t951r1185b1019],
8	)	NN	O	)	nn	10	SENT_78	[p3l936t951r1185b1019],
9	product	NN	O	product	nn	10	SENT_78	[p3l1209t950r1460b1019],
10	P	NN	O	p	dep	4	SENT_78	[p3l1483t950r1956b1019],
11	—	CD	NUMBER	—	num	12	SENT_78	[p3l1483t950r1956b1019],
12	glycoprotein	NN	O	glycoprotein	dep	4	SENT_78	[p3l1483t950r1956b1019],
13	(	CD	NUMBER	(	num	15	SENT_78	[p3l1979t950r2146b1019],
14	Pgp	NNP	O	Pgp	nn	15	SENT_78	[p3l1979t950r2146b1019],
15	)	NN	O	)	nsubj	16	SENT_78	[p3l1979t950r2146b1019],
16	represents	VBZ	O	represent	rcmod	4	SENT_78	[p3l10t1048r346b1108],
17	the	DT	O	the	det	22	SENT_78	[p3l367t1040r469b1095],
18	most	RBS	O	most	advmod	20	SENT_78	[p3l491t1048r650b1095],
19	widely	RB	O	widely	advmod	20	SENT_78	[p3l668t1040r887b1108],
20	studied	VBN	O	study	amod	22	SENT_78	[p3l906t1040r1143b1095],
21	membrane	NN	O	membrane	nn	22	SENT_78	[p3l1165t1040r1514b1095],
22	protein	NN	O	protein	dobj	16	SENT_78	[p3l1535t1041r1767b1108],
23	of	IN	O	of	_	0	SENT_78	[p3l1788t1040r1854b1095],
24	the	DT	O	the	det	29	SENT_78	[p3l1866t1040r1969b1095],
25	large	JJ	O	large	amod	29	SENT_78	[p3l1990t1040r2146b1108],
26	mammalian	JJ	O	mammalian	amod	29	SENT_78	[p3l10t1129r398b1184],
27	ABC	NNP	ORGANIZATION	ABC	nn	29	SENT_78	[p3l421t1131r552b1184],
28	transporter	NN	O	transporter	nn	29	SENT_78	[p3l578t1137r944b1197],
29	family	NN	O	family	prep_of	22	SENT_78	[p3l969t1129r1173b1197],
30	[	CD	NUMBER	[	number	31	SENT_78	[p3l1201t1129r1342b1197],
31	18	CD	NUMBER	18	num	32	SENT_78	[p3l1201t1129r1342b1197],
32	]	NN	O	]	dep	29	SENT_78	[p3l1201t1129r1342b1197],
33	.	.	O	.	_	0	SENT_78	[p3l1201t1129r1342b1197],

1	MDR1	NN	O	mdr1	nn	2	SENT_79	[p3l1371t1132r1559b1183],
2	gene	NN	O	gene	nsubj	4	SENT_79	[p3l1593t1145r1744b1197],
3	is	VBZ	O	be	cop	4	SENT_79	[p3l1772t1130r1818b1184],
4	polymorphic	JJ	O	polymorphic	_	0	SENT_79	[p3l1847t1129r2146b1197, p3l10t1217r145b1286],
5	and	CC	O	and	_	0	SENT_79	[p3l186t1217r302b1272],
6	more	RBR	O	more	advmod	7	SENT_79	[p3l344t1233r509b1272],
7	than	IN	O	than	quantmod	8	SENT_79	[p3l549t1217r694b1272],
8	40	CD	NUMBER	40	num	9	SENT_79	[p3l733t1220r811b1272],
9	SNPs	NNS	O	snp	nsubjpass	12	SENT_79	[p3l853t1220r1007b1272],
10	have	VBP	O	have	aux	12	SENT_79	[p3l1049t1217r1198b1272],
11	been	VBN	O	be	auxpass	12	SENT_79	[p3l1239t1217r1393b1272],
12	identiﬁed	VBN	O	identiﬁed	conj_and	4	SENT_79	[p3l1433t1217r1741b1272],
13	so	RB	O	so	advmod	14	SENT_79	[p3l1783t1233r1848b1272],
14	far	RB	O	far	advmod	12	SENT_79	[p3l1890t1217r1989b1273],
15	.	.	O	.	_	0	SENT_79	[p3l1890t1217r1989b1273],

1	The	DT	O	the	det	3	SENT_80	[p3l2029t1217r2146b1272],
2	C3435T	NN	O	c3435t	nn	3	SENT_80	[p3l10t1309r254b1361],
3	polymorphism	NN	O	polymorphism	nsubj	11	SENT_80	[p3l284t1306r758b1375],
4	in	IN	O	in	_	0	SENT_80	[p3l790t1307r849b1360],
5	exon	NN	O	exon	prep_in	3	SENT_80	[p3l880t1322r1034b1361],
6	26	CD	NUMBER	26	num	5	SENT_80	[p3l1065t1309r1142b1361],
7	of	IN	O	of	_	0	SENT_80	[p3l1174t1306r1240b1361],
8	the	DT	O	the	det	10	SENT_80	[p3l1263t1306r1364b1361],
9	MDR1	NN	O	mdr1	nn	10	SENT_80	[p3l1397t1309r1584b1360],
10	gene	NN	O	gene	prep_of	5	SENT_80	[p3l1624t1322r1774b1375],
11	affects	VBZ	O	affect	_	0	SENT_80	[p3l1806t1306r2013b1361],
12	the	DT	O	the	det	13	SENT_80	[p3l2044t1306r2146b1361],
13	expression	NN	O	expression	nsubj	22	SENT_80	[p3l10t1396r356b1464],
14	and	CC	O	and	_	0	SENT_80	[p3l379t1395r496b1450],
15	function	NN	O	function	conj_and	13	SENT_80	[p3l521t1395r789b1450],
16	of	IN	O	of	_	0	SENT_80	[p3l813t1395r879b1450],
17	the	DT	O	the	det	18	SENT_80	[p3l895t1395r997b1450],
18	Pgp	NNP	O	Pgp	prep_of	13	SENT_80	[p3l1022t1399r1137b1464],
19	in	IN	O	in	_	0	SENT_80	[p3l1161t1396r1221b1450],
20	many	JJ	O	many	amod	21	SENT_80	[p3l1245t1411r1425b1464],
21	ways	NNS	O	way	prep_in	18	SENT_80	[p3l1447t1411r1610b1464],
22	[	VBP	O	[	ccomp	11	SENT_80	[p3l1639t1395r1878b1464],
23	19,20	CD	NUMBER	19,20	number	24	SENT_80	[p3l1639t1395r1878b1464],
24	]	CD	NUMBER	]	dobj	22	SENT_80	[p3l1639t1395r1878b1464],
25	.	.	O	.	_	0	SENT_80	[p3l1639t1395r1878b1464],

1	C3435T	NN	O	c3435t	nn	2	SENT_81	[p3l1904t1398r2148b1450],
2	polymorphism	NN	O	polymorphism	nsubj	8	SENT_81	[p3l10t1484r484b1553],
3	in	IN	O	in	_	0	SENT_81	[p3l504t1485r563b1539],
4	the	DT	O	the	det	6	SENT_81	[p3l581t1484r683b1539],
5	MDR1	NN	O	mdr1	nn	6	SENT_81	[p3l703t1487r890b1539],
6	gene	NN	O	gene	prep_in	2	SENT_81	[p3l917t1500r1067b1553],
7	may	MD	O	may	aux	8	SENT_81	[p3l1088t1500r1225b1553],
8	limit	VB	O	limit	_	0	SENT_81	[p3l1243t1484r1395b1539],
9	the	DT	O	the	det	12	SENT_81	[p3l1412t1484r1514b1539],
10	local	JJ	O	local	amod	12	SENT_81	[p3l1534t1484r1681b1539],
11	detoxiﬁcation	NN	O	detoxiﬁcation	nn	12	SENT_81	[p3l1701t1484r2147b1539],
12	activity	NN	O	activity	dobj	8	SENT_81	[p3l10t1575r250b1642],
13	in	IN	O	in	_	0	SENT_81	[p3l269t1575r328b1628],
14	breast	NN	O	breast	nn	15	SENT_81	[p3l346t1574r545b1629],
15	tissue	NN	O	tissue	prep_in	8	SENT_81	[p3l563t1575r749b1629],
16	and	CC	O	and	_	0	SENT_81	[p3l769t1574r885b1629],
17	be	VB	O	be	cop	20	SENT_81	[p3l904t1574r978b1629],
18	a	DT	O	a	det	20	SENT_81	[p3l997t1590r1030b1629],
19	risk	NN	O	risk	nn	20	SENT_81	[p3l1050t1574r1167b1629],
20	factor	NN	O	factor	conj_and	8	SENT_81	[p3l1185t1574r1371b1629],
21	for	IN	O	for	_	0	SENT_81	[p3l1389t1574r1478b1629],
22	cancer	NN	O	cancer	nn	23	SENT_81	[p3l1496t1590r1706b1629],
23	development	NN	O	development	prep_for	20	SENT_81	[p3l1723t1574r2147b1642],
24	and	CC	O	and	_	0	SENT_81	[p3l10t1663r126b1718],
25	behaviour	NN	O	behaviour	prep_for	20	SENT_81	[p3l147t1663r473b1718],
26	[	CD	NUMBER	[	num	28	SENT_81	[p3l495t1663r636b1731],
27	21	CD	NUMBER	21	num	28	SENT_81	[p3l495t1663r636b1731],
28	]	NN	O	]	dobj	8	SENT_81	[p3l495t1663r636b1731],
29	.	.	O	.	_	0	SENT_81	[p3l495t1663r636b1731],

1	Because	IN	O	because	_	0	SENT_82	[p3l659t1666r915b1718],
2	these	DT	O	these	det	3	SENT_82	[p3l935t1663r1105b1718],
3	gene	NN	O	gene	prep_because	7	SENT_82	[p3l1124t1679r1275b1731],
4	polymorphisms	NNS	O	polymorphism	nsubjpass	7	SENT_82	[p3l1297t1663r1801b1731],
5	have	VBP	O	have	aux	7	SENT_82	[p3l1823t1663r1972b1718],
6	been	VBN	O	be	auxpass	7	SENT_82	[p3l1993t1663r2147b1718],
7	proposed	VBN	O	propose	_	0	SENT_82	[p3l10t1751r307b1820],
8	as	RB	O	as	advmod	9	SENT_82	[p3l331t1767r393b1806],
9	important	JJ	O	important	amod	10	SENT_82	[p3l419t1752r744b1820],
10	factors	NNS	O	factor	dobj	7	SENT_82	[p3l767t1751r981b1806],
11	in	IN	O	in	_	0	SENT_82	[p3l1007t1752r1066b1806],
12	chemotherapy	NN	O	chemotherapy	nn	13	SENT_82	[p3l1090t1751r1557b1820],
13	response	NN	O	response	prep_in	7	SENT_82	[p3l1579t1767r1879b1820],
14	,	,	O	,	_	0	SENT_82	[p3l1579t1767r1879b1820],
15	toxicity	NN	O	toxicity	prep_in	7	SENT_82	[p3l1903t1752r2147b1820],
16	and	CC	O	and	_	0	SENT_82	[p3l10t1840r126b1895],
17	outcome	NN	O	outcome	prep_in	7	SENT_82	[p3l153t1848r452b1904],
18	;	:	O	;	_	0	SENT_82	[p3l153t1848r452b1904],
19	and	CC	O	and	_	0	SENT_82	[p3l483t1840r599b1895],
20	considering	VBG	O	consider	partmod	28	SENT_82	[p3l625t1840r1001b1909],
21	all	PDT	O	all	dep	23	SENT_82	[p3l1025t1840r1099b1895],
22	these	DT	O	these	det	23	SENT_82	[p3l1125t1840r1295b1895],
23	background	NN	O	background	dobj	20	SENT_82	[p3l1320t1840r1701b1909],
24	and	CC	O	and	_	0	SENT_82	[p3l1726t1840r1843b1895],
25	observations	NNS	O	observation	conj_and	23	SENT_82	[p3l1869t1840r2146b1895, p3l9t1930r182b1993],
26	,	,	O	,	_	0	SENT_82	[p3l1869t1840r2146b1895, p3l9t1930r182b1993],
27	we	PRP	O	we	nsubj	28	SENT_82	[p3l221t1945r314b1984],
28	studied	VBD	O	study	conj_and	7	SENT_82	[p3l355t1929r591b1984],
29	the	DT	O	the	det	30	SENT_82	[p3l630t1929r731b1984],
30	distribution	NN	O	distribution	dobj	28	SENT_82	[p3l770t1929r1151b1984],
31	of	IN	O	of	_	0	SENT_82	[p3l1190t1929r1256b1984],
32	TSER	NN	O	tser	prep_of	30	SENT_82	[p3l1285t1932r1458b1993],
33	,	,	O	,	_	0	SENT_82	[p3l1285t1932r1458b1993],
34	MTHFR	NN	O	mthfr	nn	35	SENT_82	[p3l1498t1933r1734b1984],
35	C677T	NN	O	c677t	dobj	28	SENT_82	[p3l1770t1932r1987b1993],
36	,	,	O	,	_	0	SENT_82	[p3l1770t1932r1987b1993],
37	p53	NN	O	p53	nn	38	SENT_82	[p3l2027t1932r2143b1998],
38	codon	NN	O	codon	appos	35	SENT_82	[p3l10t2018r204b2073],
39	72	CD	NUMBER	72	dep	38	SENT_82	[p3l233t2021r306b2073],
40	and	CC	O	and	_	0	SENT_82	[p3l337t2018r453b2073],
41	MDR1	NN	O	mdr1	nn	44	SENT_82	[p3l483t2021r670b2073],
42	C3435T	NN	O	c3435t	nn	44	SENT_82	[p3l708t2021r952b2073],
43	gene	NN	O	gene	nn	44	SENT_82	[p3l977t2034r1128b2087],
44	polymorphisms	NNS	O	polymorphism	conj_and	30	SENT_82	[p3l1157t2018r1661b2087],
45	in	IN	O	in	_	0	SENT_82	[p3l1691t2019r1750b2073],
46	BC	NN	O	bc	nn	47	SENT_82	[p3l1778t2021r1859b2073],
47	patients	NNS	O	patient	prep_in	44	SENT_82	[p3l1887t2019r2145b2087],
48	from	IN	O	from	_	0	SENT_82	[p3l10t2108r163b2163],
49	Gran	NNP	LOCATION	Gran	nn	50	SENT_82	[p3l191t2111r345b2163],
50	Canaria	NNP	LOCATION	Canaria	prep_from	28	SENT_82	[p3l373t2109r614b2163],
51	treated	VBN	O	treat	partmod	50	SENT_82	[p3l641t2108r871b2163],
52	with	IN	O	with	_	0	SENT_82	[p3l897t2108r1046b2163],
53	neoadjuvant	JJ	O	neoadjuvant	amod	54	SENT_82	[p3l1074t2108r1476b2176],
54	chemotherapy	NN	O	chemotherapy	prep_with	51	SENT_82	[p3l1503t2108r1984b2176],
55	.	.	O	.	_	0	SENT_82	[p3l1503t2108r1984b2176],

1	2	LS	NUMBER	2	_	0	SENT_83	[p3l9t2289r65b2341],
2	.	.	O	.	_	0	SENT_83	[p3l9t2289r65b2341],

1	Patients	NNS	O	patient	_	0	SENT_84	[p3l104t2286r379b2340],
2	and	CC	O	and	_	0	SENT_84	[p3l405t2286r532b2340],
3	methods	NNS	O	method	conj_and	1	SENT_84	[p3l559t2286r856b2340],

1	2.1	CD	NUMBER	2.1	_	0	SENT_85	[p3l6t2466r112b2518],
2	.	.	O	.	_	0	SENT_85	[p3l6t2466r112b2518],

1	Patients	NNS	O	patient	_	0	SENT_86	[p3l153t2464r400b2518],

1	Between	IN	O	between	_	0	SENT_87	[p3l112t2644r390b2695],
2	March	NNP	DATE	March	prep_between	24	SENT_87	[p3l431t2641r635b2695],
3	2005	CD	DATE	2005	num	2	SENT_87	[p3l674t2644r830b2695],
4	and	CC	O	and	_	0	SENT_87	[p3l874t2641r991b2695],
5	March	NNP	DATE	March	conj_and	2	SENT_87	[p3l1032t2641r1236b2695],
6	2008	CD	DATE	2008	num	5	SENT_87	[p3l1276t2644r1450b2703],
7	,	,	O	,	_	0	SENT_87	[p3l1276t2644r1450b2703],
8	50	CD	NUMBER	50	number	9	SENT_87	[p3l1493t2644r1569b2695],
9	consecutive	JJ	O	consecutive	nsubjpass	24	SENT_87	[p3l1610t2642r1989b2695],
10	and	CC	O	and	_	0	SENT_87	[p3l2029t2641r2145b2695],
11	unselected	JJ	O	unselected	amod	12	SENT_87	[p3l10t2729r355b2784],
12	patients	NNS	O	patient	nsubjpass	24	SENT_87	[p3l383t2729r658b2797],
13	,	,	O	,	_	0	SENT_87	[p3l383t2729r658b2797],
14	diagnosed	VBN	O	diagnose	partmod	9	SENT_87	[p3l685t2729r1011b2797],
15	with	IN	O	with	_	0	SENT_87	[p3l1037t2729r1185b2784],
16	primary	JJ	O	primary	amod	18	SENT_87	[p3l1212t2729r1471b2797],
17	breast	NN	O	breast	nn	18	SENT_87	[p3l1495t2729r1694b2784],
18	cancer	NN	O	cancer	prep_with	14	SENT_87	[p3l1720t2744r1930b2784],
19	at	IN	O	at	_	0	SENT_87	[p3l1954t2737r2014b2784],
20	our	PRP$	O	we	poss	21	SENT_87	[p3l2040t2744r2149b2784],
21	Service	NNP	O	Service	prep_at	18	SENT_87	[p3l10t2818r253b2880],
22	,	,	O	,	_	0	SENT_87	[p3l10t2818r253b2880],
23	were	VBD	O	be	auxpass	24	SENT_87	[p3l297t2833r456b2872],
24	treated	VBN	O	treat	_	0	SENT_87	[p3l500t2817r730b2872],
25	with	IN	O	with	_	0	SENT_87	[p3l773t2817r921b2872],
26	5	CD	NUMBER	5	prep_with	24	SENT_87	[p3l967t2820r1118b2872],
27	.	.	O	.	_	0	SENT_87	[p3l967t2820r1118b2872],

1	—	NN	O	—	_	0	SENT_88	[p3l967t2820r1118b2872],
2	.	.	O	.	_	0	SENT_88	[p3l967t2820r1118b2872],

1	FU	NNP	O	FU	_	0	SENT_89	[p3l967t2820r1118b2872],
2	and	CC	O	and	_	0	SENT_89	[p3l1162t2817r1278b2872],
3	cyclophosphamide-based	JJ	O	cyclophosphamide-based	amod	5	SENT_89	[p3l1324t2817r2146b2886],
4	neoadjuvant	JJ	O	neoadjuvant	amod	5	SENT_89	[p3l10t2906r412b2975],
5	treatment	NN	O	treatment	conj_and	1	SENT_89	[p3l463t2915r801b2962],
6	.	.	O	.	_	0	SENT_89	[p3l463t2915r801b2962],

1	Patients	NNS	O	patient	nsubjpass	9	SENT_90	[p3l856t2907r1111b2961],
2	in	IN	O	in	_	0	SENT_90	[p3l1166t2907r1225b2961],
3	clinical	JJ	O	clinical	amod	4	SENT_90	[p3l1278t2906r1504b2961],
4	stages	NNS	O	stage	prep_in	1	SENT_90	[p3l1559t2915r1753b2975],
5	I	PRP	O	I	nsubj	6	SENT_90	[p3l1808t2910r1938b2961],
6	—	VBP	O	—	rcmod	4	SENT_90	[p3l1808t2910r1938b2961],
7	lV	NN	O	lv	dobj	6	SENT_90	[p3l1808t2910r1938b2961],
8	were	VBD	O	be	auxpass	9	SENT_90	[p3l1987t2922r2146b2961],
9	included	VBN	O	include	_	0	SENT_90	[p3l10t2995r287b3050],
10	in	IN	O	in	_	0	SENT_90	[p3l324t2996r383b3050],
11	the	DT	O	the	det	15	SENT_90	[p3l417t2995r519b3050],
12	study	NN	O	study	nn	15	SENT_90	[p3l555t2995r733b3064],
13	(	CD	NUMBER	(	num	15	SENT_90	[p3l767t2996r946b3064],
14	TNM	NN	O	tnm	nn	15	SENT_90	[p3l767t2996r946b3064],
15	staging	NN	O	staging	prep_in	9	SENT_90	[p3l983t2996r1228b3064],
16	,	,	O	,	_	0	SENT_90	[p3l983t2996r1228b3064],
17	American	JJ	ORGANIZATION	american	amod	19	SENT_90	[p3l1262t2996r1572b3050],
18	Joint	NNP	ORGANIZATION	Joint	nn	19	SENT_90	[p3l1598t2996r1756b3064],
19	Committee	NNP	ORGANIZATION	Committee	appos	15	SENT_90	[p3l1790t2996r2146b3050],
20	on	IN	O	on	_	0	SENT_90	[p3l10t3101r88b3140],
21	Cancer	NNP	O	Cancer	prep_on	19	SENT_90	[p3l139t3085r397b3153],
22	)	CD	NUMBER	)	num	21	SENT_90	[p3l139t3085r397b3153],
23	.	.	O	.	_	0	SENT_90	[p3l139t3085r397b3153],

1	The	DT	O	the	det	2	SENT_91	[p3l448t3085r565b3140],
2	diagnosis	NN	O	diagnosis	nsubjpass	7	SENT_91	[p3l616t3085r915b3153],
3	of	IN	O	of	_	0	SENT_91	[p3l968t3085r1034b3140],
4	the	DT	O	the	det	5	SENT_91	[p3l1077t3085r1180b3140],
5	disease	NN	O	disease	prep_of	2	SENT_91	[p3l1231t3085r1463b3140],
6	was	VBD	O	be	auxpass	7	SENT_91	[p3l1513t3101r1637b3140],
7	conﬁrmed	VBN	O	conﬁrmed	_	0	SENT_91	[p3l1691t3085r2019b3140],
8	by	IN	O	by	_	0	SENT_91	[p3l2070t3085r2148b3153],
9	histological	JJ	O	histological	amod	10	SENT_91	[p3l10t3174r379b3242],
10	examinations	NNS	O	examination	agent	7	SENT_91	[p3l426t3175r877b3229],
11	.	.	O	.	_	0	SENT_91	[p3l426t3175r877b3229],

1	All	DT	O	all	det	2	SENT_92	[p3l922t3174r1007b3228],
2	participants	NNS	O	participant	nsubj	4	SENT_92	[p3l1055t3175r1439b3242],
3	were	VBD	O	be	cop	4	SENT_92	[p3l1484t3190r1644b3229],
4	Caucasians	NNPS	MISC	Caucasians	_	0	SENT_92	[p3l1689t3175r2040b3229],
5	of	IN	MISC	of	_	0	SENT_92	[p3l2088t3174r2154b3229],
6	Canary	NNP	MISC	Canary	nn	7	SENT_92	[p3l10t3265r233b3331],
7	origin	NN	O	origin	prep_of	4	SENT_92	[p3l256t3263r458b3331],
8	.	.	O	.	_	0	SENT_92	[p3l256t3263r458b3331],

1	The	DT	O	the	det	3	SENT_93	[p3l481t3262r598b3317],
2	Ethics	NNPS	O	Ethics	nn	3	SENT_93	[p3l622t3262r811b3317],
3	Committee	NNP	ORGANIZATION	Committee	nsubj	7	SENT_93	[p3l836t3263r1193b3317],
4	of	IN	ORGANIZATION	of	_	0	SENT_93	[p3l1217t3262r1283b3317],
5	our	PRP$	ORGANIZATION	we	poss	6	SENT_93	[p3l1299t3278r1407b3317],
6	Hospital	NN	ORGANIZATION	hospital	prep_of	3	SENT_93	[p3l1429t3262r1696b3331],
7	approved	VBD	O	approve	_	0	SENT_93	[p3l1720t3262r2020b3331],
8	the	DT	O	the	det	10	SENT_93	[p3l2044t3262r2146b3317],
9	present	JJ	DATE	present	amod	10	SENT_93	[p3l10t3359r251b3420],
10	study	NN	O	study	nsubjpass	16	SENT_93	[p3l283t3351r461b3420],
11	and	CC	O	and	_	0	SENT_93	[p3l492t3351r609b3406],
12	written	VBN	O	write	amod	14	SENT_93	[p3l640t3352r880b3406],
13	informed	JJ	O	informed	amod	14	SENT_93	[p3l913t3351r1208b3406],
14	consent	NN	O	consent	conj_and	10	SENT_93	[p3l1240t3359r1490b3406],
15	was	VBD	O	be	auxpass	16	SENT_93	[p3l1520t3367r1645b3406],
16	obtained	VBN	O	obtain	ccomp	7	SENT_93	[p3l1679t3351r1960b3406],
17	from	IN	O	from	_	0	SENT_93	[p3l1994t3351r2146b3406],
18	each	DT	O	each	det	19	SENT_93	[p3l10t3440r156b3495],
19	participant	NN	O	participant	prep_from	16	SENT_93	[p3l188t3441r543b3509],
20	before	IN	O	before	mark	24	SENT_93	[p3l573t3440r776b3495],
21	biological	JJ	O	biological	amod	22	SENT_93	[p3l807t3440r1117b3509],
22	samples	NNS	O	sample	nsubjpass	24	SENT_93	[p3l1151t3440r1410b3509],
23	were	VBD	O	be	auxpass	24	SENT_93	[p3l1442t3456r1602b3495],
24	obtained	VBN	O	obtain	advcl	16	SENT_93	[p3l1634t3440r1931b3496],
25	.	.	O	.	_	0	SENT_93	[p3l1634t3440r1931b3496],

1	Blood	NN	O	blood	nn	2	SENT_94	[p3l1966t3440r2146b3495],
2	samples	NNS	O	sample	nsubjpass	4	SENT_94	[p3l11t3529r269b3598],
3	were	VBD	O	be	auxpass	4	SENT_94	[p3l302t3545r461b3584],
4	collected	VBN	O	collect	_	0	SENT_94	[p3l494t3529r781b3584],
5	at	IN	O	at	_	0	SENT_94	[p3l814t3538r874b3584],
6	the	DT	O	the	det	8	SENT_94	[p3l906t3529r1007b3584],
7	ﬁrst	JJ	O	ﬁrst	amod	8	SENT_94	[p3l1041t3529r1168b3584],
8	visit	NN	O	visit	prep_at	4	SENT_94	[p3l1197t3530r1349b3585],
9	.	.	O	.	_	0	SENT_94	[p3l1197t3530r1349b3585],

1	All	DT	O	all	det	2	SENT_95	[p3l1381t3529r1467b3584],
2	women	NNS	O	woman	nsubj	6	SENT_95	[p3l1499t3545r1741b3584],
3	in	IN	O	in	_	0	SENT_95	[p3l1774t3530r1833b3584],
4	this	DT	O	this	det	5	SENT_95	[p3l1865t3529r1982b3584],
5	trial	NN	O	trial	prep_in	2	SENT_95	[p3l2016t3529r2145b3584],
6	ﬁlled	VBD	O	ﬁlled	_	0	SENT_95	[p3l10t3619r170b3674],
7	out	RP	O	out	prt	6	SENT_95	[p3l211t3627r316b3674],
8	a	DT	O	a	det	10	SENT_95	[p3l354t3635r387b3674],
9	structured	JJ	O	structured	amod	10	SENT_95	[p3l427t3619r761b3674],
10	questionnaire	NN	O	questionnaire	dobj	6	SENT_95	[p3l801t3620r1245b3687],
11	designed	VBN	O	design	partmod	10	SENT_95	[p3l1285t3619r1571b3687],
12	by	IN	O	by	_	0	SENT_95	[p3l1610t3619r1688b3687],
13	the	DT	O	the	det	14	SENT_95	[p3l1726t3619r1827b3674],
14	“	CD	NUMBER	“	agent	11	SENT_95	[p3l1868t3622r2033b3674],
15	CDC	NNP	O	CDC	tmod	11	SENT_95	[p3l1868t3622r2033b3674],
16	de	IN	O	de	amod	15	SENT_95	[p3l2072t3619r2146b3674],

1	Canarias	NNP	O	Canarias	nn	2	SENT_96	[p4l10t18r314b72],
2	”	NNP	O	”	_	0	SENT_96	[p4l10t18r314b72],
3	project	NN	O	project	dep	2	SENT_96	[p4l337t18r563b85],
4	[	CD	NUMBER	[	number	5	SENT_96	[p4l587t17r728b85],
5	22	CD	NUMBER	22	num	6	SENT_96	[p4l587t17r728b85],
6	]	NN	O	]	dep	3	SENT_96	[p4l587t17r728b85],
7	.	.	O	.	_	0	SENT_96	[p4l587t17r728b85],

1	This	DT	O	this	det	2	SENT_97	[p4l749t17r881b72],
2	questionnaire	NN	O	questionnaire	nsubj	3	SENT_97	[p4l905t18r1349b85],
3	included	VBD	O	include	_	0	SENT_97	[p4l1372t17r1649b72],
4	patient	JJ	O	patient	amod	5	SENT_97	[p4l1672t18r1900b85],
5	history	NN	O	history	dobj	3	SENT_97	[p4l1922t17r2148b85],
6	and	CC	O	and	_	0	SENT_97	[p4l10t105r126b160],
7	risk	NN	O	risk	nn	8	SENT_97	[p4l150t105r268b160],
8	factors	NNS	O	factor	dobj	3	SENT_97	[p4l289t105r504b160],
9	related	VBN	O	relate	partmod	5	SENT_97	[p4l528t105r751b160],
10	to	TO	O	to	_	0	SENT_97	[p4l774t113r836b160],
11	BC	NNP	O	BC	nn	12	SENT_97	[p4l860t108r941b160],
12	development	NN	O	development	prep_to	9	SENT_97	[p4l963t105r1402b174],
13	.	.	O	.	_	0	SENT_97	[p4l963t105r1402b174],

1	Data	NNS	O	datum	nsubjpass	3	SENT_98	[p4l1427t109r1573b160],
2	were	VBD	O	be	auxpass	3	SENT_98	[p4l1594t121r1753b160],
3	collected	VBN	O	collect	_	0	SENT_98	[p4l1776t105r2063b160],
4	in	IN	O	in	_	0	SENT_98	[p4l2087t106r2146b160],
5	all	DT	O	all	det	6	SENT_98	[p4l10t194r84b249],
6	cases	NNS	O	case	prep_in	3	SENT_98	[p4l126t194r1357b263],
7	.	.	O	.	_	0	SENT_98	[p4l126t194r1357b263],

1	ImmunohistochemistryEstrogen	NN	O	immunohistochemistryestrogen	nn	2	SENT_99	[p4l126t194r1357b263],
2	receptor	NN	O	receptor	nsubjpass	9	SENT_99	[p4l1399t202r1681b263],
3	,	,	O	,	_	0	SENT_99	[p4l1399t202r1681b263],
4	progesterone	NN	O	progesterone	nn	5	SENT_99	[p4l1723t202r2146b263],
5	receptor	NN	O	receptor	nsubjpass	9	SENT_99	[p4l10t292r280b352],
6	and	CC	O	and	_	0	SENT_99	[p4l319t283r435b338],
7	erbB2	NN	O	erbb2	nsubjpass	9	SENT_99	[p4l478t283r661b338],
8	were	VBD	O	be	auxpass	9	SENT_99	[p4l703t299r862b338],
9	determined	VBN	O	determine	_	0	SENT_99	[p4l903t283r1277b338],
10	in	IN	O	in	_	0	SENT_99	[p4l1319t284r1378b338],
11	the	DT	O	the	det	13	SENT_99	[p4l1419t283r1520b338],
12	tumour	NN	O	tumour	nn	13	SENT_99	[p4l1561t292r1805b338],
13	tissue	NN	O	tissue	prep_in	9	SENT_99	[p4l1843t284r2029b338],
14	by	IN	O	by	_	0	SENT_99	[p4l2070t283r2148b352],
15	immunohistochemistry	NN	O	immunohistochemistry	agent	9	SENT_99	[p4l10t372r785b441],
16	.	.	O	.	_	0	SENT_99	[p4l10t372r785b441],

1	Immunostaining	NN	O	immunostaining	nsubj	5	SENT_100	[p4l821t373r1357b441],
2	was	VBD	O	be	aux	3	SENT_100	[p4l1388t388r1512b427],
3	done	VBN	O	do	_	0	SENT_100	[p4l1548t372r1705b427],
4	as	IN	O	as	_	0	SENT_100	[p4l1738t388r1801b427],
5	described	VBN	O	describe	conj_as	3	SENT_100	[p4l1837t372r2146b427],
6	elsewhere	RB	O	elsewhere	advmod	5	SENT_100	[p4l10t462r337b517],
7	[	RB	O	[	advmod	5	SENT_100	[p4l370t462r512b530],
8	23	CD	NUMBER	23	num	9	SENT_100	[p4l370t462r512b530],
9	]	NN	O	]	dobj	3	SENT_100	[p4l370t462r512b530],
10	.	.	O	.	_	0	SENT_100	[p4l370t462r512b530],

1	For	IN	O	for	_	0	SENT_101	[p4l544t465r645b517],
2	estrogen	NN	O	estrogen	nn	3	SENT_101	[p4l673t470r950b530],
3	receptor	NN	O	receptor	prep_for	11	SENT_101	[p4l980t470r1250b530],
4	and	CC	O	and	_	0	SENT_101	[p4l1278t462r1394b517],
5	progesterone	NN	O	progesterone	nn	7	SENT_101	[p4l1425t470r1848b530],
6	receptor	NN	O	receptor	nn	7	SENT_101	[p4l1879t470r2149b530],
7	staining	NN	O	staining	conj_and	3	SENT_101	[p4l11t552r282b619],
8	,	,	O	,	_	0	SENT_101	[p4l11t552r282b619],
9	cells	NNS	O	cell	nsubjpass	11	SENT_101	[p4l302t551r440b606],
10	were	VBD	O	be	auxpass	11	SENT_101	[p4l459t567r618b606],
11	considered	VBN	O	consider	_	0	SENT_101	[p4l637t551r987b606],
12	positive	JJ	O	positive	acomp	11	SENT_101	[p4l1007t552r1259b619],
13	when	WRB	O	when	advmod	19	SENT_101	[p4l1276t551r1456b606],
14	210	CD	PERCENT	210	num	15	SENT_101	[p4l1477t554r1650b615],
15	%	NN	PERCENT	%	nsubj	19	SENT_101	[p4l1477t554r1650b615],
16	of	IN	O	of	_	0	SENT_101	[p4l1669t551r1735b606],
17	tumour	NN	O	tumour	nn	18	SENT_101	[p4l1745t559r1989b606],
18	cells	NNS	O	cell	prep_of	15	SENT_101	[p4l2006t551r2145b606],
19	showed	VBD	O	show	advcl	11	SENT_101	[p4l11t639r258b694],
20	positive	JJ	O	positive	amod	21	SENT_101	[p4l285t640r537b708],
21	staining	NN	O	staining	dobj	19	SENT_101	[p4l566t640r837b708],
22	.	.	O	.	_	0	SENT_101	[p4l566t640r837b708],

1	For	IN	O	for	_	0	SENT_102	[p4l866t643r967b694],
2	erbB2	NN	O	erbb2	nn	3	SENT_102	[p4l992t639r1175b694],
3	staining	NN	O	staining	prep_for	10	SENT_102	[p4l1205t640r1476b708],
4	,	,	O	,	_	0	SENT_102	[p4l1205t640r1476b708],
5	only	RB	O	only	advmod	8	SENT_102	[p4l1504t639r1644b708],
6	the	DT	O	the	det	8	SENT_102	[p4l1669t639r1770b694],
7	membrane	NN	O	membrane	nn	8	SENT_102	[p4l1798t639r2146b694],
8	staining	NN	O	staining	nsubjpass	10	SENT_102	[p4l11t729r268b797],
9	was	VBD	O	be	auxpass	10	SENT_102	[p4l297t744r421b783],
10	considered	VBN	O	consider	_	0	SENT_102	[p4l455t728r805b783],
11	as	IN	O	as	_	0	SENT_102	[p4l838t744r900b783],
12	positive	JJ	O	positive	prep_as	10	SENT_102	[p4l934t729r1202b797],
13	.	.	O	.	_	0	SENT_102	[p4l934t729r1202b797],

1	The	DT	O	the	det	2	SENT_103	[p4l1233t728r1350b783],
2	score	NN	NUMBER	score	nsubjpass	7	SENT_103	[p4l1383t744r1548b783],
3	of	IN	O	of	_	0	SENT_103	[p4l1581t728r1647b783],
4	erbB2	NN	O	erbb2	nn	5	SENT_103	[p4l1672t728r1855b783],
5	staining	NN	O	staining	prep_of	2	SENT_103	[p4l1891t729r2147b797],
6	was	VBD	O	be	auxpass	7	SENT_103	[p4l8t833r133b872],
7	graded	VBN	O	grade	_	0	SENT_103	[p4l151t817r371b886],
8	as	IN	O	as	mark	9	SENT_103	[p4l391t833r453b872],
9	follows	VBZ	O	follow	advcl	7	SENT_103	[p4l474t817r726b873],
10	:	:	O	:	_	0	SENT_103	[p4l474t817r726b873],
11	No	DT	O	no	det	15	SENT_103	[p4l751t821r837b872],
12	staining	NN	O	staining	nn	15	SENT_103	[p4l857t818r1114b886],
13	or	CC	O	or	_	0	SENT_103	[p4l1131t833r1197b872],
14	membrane	NN	O	membrane	nn	15	SENT_103	[p4l1214t817r1562b872],
15	staining	NN	O	staining	nsubjpass	25	SENT_103	[p4l1582t818r1839b886],
16	observed	VBN	O	observe	partmod	15	SENT_103	[p4l1856t817r2146b872],
17	in	IN	O	in	_	0	SENT_103	[p4l10t907r70b961],
18	<	JJR	PERCENT	<	prep_in	16	SENT_103	[p4l126t909r298b963],
19	10	CD	PERCENT	10	number	20	SENT_103	[p4l126t909r298b963],
20	%	NN	PERCENT	%	amod	18	SENT_103	[p4l126t909r298b963],
21	of	IN	O	of	_	0	SENT_103	[p4l351t906r418b961],
22	tumour	NN	O	tumour	nn	23	SENT_103	[p4l462t915r706b961],
23	cells	NNS	O	cell	prep_of	18	SENT_103	[p4l757t906r896b961],
24	was	VBD	O	be	auxpass	25	SENT_103	[p4l949t922r1073b961],
25	given	VBN	O	give	parataxis	7	SENT_103	[p4l1126t907r1300b975],
26	a	DT	O	a	det	28	SENT_103	[p4l1353t922r1385b961],
27	score	NN	NUMBER	score	nn	28	SENT_103	[p4l1439t922r1604b961],
28	o	NN	O	o	dobj	25	SENT_103	[p4l1657t909r1713b970],
29	;	:	O	;	_	0	SENT_103	[p4l1657t909r1713b970],
30	faint/barely	RB	O	faint/barely	advmod	31	SENT_103	[p4l1771t906r2147b975],
31	perceptible	JJ	O	perceptible	amod	33	SENT_103	[p4l10t996r372b1064],
32	membrane	NN	O	membrane	nn	33	SENT_103	[p4l400t996r749b1051],
33	staining	NN	O	staining	nsubjpass	43	SENT_103	[p4l777t997r1034b1064],
34	detected	VBN	O	detect	partmod	33	SENT_103	[p4l1060t996r1335b1051],
35	in	IN	O	in	_	0	SENT_103	[p4l1363t997r1422b1050],
36	>	JJR	O	>	prep_in	34	SENT_103	[p4l1452t999r1625b1053],
37	10	CD	PERCENT	10	number	38	SENT_103	[p4l1452t999r1625b1053],
38	%	NN	PERCENT	%	amod	36	SENT_103	[p4l1452t999r1625b1053],
39	of	IN	O	of	_	0	SENT_103	[p4l1652t996r1718b1051],
40	tumour	NN	O	tumour	nn	41	SENT_103	[p4l1737t1004r1981b1051],
41	cells	NNS	O	cell	prep_of	36	SENT_103	[p4l2006t996r2145b1051],
42	was	VBD	O	be	auxpass	43	SENT_103	[p4l8t1101r133b1140],
43	scored	VBN	O	score	parataxis	7	SENT_103	[p4l178t1085r385b1140],
44	as	IN	O	as	_	0	SENT_103	[p4l427t1101r490b1140],
45	1	CD	NUMBER	1	prep_as	43	SENT_103	[p4l538t1088r629b1148],
46	+	CC	O	+	cc	45	SENT_103	[p4l538t1088r629b1148],
47	;	:	O	;	_	0	SENT_103	[p4l538t1088r629b1148],
48	a	DT	O	a	det	54	SENT_103	[p4l678t1101r710b1140],
49	moderate	JJ	O	moderate	amod	54	SENT_103	[p4l754t1085r1061b1140],
50	or	CC	O	or	_	0	SENT_103	[p4l1104t1101r1170b1140],
51	strong	JJ	O	strong	conj_or	49	SENT_103	[p4l1212t1093r1415b1153],
52	complete	JJ	O	complete	amod	54	SENT_103	[p4l1457t1085r1754b1153],
53	membrane	NN	O	membrane	nn	54	SENT_103	[p4l1798t1085r2146b1140],
54	staining	NN	O	staining	dep	45	SENT_103	[p4l11t1174r268b1242],
55	observed	VBN	O	observe	partmod	54	SENT_103	[p4l297t1173r586b1228],
56	in	IN	O	in	_	0	SENT_103	[p4l619t1174r678b1228],
57	>	JJR	PERCENT	>	prep_in	55	SENT_103	[p4l712t1176r884b1230],
58	10	CD	PERCENT	10	num	59	SENT_103	[p4l712t1176r884b1230],
59	%	NN	PERCENT	%	nsubjpass	64	SENT_103	[p4l712t1176r884b1230],
60	of	IN	O	of	_	0	SENT_103	[p4l915t1173r981b1228],
61	tumour	NN	O	tumour	nn	62	SENT_103	[p4l1005t1181r1248b1228],
62	cells	NNS	O	cell	prep_of	59	SENT_103	[p4l1277t1173r1415b1228],
63	was	VBD	O	be	auxpass	64	SENT_103	[p4l1446t1189r1571b1228],
64	graded	VBN	O	grade	rcmod	57	SENT_103	[p4l1602t1173r1822b1242],
65	2	CD	NUMBER	2	dobj	64	SENT_103	[p4l1853t1176r1928b1228],
66	+	CC	O	+	_	0	SENT_103	[p4l1853t1176r1928b1228],
67	or	CC	O	or	_	0	SENT_103	[p4l1960t1189r2026b1228],
68	3	CD	NUMBER	3	dobj	64	SENT_103	[p4l2053t1176r2145b1237],
69	+	CC	O	+	cc	68	SENT_103	[p4l2053t1176r2145b1237],
70	,	,	O	,	_	0	SENT_103	[p4l2053t1176r2145b1237],
71	respectively	RB	O	respectively	advmod	68	SENT_103	[p4l10t1262r413b1331],
72	.	.	O	.	_	0	SENT_103	[p4l10t1262r413b1331],

1	A	DT	O	a	det	2	SENT_104	[p4l434t1264r481b1316],
2	score	NN	NUMBER	score	nsubjpass	9	SENT_104	[p4l500t1278r665b1317],
3	of	IN	O	of	_	0	SENT_104	[p4l687t1262r753b1317],
4	O	NN	O	o	prep_of	2	SENT_104	[p4l767t1265r803b1317],
5	or	CC	O	or	_	0	SENT_104	[p4l825t1278r891b1317],
6	1	CD	NUMBER	1	prep_of	2	SENT_104	[p4l914t1265r986b1316],
7	+	CC	O	+	cc	6	SENT_104	[p4l914t1265r986b1316],
8	was	VBD	O	be	auxpass	9	SENT_104	[p4l1006t1278r1131b1317],
9	considered	VBN	O	consider	_	0	SENT_104	[p4l1153t1262r1503b1317],
10	negative	JJ	O	negative	acomp	9	SENT_104	[p4l1526t1263r1813b1331],
11	.	.	O	.	_	0	SENT_104	[p4l1526t1263r1813b1331],

1	A	DT	O	a	det	2	SENT_105	[p4l1834t1264r1881b1316],
2	score	NN	TIME	score	nsubjpass	8	SENT_105	[p4l1901t1278r2066b1317],
3	of	IN	TIME	of	_	0	SENT_105	[p4l2088t1262r2154b1317],
4	2	CD	TIME	2	prep_of	2	SENT_105	[p4l10t1354r85b1406],
5	+	CC	O	+	cc	8	SENT_105	[p4l10t1354r85b1406],
6	was	VBD	O	be	auxpass	8	SENT_105	[p4l111t1367r235b1406],
7	subsequently	RB	O	subsequently	advmod	8	SENT_105	[p4l265t1351r695b1420],
8	conﬁrmed	VBN	O	conﬁrmed	_	0	SENT_105	[p4l720t1351r1048b1406],
9	by	IN	O	by	_	0	SENT_105	[p4l1075t1351r1153b1420],
10	the	DT	O	the	det	12	SENT_105	[p4l1178t1351r1279b1406],
11	FISH	NN	O	fish	nn	12	SENT_105	[p4l1308t1354r1449b1406],
12	technique	NN	O	technique	agent	8	SENT_105	[p4l1476t1351r1797b1420],
13	[	CD	NUMBER	[	number	14	SENT_105	[p4l1827t1351r1968b1420],
14	24	CD	NUMBER	24	num	15	SENT_105	[p4l1827t1351r1968b1420],
15	]	NN	O	]	dep	8	SENT_105	[p4l1827t1351r1968b1420],
16	.	.	O	.	_	0	SENT_105	[p4l1827t1351r1968b1420],

1	Only	RB	O	only	quantmod	2	SENT_106	[p4l1998t1351r2148b1420],
2	2	CD	NUMBER	2	nsubjpass	8	SENT_106	[p4l10t1440r297b1509],
3	+	CC	O	+	cc	2	SENT_106	[p4l10t1440r297b1509],
4	/	:	O	/	punct	5	SENT_106	[p4l10t1440r297b1509],
5	FISH	NN	O	fish	dep	2	SENT_106	[p4l10t1440r297b1509],
6	+	CC	O	+	cc	8	SENT_106	[p4l10t1440r297b1509],
7	were	VBD	O	be	auxpass	8	SENT_106	[p4l331t1456r490b1495],
8	considered	VBN	O	consider	_	0	SENT_106	[p4l526t1440r876b1495],
9	as	IN	O	as	_	0	SENT_106	[p4l912t1456r974b1495],
10	erbB2	NN	O	erbb2	prep_as	8	SENT_106	[p4l1012t1440r1195b1495],
11	positive	JJ	O	positive	amod	10	SENT_106	[p4l1233t1441r1501b1509],
12	.	.	O	.	_	0	SENT_106	[p4l1233t1441r1501b1509],

1	A	DT	O	a	det	2	SENT_107	[p4l1536t1443r1582b1495],
2	score	NN	TIME	score	nsubjpass	7	SENT_107	[p4l1617t1456r1781b1495],
3	of	IN	TIME	of	_	0	SENT_107	[p4l1817t1440r1883b1495],
4	3	CD	TIME	3	prep_of	2	SENT_107	[p4l1910t1443r1986b1495],
5	+	CC	O	+	cc	7	SENT_107	[p4l1910t1443r1986b1495],
6	was	VBD	O	be	auxpass	7	SENT_107	[p4l2020t1456r2145b1495],
7	considered	VBN	O	consider	_	0	SENT_107	[p4l10t1530r360b1585],
8	positive	JJ	O	positive	acomp	7	SENT_107	[p4l380t1531r633b1598],
9	as	IN	O	as	_	0	SENT_107	[p4l653t1546r716b1585],
10	wel1	NN	O	wel1	prep_as	7	SENT_107	[p4l735t1530r1230b1585],
11	.	.	O	.	_	0	SENT_107	[p4l735t1530r1230b1585],

1	Treatment	NN	O	treatment	nn	3	SENT_108	[p4l735t1530r1230b1585],
2	protocolsAll	NN	O	protocolsall	nn	3	SENT_108	[p4l1249t1530r1635b1598],
3	treatments	NNS	O	treatment	nsubj	4	SENT_108	[p4l1655t1538r2008b1585],
4	had	VBD	O	have	_	0	SENT_108	[p4l2030t1530r2145b1585],
5	cyclophosphamide	NN	O	cyclophosphamide	dobj	4	SENT_108	[p4l10t1619r616b1687],
6	as	IN	O	as	_	0	SENT_108	[p4l639t1634r701b1674],
7	common	JJ	O	common	amod	8	SENT_108	[p4l725t1634r1008b1674],
8	drug	NN	O	drug	prep_as	5	SENT_108	[p4l1031t1618r1193b1687],
9	.	.	O	.	_	0	SENT_108	[p4l1031t1618r1193b1687],

1	Depending	VBG	O	depend	dep	163	SENT_109	[p4l1218t1619r1567b1687],
2	on	IN	O	on	dep	163	SENT_109	[p4l1589t1634r1667b1674],
3	the	DT	O	the	dep	163	SENT_109	[p4l1689t1619r1791b1674],
4	pathological	JJ	O	pathological	dep	163	SENT_109	[p4l1814t1618r2146b1687, p4l10t1707r96b1762],
5	characteristics	NNS	O	characteristic	dep	163	SENT_109	[p4l148t1707r612b1762],
6	of	IN	O	of	dep	163	SENT_109	[p4l664t1707r730b1762],
7	the	DT	O	the	dep	163	SENT_109	[p4l772t1707r874b1762],
8	tumour	NN	O	tumour	dep	163	SENT_109	[p4l924t1715r1181b1770],
9	,	,	O	,	_	0	SENT_109	[p4l924t1715r1181b1770],
10	four	CD	NUMBER	four	dep	163	SENT_109	[p4l1232t1707r1364b1762],
11	different	JJ	O	different	dep	163	SENT_109	[p4l1412t1707r1690b1762],
12	protocols	NNS	O	protocol	dep	163	SENT_109	[p4l1739t1707r2036b1776],
13	of	IN	O	of	dep	163	SENT_109	[p4l2088t1707r2154b1762],
14	treatment	NN	O	treatment	dep	163	SENT_109	[p4l9t1804r333b1851],
15	were	VBD	O	be	dep	163	SENT_109	[p4l376t1812r536b1851],
16	administered	VBN	O	administer	dep	163	SENT_109	[p4l583t1796r1009b1851],
17	to	TO	O	to	dep	163	SENT_109	[p4l1056t1804r1117b1851],
18	the	DT	O	the	dep	163	SENT_109	[p4l1164t1796r1266b1851],
19	patients	NNS	O	patient	dep	163	SENT_109	[p4l1312t1797r1570b1865],
20	as	IN	O	as	dep	163	SENT_109	[p4l1618t1812r1680b1851],
21	follows	VBZ	O	follow	dep	163	SENT_109	[p4l1728t1796r1980b1852],
22	:	:	O	:	_	0	SENT_109	[p4l1728t1796r1980b1852],
23	FEC	NN	ORGANIZATION	fec	dep	163	SENT_109	[p4l2033t1799r2147b1851],
24	regimen	NN	O	regimen	dep	163	SENT_109	[p4l10t1885r275b1953],
25	(	CD	NUMBER	(	dep	163	SENT_109	[p4l309t1884r779b1953],
26	5-ﬂuorouracil	NN	O	5-ﬂuorouracil	dep	163	SENT_109	[p4l309t1884r779b1953],
27	600	CD	NUMBER	600	dep	163	SENT_109	[p4l814t1887r931b1939],
28	mg/m2	NN	O	mg/m2	dep	163	SENT_109	[p4l954t1874r1188b1953],
29	,	,	O	,	_	0	SENT_109	[p4l954t1874r1188b1953],
30	epirubicin	NN	O	epirubicin	dep	163	SENT_109	[p4l1224t1884r1551b1953],
31	90	CD	NUMBER	90	dep	163	SENT_109	[p4l1585t1887r1662b1939],
32	mg/m2	NN	O	mg/m2	dep	163	SENT_109	[p4l1684t1874r1920b1953],
33	,	,	O	,	_	0	SENT_109	[p4l1684t1874r1920b1953],
34	cyclophosphamide	NN	O	cyclophosphamide	dep	163	SENT_109	[p4l1954t1885r2146b1953, p4l10t1972r448b2041],
35	600	CD	NUMBER	600	dep	163	SENT_109	[p4l467t1975r584b2027],
36	mg/m2	NN	O	mg/m2	dep	163	SENT_109	[p4l606t1962r841b2041],
37	,	,	O	,	_	0	SENT_109	[p4l606t1962r841b2041],
38	on	IN	O	on	dep	163	SENT_109	[p4l861t1989r939b2027],
39	day	NN	DURATION	day	dep	163	SENT_109	[p4l957t1973r1071b2041],
40	1	CD	NUMBER	1	dep	163	SENT_109	[p4l1093t1976r1141b2036],
41	,	,	O	,	_	0	SENT_109	[p4l1093t1976r1141b2036],
42	1	CD	NUMBER	1	dep	163	SENT_109	[p4l1163t1976r1188b2027],
43	5-day	JJ	DURATION	5-day	dep	163	SENT_109	[p4l1202t1972r1386b2041],
44	intervals	NNS	O	interval	dep	163	SENT_109	[p4l1403t1973r1681b2027],
45	for	IN	O	for	dep	163	SENT_109	[p4l1701t1972r1790b2027],
46	six	CD	NUMBER	six	dep	163	SENT_109	[p4l1808t1973r1896b2027],
47	cycles	NNS	O	cycle	dep	163	SENT_109	[p4l1913t1972r2146b2041],
48	)	RB	O	)	dep	163	SENT_109	[p4l1913t1972r2146b2041],
49	,	,	O	,	_	0	SENT_109	[p4l1913t1972r2146b2041],
50	FEC	NN	ORGANIZATION	fec	dep	163	SENT_109	[p4l10t2064r124b2116],
51	+	CC	O	+	dep	163	SENT_109	[p4l145t2073r179b2107],
52	docetaxel	NN	O	docetaxel	dep	163	SENT_109	[p4l201t2061r508b2116],
53	regimen	NN	O	regimen	dep	163	SENT_109	[p4l559t2062r824b2129],
54	(	CD	NUMBER	(	dep	163	SENT_109	[p4l874t2061r1344b2129],
55	5-ﬂuorouracil	NN	O	5-ﬂuorouracil	dep	163	SENT_109	[p4l874t2061r1344b2129],
56	600	CD	NUMBER	600	dep	163	SENT_109	[p4l1395t2064r1511b2116],
57	mg/m2	NN	O	mg/m2	dep	163	SENT_109	[p4l1533t2051r1769b2129],
58	,	,	O	,	_	0	SENT_109	[p4l1533t2051r1769b2129],
59	epirubicin	NN	O	epirubicin	dep	163	SENT_109	[p4l1819t2061r2146b2129],
60	90	CD	NUMBER	90	dep	163	SENT_109	[p4l10t2151r87b2203],
61	mg/m2	NN	O	mg/m2	dep	163	SENT_109	[p4l109t2138r344b2217],
62	,	,	O	,	_	0	SENT_109	[p4l109t2138r344b2217],
63	cyclophosphamide	NN	O	cyclophosphamide	dep	163	SENT_109	[p4l404t2148r1009b2217],
64	600	CD	NUMBER	600	dep	163	SENT_109	[p4l1069t2151r1185b2203],
65	mg/m2	NN	O	mg/m2	dep	163	SENT_109	[p4l1208t2138r1443b2217],
66	,	,	O	,	_	0	SENT_109	[p4l1208t2138r1443b2217],
67	on	IN	O	on	dep	163	SENT_109	[p4l1502t2164r1580b2203],
68	day	NN	DURATION	day	dep	163	SENT_109	[p4l1639t2148r1753b2217],
69	1	CD	NUMBER	1	dep	163	SENT_109	[p4l1814t2151r1863b2212],
70	,	,	O	,	_	0	SENT_109	[p4l1814t2151r1863b2212],
71	15-day	JJ	DURATION	15-day	dep	163	SENT_109	[p4l1926t2148r2147b2217],
72	intervals	NNS	O	interval	dep	163	SENT_109	[p4l11t2248r289b2303],
73	for	IN	O	for	dep	163	SENT_109	[p4l332t2248r421b2303],
74	four	CD	NUMBER	four	dep	163	SENT_109	[p4l461t2248r593b2303],
75	cycles	NNS	O	cycle	dep	163	SENT_109	[p4l632t2248r823b2316],
76	followed	VBN	O	follow	dep	163	SENT_109	[p4l866t2248r1146b2303],
77	by	IN	O	by	dep	163	SENT_109	[p4l1187t2248r1265b2316],
78	docetaxel	NN	O	docetaxel	dep	163	SENT_109	[p4l1305t2248r1612b2303],
79	100	CD	NUMBER	100	dep	163	SENT_109	[p4l1658t2251r1772b2303],
80	mg/m2	NN	O	mg/m2	dep	163	SENT_109	[p4l1794t2238r2029b2316],
81	,	,	O	,	_	0	SENT_109	[p4l1794t2238r2029b2316],
82	on	IN	O	on	dep	163	SENT_109	[p4l2072t2264r2150b2303],
83	day	NN	DURATION	day	dep	163	SENT_109	[p4l11t2336r125b2405],
84	1	CD	NUMBER	1	dep	163	SENT_109	[p4l158t2339r207b2400],
85	,	,	O	,	_	0	SENT_109	[p4l158t2339r207b2400],
86	21-day	JJ	DURATION	21-day	dep	163	SENT_109	[p4l238t2336r464b2405],
87	intervals	NNS	O	interval	dep	163	SENT_109	[p4l495t2336r773b2391],
88	for	IN	O	for	dep	163	SENT_109	[p4l805t2336r895b2391],
89	four	CD	NUMBER	four	dep	163	SENT_109	[p4l924t2336r1056b2391],
90	cycles	NNS	O	cycle	dep	163	SENT_109	[p4l1085t2336r1318b2405],
91	)	RB	O	)	dep	163	SENT_109	[p4l1085t2336r1318b2405],
92	,	,	O	,	_	0	SENT_109	[p4l1085t2336r1318b2405],
93	FEC	NN	ORGANIZATION	fec	dep	163	SENT_109	[p4l1351t2339r1465b2391],
94	+	CC	O	+	dep	163	SENT_109	[p4l1486t2348r1520b2382],
95	paclitaxel	NN	O	paclitaxel	dep	163	SENT_109	[p4l1542t2336r1852b2405],
96	regimen	NN	O	regimen	dep	163	SENT_109	[p4l1885t2337r2150b2405],
97	(	CD	NUMBER	(	dep	163	SENT_109	[p4l11t2424r481b2492],
98	5-ﬂuorouracil	NN	O	5-ﬂuorouracil	dep	163	SENT_109	[p4l11t2424r481b2492],
99	600	CD	NUMBER	600	dep	163	SENT_109	[p4l522t2427r639b2479],
100	mg/m2	NN	O	mg/m2	dep	163	SENT_109	[p4l661t2414r897b2493],
101	,	,	O	,	_	0	SENT_109	[p4l661t2414r897b2493],
102	epirubicin	NN	O	epirubicin	dep	163	SENT_109	[p4l937t2424r1265b2493],
103	90	CD	NUMBER	90	dep	163	SENT_109	[p4l1305t2427r1382b2479],
104	mg/m2	NN	O	mg/m2	dep	163	SENT_109	[p4l1404t2414r1639b2493],
105	,	,	O	,	_	0	SENT_109	[p4l1404t2414r1639b2493],
106	cyclophosphamide	NN	O	cyclophosphamide	dep	163	SENT_109	[p4l1681t2424r2150b2493, p4l11t2513r171b2568],
107	600	CD	NUMBER	600	dep	163	SENT_109	[p4l221t2516r338b2568],
108	mg/m2	NN	O	mg/m2	dep	163	SENT_109	[p4l361t2502r596b2581],
109	,	,	O	,	_	0	SENT_109	[p4l361t2502r596b2581],
110	on	IN	O	on	dep	163	SENT_109	[p4l646t2529r724b2568],
111	day	NN	DURATION	day	dep	163	SENT_109	[p4l774t2513r888b2581],
112	1	CD	NUMBER	1	dep	163	SENT_109	[p4l940t2516r988b2576],
113	,	,	O	,	_	0	SENT_109	[p4l940t2516r988b2576],
114	15-day	JJ	DURATION	15-day	dep	163	SENT_109	[p4l1042t2513r1264b2581],
115	intervals	NNS	O	interval	dep	163	SENT_109	[p4l1313t2513r1591b2568],
116	for	IN	O	for	dep	163	SENT_109	[p4l1642t2513r1732b2568],
117	four	CD	NUMBER	four	dep	163	SENT_109	[p4l1779t2513r1911b2568],
118	cycles	NNS	O	cycle	dep	163	SENT_109	[p4l1958t2513r2149b2581],
119	followed	VBN	O	follow	dep	163	SENT_109	[p4l11t2600r290b2655],
120	by	IN	O	by	dep	163	SENT_109	[p4l324t2600r402b2669],
121	paclitaxel	NN	O	paclitaxel	dep	163	SENT_109	[p4l434t2600r744b2669],
122	100	CD	NUMBER	100	dep	163	SENT_109	[p4l782t2603r896b2655],
123	mg/m2	NN	O	mg/m2	dep	163	SENT_109	[p4l918t2590r1154b2669],
124	,	,	O	,	_	0	SENT_109	[p4l918t2590r1154b2669],
125	on	IN	O	on	dep	163	SENT_109	[p4l1188t2617r1267b2655],
126	day	NN	DURATION	day	dep	163	SENT_109	[p4l1300t2600r1414b2669],
127	1	CD	NUMBER	1	dep	163	SENT_109	[p4l1450t2604r1498b2664],
128	,	,	O	,	_	0	SENT_109	[p4l1450t2604r1498b2664],
129	7-day	JJ	DURATION	7-day	dep	163	SENT_109	[p4l1534t2600r1718b2669],
130	intervals	NNS	O	interval	dep	163	SENT_109	[p4l1750t2600r2027b2655],
131	for	IN	O	for	dep	163	SENT_109	[p4l2063t2600r2152b2655],
132	four	CD	NUMBER	four	dep	163	SENT_109	[p4l11t2689r143b2744],
133	cycles	NNS	O	cycle	dep	163	SENT_109	[p4l167t2689r384b2757],
134	)	CD	NUMBER	)	dep	163	SENT_109	[p4l167t2689r384b2757],
135	and	CC	O	and	dep	163	SENT_109	[p4l411t2689r527b2744],
136	CMF	NNP	O	CMF	dep	163	SENT_109	[p4l554t2692r697b2744],
137	(	CD	NUMBER	(	dep	163	SENT_109	[p4l721t2689r1355b2757],
138	cyclophosphamide	NN	O	cyclophosphamide	dep	163	SENT_109	[p4l721t2689r1355b2757],
139	600	CD	NUMBER	600	dep	163	SENT_109	[p4l1381t2692r1498b2744],
140	mg/m2	NN	O	mg/m2	dep	163	SENT_109	[p4l1521t2678r1756b2757],
141	,	,	O	,	_	0	SENT_109	[p4l1521t2678r1756b2757],
142	methotrex	NN	O	methotrex	dep	163	SENT_109	[p4l1784t2689r2150b2744],
143	—	CD	NUMBER	—	dep	163	SENT_109	[p4l1784t2689r2150b2744],
144	ate	VBD	O	eat	dep	163	SENT_109	[p4l11t2785r106b2832],
145	40	CD	NUMBER	40	dep	163	SENT_109	[p4l164t2780r243b2832],
146	mg/m2	NN	O	mg/m2	dep	163	SENT_109	[p4l265t2767r500b2845],
147	,	,	O	,	_	0	SENT_109	[p4l265t2767r500b2845],
148	5	CD	NUMBER	5	dep	163	SENT_109	[p4l562t2777r1005b2832],
149	—	NN	O	—	dep	163	SENT_109	[p4l562t2777r1005b2832],
150	ﬂuorouracil	NN	O	ﬂuorouracil	dep	163	SENT_109	[p4l562t2777r1005b2832],
151	600	CD	NUMBER	600	dep	163	SENT_109	[p4l1067t2780r1184b2832],
152	mg/m2	NN	O	mg/m2	dep	163	SENT_109	[p4l1206t2767r1441b2845],
153	,	,	O	,	_	0	SENT_109	[p4l1206t2767r1441b2845],
154	on	IN	O	on	dep	163	SENT_109	[p4l1502t2793r1580b2832],
155	day	NN	DURATION	day	dep	163	SENT_109	[p4l1640t2777r1754b2845],
156	1	CD	NUMBER	1	dep	163	SENT_109	[p4l1816t2780r1864b2840],
157	,	,	O	,	_	0	SENT_109	[p4l1816t2780r1864b2840],
158	21-day	JJ	DURATION	21-day	dep	163	SENT_109	[p4l1925t2777r2151b2845],
159	intervals	NNS	O	interval	dep	163	SENT_109	[p4l11t2865r289b2920],
160	for	IN	O	for	dep	163	SENT_109	[p4l316t2865r405b2920],
161	six	CD	NUMBER	six	dep	163	SENT_109	[p4l429t2866r518b2920],
162	cycles	NNS	O	cycle	dep	163	SENT_109	[p4l542t2865r775b2934],
163	)	CD	NUMBER	)	_	0	SENT_109	[p4l542t2865r775b2934],
164	.	.	O	.	_	0	SENT_109	[p4l542t2865r775b2934],

1	After	IN	O	after	_	0	SENT_110	[p4l798t2865r961b2920],
2	completion	NN	O	completion	prep_after	8	SENT_110	[p4l984t2865r1350b2934],
3	of	IN	O	of	_	0	SENT_110	[p4l1375t2865r1441b2920],
4	neoadjuvant	JJ	O	neoadjuvant	amod	5	SENT_110	[p4l1459t2865r1862b2934],
5	therapy	NN	O	therapy	prep_of	2	SENT_110	[p4l1885t2865r2149b2934],
6	,	,	O	,	_	0	SENT_110	[p4l1885t2865r2149b2934],
7	patients	NNS	O	patient	nsubj	8	SENT_110	[p4l11t2955r269b3023],
8	received	VBD	O	receive	_	0	SENT_110	[p4l312t2954r581b3009],
9	either	CC	O	either	prep	8	SENT_110	[p4l623t2954r814b3009],
10	breast	NN	O	breast	nn	11	SENT_110	[p4l852t2954r1435b3023],
11	—	NN	O	—	dep	9	SENT_110	[p4l852t2954r1435b3023],
12	conserving	VBG	O	conserve	xcomp	8	SENT_110	[p4l852t2954r1435b3023],
13	surgery	NN	O	surgery	dobj	12	SENT_110	[p4l1476t2970r1718b3023],
14	or	CC	O	or	_	0	SENT_110	[p4l1757t2970r1823b3009],
15	modified	VBN	O	modify	amod	17	SENT_110	[p4l1864t2954r2149b3009],
16	radical	JJ	O	radical	amod	17	SENT_110	[p4l11t3043r226b3098],
17	mastectomy	NN	O	mastectomy	conj_or	13	SENT_110	[p4l266t3052r665b3112],
18	depending	VBG	O	depend	_	0	SENT_110	[p4l702t3043r1043b3112],
19	on	IN	O	on	prepc_depending_on	12	SENT_110	[p4l1081t3059r1159b3098],
20	the	DT	O	the	det	22	SENT_110	[p4l1198t3043r1300b3098],
21	tumour	NN	O	tumour	nn	22	SENT_110	[p4l1338t3052r1582b3098],
22	size	NN	O	size	pobj	12	SENT_110	[p4l1620t3044r1755b3099],
23	.	.	O	.	_	0	SENT_110	[p4l1620t3044r1755b3099],

1	The	DT	ORGANIZATION	the	det	5	SENT_111	[p4l1792t3043r1910b3098],
2	World	NNP	ORGANIZATION	World	nn	5	SENT_111	[p4l1946t3043r2149b3098],
3	Health	NNP	ORGANIZATION	Health	nn	5	SENT_111	[p4l11t3132r224b3187],
4	Organization	NNP	ORGANIZATION	Organization	nn	5	SENT_111	[p4l242t3133r659b3201],
5	criterion	NN	O	criterion	nsubjpass	7	SENT_111	[p4l677t3133r953b3187],
6	was	VBD	O	be	auxpass	7	SENT_111	[p4l969t3148r1093b3187],
7	applied	VBN	O	apply	_	0	SENT_111	[p4l1114t3132r1351b3201],
8	to	TO	O	to	aux	9	SENT_111	[p4l1369t3141r1431b3187],
9	assess	VB	O	assess	xcomp	7	SENT_111	[p4l1450t3148r1644b3187],
10	the	DT	O	the	det	11	SENT_111	[p4l1663t3132r1766b3187],
11	response	NN	O	response	dobj	9	SENT_111	[p4l1785t3148r2069b3201],
12	to	TO	O	to	_	0	SENT_111	[p4l2088t3141r2149b3187],
13	therapy	NN	O	therapy	prep_to	9	SENT_111	[p4l10t3222r260b3290],
14	[	CD	NUMBER	[	num	13	SENT_111	[p4l292t3222r434b3290],
15	25	CD	NUMBER	25	num	16	SENT_111	[p4l292t3222r434b3290],
16	]	NN	O	]	dep	13	SENT_111	[p4l292t3222r434b3290],
17	.	.	O	.	_	0	SENT_111	[p4l292t3222r434b3290],

1	A	DT	O	a	det	4	SENT_112	[p4l464t3224r510b3276],
2	complete	JJ	O	complete	amod	4	SENT_112	[p4l539t3222r837b3290],
3	pathologic	JJ	O	pathologic	amod	4	SENT_112	[p4l867t3222r1206b3290],
4	response	NN	O	response	nsubjpass	6	SENT_112	[p4l1237t3238r1521b3290],
5	was	VBD	O	be	auxpass	6	SENT_112	[p4l1550t3238r1675b3277],
6	deﬁned	VBN	O	deﬁned	_	0	SENT_112	[p4l1707t3222r1946b3277],
7	as	IN	O	as	_	0	SENT_112	[p4l1977t3238r2039b3277],
8	no	DT	O	no	det	9	SENT_112	[p4l2073t3238r2150b3277],
9	evidence	NN	O	evidence	prep_as	6	SENT_112	[p4l11t3311r294b3366],
10	of	IN	O	of	_	0	SENT_112	[p4l335t3311r401b3366],
11	residual	JJ	O	residual	amod	13	SENT_112	[p4l435t3311r690b3366],
12	invasive	JJ	O	invasive	amod	13	SENT_112	[p4l732t3312r994b3366],
13	disease	NN	O	disease	prep_of	9	SENT_112	[p4l1035t3311r1267b3366],
14	in	IN	O	in	_	0	SENT_112	[p4l1308t3312r1367b3365],
15	the	DT	O	the	det	19	SENT_112	[p4l1407t3311r1509b3366],
16	breast	NN	O	breast	nn	19	SENT_112	[p4l1549t3311r1748b3366],
17	and	CC	O	and	_	0	SENT_112	[p4l1786t3311r1903b3366],
18	lymph	NN	O	lymph	nn	19	SENT_112	[p4l1945t3311r2150b3379],
19	nodes	NNS	O	node	prep_in	13	SENT_112	[p4l11t3399r214b3455],
20	.	.	O	.	_	0	SENT_112	[p4l11t3399r214b3455],

1	A	DT	O	a	det	2	SENT_113	[p4l255t3402r302b3454],
2	<	JJR	O	<	nsubjpass	8	SENT_113	[p4l344t3402r517b3456],
3	50	CD	PERCENT	50	number	4	SENT_113	[p4l344t3402r517b3456],
4	%	NN	PERCENT	%	amod	2	SENT_113	[p4l344t3402r517b3456],
5	of	IN	O	of	_	0	SENT_113	[p4l559t3399r625b3454],
6	response	NN	O	response	prep_of	2	SENT_113	[p4l660t3415r945b3468],
7	was	VBD	O	be	auxpass	8	SENT_113	[p4l985t3415r1110b3454],
8	considered	VBN	O	consider	_	0	SENT_113	[p4l1153t3399r1503b3454],
9	when	WRB	O	when	advmod	12	SENT_113	[p4l1544t3399r1724b3454],
10	the	DT	O	the	det	11	SENT_113	[p4l1765t3399r1866b3454],
11	tumour	NN	O	tumour	nsubj	12	SENT_113	[p4l1908t3407r2152b3454],
12	reduced	VBD	O	reduce	advcl	8	SENT_113	[p4l11t3488r268b3543],
13	its	PRP$	O	its	poss	14	SENT_113	[p4l297t3489r370b3543],
14	size	NN	O	size	dep	12	SENT_113	[p4l400t3489r520b3543],
15	<	JJR	O	<	dobj	12	SENT_113	[p4l550t3491r739b3545],
16	50	CD	PERCENT	50	number	17	SENT_113	[p4l550t3491r739b3545],
17	%	NN	PERCENT	%	amod	15	SENT_113	[p4l550t3491r739b3545],
18	.	.	O	.	_	0	SENT_113	[p4l550t3491r739b3545],

1	A	DT	O	a	det	2	SENT_114	[p4l766t3490r813b3542],
2	>	JJR	O	>	nsubjpass	8	SENT_114	[p4l841t3491r1013b3545],
3	50	CD	PERCENT	50	number	4	SENT_114	[p4l841t3491r1013b3545],
4	%	NN	PERCENT	%	amod	2	SENT_114	[p4l841t3491r1013b3545],
5	of	IN	O	of	_	0	SENT_114	[p4l1042t3488r1108b3543],
6	response	NN	O	response	prep_of	2	SENT_114	[p4l1128t3504r1413b3557],
7	was	VBD	O	be	auxpass	8	SENT_114	[p4l1439t3504r1564b3543],
8	considered	VBN	O	consider	_	0	SENT_114	[p4l1593t3488r1944b3543],
9	when	WRB	O	when	advmod	12	SENT_114	[p4l1970t3488r2150b3543],
10	the	DT	O	the	det	11	SENT_114	[p4l10t3577r112b3632],
11	tumour	NN	O	tumour	nsubj	12	SENT_114	[p4l130t3586r374b3632],
12	reduced	VBD	O	reduce	advcl	8	SENT_114	[p4l391t3577r648b3632],
13	its	PRP$	O	its	poss	14	SENT_114	[p4l668t3578r741b3632],
14	size	NN	O	size	dep	12	SENT_114	[p4l761t3578r881b3632],
15	>	JJR	O	>	dobj	12	SENT_114	[p4l903t3580r1091b3634],
16	50	CD	PERCENT	50	number	17	SENT_114	[p4l903t3580r1091b3634],
17	%	NN	PERCENT	%	amod	15	SENT_114	[p4l903t3580r1091b3634],
18	.	.	O	.	_	0	SENT_114	[p4l903t3580r1091b3634],

1	And	CC	O	and	cc	5	SENT_115	[p4l1108t3577r1237b3632],
2	no	DT	O	no	det	3	SENT_115	[p4l1256t3593r1333b3632],
3	response	NN	O	response	nsubjpass	5	SENT_115	[p4l1353t3593r1638b3646],
4	was	VBD	O	be	auxpass	5	SENT_115	[p4l1655t3593r1779b3632],
5	considered	VBN	O	consider	_	0	SENT_115	[p4l1799t3577r2150b3632],
6	when	WRB	O	when	advmod	11	SENT_115	[p4l9t3666r189b3721],
7	the	DT	O	the	det	8	SENT_115	[p4l230t3666r332b3721],
8	tumour	NN	O	tumour	nsubj	11	SENT_115	[p4l374t3675r618b3721],
9	did	VBD	O	do	aux	11	SENT_115	[p4l659t3666r758b3721],
10	not	RB	O	not	neg	11	SENT_115	[p4l802t3675r907b3721],
11	modify	VB	O	modify	advcl	5	SENT_115	[p4l949t3666r1176b3735],
12	its	PRP$	O	its	poss	13	SENT_115	[p4l1218t3667r1291b3721],
13	size	NN	O	size	dobj	11	SENT_115	[p4l1335t3667r1455b3721],
14	after	IN	O	after	_	0	SENT_115	[p4l1497t3666r1648b3721],
15	PST	NNP	O	PST	prep_after	11	SENT_115	[p4l1688t3669r1814b3722],
16	.	.	O	.	_	0	SENT_115	[p4l1688t3669r1814b3722],

1	Common	JJ	O	common	_	0	SENT_116	[p4l1859t3669r2151b3721],

1	Toxicity	NN	O	toxicity	nn	2	SENT_117	[p5l8t18r268b85],
2	Criteria	NNS	O	criterion	nsubj	3	SENT_117	[p5l284t18r523b72],
3	(	VBP	O	(	_	0	SENT_117	[p5l540t17r839b85],
4	National	NNP	ORGANIZATION	National	nn	7	SENT_117	[p5l540t17r839b85],
5	Cancer	NNP	ORGANIZATION	Cancer	nn	7	SENT_117	[p5l858t20r1077b72],
6	Institute	NNP	ORGANIZATION	Institute	nn	7	SENT_117	[p5l1093t17r1391b85],
7	)	NN	O	)	nsubjpass	9	SENT_117	[p5l1093t17r1391b85],
8	was	VBD	O	be	auxpass	9	SENT_117	[p5l1407t33r1531b72],
9	used	VBN	O	use	ccomp	3	SENT_117	[p5l1550t17r1698b72],
10	to	TO	O	to	aux	11	SENT_117	[p5l1716t25r1778b72],
11	classify	VB	O	classify	xcomp	9	SENT_117	[p5l1796t17r2032b85],
12	the	DT	O	the	det	13	SENT_117	[p5l2048t17r2150b72],
13	grade	NN	O	grade	dobj	11	SENT_117	[p5l10t106r188b174],
14	of	IN	O	of	_	0	SENT_117	[p5l217t106r283b161],
15	adverse	JJ	O	adverse	amod	16	SENT_117	[p5l303t106r550b161],
16	reaction	NN	O	reaction	prep_of	13	SENT_117	[p5l579t107r840b161],
17	to	TO	O	to	_	0	SENT_117	[p5l868t114r930b161],
18	chemotherapy	NN	O	chemotherapy	prep_to	11	SENT_117	[p5l958t106r1440b174],
19	.	.	O	.	_	0	SENT_117	[p5l958t106r1440b174],

1	2.4	CD	NUMBER	2.4	_	0	SENT_118	[p5l7t287r113b339],
2	.	.	O	.	_	0	SENT_118	[p5l7t287r113b339],

1	Genotyping	VBG	O	genotype	_	0	SENT_119	[p5l157t285r512b353],

1	Polymorphic	JJ	O	polymorphic	amod	2	SENT_120	[p5l113t462r523b531],
2	sites	NNS	O	site	nsubjpass	26	SENT_120	[p5l548t463r689b517],
3	in	IN	O	in	_	0	SENT_120	[p5l716t463r776b517],
4	TYMS	NN	O	tym	nn	7	SENT_120	[p5l798t465r982b517],
5	(	CD	NUMBER	(	num	7	SENT_120	[p5l1007t463r1230b531],
6	TSER	NN	O	tser	nn	7	SENT_120	[p5l1007t463r1230b531],
7	)	NN	O	)	prep_in	2	SENT_120	[p5l1007t463r1230b531],
8	,	,	O	,	_	0	SENT_120	[p5l1007t463r1230b531],
9	MTHFR	NN	O	mthfr	nn	12	SENT_120	[p5l1257t466r1494b517],
10	(	CD	NUMBER	(	num	12	SENT_120	[p5l1516t462r1785b531],
11	C677T	NN	O	c677t	nn	12	SENT_120	[p5l1516t462r1785b531],
12	)	NN	O	)	conj_and	2	SENT_120	[p5l1516t462r1785b531],
13	,	,	O	,	_	0	SENT_120	[p5l1516t462r1785b531],
14	p53	NN	O	p53	nn	15	SENT_120	[p5l1812t465r1928b531],
15	codon	NN	O	codon	conj_and	2	SENT_120	[p5l1956t462r2150b517],
16	72	CD	NUMBER	72	number	17	SENT_120	[p5l12t555r86b606],
17	(	CD	NUMBER	(	num	19	SENT_120	[p5l118t552r412b620],
18	Arg/Pro	NN	O	arg/pro	nn	19	SENT_120	[p5l118t552r412b620],
19	)	NN	O	)	dep	15	SENT_120	[p5l118t552r412b620],
20	and	CC	O	and	_	0	SENT_120	[p5l441t552r557b607],
21	MDR1	NN	O	mdr1	nn	24	SENT_120	[p5l588t555r776b606],
22	(	CD	NUMBER	(	num	24	SENT_120	[p5l814t552r1109b620],
23	C3435T	NN	O	c3435t	nn	24	SENT_120	[p5l814t552r1109b620],
24	)	NN	O	)	conj_and	2	SENT_120	[p5l814t552r1109b620],
25	were	VBD	O	be	auxpass	26	SENT_120	[p5l1136t568r1296b607],
26	examined	VBN	O	examine	_	0	SENT_120	[p5l1326t552r1642b607],
27	by	IN	O	by	_	0	SENT_120	[p5l1671t552r1748b620],
28	polymerase	NN	O	polymerase	nn	35	SENT_120	[p5l1776t552r2150b620],
29	chain	NN	O	chain	nn	35	SENT_120	[p5l11t641r184b696],
30	reaction	NN	O	reaction	nn	35	SENT_120	[p5l222t642r850b696],
31	—	NN	O	—	nn	35	SENT_120	[p5l222t642r850b696],
32	restriction	NN	O	restriction	nn	35	SENT_120	[p5l222t642r850b696],
33	fragment	NN	O	fragment	nn	35	SENT_120	[p5l888t641r1183b709],
34	length	NN	O	length	nn	35	SENT_120	[p5l1220t641r1424b709],
35	polymorphism	NN	O	polymorphism	agent	26	SENT_120	[p5l1461t641r1936b709],
36	(	CD	NUMBER	(	num	37	SENT_120	[p5l1973t641r2149b709],
37	PCR	NN	O	pcr	dep	35	SENT_120	[p5l1973t641r2149b709],
38	—	CD	NUMBER	—	num	41	SENT_120	[p5l1973t641r2149b709],
39	RFLP	NN	MISC	rflp	nn	41	SENT_120	[p5l11t729r186b798],
40	)	NN	O	)	nn	41	SENT_120	[p5l11t729r186b798],
41	analysis	NN	O	analysis	tmod	26	SENT_120	[p5l221t729r476b798],
42	as	IN	O	as	_	0	SENT_120	[p5l512t745r574b784],
43	previously	RB	DATE	previously	advmod	44	SENT_120	[p5l610t729r948b798],
44	reported	VBN	O	report	amod	45	SENT_120	[p5l982t729r1257b798],
45	[	NN	O	[	prep_as	41	SENT_120	[p5l1296t729r1437b798],
46	26	CD	NUMBER	26	num	47	SENT_120	[p5l1296t729r1437b798],
47	]	NN	O	]	dep	41	SENT_120	[p5l1296t729r1437b798],
48	.	.	O	.	_	0	SENT_120	[p5l1296t729r1437b798],

1	Except	IN	O	except	_	0	SENT_121	[p5l1474t733r1688b798],
2	for	IN	O	for	prepc_except_for	9	SENT_121	[p5l1722t729r1811b784],
3	TSER	NN	O	tser	pobj	9	SENT_121	[p5l1840t732r2013b793],
4	,	,	O	,	_	0	SENT_121	[p5l1840t732r2013b793],
5	the	DT	O	the	det	7	SENT_121	[p5l2048t729r2150b784],
6	ampliﬁed	JJ	O	ampliﬁed	amod	7	SENT_121	[p5l11t818r316b887],
7	fragments	NNS	O	fragment	nsubjpass	9	SENT_121	[p5l348t818r672b887],
8	were	VBD	O	be	auxpass	9	SENT_121	[p5l704t834r863b873],
9	digested	VBN	O	digest	_	0	SENT_121	[p5l896t818r1166b887],
10	with	IN	O	with	_	0	SENT_121	[p5l1197t818r1345b873],
11	the	DT	O	the	det	13	SENT_121	[p5l1376t818r1478b873],
12	appropriate	JJ	O	appropriate	amod	13	SENT_121	[p5l1509t819r1886b887],
13	restriction	NN	O	restriction	prep_with	9	SENT_121	[p5l1919t819r2149b873, p5l10t908r137b962],
14	endonucleases	NNS	O	endonuclease	nsubj	15	SENT_121	[p5l157t907r626b962],
15	(	VBP	O	(	rcmod	13	SENT_121	[p5l648t907r822b976],
16	New	NNP	LOCATION	New	nn	19	SENT_121	[p5l648t907r822b976],
17	England	NNP	LOCATION	England	nn	19	SENT_121	[p5l840t907r1098b976],
18	BioLabs	NNP	O	BioLabs	nn	19	SENT_121	[p5l1120t907r1405b976],
19	)	NN	O	)	dobj	15	SENT_121	[p5l1120t907r1405b976],
20	.	.	O	.	_	0	SENT_121	[p5l1120t907r1405b976],

1	After	IN	O	after	_	0	SENT_122	[p5l1424t907r1586b962],
2	incubation	NN	O	incubation	prep_after	14	SENT_122	[p5l1605t907r1949b962],
3	at	IN	O	at	_	0	SENT_122	[p5l1969t916r2029b962],
4	the	DT	O	the	det	6	SENT_122	[p5l2048t907r2150b962],
5	optimal	JJ	O	optimal	amod	6	SENT_122	[p5l11t996r258b1065],
6	temperature	NN	O	temperature	prep_at	2	SENT_122	[p5l288t1005r707b1065],
7	,	,	O	,	_	0	SENT_122	[p5l288t1005r707b1065],
8	20	CD	NUMBER	20	num	9	SENT_122	[p5l737t999r814b1051],
9	ul	NN	O	ul	nsubjpass	14	SENT_122	[p5l840t996r908b1068],
10	of	IN	O	of	_	0	SENT_122	[p5l938t996r1004b1051],
11	digested	VBN	O	digest	amod	12	SENT_122	[p5l1026t996r1296b1065],
12	product	NN	O	product	prep_of	9	SENT_122	[p5l1326t996r1578b1065],
13	was	VBD	O	be	auxpass	14	SENT_122	[p5l1604t1012r1728b1051],
14	analyzed	VBN	O	analyze	_	0	SENT_122	[p5l1759t996r2045b1065],
15	by	IN	O	by	_	0	SENT_122	[p5l2073t996r2151b1065],
16	gel	NN	O	gel	nn	17	SENT_122	[p5l9t1085r101b1153],
17	electrophoresis	NN	O	electrophoresis	agent	14	SENT_122	[p5l154t1085r647b1153],
18	on	IN	O	on	_	0	SENT_122	[p5l699t1101r777b1140],
19	a	DT	O	a	det	27	SENT_122	[p5l828t1101r861b1140],
20	2	CD	PERCENT	2	num	21	SENT_122	[p5l912t1088r1075b1140],
21	—	NN	PERCENT	—	npadvmod	24	SENT_122	[p5l912t1088r1075b1140],
22	3	CD	PERCENT	3	number	23	SENT_122	[p5l912t1088r1075b1140],
23	%	NN	PERCENT	%	amod	21	SENT_122	[p5l912t1088r1075b1140],
24	low	JJ	O	low	amod	27	SENT_122	[p5l1127t1085r1245b1140],
25	melting	NN	O	melting	nn	27	SENT_122	[p5l1295t1085r1544b1153],
26	agarose	NN	O	agarose	nn	27	SENT_122	[p5l1594t1101r1838b1153],
27	gel	NN	O	gel	prep_on	17	SENT_122	[p5l1888t1085r1980b1153],
28	and	CC	O	and	_	0	SENT_122	[p5l2033t1085r2149b1140],
29	visualized	VBN	O	visualize	conj_and	14	SENT_122	[p5l9t1174r333b1229],
30	under	IN	O	under	_	0	SENT_122	[p5l358t1174r548b1229],
31	ultraviolet	JJ	O	ultraviolet	amod	32	SENT_122	[p5l570t1174r907b1229],
32	light	NN	O	light	prep_under	29	SENT_122	[p5l930t1174r1076b1242],
33	in	IN	O	in	_	0	SENT_122	[p5l1099t1175r1159b1228],
34	a	DT	O	a	det	38	SENT_122	[p5l1183t1190r1215b1229],
35	ChemiDoc	NNP	MISC	ChemiDoc	nn	38	SENT_122	[p5l1239t1174r1569b1229],
36	System	NNP	MISC	System	nn	38	SENT_122	[p5l1592t1177r1824b1242],
37	(	NNP	O	(	nn	38	SENT_122	[p5l1848t1174r2150b1242],
38	Bio	NNP	O	Bio	prep_in	32	SENT_122	[p5l1848t1174r2150b1242],
39	.	.	O	.	_	0	SENT_122	[p5l1848t1174r2150b1242],

1	—	NN	O	—	_	0	SENT_123	[p5l1848t1174r2150b1242],
2	.	.	O	.	_	0	SENT_123	[p5l1848t1174r2150b1242],

1	Rad	NN	MISC	rad	nn	2	SENT_124	[p5l1848t1174r2150b1242],
2	)	NN	O	)	_	0	SENT_124	[p5l1848t1174r2150b1242],
3	after	IN	O	after	_	0	SENT_124	[p5l11t1262r161b1317],
4	staining	VBG	O	stain	prepc_after	2	SENT_124	[p5l187t1263r445b1331],
5	with	IN	O	with	_	0	SENT_124	[p5l470t1262r618b1317],
6	ethidium	NN	O	ethidium	nn	7	SENT_124	[p5l646t1262r941b1317],
7	bromide	NN	O	bromide	prep_with	4	SENT_124	[p5l968t1262r1239b1317],
8	(	CD	NUMBER	(	num	10	SENT_124	[p5l1267t1262r1528b1331],
9	Pierce	NNP	PERSON	Pierce	nn	10	SENT_124	[p5l1267t1262r1528b1331],
10	)	NN	O	)	dobj	4	SENT_124	[p5l1267t1262r1528b1331],
11	.	.	O	.	_	0	SENT_124	[p5l1267t1262r1528b1331],

1	2.5	CD	NUMBER	2.5	_	0	SENT_125	[p5l7t1443r113b1496],
2	.	.	O	.	_	0	SENT_125	[p5l7t1443r113b1496],

1	Statistical	JJ	O	statistical	amod	2	SENT_126	[p5l153t1440r457b1495],
2	analyses	NNS	O	analysis	_	0	SENT_126	[p5l484t1440r743b1509],

1	Determination	NN	O	determination	_	0	SENT_127	[p5l113t1620r584b1674],
2	of	IN	O	of	_	0	SENT_127	[p5l633t1619r700b1674],
3	the	DT	O	the	det	4	SENT_127	[p5l741t1619r842b1674],
4	deviation	NN	O	deviation	prep_of	1	SENT_127	[p5l892t1619r1193b1674],
5	from	IN	O	from	_	0	SENT_127	[p5l1243t1619r1395b1674],
6	the	DT	O	the	det	7	SENT_127	[p5l1443t1619r1545b1674],
7	Hardy	NNP	PERSON	Hardy	prep_from	1	SENT_127	[p5l1595t1619r2152b1687],
8	.	.	O	.	_	0	SENT_127	[p5l1595t1619r2152b1687],

1	—	NN	O	—	_	0	SENT_128	[p5l1595t1619r2152b1687],
2	.	.	O	.	_	0	SENT_128	[p5l1595t1619r2152b1687],

1	Weinberg	NNP	PERSON	Weinberg	nn	2	SENT_129	[p5l1595t1619r2152b1687],
2	equilibrium	NN	O	equilibrium	nsubjpass	4	SENT_129	[p5l11t1707r391b1776],
3	was	VBD	O	be	auxpass	4	SENT_129	[p5l420t1723r544b1762],
4	made	VBN	O	make	_	0	SENT_129	[p5l577t1707r752b1762],
5	using	VBG	O	use	xcomp	4	SENT_129	[p5l784t1708r957b1776],
6	the	DT	O	the	det	10	SENT_129	[p5l986t1707r1087b1762],
7	chi	NN	O	chus	nn	10	SENT_129	[p5l1119t1707r1458b1776],
8	—	NN	O	—	nn	10	SENT_129	[p5l1119t1707r1458b1776],
9	square	JJ	O	square	amod	10	SENT_129	[p5l1119t1707r1458b1776],
10	test	NN	O	test	dobj	5	SENT_129	[p5l1488t1715r1621b1763],
11	.	.	O	.	_	0	SENT_129	[p5l1488t1715r1621b1763],

1	Chi	NNP	O	Chi	nsubjpass	6	SENT_130	[p5l1654t1707r2002b1776],
2	—	CD	NUMBER	—	num	1	SENT_130	[p5l1654t1707r2002b1776],
3	square	JJ	O	square	amod	4	SENT_130	[p5l1654t1707r2002b1776],
4	test	NN	O	test	dep	1	SENT_130	[p5l2032t1715r2151b1762],
5	was	VBD	O	be	auxpass	6	SENT_130	[p5l9t1812r133b1851],
6	used	VBN	O	use	_	0	SENT_130	[p5l174t1796r322b1851],
7	in	IN	O	in	_	0	SENT_130	[p5l362t1797r421b1851],
8	the	DT	O	the	det	10	SENT_130	[p5l460t1796r561b1851],
9	bivariate	JJ	O	bivariate	amod	10	SENT_130	[p5l600t1796r884b1851],
10	analysis	NN	O	analysis	prep_in	6	SENT_130	[p5l923t1796r1179b1865],
11	of	IN	O	of	_	0	SENT_130	[p5l1219t1796r1285b1851],
12	categorical	JJ	O	categorical	amod	13	SENT_130	[p5l1317t1796r1665b1865],
13	variables	NNS	O	variable	prep_of	10	SENT_130	[p5l1704t1796r2010b1852],
14	.	.	O	.	_	0	SENT_130	[p5l1704t1796r2010b1852],

1	For	IN	O	for	_	0	SENT_131	[p5l2050t1800r2152b1851],
2	multivariate	JJ	O	multivariate	amod	3	SENT_131	[p5l11t1886r409b1941],
3	analysis	NN	O	analysis	prep_for	10	SENT_131	[p5l429t1886r702b1954],
4	,	,	O	,	_	0	SENT_131	[p5l429t1886r702b1954],
5	binary	JJ	O	binary	amod	8	SENT_131	[p5l723t1886r930b1954],
6	logistic	JJ	O	logistic	amod	8	SENT_131	[p5l950t1886r1180b1954],
7	regression	NN	O	regression	nn	8	SENT_131	[p5l1200t1886r1532b1954],
8	model	NN	O	model	nsubjpass	10	SENT_131	[p5l1553t1886r1752b1941],
9	was	VBD	O	be	auxpass	10	SENT_131	[p5l1772t1901r1897b1941],
10	used	VBN	O	use	_	0	SENT_131	[p5l1919t1886r2066b1941],
11	to	TO	O	to	aux	12	SENT_131	[p5l2088t1894r2149b1941],
12	calculate	VB	O	calculate	xcomp	10	SENT_131	[p5l11t1974r296b2029],
13	the	DT	O	the	det	15	SENT_131	[p5l333t1974r435b2029],
14	odds	NNS	O	odds	nn	15	SENT_131	[p5l472t1974r622b2029],
15	ratio	NN	O	ratio	nsubj	27	SENT_131	[p5l661t1975r809b2029],
16	and	CC	O	and	_	0	SENT_131	[p5l847t1974r963b2029],
17	the	DT	O	the	det	25	SENT_131	[p5l1001t1974r1103b2029],
18	corresponding	JJ	O	corresponding	amod	25	SENT_131	[p5l1141t1974r1606b2043],
19	95	CD	PERCENT	95	number	20	SENT_131	[p5l1642t1977r1765b2029],
20	%	NN	PERCENT	%	amod	25	SENT_131	[p5l1642t1977r1765b2029],
21	conﬁdence	NN	O	conﬁdence	nn	25	SENT_131	[p5l1802t1974r2150b2029],
22	interval	NN	O	interval	nn	25	SENT_131	[p5l11t2064r257b2119],
23	(	CD	NUMBER	(	num	25	SENT_131	[p5l277t2064r389b2132],
24	CI	NN	O	ci	nn	25	SENT_131	[p5l277t2064r389b2132],
25	)	NN	O	)	nsubj	27	SENT_131	[p5l277t2064r389b2132],
26	to	TO	O	to	aux	27	SENT_131	[p5l408t2072r469b2119],
27	set	VB	O	set	xcomp	12	SENT_131	[p5l489t2072r580b2119],
28	the	DT	O	the	det	29	SENT_131	[p5l596t2064r698b2119],
29	association	NN	O	association	dobj	27	SENT_131	[p5l717t2065r1075b2119],
30	between	IN	O	between	_	0	SENT_131	[p5l1093t2064r1370b2119],
31	the	DT	O	the	det	32	SENT_131	[p5l1387t2064r1489b2119],
32	polymorphisms	NNS	O	polymorphism	prep_between	29	SENT_131	[p5l1508t2064r2013b2132],
33	and	CC	O	and	_	0	SENT_131	[p5l2033t2064r2149b2119],
34	other	JJ	O	other	amod	35	SENT_131	[p5l11t2153r183b2207],
35	variables	NNS	O	variable	conj_and	32	SENT_131	[p5l218t2153r524b2207],
36	.	.	O	.	_	0	SENT_131	[p5l218t2153r524b2207],

1	All	DT	O	all	det	2	SENT_132	[p5l563t2153r650b2206],
2	tests	NNS	O	test	nsubj	5	SENT_132	[p5l690t2161r837b2207],
3	were	VBD	O	be	cop	5	SENT_132	[p5l877t2168r1037b2207],
4	two	CD	NUMBER	two	num	5	SENT_132	[p5l1077t2153r1401b2207],
5	—	CD	NUMBER	—	_	0	SENT_132	[p5l1077t2153r1401b2207],
6	sided	VBD	O	side	rcmod	5	SENT_132	[p5l1077t2153r1401b2207],
7	and	CC	O	and	_	0	SENT_132	[p5l1442t2153r1558b2207],
8	differences	NNS	O	difference	nsubjpass	10	SENT_132	[p5l1599t2153r1951b2207],
9	were	VBD	O	be	auxpass	10	SENT_132	[p5l1990t2169r2150b2207],
10	considered	VBN	O	consider	conj_and	5	SENT_132	[p5l11t2240r361b2295],
11	signiﬁcant	NN	O	signiﬁcant	dobj	10	SENT_132	[p5l380t2240r715b2309],
12	when	WRB	O	when	advmod	16	SENT_132	[p5l730t2240r910b2295],
13	p	NN	O	p	nn	14	SENT_132	[p5l923t2256r961b2309],
14	values	NNS	O	value	nsubj	16	SENT_132	[p5l978t2240r1181b2295],
15	were	VBD	O	be	cop	16	SENT_132	[p5l1199t2256r1358b2295],
16	<	JJR	O	<	advcl	10	SENT_132	[p5l1379t2243r1580b2297],
17	0.05	CD	NUMBER	0.05	advmod	16	SENT_132	[p5l1379t2243r1580b2297],
18	.	.	O	.	_	0	SENT_132	[p5l1379t2243r1580b2297],

1	All	DT	O	all	det	2	SENT_133	[p5l1597t2240r1683b2295],
2	analyses	NNS	O	analysis	nsubjpass	4	SENT_133	[p5l1702t2240r1973b2309],
3	were	VBD	O	be	auxpass	4	SENT_133	[p5l1990t2256r2150b2295],
4	performed	VBN	O	perform	_	0	SENT_133	[p5l11t2329r349b2398],
5	with	IN	O	with	_	0	SENT_133	[p5l369t2329r517b2384],
6	SPSS	NNS	ORGANIZATION	spss	prep_with	4	SENT_133	[p5l538t2332r682b2384],
7	for	IN	O	for	_	0	SENT_133	[p5l704t2329r793b2384],
8	Windows	NNP	MISC	Windows	prep_for	6	SENT_133	[p5l808t2329r1117b2384],
9	(	CD	NUMBER	(	num	8	SENT_133	[p5l1139t2329r1400b2397],
10	version	NN	O	version	dep	6	SENT_133	[p5l1139t2329r1400b2397],
11	15.0	CD	NUMBER	15.0	num	10	SENT_133	[p5l1424t2332r1575b2393],
12	;	:	O	;	_	0	SENT_133	[p5l1424t2332r1575b2393],
13	SPSS	NNP	ORGANIZATION	SPSS	nn	15	SENT_133	[p5l1602t2332r1763b2393],
14	,	,	O	,	_	0	SENT_133	[p5l1602t2332r1763b2393],
15	Chicago	NNP	LOCATION	Chicago	dep	6	SENT_133	[p5l1784t2329r2050b2398],
16	,	,	O	,	_	0	SENT_133	[p5l1784t2329r2050b2398],
17	IL	NN	O	il	nn	18	SENT_133	[p5l2072t2329r2149b2397],
18	)	NN	O	)	appos	15	SENT_133	[p5l2072t2329r2149b2397],

1	3	LS	NUMBER	3	_	0	SENT_134	[p5l9t2510r66b2562],
2	.	.	O	.	_	0	SENT_134	[p5l9t2510r66b2562],

1	Results	NNS	O	result	_	0	SENT_135	[p5l105t2507r347b2562],

1	The	DT	O	the	det	3	SENT_136	[p5l110t2686r227b2741],
2	study	NN	O	study	nn	3	SENT_136	[p5l253t2686r431b2754],
3	population	NN	O	population	nsubj	4	SENT_136	[p5l455t2686r805b2754],
4	consisted	VBD	O	consist	_	0	SENT_136	[p5l830t2686r1131b2741],
5	of	IN	O	of	_	0	SENT_136	[p5l1157t2686r1223b2741],
6	50	CD	NUMBER	50	num	7	SENT_136	[p5l1242t2689r1317b2741],
7	women	NNS	O	woman	prep_of	4	SENT_136	[p5l1341t2702r1583b2741],
8	with	IN	O	with	_	0	SENT_136	[p5l1607t2686r1755b2741],
9	histological	JJ	O	histological	amod	12	SENT_136	[p5l1780t2686r2149b2754],
10	conﬁrmed	JJ	O	conﬁrmed	amod	12	SENT_136	[p5l11t2774r339b2829],
11	breast	NN	O	breast	nn	12	SENT_136	[p5l356t2774r556b2829],
12	cancer	NN	O	cancer	prep_with	4	SENT_136	[p5l573t2790r783b2829],
13	treated	VBN	O	treat	partmod	12	SENT_136	[p5l798t2774r1027b2829],
14	with	IN	O	with	_	0	SENT_136	[p5l1044t2774r1193b2829],
15	5	CD	NUMBER	5	prep_with	13	SENT_136	[p5l1211t2778r1362b2829],
16	.	.	O	.	_	0	SENT_136	[p5l1211t2778r1362b2829],

1	—	NN	O	—	_	0	SENT_137	[p5l1211t2778r1362b2829],
2	.	.	O	.	_	0	SENT_137	[p5l1211t2778r1362b2829],

1	FU	NN	O	fu	nn	4	SENT_138	[p5l1211t2778r1362b2829],
2	and	CC	O	and	_	0	SENT_138	[p5l1380t2774r1496b2829],
3	cyclophosphamide	NN	O	cyclophosphamide	nn	4	SENT_138	[p5l1515t2774r2149b2843],
4	—	NN	O	—	nsubj	5	SENT_138	[p5l1515t2774r2149b2843],
5	based	VBN	O	base	_	0	SENT_138	[p5l10t2863r194b2918],
6	neoadjuvant	JJ	O	neoadjuvant	amod	7	SENT_138	[p5l232t2863r635b2932],
7	treatment	NN	O	treatment	dobj	5	SENT_138	[p5l671t2871r1009b2918],
8	.	.	O	.	_	0	SENT_138	[p5l671t2871r1009b2918],

1	Age	NNP	O	Age	nsubj	2	SENT_139	[p5l1045t2865r1165b2932],
2	ranged	VBD	O	range	dep	9	SENT_139	[p5l1203t2863r1423b2932],
3	from	IN	O	from	_	0	SENT_139	[p5l1461t2863r1614b2918],
4	33	CD	DURATION	33	number	6	SENT_139	[p5l1650t2866r1726b2918],
5	to	TO	DURATION	to	dep	6	SENT_139	[p5l1766t2871r1828b2918],
6	76	CD	DURATION	76	num	7	SENT_139	[p5l1867t2866r1943b2918],
7	years	NNS	NUMBER	year	prep_from	2	SENT_139	[p5l1980t2879r2149b2932],
8	(	RB	O	(	advmod	9	SENT_139	[p5l11t2953r215b3021],
9	mean	VBP	O	mean	_	0	SENT_139	[p5l11t2953r215b3021],
10	53.24	CD	NUMBER	53.24	nsubj	9	SENT_139	[p5l249t2955r441b3016],
11	,	,	O	,	_	0	SENT_139	[p5l249t2955r441b3016],
12	median	JJ	O	median	amod	14	SENT_139	[p5l475t2952r715b3007],
13	50.50	CD	DURATION	50.50	num	14	SENT_139	[p5l750t2955r924b3008],
14	years	NNS	NUMBER	year	appos	10	SENT_139	[p5l956t2953r1152b3021],
15	)	RB	O	)	advmod	14	SENT_139	[p5l956t2953r1152b3021],
16	at	IN	O	at	_	0	SENT_139	[p5l1185t2961r1245b3007],
17	the	DT	O	the	det	18	SENT_139	[p5l1277t2952r1379b3007],
18	time	NN	O	time	prep_at	14	SENT_139	[p5l1412t2953r1558b3007],
19	of	IN	O	of	_	0	SENT_139	[p5l1592t2952r1658b3007],
20	diagnosis	NN	O	diagnosis	prep_of	18	SENT_139	[p5l1684t2952r2000b3021],
21	.	.	O	.	_	0	SENT_139	[p5l1684t2952r2000b3021],

1	The	DT	O	the	det	2	SENT_140	[p5l2033t2952r2150b3007],
2	majority	NN	O	majority	nsubj	7	SENT_140	[p5l11t3042r287b3110],
3	of	IN	O	of	_	0	SENT_140	[p5l323t3041r389b3096],
4	women	NNS	O	woman	prep_of	2	SENT_140	[p5l418t3057r660b3096],
5	were	VBD	O	be	cop	7	SENT_140	[p5l696t3057r856b3096],
6	postmenopausal	JJ	O	postmenopausal	amod	7	SENT_140	[p5l894t3041r1424b3110],
7	(	NN	O	(	_	0	SENT_140	[p5l1463t3041r1657b3110],
8	58	CD	PERCENT	58	number	9	SENT_140	[p5l1463t3041r1657b3110],
9	%	NN	PERCENT	%	amod	7	SENT_140	[p5l1463t3041r1657b3110],
10	)	CD	NUMBER	)	dep	20	SENT_140	[p5l1463t3041r1657b3110],
11	:	:	O	:	_	0	SENT_140	[p5l1463t3041r1657b3110],
12	due	JJ	O	due	dep	10	SENT_140	[p5l1700t3041r1817b3096],
13	to	TO	O	to	_	0	SENT_140	[p5l1854t3050r1916b3096],
14	stated	JJ	O	stated	amod	15	SENT_140	[p5l1955t3041r2149b3096],
15	change	NN	O	change	prep_to	12	SENT_140	[p5l11t3131r237b3199],
16	in	IN	O	in	_	0	SENT_140	[p5l262t3132r321b3185],
17	life	NN	O	life	prep_in	15	SENT_140	[p5l346t3131r444b3186],
18	(	CD	NUMBER	(	number	19	SENT_140	[p5l468t3131r656b3199],
19	89.7	CD	NUMBER	89.7	num	20	SENT_140	[p5l468t3131r656b3199],
20	)	NN	O	)	dep	28	SENT_140	[p5l468t3131r656b3199],
21	or	CC	O	or	_	0	SENT_140	[p5l681t3147r747b3186],
22	due	JJ	O	due	_	0	SENT_140	[p5l769t3131r886b3186],
23	to	TO	O	to	_	0	SENT_140	[p5l910t3139r972b3186],
24	hysterectomy	NN	O	hysterectomy	prep_due_to	27	SENT_140	[p5l997t3131r1440b3199],
25	(	CD	PERCENT	(	num	24	SENT_140	[p5l1463t3131r1710b3199],
26	10.3	CD	PERCENT	10.3	num	27	SENT_140	[p5l1463t3131r1710b3199],
27	%	NN	PERCENT	%	dep	28	SENT_140	[p5l1463t3131r1710b3199],
28	)	CD	NUMBER	)	dep	7	SENT_140	[p5l1463t3131r1710b3199],
29	.	.	O	.	_	0	SENT_140	[p5l1463t3131r1710b3199],

1	The	DT	O	the	det	2	SENT_141	[p5l1733t3131r1851b3186],
2	majority	NN	O	majority	nsubj	5	SENT_141	[p5l1876t3132r2152b3199],
3	of	IN	O	of	_	0	SENT_141	[p5l11t3220r77b3275],
4	patients	NNS	O	patient	prep_of	2	SENT_141	[p5l119t3221r377b3288],
5	responded	VBD	O	respond	_	0	SENT_141	[p5l428t3220r765b3288],
6	to	TO	O	to	_	0	SENT_141	[p5l815t3228r877b3275],
7	the	DT	O	the	det	9	SENT_141	[p5l926t3220r1028b3275],
8	neoadjuvant	JJ	O	neoadjuvant	amod	9	SENT_141	[p5l1078t3220r1481b3288],
9	therapy	NN	O	therapy	prep_to	5	SENT_141	[p5l1529t3220r1797b3288],
10	:	:	O	:	_	0	SENT_141	[p5l1529t3220r1797b3288],
11	complete	JJ	O	complete	amod	12	SENT_141	[p5l1852t3220r2150b3288],
12	response	NN	O	response	dep	9	SENT_141	[p5l11t3324r311b3377],
13	,	,	O	,	_	0	SENT_141	[p5l11t3324r311b3377],
14	30	CD	PERCENT	30	num	15	SENT_141	[p5l336t3311r478b3372],
15	%	NN	PERCENT	%	appos	12	SENT_141	[p5l336t3311r478b3372],
16	;	:	O	;	_	0	SENT_141	[p5l336t3311r478b3372],
17	>	JJR	PERCENT	>	dep	9	SENT_141	[p5l511t3311r684b3365],
18	50	CD	PERCENT	50	number	19	SENT_141	[p5l511t3311r684b3365],
19	%	NN	PERCENT	%	amod	17	SENT_141	[p5l511t3311r684b3365],
20	of	IN	O	of	_	0	SENT_141	[p5l709t3308r776b3363],
21	response	NN	O	response	prep_of	17	SENT_141	[p5l793t3324r1093b3377],
22	,	,	O	,	_	0	SENT_141	[p5l793t3324r1093b3377],
23	52	CD	PERCENT	52	number	24	SENT_141	[p5l1120t3311r1261b3372],
24	%	NN	PERCENT	%	amod	17	SENT_141	[p5l1120t3311r1261b3372],
25	;	:	O	;	_	0	SENT_141	[p5l1120t3311r1261b3372],
26	<	JJR	PERCENT	<	conj_and	12	SENT_141	[p5l1294t3311r1467b3365],
27	50	CD	PERCENT	50	number	28	SENT_141	[p5l1294t3311r1467b3365],
28	%	NN	PERCENT	%	amod	26	SENT_141	[p5l1294t3311r1467b3365],
29	of	IN	O	of	_	0	SENT_141	[p5l1492t3308r1559b3363],
30	response	NN	O	response	prep_of	26	SENT_141	[p5l1576t3324r1876b3377],
31	,	,	O	,	_	0	SENT_141	[p5l1576t3324r1876b3377],
32	8	CD	PERCENT	8	number	33	SENT_141	[p5l1903t3311r2003b3372],
33	%	NN	PERCENT	%	amod	26	SENT_141	[p5l1903t3311r2003b3372],
34	;	:	O	;	_	0	SENT_141	[p5l1903t3311r2003b3372],
35	and	CC	O	and	_	0	SENT_141	[p5l2033t3308r2149b3363],
36	no	DT	O	no	det	37	SENT_141	[p5l11t3413r88b3452],
37	response	NN	O	response	dep	9	SENT_141	[p5l109t3413r409b3466],
38	,	,	O	,	_	0	SENT_141	[p5l109t3413r409b3466],
39	6	CD	PERCENT	6	num	40	SENT_141	[p5l430t3400r526b3452],
40	%	NN	PERCENT	%	appos	37	SENT_141	[p5l430t3400r526b3452],
41	.	.	O	.	_	0	SENT_141	[p5l430t3400r526b3452],

1	Demographic	JJ	MISC	demographic	nsubjpass	7	SENT_142	[p5l548t3397r980b3466],
2	and	CC	O	and	_	0	SENT_142	[p5l999t3397r1115b3452],
3	clinic	NN	O	clinic	nn	5	SENT_142	[p5l1136t3397r1306b3452],
4	pathologic	JJ	O	pathologic	amod	5	SENT_142	[p5l1326t3397r1664b3466],
5	characteristics	NNS	O	characteristic	conj_and	1	SENT_142	[p5l1683t3397r2149b3452],
6	are	VBP	O	be	auxpass	7	SENT_142	[p5l11t3502r108b3541],
7	detailed	VBN	O	detail	_	0	SENT_142	[p5l137t3486r395b3541],
8	in	IN	O	in	_	0	SENT_142	[p5l425t3487r484b3541],
9	Tables	NNP	O	Tables	prep_in	7	SENT_142	[p5l509t3486r714b3541],
10	1	CD	NUMBER	1	num	9	SENT_142	[p5l747t3489r771b3541],
11	and	CC	O	and	_	0	SENT_142	[p5l809t3486r925b3541],
12	2	CD	NUMBER	2	conj_and	9	SENT_142	[p5l954t3489r1006b3550],
13	,	,	O	,	_	0	SENT_142	[p5l954t3489r1006b3550],
14	respectively	RB	O	respectively	advmod	7	SENT_142	[p5l1036t3486r1440b3555],
15	.	.	O	.	_	0	SENT_142	[p5l1036t3486r1440b3555],

1	TSER	NNP	O	TSER	nsubjpass	16	SENT_143	[p5l1467t3489r1640b3550],
2	,	,	O	,	_	0	SENT_143	[p5l1467t3489r1640b3550],
3	MTHFR	NNP	O	MTHFR	nn	4	SENT_143	[p5l1670t3490r1907b3541],
4	C677T	NNP	O	C677T	conj_and	1	SENT_143	[p5l1933t3489r2149b3550],
5	,	,	O	,	_	0	SENT_143	[p5l1933t3489r2149b3550],
6	p53	NN	O	p53	nn	7	SENT_143	[p5l11t3578r127b3644],
7	Arg72Pro	NN	O	arg72pro	conj_and	1	SENT_143	[p5l149t3578r451b3644],
8	and	CC	O	and	_	0	SENT_143	[p5l472t3575r588b3630],
9	MDR1	NN	O	mdr1	nn	10	SENT_143	[p5l611t3578r799b3630],
10	C3435T	NN	O	c3435t	conj_and	1	SENT_143	[p5l830t3578r1074b3630],
11	allelic	JJ	O	allelic	amod	14	SENT_143	[p5l1093t3575r1282b3630],
12	and	CC	O	and	_	0	SENT_143	[p5l1303t3575r1419b3630],
13	genotypic	JJ	O	genotypic	conj_and	11	SENT_143	[p5l1440t3576r1758b3644],
14	frequencies	NNS	O	frequency	dep	10	SENT_143	[p5l1779t3575r2149b3644],
15	were	VBD	O	be	auxpass	16	SENT_143	[p5l9t3681r168b3720],
16	estimated	VBN	O	estimate	_	0	SENT_143	[p5l200t3665r518b3720],
17	(	RB	O	(	amod	20	SENT_143	[p5l550t3665r748b3733],
18	Table	NNP	O	Table	tmod	17	SENT_143	[p5l550t3665r748b3733],
19	3	CD	NUMBER	3	num	18	SENT_143	[p5l778t3665r857b3733],
20	)	NN	O	)	dobj	16	SENT_143	[p5l778t3665r857b3733],
21	.	.	O	.	_	0	SENT_143	[p5l778t3665r857b3733],

1	Observed	VBN	O	observe	dep	6	SENT_144	[p5l889t3665r1191b3720],
2	allelic	JJ	O	allelic	amod	3	SENT_144	[p5l1222t3665r1411b3720],
3	frequencies	NNS	O	frequency	nsubj	6	SENT_144	[p5l1442t3665r1812b3733],
4	were	VBD	O	be	cop	6	SENT_144	[p5l1842t3681r2002b3720],
5	(	CD	PERCENT	(	num	6	SENT_144	[p5l2033t3665r2144b3733],
6	%	NN	PERCENT	%	_	0	SENT_144	[p5l2033t3665r2144b3733],
7	)	CD	NUMBER	)	dep	6	SENT_144	[p5l2033t3665r2144b3733],
8	:	:	O	:	_	0	SENT_144	[p5l2033t3665r2144b3733],

1	TSER	NN	O	tser	_	0	SENT_145	[p6l8t20r181b80],
2	,	,	O	,	_	0	SENT_145	[p6l8t20r181b80],
3	(	NN	O	(	appos	1	SENT_145	[p6l216t17r304b85],
4	2	CD	NUMBER	2	num	3	SENT_145	[p6l216t17r304b85],
5	)	CD	NUMBER	)	number	6	SENT_145	[p6l216t17r304b85],
6	54	CD	NUMBER	54	dep	3	SENT_145	[p6l340t20r417b72],
7	and	CC	O	and	_	0	SENT_145	[p6l452t17r568b72],
8	(	CD	NUMBER	(	number	9	SENT_145	[p6l603t17r691b85],
9	3	CD	NUMBER	3	conj_and	3	SENT_145	[p6l603t17r691b85],
10	)	NN	O	)	dep	9	SENT_145	[p6l603t17r691b85],
11	46	CD	NUMBER	46	num	10	SENT_145	[p6l724t20r823b80],
12	;	:	O	;	_	0	SENT_145	[p6l724t20r823b80],
13	MTHFR	NNP	O	MTHFR	nn	14	SENT_145	[p6l863t20r1100b71],
14	C677T	NNP	O	C677T	dep	9	SENT_145	[p6l1131t20r1348b80],
15	,	,	O	,	_	0	SENT_145	[p6l1131t20r1348b80],
16	(	CD	NUMBER	(	num	17	SENT_145	[p6l1383t17r1473b85],
17	C	NN	O	c	appos	14	SENT_145	[p6l1383t17r1473b85],
18	)	CD	NUMBER	)	number	19	SENT_145	[p6l1383t17r1473b85],
19	59	CD	NUMBER	59	dep	17	SENT_145	[p6l1509t20r1584b72],
20	and	CC	O	and	_	0	SENT_145	[p6l1620t17r1736b72],
21	(	CD	NUMBER	(	num	22	SENT_145	[p6l1771t17r1858b85],
22	T	NN	O	t	appos	14	SENT_145	[p6l1771t17r1858b85],
23	)	CD	NUMBER	)	number	24	SENT_145	[p6l1771t17r1858b85],
24	41	CD	NUMBER	41	dep	22	SENT_145	[p6l1891t20r1990b80],
25	;	:	O	;	_	0	SENT_145	[p6l1891t20r1990b80],
26	p53	NN	O	p53	nn	27	SENT_145	[p6l2030t20r2146b85],
27	Arg72Pro	NN	O	arg72pro	dep	9	SENT_145	[p6l8t108r326b174],
28	,	,	O	,	_	0	SENT_145	[p6l8t108r326b174],
29	(	CD	NUMBER	(	num	30	SENT_145	[p6l350t105r511b174],
30	Arg	NN	O	arg	appos	27	SENT_145	[p6l350t105r511b174],
31	)	CD	NUMBER	)	number	32	SENT_145	[p6l350t105r511b174],
32	73	CD	NUMBER	73	dep	30	SENT_145	[p6l536t108r609b160],
33	and	CC	O	and	_	0	SENT_145	[p6l636t105r753b160],
34	(	CD	NUMBER	(	conj_and	30	SENT_145	[p6l777t105r933b174],
35	Pro	FW	O	pro	nn	36	SENT_145	[p6l777t105r933b174],
36	)	FW	O	)	dep	34	SENT_145	[p6l777t105r933b174],
37	27	CD	NUMBER	27	dep	34	SENT_145	[p6l957t108r1055b169],
38	;	:	O	;	_	0	SENT_145	[p6l957t108r1055b169],
39	MDR1	NN	O	mdr1	nn	40	SENT_145	[p6l1084t108r1272b160],
40	C3435T	NN	O	c3435t	dep	9	SENT_145	[p6l1305t108r1563b169],
41	,	,	O	,	_	0	SENT_145	[p6l1305t108r1563b169],
42	(	NN	O	(	nn	43	SENT_145	[p6l1587t105r1678b174],
43	C	NN	O	c	appos	40	SENT_145	[p6l1587t105r1678b174],
44	)	CD	NUMBER	)	number	45	SENT_145	[p6l1587t105r1678b174],
45	52	CD	NUMBER	52	dep	43	SENT_145	[p6l1702t108r1777b160],
46	and	CC	O	and	_	0	SENT_145	[p6l1803t105r1919b160],
47	(	CD	NUMBER	(	num	48	SENT_145	[p6l1944t105r2031b173],
48	T	NN	O	t	conj_and	43	SENT_145	[p6l1944t105r2031b173],
49	)	CD	NUMBER	)	number	50	SENT_145	[p6l1944t105r2031b173],
50	48	CD	NUMBER	48	dep	48	SENT_145	[p6l2053t108r2148b161],
51	.	.	O	.	_	0	SENT_145	[p6l2053t108r2148b161],

1	The	DT	O	the	det	3	SENT_146	[p6l8t194r125b249],
2	genotype	NN	O	genotype	nn	3	SENT_146	[p6l148t202r446b263],
3	distributions	NNS	O	distribution	nsubj	4	SENT_146	[p6l471t194r882b249],
4	were	VBD	O	be	_	0	SENT_146	[p6l906t210r1066b249],
5	in	IN	O	in	_	0	SENT_146	[p6l1090t195r1150b248],
6	Hardy	NNP	LOCATION	Hardy	prep_in	4	SENT_146	[p6l1174t194r1731b263],
7	.	.	O	.	_	0	SENT_146	[p6l1174t194r1731b263],

1	—	NN	O	—	_	0	SENT_147	[p6l1174t194r1731b263],
2	.	.	O	.	_	0	SENT_147	[p6l1174t194r1731b263],

1	Weinberg	NNP	PERSON	Weinberg	_	0	SENT_148	[p6l1174t194r1731b263],
2	equilibrium	NN	O	equilibrium	dep	1	SENT_148	[p6l1753t194r2148b263],
3	.	.	O	.	_	0	SENT_148	[p6l1753t194r2148b263],

1	We	PRP	O	we	nsubj	4	SENT_149	[p6l8t287r116b338],
2	did	VBD	O	do	aux	4	SENT_149	[p6l172t283r271b338],
3	not	RB	O	not	neg	4	SENT_149	[p6l328t292r433b338],
4	observe	VB	O	observe	_	0	SENT_149	[p6l487t283r735b338],
5	differences	NNS	O	difference	dobj	4	SENT_149	[p6l791t283r1143b338],
6	in	IN	O	in	_	0	SENT_149	[p6l1199t284r1259b338],
7	the	DT	O	the	det	8	SENT_149	[p6l1313t283r1415b338],
8	gene	NN	O	gene	prep_in	5	SENT_149	[p6l1468t299r1620b352],
9	polymorphism	NN	O	polymorphism	nn	10	SENT_149	[p6l1675t283r2150b352],
10	distributions	NNS	O	distribution	dep	23	SENT_149	[p6l11t372r422b427],
11	between	IN	O	between	_	0	SENT_149	[p6l449t372r726b427],
12	breast	NN	O	breast	nn	14	SENT_149	[p6l752t372r951b427],
13	cancer	NN	O	cancer	nn	14	SENT_149	[p6l975t388r1186b427],
14	patients	NNS	O	patient	prep_between	10	SENT_149	[p6l1210t373r1468b441],
15	and	CC	O	and	_	0	SENT_149	[p6l1495t372r1612b427],
16	general	JJ	O	general	amod	17	SENT_149	[p6l1637t372r1874b441],
17	population	NN	O	population	conj_and	10	SENT_149	[p6l1902t372r2149b441, p6l10t463r137b517],
18	from	IN	O	from	_	0	SENT_149	[p6l165t462r317b517],
19	our	PRP$	O	we	poss	20	SENT_149	[p6l345t478r453b517],
20	region	NN	O	region	prep_from	17	SENT_149	[p6l480t463r683b530],
21	(	CD	NUMBER	(	num	22	SENT_149	[p6l710t462r770b530],
22	p	NN	O	p	dep	23	SENT_149	[p6l710t462r770b530],
23	>	JJR	O	>	dep	5	SENT_149	[p6l796t478r839b519],
24	0.05	CD	NUMBER	0.05	num	25	SENT_149	[p6l864t462r1040b530],
25	)	NN	O	)	dep	23	SENT_149	[p6l864t462r1040b530],
26	.	.	O	.	_	0	SENT_149	[p6l864t462r1040b530],

1	The	DT	O	the	det	2	SENT_150	[p6l1066t462r1184b517],
2	distribution	NN	O	distribution	_	0	SENT_150	[p6l1212t462r1594b517],
3	of	IN	O	of	_	0	SENT_150	[p6l1621t462r1687b517],
4	initial	JJ	O	initial	amod	6	SENT_150	[p6l1708t462r1893b517],
5	clinical	JJ	O	clinical	amod	6	SENT_150	[p6l1922t462r2149b517],
6	stage	NN	O	stage	prep_of	2	SENT_150	[p6l12t558r192b619],
7	,	,	O	,	_	0	SENT_150	[p6l12t558r192b619],
8	tumour	NN	O	tumour	nn	9	SENT_150	[p6l211t558r455b605],
9	size	NN	O	size	appos	6	SENT_150	[p6l472t551r607b614],
10	,	,	O	,	_	0	SENT_150	[p6l472t551r607b614],
11	estrogen	NN	O	estrogen	nn	15	SENT_150	[p6l628t558r904b619],
12	or	CC	O	or	_	0	SENT_150	[p6l923t566r989b605],
13	progesterone	NN	O	progesterone	nn	15	SENT_150	[p6l1007t558r1431b619],
14	receptor	NN	O	receptor	nn	15	SENT_150	[p6l1450t558r1721b619],
15	status	NN	O	status	dep	2	SENT_150	[p6l1738t558r1944b614],
16	,	,	O	,	_	0	SENT_150	[p6l1738t558r1944b614],
17	erbB2	NN	O	erbb2	appos	15	SENT_150	[p6l1964t550r2147b605],

1	636	CD	NUMBER	636	_	0	SENT_151	[p6l312t696r356b717],
2	LA.	NN	O	la.	dep	1	SENT_151	[p6l940t696r981b717],
3	.	.	O	.	_	0	SENT_151	[p6l940t696r981b717],

1	Henrz	JJ	PERSON	henrz	amod	2	SENT_152	[p6l992t694r1258b722],
2	’	NN	O	’	_	0	SENT_152	[p6l992t694r1258b722],
3	quez	NN	O	quez	dep	2	SENT_152	[p6l992t694r1258b722],
4	.	.	O	.	_	0	SENT_152	[p6l992t694r1258b722],

1	—	NN	O	—	_	0	SENT_153	[p6l992t694r1258b722],
2	.	.	O	.	_	0	SENT_153	[p6l992t694r1258b722],

1	Hemcindez	NNP	O	Hemcindez	_	0	SENT_154	[p6l992t694r1258b722],
2	et	FW	O	et	nn	3	SENT_154	[p6l1268t698r1291b717],
3	al.	FW	O	al.	dep	1	SENT_154	[p6l1300t695r1326b717],
4	/	:	O	/	punct	1	SENT_154	[p6l1331t695r1342b722],
5	Cancer	NNP	O	Cancer	nn	6	SENT_154	[p6l1347t696r1430b717],
6	Epidemiology	NNP	O	Epidemiology	dep	1	SENT_154	[p6l1438t695r1601b722],
7	34	CD	NUMBER	34	number	8	SENT_154	[p6l1610t696r1640b717],
8	(	CD	NUMBER	(	num	9	SENT_154	[p6l1651t695r1731b722],
9	2010	CD	DATE	2010	dep	6	SENT_154	[p6l1651t695r1731b722],
10	)	CD	NUMBER	)	number	11	SENT_154	[p6l1651t695r1731b722],
11	634-638	CD	NUMBER	634-638	num	9	SENT_154	[p6l1742t696r1848b717],

1	Table	NNP	O	Table	_	0	SENT_155	[p6l11t825r158b868],
2	1	CD	NUMBER	1	num	4	SENT_155	[p6l181t827r205b868],
3	Demographic	JJ	MISC	demographic	amod	4	SENT_155	[p6l14t896r359b950],
4	characteristics	NNS	O	characteristic	dep	1	SENT_155	[p6l382t896r754b940],
5	of	IN	O	of	_	0	SENT_155	[p6l778t896r831b940],
6	cancer	NN	O	cancer	nn	7	SENT_155	[p6l847t909r1015b940],
7	patients	NNS	O	patient	prep_of	4	SENT_155	[p6l1036t897r1256b950],
8	.	.	O	.	_	0	SENT_155	[p6l1036t897r1256b950],

1	Characteristics	NNS	O	characteristic	nn	2	SENT_156	[p6l65t1019r444b1063],
2	Cases	NNS	O	case	nsubj	3	SENT_156	[p6l1126t1022r1265b1063],
3	(	VBP	O	(	_	0	SENT_156	[p6l1289t1020r1359b1073],
4	n	NN	O	n	dobj	3	SENT_156	[p6l1289t1020r1359b1073],
5	)	CD	PERCENT	)	num	6	SENT_156	[p6l1289t1020r1359b1073],
6	%	NN	PERCENT	%	dep	4	SENT_156	[p6l2006t1022r2038b1063],

1	Total	JJ	O	total	_	0	SENT_157	[p6l58t1131r187b1174],
2	50	CD	NUMBER	50	number	3	SENT_157	[p6l1127t1133r1188b1174],
3	100	CD	NUMBER	100	dep	1	SENT_157	[p6l2009t1133r2100b1174],

1	Age	NNP	O	Age	_	0	SENT_158	[p6l58t1251r154b1304],
2	(	CD	NUMBER	(	num	3	SENT_158	[p6l177t1249r353b1304],
3	years	NNS	NUMBER	year	dep	1	SENT_158	[p6l177t1249r353b1304],
4	)	IN	O	)	amod	3	SENT_158	[p6l177t1249r353b1304],

1	BMI	NN	O	bmus	_	0	SENT_159	[p6l61t1586r161b1627],
2	(	CD	NUMBER	(	num	4	SENT_159	[p6l184t1575r382b1638],
3	kg/m2	NN	O	kg/m2	nn	4	SENT_159	[p6l184t1575r382b1638],
4	)	NN	O	)	dep	1	SENT_159	[p6l184t1575r382b1638],

1	325	CD	NUMBER	325	number	2	SENT_160	[p6l113t1658r214b1706],
2	18	CD	NUMBER	18	num	4	SENT_160	[p6l1129t1658r1186b1699],
3	36	CD	NUMBER	36	number	4	SENT_160	[p6l2037t1658r2100b1699],
4	25.1	CD	NUMBER	25.1	_	0	SENT_160	[p6l110t1730r317b1772],
5	—	CD	NUMBER	—	number	6	SENT_160	[p6l110t1730r317b1772],
6	30	CD	NUMBER	30	num	8	SENT_160	[p6l110t1730r317b1772],
7	17	CD	NUMBER	17	number	8	SENT_160	[p6l1129t1730r1187b1771],
8	34	CD	NUMBER	34	dep	4	SENT_160	[p6l2037t1730r2100b1772],
9	230	CD	NUMBER	230	number	10	SENT_160	[p6l113t1802r216b1850],
10	14	CD	NUMBER	14	num	8	SENT_160	[p6l1129t1802r1188b1843],
11	28	CD	NUMBER	28	num	12	SENT_160	[p6l2038t1802r2098b1843],
12	ND	NN	ORGANIZATION	nd	dep	4	SENT_160	[p6l111t1874r188b1915],
13	1	CD	NUMBER	1	number	14	SENT_160	[p6l1162t1874r1181b1915],
14	2	CD	NUMBER	2	dep	12	SENT_160	[p6l2071t1874r2098b1915],

1	Smokers	NNS	O	smoker	_	0	SENT_161	[p6l61t1990r278b2034],

1	No	DT	O	no	det	3	SENT_162	[p6l111t2065r180b2106],
2	42	CD	NUMBER	42	num	3	SENT_162	[p6l1124t2065r1186b2106],
3	84	CD	NUMBER	84	_	0	SENT_162	[p6l2038t2065r2100b2106],
4	Yes	UH	O	yes	dep	5	SENT_162	[p6l108t2138r195b2179],
5	7	CD	NUMBER	7	rcmod	3	SENT_162	[p6l1160t2138r1187b2178],
6	14	CD	NUMBER	14	num	7	SENT_162	[p6l2041t2137r2100b2178],
7	ND	NN	ORGANIZATION	nd	dep	3	SENT_162	[p6l111t2210r188b2251],
8	1	CD	NUMBER	1	number	9	SENT_162	[p6l1162t2210r1182b2251],
9	2	CD	NUMBER	2	dep	7	SENT_162	[p6l2071t2210r2098b2251],

1	Age	NN	O	age	_	0	SENT_163	[p6l58t2328r154b2380],
2	of	IN	O	of	_	0	SENT_163	[p6l177t2325r230b2369],
3	menarche	NN	O	menarche	prep_of	1	SENT_163	[p6l247t2326r502b2369],

1	<	JJR	O	<	_	0	SENT_164	[p6l113t2399r214b2442],
2	12	CD	DURATION	12	num	3	SENT_164	[p6l113t2399r214b2442],
3	years	NNS	NUMBER	year	npadvmod	4	SENT_164	[p6l237t2410r372b2451],
4	old	JJ	DURATION	old	dep	1	SENT_164	[p6l396t2397r474b2441],
5	11	CD	NUMBER	11	number	6	SENT_164	[p6l1129t2399r1182b2440],
6	22	CD	NUMBER	22	prep	1	SENT_164	[p6l2038t2399r2098b2440],
7	212	CD	DURATION	212	num	8	SENT_164	[p6l113t2470r214b2519],
8	years	NNS	NUMBER	year	dep	6	SENT_164	[p6l237t2481r372b2523],
9	old	JJ	DURATION	old	dep	1	SENT_164	[p6l396t2468r474b2512],
10	39	CD	NUMBER	39	number	11	SENT_164	[p6l1125t2470r1187b2512],
11	78	CD	NUMBER	78	dep	9	SENT_164	[p6l2039t2470r2098b2512],

1	Menopause	NN	O	menopause	_	0	SENT_165	[p6l61t2589r357b2641],

1	No	DT	O	no	det	3	SENT_166	[p6l111t2661r180b2702],
2	20	CD	NUMBER	20	num	3	SENT_166	[p6l1126t2661r1188b2702],
3	40	CD	NUMBER	40	_	0	SENT_166	[p6l2037t2661r2100b2702],
4	Yes	UH	O	yes	dep	5	SENT_166	[p6l108t2734r195b2775],
5	29	CD	NUMBER	29	rcmod	3	SENT_166	[p6l1126t2733r1187b2775],
6	58	CD	NUMBER	58	num	7	SENT_166	[p6l2039t2733r2098b2775],
7	ND	NN	ORGANIZATION	nd	dep	3	SENT_166	[p6l111t2807r188b2847],
8	1	CD	NUMBER	1	number	9	SENT_166	[p6l1162t2806r1182b2847],
9	2	CD	NUMBER	2	dep	7	SENT_166	[p6l2071t2806r2098b2847],

1	Oral	JJ	O	oral	amod	2	SENT_167	[p6l61t2922r166b2966],
2	contraceptives	NNS	O	contraceptive	_	0	SENT_167	[p6l190t2923r565b2977],
3	exposure	NN	O	exposure	dep	2	SENT_167	[p6l588t2935r823b2977],
4	(	CD	NUMBER	(	num	3	SENT_167	[p6l845t2922r999b2976],
5	more	JJR	DURATION	more	mwe	6	SENT_167	[p6l845t2922r999b2976],
6	than	IN	DURATION	than	quantmod	7	SENT_167	[p6l1022t2922r1138b2966],
7	1	CD	DURATION	1	num	8	SENT_167	[p6l1163t2925r1182b2965],
8	year	NN	NUMBER	year	npadvmod	3	SENT_167	[p6l1210t2935r1323b2977],
9	of	IN	O	of	_	0	SENT_167	[p6l1344t2922r1397b2966],
10	exposure	NN	O	exposure	nn	11	SENT_167	[p6l1413t2922r1667b2977],
11	)	NN	O	)	prep_of	3	SENT_167	[p6l1413t2922r1667b2977],

1	No	DT	O	no	det	3	SENT_168	[p6l111t2997r180b3038],
2	25	CD	NUMBER	25	num	3	SENT_168	[p6l1126t2997r1186b3038],
3	50	CD	NUMBER	50	_	0	SENT_168	[p6l2039t2997r2100b3038],
4	Yes	UH	O	yes	dep	5	SENT_168	[p6l108t3069r195b3110],
5	24	CD	NUMBER	24	rcmod	3	SENT_168	[p6l1126t3069r1188b3110],
6	48	CD	NUMBER	48	num	7	SENT_168	[p6l2036t3069r2098b3110],
7	ND	NN	ORGANIZATION	nd	dep	3	SENT_168	[p6l111t3142r188b3183],
8	1	CD	NUMBER	1	number	9	SENT_168	[p6l1162t3142r1182b3182],
9	2	CD	NUMBER	2	dep	7	SENT_168	[p6l2071t3141r2098b3182],

1	Estrogens	NNS	O	estrogen	_	0	SENT_169	[p6l61t3260r308b3312],
2	exposure	NN	O	exposure	dep	1	SENT_169	[p6l332t3270r566b3312],
3	after	IN	O	after	_	0	SENT_169	[p6l588t3257r708b3301],
4	menopause	NN	O	menopause	prep_after	2	SENT_169	[p6l730t3270r1025b3312],

1	No	DT	O	no	det	2	SENT_170	[p6l111t3333r180b3373],
2	27	CD	NUMBER	27	_	0	SENT_170	[p6l1126t3332r1187b3373],
3	93	CD	NUMBER	93	dep	2	SENT_170	[p6l2038t3332r2097b3373],
4	Yes	UH	O	yes	dep	6	SENT_170	[p6l108t3405r195b3446],
5	2	CD	NUMBER	2	num	6	SENT_170	[p6l1159t3404r1186b3445],
6	7	CD	NUMBER	7	rcmod	3	SENT_170	[p6l2072t3405r2099b3445],

1	Descendants	NNS	O	descendant	_	0	SENT_171	[p6l61t3520r385b3564],

1	No	DT	O	no	det	3	SENT_172	[p6l111t3595r180b3636],
2	9	CD	NUMBER	9	num	3	SENT_172	[p6l1159t3595r1187b3636],
3	18	CD	NUMBER	18	_	0	SENT_172	[p6l2041t3595r2098b3636],
4	Yes	UH	O	yes	dep	5	SENT_172	[p6l108t3668r195b3709],
5	40	CD	NUMBER	40	rcmod	3	SENT_172	[p6l1125t3668r1188b3709],
6	80	CD	NUMBER	80	num	7	SENT_172	[p6l2039t3668r2100b3709],
7	ND	NN	ORGANIZATION	nd	dep	3	SENT_172	[p6l111t3741r188b3781],
8	1	CD	NUMBER	1	number	9	SENT_172	[p6l1162t3740r1182b3781],
9	2	CD	NUMBER	2	dep	7	SENT_172	[p6l2071t3740r2098b3781],

1	Age	NN	O	age	_	0	SENT_173	[p7l58t57r154b109],
2	at	IN	O	at	_	0	SENT_173	[p7l177t62r224b99],
3	ﬁrst	JJ	O	ﬁrst	amod	4	SENT_173	[p7l246t55r348b99],
4	labour	NN	O	labour	prep_at	1	SENT_173	[p7l370t55r536b99],

1	<	JJR	O	<	_	0	SENT_174	[p7l113t129r216b172],
2	30	CD	DURATION	30	num	3	SENT_174	[p7l113t129r216b172],
3	years	NNS	NUMBER	year	npadvmod	4	SENT_174	[p7l236t139r372b181],
4	old	JJ	DURATION	old	dep	1	SENT_174	[p7l395t126r474b170],
5	29	CD	NUMBER	29	number	6	SENT_174	[p7l1126t129r1187b170],
6	73	CD	NUMBER	73	prep	1	SENT_174	[p7l2039t129r2097b170],
7	230	CD	DURATION	230	num	8	SENT_174	[p7l113t200r216b248],
8	years	NNS	NUMBER	year	dep	6	SENT_174	[p7l236t210r372b252],
9	old	JJ	DURATION	old	dep	1	SENT_174	[p7l395t198r474b241],
10	11	CD	NUMBER	11	number	11	SENT_174	[p7l1129t200r1181b241],
11	27	CD	NUMBER	27	dep	9	SENT_174	[p7l2038t200r2099b241],

1	Lactation	NN	O	lactation	_	0	SENT_175	[p7l61t317r297b360],

1	No	DT	O	no	det	2	SENT_176	[p7l111t391r180b432],
2	14	CD	NUMBER	14	_	0	SENT_176	[p7l1129t390r1188b431],
3	35	CD	NUMBER	35	dep	2	SENT_176	[p7l2037t390r2098b432],
4	Yes	UH	O	yes	dep	6	SENT_176	[p7l108t463r195b504],
5	26	CD	NUMBER	26	num	6	SENT_176	[p7l1126t463r1188b504],
6	65	CD	NUMBER	65	rcmod	3	SENT_176	[p7l2038t463r2098b504],

1	Family	NNP	O	Family	_	0	SENT_177	[p7l61t579r234b633],
2	history	NN	O	history	dep	1	SENT_177	[p7l256t577r458b633],
3	‘‘	CD	NUMBER	‘‘	num	4	SENT_177	[p7l256t577r458b633],
4	‘	NN	O	‘	dep	1	SENT_177	[p7l256t577r458b633],

1	No	DT	O	no	det	3	SENT_178	[p7l111t654r180b695],
2	43	CD	NUMBER	43	num	3	SENT_178	[p7l1124t653r1186b695],
3	86	CD	NUMBER	86	_	0	SENT_178	[p7l2038t653r2100b695],
4	Yes	UH	O	yes	dep	5	SENT_178	[p7l108t727r195b768],
5	6	CD	NUMBER	6	rcmod	3	SENT_178	[p7l1159t726r1188b768],
6	12	CD	NUMBER	12	num	7	SENT_178	[p7l2041t726r2098b767],
7	ND	NN	ORGANIZATION	nd	dep	3	SENT_178	[p7l111t799r188b840],
8	1	CD	NUMBER	1	number	9	SENT_178	[p7l1162t799r1182b840],
9	2	CD	NUMBER	2	dep	7	SENT_178	[p7l2071t799r2098b840],

1	ND	NNP	ORGANIZATION	ND	_	0	SENT_179	[p7l14t912r104b960],
2	,	,	O	,	_	0	SENT_179	[p7l14t912r104b960],
3	non-determined	JJ	O	non-determined	appos	1	SENT_179	[p7l129t909r563b953],
4	.	.	O	.	_	0	SENT_179	[p7l129t909r563b953],

1	a	DT	O	a	det	3	SENT_180	[p7l64t979r84b1000],
2	Family	NNP	O	Family	nn	3	SENT_180	[p7l119t981r292b1035],
3	history	NN	O	history	_	0	SENT_180	[p7l314t981r494b1035],
4	of	IN	O	of	_	0	SENT_180	[p7l516t981r569b1024],
5	breast	NN	O	breast	nn	6	SENT_180	[p7l585t981r744b1024],
6	cancer	NN	O	cancer	prep_of	3	SENT_180	[p7l766t993r934b1024],
7	in	IN	O	in	_	0	SENT_180	[p7l955t982r1002b1024],
8	ﬁrst	JJ	O	ﬁrst	amod	10	SENT_180	[p7l1025t981r1127b1024],
9	degree	NN	O	degree	nn	10	SENT_180	[p7l1148t981r1319b1035],
10	relatives	NNS	O	relative	prep_in	3	SENT_180	[p7l1343t981r1573b1025],
11	.	.	O	.	_	0	SENT_180	[p7l1343t981r1573b1025],

1	expression	NN	O	expression	nsubj	12	SENT_181	[p7l14t1182r375b1249],
2	,	,	O	,	_	0	SENT_181	[p7l14t1182r375b1249],
3	response	NN	O	response	nn	5	SENT_181	[p7l407t1197r692b1249],
4	to	TO	O	to	dep	5	SENT_181	[p7l722t1189r784b1236],
5	treatment	NN	O	treatment	nsubj	12	SENT_181	[p7l814t1189r1138b1236],
6	and	CC	O	and	_	0	SENT_181	[p7l1167t1181r1283b1236],
7	multifocal	JJ	O	multifocal	amod	8	SENT_181	[p7l1315t1181r1641b1236],
8	lesion	NN	O	lesion	nsubj	12	SENT_181	[p7l1673t1181r1861b1236],
9	was	VBD	O	be	cop	12	SENT_181	[p7l1890t1197r2015b1236],
10	not	RB	O	not	neg	12	SENT_181	[p7l2047t1189r2152b1236],
11	signiﬁcantly	RB	O	signiﬁcantly	advmod	12	SENT_181	[p7l15t1269r410b1338],
12	different	JJ	O	different	_	0	SENT_181	[p7l433t1269r711b1324],
13	among	IN	O	among	_	0	SENT_181	[p7l732t1285r952b1338],
14	the	DT	O	the	det	16	SENT_181	[p7l973t1269r1075b1324],
15	polymorphic	JJ	O	polymorphic	amod	16	SENT_181	[p7l1098t1269r1509b1338],
16	variants	NNS	O	variant	prep_among	12	SENT_181	[p7l1530t1270r1805b1333],
17	,	,	O	,	_	0	SENT_181	[p7l1530t1270r1805b1333],
18	indicating	VBG	O	indicate	xcomp	12	SENT_181	[p7l1830t1269r2152b1338],
19	that	IN	O	that	complm	23	SENT_181	[p7l14t1358r143b1413],
20	the	DT	O	the	det	22	SENT_181	[p7l200t1358r302b1413],
21	gene	NN	O	gene	nn	22	SENT_181	[p7l358t1374r509b1427],
22	polymorphisms	NNS	O	polymorphism	nsubj	23	SENT_181	[p7l568t1358r1072b1427],
23	had	VBD	O	have	ccomp	18	SENT_181	[p7l1131t1358r1247b1413],
24	similar	JJ	O	similar	amod	27	SENT_181	[p7l1307t1358r1530b1413],
25	clinic	NN	O	clinic	nn	27	SENT_181	[p7l1586t1358r1756b1413],
26	pathologic	JJ	O	pathologic	amod	27	SENT_181	[p7l1814t1358r2152b1427],
27	characteristics	NNS	O	characteristic	dobj	23	SENT_181	[p7l14t1448r479b1503],
28	before	IN	O	before	mark	33	SENT_181	[p7l500t1447r702b1503],
29	the	DT	O	the	det	31	SENT_181	[p7l722t1448r824b1503],
30	neoadjuvant	JJ	O	neoadjuvant	amod	31	SENT_181	[p7l845t1448r1247b1516],
31	chemotherapy	NN	O	chemotherapy	nsubjpass	33	SENT_181	[p7l1266t1448r1734b1516],
32	was	VBD	O	be	auxpass	33	SENT_181	[p7l1751t1463r1875b1503],
33	applied	VBN	O	apply	advcl	23	SENT_181	[p7l1897t1448r2149b1516],
34	.	.	O	.	_	0	SENT_181	[p7l1897t1448r2149b1516],

1	The	DT	O	the	det	2	SENT_182	[p7l12t1536r129b1591],
2	association	NN	O	association	nsubjpass	14	SENT_182	[p7l156t1537r514b1591],
3	between	IN	O	between	_	0	SENT_182	[p7l540t1536r818b1591],
4	the	DT	O	the	det	8	SENT_182	[p7l844t1536r946b1591],
5	different	JJ	O	different	amod	8	SENT_182	[p7l973t1536r1251b1591],
6	gene	NN	O	gene	nn	8	SENT_182	[p7l1277t1552r1427b1605],
7	polymorphic	JJ	O	polymorphic	amod	8	SENT_182	[p7l1455t1536r1867b1605],
8	variants	NNS	O	variant	prep_between	2	SENT_182	[p7l1891t1537r2150b1591],
9	and	CC	O	and	_	0	SENT_182	[p7l14t1626r130b1681],
10	chemotherapy	NN	O	chemotherapy	nn	11	SENT_182	[p7l178t1626r646b1694],
11	toxicity	NN	O	toxicity	prep_between	2	SENT_182	[p7l690t1627r934b1694],
12	was	VBD	O	be	auxpass	14	SENT_182	[p7l978t1642r1102b1681],
13	also	RB	O	also	advmod	14	SENT_182	[p7l1150t1626r1275b1681],
14	evaluated	VBN	O	evaluate	_	0	SENT_182	[p7l1322t1626r1651b1681],
15	.	.	O	.	_	0	SENT_182	[p7l1322t1626r1651b1681],

1	Seventy	CD	NUMBER	seventy	num	2	SENT_183	[p7l1699t1626r2151b1694],
2	—	CD	NUMBER	—	nsubj	12	SENT_183	[p7l1699t1626r2151b1694],
3	three	CD	NUMBER	three	num	5	SENT_183	[p7l1699t1626r2151b1694],
4	point	NN	O	point	nn	5	SENT_183	[p7l15t1716r183b1783],
5	ﬁve	NN	O	ﬁve	dep	2	SENT_183	[p7l207t1715r321b1770],
6	(	CD	NUMBER	(	number	7	SENT_183	[p7l346t1715r534b1783],
7	73.5	CD	PERCENT	73.5	num	9	SENT_183	[p7l346t1715r534b1783],
8	)	NN	PERCENT	)	nn	9	SENT_183	[p7l346t1715r534b1783],
9	percent	NN	PERCENT	percent	dep	2	SENT_183	[p7l559t1723r803b1783],
10	of	IN	O	of	_	0	SENT_183	[p7l827t1715r893b1770],
11	patients	NNS	O	patient	prep_of	9	SENT_183	[p7l910t1716r1168b1783],
12	suffered	VBD	O	suffer	_	0	SENT_183	[p7l1195t1715r1454b1770],
13	any	DT	O	any	det	15	SENT_183	[p7l1479t1731r1595b1783],
14	adverse	JJ	O	adverse	amod	15	SENT_183	[p7l1618t1715r1864b1770],
15	reaction	NN	O	reaction	dobj	12	SENT_183	[p7l1890t1716r2151b1770],
16	to	TO	O	to	_	0	SENT_183	[p7l14t1811r76b1858],
17	chemotherapy	NN	O	chemotherapy	prep_to	12	SENT_183	[p7l125t1803r607b1872],
18	,	,	O	,	_	0	SENT_183	[p7l125t1803r607b1872],
19	with	IN	O	with	_	0	SENT_183	[p7l654t1803r802b1858],
20	16.7	CD	PERCENT	16.7	num	21	SENT_183	[p7l854t1806r1031b1859],
21	%	NN	PERCENT	%	prep_with	12	SENT_183	[p7l854t1806r1031b1859],
22	of	IN	O	of	_	0	SENT_183	[p7l1079t1803r1145b1858],
23	them	PRP	O	they	nsubj	24	SENT_183	[p7l1186t1803r1353b1858],
24	experiencing	VBG	O	experience	prepc_of	21	SENT_183	[p7l1402t1804r1819b1872],
25	a	DT	O	a	det	28	SENT_183	[p7l1866t1819r1898b1858],
26	severe	JJ	O	severe	amod	28	SENT_183	[p7l1947t1819r2151b1858],
27	adverse	JJ	O	adverse	amod	28	SENT_183	[p7l14t1892r260b1947],
28	reaction	NN	O	reaction	dobj	24	SENT_183	[p7l322t1893r583b1947],
29	to	TO	O	to	_	0	SENT_183	[p7l643t1900r705b1947],
30	treatment	NN	O	treatment	prep_to	24	SENT_183	[p7l765t1900r1089b1947],
31	(	JJ	O	(	amod	32	SENT_183	[p7l1149t1892r1383b1961],
32	grades	NNS	O	grade	tmod	24	SENT_183	[p7l1149t1892r1383b1961],
33	3-4	CD	NUMBER	3-4	num	34	SENT_183	[p7l1444t1892r1605b1960],
34	)	NN	O	)	dep	32	SENT_183	[p7l1444t1892r1605b1960],
35	.	.	O	.	_	0	SENT_183	[p7l1444t1892r1605b1960],

1	Nausea	NN	O	nausea	nsubj	28	SENT_184	[p7l1668t1895r1900b1947],
2	(	CD	PERCENT	(	number	3	SENT_184	[p7l1961t1892r2150b1960],
3	32	CD	PERCENT	32	num	4	SENT_184	[p7l1961t1892r2150b1960],
4	%	NN	PERCENT	%	dep	1	SENT_184	[p7l1961t1892r2150b1960],
5	)	CD	NUMBER	)	dep	1	SENT_184	[p7l1961t1892r2150b1960],
6	,	,	O	,	_	0	SENT_184	[p7l1961t1892r2150b1960],
7	mucositis	NN	O	mucositis	conj_and	1	SENT_184	[p7l15t1982r322b2036],
8	(	CD	PERCENT	(	number	9	SENT_184	[p7l348t1981r537b2050],
9	24	CD	PERCENT	24	num	10	SENT_184	[p7l348t1981r537b2050],
10	%	NN	PERCENT	%	dep	7	SENT_184	[p7l348t1981r537b2050],
11	)	CD	NUMBER	)	dep	7	SENT_184	[p7l348t1981r537b2050],
12	,	,	O	,	_	0	SENT_184	[p7l348t1981r537b2050],
13	asthenia	FW	O	asthenia	nn	14	SENT_184	[p7l562t1981r833b2036],
14	(	FW	O	(	amod	16	SENT_184	[p7l856t1982r1030b2050],
15	22	CD	PERCENT	22	num	16	SENT_184	[p7l856t1982r1030b2050],
16	%	NN	PERCENT	%	nsubj	28	SENT_184	[p7l856t1982r1030b2050],
17	)	CD	NUMBER	)	dep	16	SENT_184	[p7l856t1982r1030b2050],
18	and	CC	O	and	_	0	SENT_184	[p7l1054t1981r1170b2036],
19	diarrhea	NN	O	diarrhea	nsubj	28	SENT_184	[p7l1195t1981r1463b2036],
20	(	CD	PERCENT	(	number	21	SENT_184	[p7l1488t1982r1661b2050],
21	14	CD	PERCENT	14	num	22	SENT_184	[p7l1488t1982r1661b2050],
22	%	NN	PERCENT	%	dep	19	SENT_184	[p7l1488t1982r1661b2050],
23	)	CD	NUMBER	)	dep	19	SENT_184	[p7l1488t1982r1661b2050],
24	were	VBD	O	be	cop	28	SENT_184	[p7l1683t1997r1843b2036],
25	the	DT	O	the	det	28	SENT_184	[p7l1866t1981r1968b2036],
26	most	RBS	O	most	advmod	28	SENT_184	[p7l1993t1990r2152b2036],
27	common	JJ	O	common	amod	28	SENT_184	[p7l14t2086r297b2125],
28	reactions	NNS	O	reaction	_	0	SENT_184	[p7l363t2071r655b2125],
29	observed	VBN	O	observe	partmod	28	SENT_184	[p7l722t2070r1028b2126],
30	.	.	O	.	_	0	SENT_184	[p7l722t2070r1028b2126],

1	A	DT	O	a	det	3	SENT_185	[p7l1093t2073r1139b2125],
2	signiﬁcant	JJ	O	signiﬁcant	amod	3	SENT_185	[p7l1204t2070r1539b2139],
3	association	NN	O	association	nsubjpass	5	SENT_185	[p7l1603t2071r1961b2125],
4	was	VBD	O	be	auxpass	5	SENT_185	[p7l2025t2086r2150b2125],
5	observed	VBN	O	observe	_	0	SENT_185	[p7l14t2160r304b2215],
6	between	IN	O	between	_	0	SENT_185	[p7l324t2160r601b2215],
7	age	NN	O	age	prep_between	5	SENT_185	[p7l621t2176r728b2228],
8	and	CC	O	and	_	0	SENT_185	[p7l748t2160r864b2215],
9	the	DT	O	the	det	10	SENT_185	[p7l885t2160r986b2215],
10	development	NN	O	development	dep	19	SENT_185	[p7l1007t2160r1431b2228],
11	of	IN	O	of	_	0	SENT_185	[p7l1450t2160r1516b2215],
12	an	DT	O	a	det	16	SENT_185	[p7l1529t2176r1604b2215],
13	adverse	JJ	O	adverse	amod	16	SENT_185	[p7l1623t2160r1869b2215],
14	reaction	NN	O	reaction	nn	16	SENT_185	[p7l1890t2161r2151b2215],
15	(	NN	O	(	nn	16	SENT_185	[p7l14t2249r75b2317],
16	p	NN	O	p	prep_of	10	SENT_185	[p7l14t2249r75b2317],
17	=	JJ	O	=	amod	19	SENT_185	[p7l97t2272r130b2288],
18	0.048	CD	NUMBER	0.048	num	19	SENT_185	[p7l153t2249r370b2317],
19	)	NN	O	)	conj_and	5	SENT_185	[p7l153t2249r370b2317],
20	.	.	O	.	_	0	SENT_185	[p7l153t2249r370b2317],

1	Thirty	CD	PERCENT	thirty	num	2	SENT_186	[p7l396t2249r593b2317],
2	percent	NN	PERCENT	percent	nsubj	11	SENT_186	[p7l619t2257r862b2317],
3	of	IN	O	of	_	0	SENT_186	[p7l888t2249r954b2304],
4	patients	NNS	O	patient	prep_of	2	SENT_186	[p7l973t2250r1231b2317],
5	older	JJR	O	older	amod	4	SENT_186	[p7l1259t2249r1425b2304],
6	than	IN	O	than	_	0	SENT_186	[p7l1449t2249r1594b2304],
7	60	CD	DURATION	60	num	8	SENT_186	[p7l1621t2252r1697b2304],
8	years	NNS	NUMBER	year	prep_than	5	SENT_186	[p7l1722t2265r1891b2317],
9	did	VBD	O	do	aux	11	SENT_186	[p7l1919t2249r2019b2304],
10	not	RB	O	not	neg	11	SENT_186	[p7l2047t2257r2152b2304],
11	suffered	VBN	O	suffer	_	0	SENT_186	[p7l15t2337r274b2392],
12	serious	JJ	O	serious	amod	14	SENT_186	[p7l294t2338r520b2392],
13	adverse	JJ	O	adverse	amod	14	SENT_186	[p7l540t2337r786b2392],
14	reaction	NN	O	reaction	dobj	11	SENT_186	[p7l805t2338r1081b2401],
15	,	,	O	,	_	0	SENT_186	[p7l805t2338r1081b2401],
16	in	IN	O	in	_	0	SENT_186	[p7l1101t2338r1160b2392],
17	contrast	NN	O	contrast	prep_in	11	SENT_186	[p7l1179t2345r1441b2392],
18	to	TO	O	to	_	0	SENT_186	[p7l1458t2345r1520b2392],
19	83.4	CD	PERCENT	83.4	num	20	SENT_186	[p7l1539t2340r1718b2393],
20	%	NN	PERCENT	%	prep_to	17	SENT_186	[p7l1539t2340r1718b2393],
21	of	IN	O	of	_	0	SENT_186	[p7l1737t2337r1803b2392],
22	patients	NNS	O	patient	prep_of	20	SENT_186	[p7l1814t2338r2072b2406],
23	in	IN	O	in	_	0	SENT_186	[p7l2092t2338r2151b2392],
24	the	DT	O	the	det	26	SENT_186	[p7l14t2426r116b2481],
25	same	JJ	O	same	amod	26	SENT_186	[p7l139t2442r303b2481],
26	range	NN	O	range	prep_in	22	SENT_186	[p7l326t2442r504b2495],
27	of	IN	O	of	_	0	SENT_186	[p7l527t2426r593b2481],
28	age	NN	O	age	prep_of	26	SENT_186	[p7l606t2442r713b2495],
29	who	WP	O	who	nsubj	30	SENT_186	[p7l734t2426r873b2481],
30	did	VBD	O	do	rcmod	20	SENT_186	[p7l896t2426r996b2481],
31	it	PRP	O	it	dobj	30	SENT_186	[p7l1018t2427r1077b2481],
32	.	.	O	.	_	0	SENT_186	[p7l1018t2427r1077b2481],

1	This	DT	O	this	det	2	SENT_187	[p7l1098t2426r1229b2481],
2	proﬁle	NN	O	proﬁle	nsubj	14	SENT_187	[p7l1253t2426r1461b2495],
3	appeared	VBD	O	appear	cop	14	SENT_187	[p7l1482t2426r1779b2495],
4	inverted	VBN	O	invert	dep	14	SENT_187	[p7l1802t2426r2069b2481],
5	in	IN	O	in	_	0	SENT_187	[p7l2092t2427r2151b2480],
6	women	NNS	O	woman	prep_in	4	SENT_187	[p7l13t2531r255b2570],
7	with	IN	O	with	_	0	SENT_187	[p7l294t2515r442b2570],
8	<	JJR	O	<	prep_with	14	SENT_187	[p7l485t2518r614b2572],
9	50	CD	DURATION	50	num	10	SENT_187	[p7l485t2518r614b2572],
10	years	NNS	NUMBER	year	npadvmod	11	SENT_187	[p7l653t2531r821b2584],
11	old	JJ	DURATION	old	amod	8	SENT_187	[p7l864t2515r961b2570],
12	(	CD	PERCENT	(	number	13	SENT_187	[p7l1003t2515r1209b2584],
13	53.4	CD	PERCENT	53.4	num	14	SENT_187	[p7l1003t2515r1209b2584],
14	%	NN	PERCENT	%	_	0	SENT_187	[p7l1003t2515r1209b2584],
15	versus	CC	O	versus	prep	14	SENT_187	[p7l1248t2531r1453b2570],
16	16.6	CD	PERCENT	16.6	num	17	SENT_187	[p7l1499t2516r1717b2584],
17	%	NN	PERCENT	%	dep	15	SENT_187	[p7l1499t2516r1717b2584],
18	)	CD	NUMBER	)	tmod	14	SENT_187	[p7l1499t2516r1717b2584],
19	.	.	O	.	_	0	SENT_187	[p7l1499t2516r1717b2584],

1	We	PRP	O	we	nsubj	4	SENT_188	[p7l1756t2519r1865b2570],
2	did	VBD	O	do	aux	4	SENT_188	[p7l1905t2515r2005b2570],
3	not	RB	O	not	neg	4	SENT_188	[p7l2047t2524r2152b2570],
4	observe	VB	O	observe	_	0	SENT_188	[p7l14t2604r262b2659],
5	signiﬁcant	JJ	O	signiﬁcant	amod	6	SENT_188	[p7l292t2604r626b2673],
6	association	NN	O	association	dobj	4	SENT_188	[p7l653t2605r1011b2659],
7	between	IN	O	between	_	0	SENT_188	[p7l1037t2604r1315b2659],
8	response	NN	O	response	nn	9	SENT_188	[p7l1343t2620r1628b2673],
9	rates	NNS	O	rate	prep_between	6	SENT_188	[p7l1656t2613r1810b2659],
10	to	TO	O	to	_	0	SENT_188	[p7l1839t2613r1900b2659],
11	neoadjuvant	JJ	O	neoadjuvant	amod	12	SENT_188	[p7l1930t2604r2150b2659, p7l7t2694r219b2761],
12	therapy	NN	O	therapy	prep_to	4	SENT_188	[p7l254t2693r504b2761],
13	and	CC	O	and	_	0	SENT_188	[p7l540t2693r656b2748],
14	adverse	JJ	O	adverse	amod	15	SENT_188	[p7l694t2693r940b2748],
15	reaction	NN	O	reaction	conj_and	12	SENT_188	[p7l978t2694r1239b2748],
16	to	TO	O	to	_	0	SENT_188	[p7l1276t2701r1337b2748],
17	chemotherapy	NN	O	chemotherapy	nn	20	SENT_188	[p7l1375t2693r1843b2761],
18	(	CD	NUMBER	(	num	20	SENT_188	[p7l1879t2682r1979b2762],
19	X2	NN	O	x2	nn	20	SENT_188	[p7l1879t2682r1979b2762],
20	test	NN	O	test	prep_to	4	SENT_188	[p7l2017t2701r2150b2756],
21	,	,	O	,	_	0	SENT_188	[p7l2017t2701r2150b2756],
22	p	NN	O	p	dep	23	SENT_188	[p7l10t2798r48b2850],
23	>	JJR	O	>	appos	20	SENT_188	[p7l73t2798r117b2839],
24	0.05	CD	NUMBER	0.05	num	25	SENT_188	[p7l142t2782r317b2850],
25	)	NN	O	)	dep	23	SENT_188	[p7l142t2782r317b2850],
26	.	.	O	.	_	0	SENT_188	[p7l142t2782r317b2850],

1	In	IN	O	in	dep	7	SENT_189	[p7l344t2785r404b2836],
2	univariate	JJ	O	univariate	amod	3	SENT_189	[p7l428t2783r755b2837],
3	analysis	NN	O	analysis	pobj	1	SENT_189	[p7l780t2782r1052b2850],
4	,	,	O	,	_	0	SENT_189	[p7l780t2782r1052b2850],
5	a	DT	O	a	det	7	SENT_189	[p7l1077t2798r1109b2837],
6	signiﬁcant	JJ	O	signiﬁcant	amod	7	SENT_189	[p7l1135t2782r1470b2850],
7	association	NN	O	association	_	0	SENT_189	[p7l1493t2783r1850b2837],
8	between	IN	O	between	_	0	SENT_189	[p7l1874t2782r2151b2837],
9	Table	NNP	O	Table	prep_between	7	SENT_189	[p7l9t2865r155b2908],
10	2	CD	NUMBER	2	num	13	SENT_189	[p7l177t2867r206b2908],
11	Clinic	NNP	O	Clinic	nn	13	SENT_189	[p7l12t2936r154b2980],
12	pathologic	JJ	O	pathologic	amod	13	SENT_189	[p7l176t2936r447b2990],
13	characteristics	NNS	O	characteristic	dep	9	SENT_189	[p7l469t2936r840b2980],
14	of	IN	O	of	_	0	SENT_189	[p7l864t2936r917b2980],
15	cancer	NN	O	cancer	nn	16	SENT_189	[p7l934t2949r1102b2980],
16	patients	NNS	O	patient	prep_of	7	SENT_189	[p7l1122t2937r1341b2990],
17	.	.	O	.	_	0	SENT_189	[p7l1122t2937r1341b2990],

1	Characteristics	NNS	O	characteristic	nn	2	SENT_190	[p7l63t3059r441b3103],
2	Cases	NNS	O	case	nsubj	3	SENT_190	[p7l1197t3062r1336b3103],
3	(	VBP	O	(	_	0	SENT_190	[p7l1359t3059r1430b3114],
4	n	NN	O	n	dobj	3	SENT_190	[p7l1359t3059r1430b3114],
5	)	CD	PERCENT	)	num	6	SENT_190	[p7l1359t3059r1430b3114],
6	%	NN	PERCENT	%	dep	4	SENT_190	[p7l2032t3062r2064b3103],

1	Tumour	NN	O	tumour	nn	2	SENT_191	[p7l56t3174r264b3214],
2	type	NN	O	type	_	0	SENT_191	[p7l283t3177r395b3225],

1	Ductal	JJ	O	ductal	amod	2	SENT_192	[p7l108t3243r273b3287],
2	carcinoma	NN	O	carcinoma	_	0	SENT_192	[p7l296t3244r563b3287],
3	46	CD	NUMBER	46	number	4	SENT_192	[p7l1195t3245r1259b3287],
4	92	CD	NUMBER	92	num	6	SENT_192	[p7l2033t3245r2093b3287],
5	Lobular	JJ	O	lobular	amod	6	SENT_192	[p7l108t3316r302b3359],
6	carcinoma	NN	O	carcinoma	dep	2	SENT_192	[p7l323t3316r590b3359],
7	4	CD	NUMBER	4	number	8	SENT_192	[p7l1228t3318r1259b3359],
8	8	CD	NUMBER	8	amod	6	SENT_192	[p7l2066t3318r2093b3359],

1	Chemotherapy	NN	O	chemotherapy	nn	2	SENT_193	[p7l58t3434r439b3488],
2	regimens	NNS	O	regimen	_	0	SENT_193	[p7l461t3435r697b3488],

1	FEC	NN	ORGANIZATION	fec	_	0	SENT_194	[p7l108t3508r199b3550],
2	1	CD	NUMBER	1	number	3	SENT_194	[p7l1232t3509r1252b3549],
3	2	CD	NUMBER	2	dep	1	SENT_194	[p7l2065t3508r2093b3549],
4	FEC	NN	ORGANIZATION	fec	dep	3	SENT_194	[p7l108t3579r199b3620],
5	+	CC	O	+	_	0	SENT_194	[p7l211t3586r238b3613],
6	paclitaxel	NN	O	paclitaxel	dep	1	SENT_194	[p7l252t3576r499b3631],
7	34	CD	NUMBER	34	number	8	SENT_194	[p7l1196t3579r1259b3620],
8	68	CD	NUMBER	68	num	9	SENT_194	[p7l2033t3579r2093b3620],
9	FEC	NN	ORGANIZATION	fec	dep	6	SENT_194	[p7l108t3651r199b3692],
10	+	CC	O	+	_	0	SENT_194	[p7l211t3658r238b3686],
11	docetaxel	NN	O	docetaxel	conj_+	6	SENT_194	[p7l251t3649r497b3692],
12	14	CD	NUMBER	14	number	13	SENT_194	[p7l1200t3651r1259b3692],
13	28	CD	NUMBER	28	num	14	SENT_194	[p7l2033t3651r2093b3692],
14	CMF	NN	ORGANIZATION	cmf	dep	11	SENT_194	[p7l108t3723r222b3765],
15	1	CD	NUMBER	1	number	16	SENT_194	[p7l1233t3724r1252b3764],
16	2	CD	NUMBER	2	num	14	SENT_194	[p7l2065t3723r2093b3764],

1	ER	NN	O	er	nn	2	SENT_195	[p8l59t49r124b90],
2	status	NN	O	status	_	0	SENT_195	[p8l144t53r295b90],
3	Negative	JJ	O	negative	amod	5	SENT_195	[p8l108t118r333b172],
4	23	CD	NUMBER	23	number	5	SENT_195	[p8l1197t120r1256b161],
5	46	CD	NUMBER	46	dep	2	SENT_195	[p8l2031t120r2094b161],
6	Positive	JJ	O	positive	amod	8	SENT_195	[p8l108t191r308b234],
7	27	CD	NUMBER	27	number	8	SENT_195	[p8l1197t193r1258b234],
8	54	CD	NUMBER	54	dep	5	SENT_195	[p8l2033t193r2095b234],

1	PR	NN	O	pr	nn	2	SENT_196	[p8l58t311r124b352],
2	status	NN	O	status	_	0	SENT_196	[p8l144t315r295b352],

1	Negative	JJ	O	negative	_	0	SENT_197	[p8l108t381r333b434],
2	30	CD	NUMBER	30	number	3	SENT_197	[p8l1197t382r1260b424],
3	60	CD	NUMBER	60	dep	1	SENT_197	[p8l2033t382r2095b424],
4	Positive	JJ	O	positive	dep	1	SENT_197	[p8l108t453r308b496],
5	20	CD	NUMBER	20	number	6	SENT_197	[p8l1198t455r1260b496],
6	40	CD	NUMBER	40	dep	4	SENT_197	[p8l2032t455r2095b496],

1	erbB2	NN	O	erbb2	nn	2	SENT_198	[p8l58t571r205b614],
2	status	NN	O	status	_	0	SENT_198	[p8l230t577r381b614],

1	Negative	JJ	O	negative	amod	2	SENT_199	[p8l108t643r333b696],
2	31	CD	NUMBER	31	_	0	SENT_199	[p8l1196t644r1252b686],
3	62	CD	NUMBER	62	dep	2	SENT_199	[p8l2033t644r2093b686],
4	Positive	JJ	O	positive	amod	7	SENT_199	[p8l108t715r308b758],
5	18	CD	NUMBER	18	number	6	SENT_199	[p8l1200t716r1257b758],
6	36	CD	NUMBER	36	amod	7	SENT_199	[p8l2032t716r2094b758],
7	ND	NN	ORGANIZATION	nd	dep	3	SENT_199	[p8l108t789r186b830],
8	1	CD	NUMBER	1	number	9	SENT_199	[p8l1232t789r1252b830],
9	2	CD	NUMBER	2	num	7	SENT_199	[p8l2065t789r2093b830],

1	Clinical	JJ	O	clinical	amod	2	SENT_200	[p8l58t905r247b948],
2	stage	NN	O	stage	_	0	SENT_200	[p8l270t911r402b959],

1	I	PRP	O	I	dep	7	SENT_201	[p8l108t980r121b1020],
2	1	CD	NUMBER	1	number	3	SENT_201	[p8l1233t980r1252b1020],
3	2	CD	NUMBER	2	dep	1	SENT_201	[p8l2065t979r2093b1020],
4	II	CD	NUMBER	ii	num	5	SENT_201	[p8l108t1053r139b1093],
5	26	CD	NUMBER	26	dep	3	SENT_201	[p8l1197t1052r1259b1094],
6	52	CD	NUMBER	52	dep	7	SENT_201	[p8l2033t1052r2093b1094],
7	III	NNP	O	III	dep	12	SENT_201	[p8l108t1125r156b1166],
8	22	CD	NUMBER	22	num	7	SENT_201	[p8l1197t1125r1257b1166],
9	44	CD	NUMBER	44	num	10	SENT_201	[p8l2031t1125r2095b1166],
10	IV	CD	NUMBER	iv	dep	7	SENT_201	[p8l108t1198r161b1239],
11	1	CD	NUMBER	1	num	12	SENT_201	[p8l1232t1198r1252b1239],
12	2	CD	NUMBER	2	_	0	SENT_201	[p8l2065t1198r2093b1239],

1	Tumour	NN	O	tumour	nn	2	SENT_202	[p8l56t1317r264b1357],
2	size	NN	O	size	_	0	SENT_202	[p8l285t1314r380b1357],
3	(	CD	NUMBER	(	num	4	SENT_202	[p8l402t1314r546b1368],
4	TNM	NN	O	tnm	dep	2	SENT_202	[p8l402t1314r546b1368],
5	staging	NN	O	staging	nn	6	SENT_202	[p8l570t1314r774b1368],
6	)	NN	O	)	dep	2	SENT_202	[p8l570t1314r774b1368],

1	1	CD	NUMBER	1	number	2	SENT_203	[p8l111t1389r131b1429],
2	14	CD	NUMBER	14	num	4	SENT_203	[p8l1200t1388r1259b1429],
3	28	CD	NUMBER	28	number	4	SENT_203	[p8l2033t1388r2093b1430],
4	2	CD	DATE	2	_	0	SENT_203	[p8l108t1460r135b1501],
5	19	CD	DATE	19	number	6	SENT_203	[p8l1200t1460r1258b1501],
6	38	CD	DATE	38	amod	4	SENT_203	[p8l2032t1460r2093b1501],
7	3	CD	DATE	3	number	8	SENT_203	[p8l107t1532r134b1573],
8	12	CD	DATE	12	num	10	SENT_203	[p8l1200t1532r1257b1573],
9	24	CD	DATE	24	number	10	SENT_203	[p8l2033t1532r2095b1573],
10	4	CD	NUMBER	4	dep	4	SENT_203	[p8l106t1604r137b1645],
11	5	CD	NUMBER	5	number	12	SENT_203	[p8l1230t1605r1257b1646],
12	1	CD	NUMBER	1	num	13	SENT_203	[p8l2036t1605r2056b1645],
13	O	NN	O	o	dep	10	SENT_203	[p8l2066t1604r2095b1646],

1	Multifocal	JJ	O	multifocal	_	0	SENT_204	[p8l59t1720r320b1764],
2	No	DT	O	no	det	4	SENT_204	[p8l108t1796r178b1837],
3	41	CD	NUMBER	41	num	4	SENT_204	[p8l1195t1795r1253b1836],
4	82	CD	NUMBER	82	dep	1	SENT_204	[p8l2033t1795r2093b1837],
5	Yes	UH	O	yes	dep	6	SENT_204	[p8l106t1868r192b1909],
6	9	CD	NUMBER	9	rcmod	4	SENT_204	[p8l1230t1868r1258b1909],
7	1	CD	NUMBER	1	num	8	SENT_204	[p8l2035t1868r2055b1909],
8	8	CD	NUMBER	8	dep	1	SENT_204	[p8l2066t1868r2093b1909],

1	ND	NNP	ORGANIZATION	ND	_	0	SENT_205	[p8l12t1981r102b2029],
2	,	,	O	,	_	0	SENT_205	[p8l12t1981r102b2029],
3	non-determined	JJ	O	non-determined	appos	1	SENT_205	[p8l126t1979r563b2029],
4	;	:	O	;	_	0	SENT_205	[p8l126t1979r563b2029],
5	ER	NN	O	er	dep	1	SENT_205	[p8l590t1981r665b2029],
6	,	,	O	,	_	0	SENT_205	[p8l590t1981r665b2029],
7	estrogen	NN	O	estrogen	nn	8	SENT_205	[p8l688t1985r909b2033],
8	receptor	NN	O	receptor	appos	5	SENT_205	[p8l932t1985r1162b2033],
9	;	:	O	;	_	0	SENT_205	[p8l932t1985r1162b2033],
10	PR	NN	O	pr	dep	1	SENT_205	[p8l1189t1981r1263b2029],
11	,	,	O	,	_	0	SENT_205	[p8l1189t1981r1263b2029],
12	progesterone	NN	O	progesterone	nn	13	SENT_205	[p8l1287t1985r1625b2033],
13	receptor	NN	O	receptor	appos	10	SENT_205	[p8l1648t1985r1874b2033],
14	.	.	O	.	_	0	SENT_205	[p8l1648t1985r1874b2033],

1	Table	NNP	O	Table	_	0	SENT_206	[p8l9t2163r155b2206],
2	3	CD	NUMBER	3	num	1	SENT_206	[p8l176t2165r206b2206],
3	Genotypic	JJ	O	genotypic	amod	6	SENT_206	[p8l12t2235r273b2288],
4	and	CC	O	and	_	0	SENT_206	[p8l295t2234r388b2278],
5	allelic	JJ	O	allelic	amod	6	SENT_206	[p8l411t2234r562b2278],
6	frequencies	NNS	O	frequency	dep	1	SENT_206	[p8l584t2234r880b2288],
7	of	IN	O	of	_	0	SENT_206	[p8l903t2234r956b2278],
8	gene	NN	O	gene	nn	9	SENT_206	[p8l972t2247r1092b2288],
9	polymorphisms	NNS	O	polymorphism	prep_of	6	SENT_206	[p8l1115t2234r1518b2288],
10	in	IN	O	in	_	0	SENT_206	[p8l1542t2235r1590b2277],
11	this	DT	O	this	det	12	SENT_206	[p8l1611t2234r1705b2278],
12	study	NN	O	study	prep_in	9	SENT_206	[p8l1729t2234r1882b2288],
13	.	.	O	.	_	0	SENT_206	[p8l1729t2234r1882b2288],

1	n	NN	O	n	nn	2	SENT_207	[p8l544t2385r571b2416],
2	Genotypes	NNS	O	genotype	nsubj	3	SENT_207	[p8l713t2375r984b2427],
3	(	VBP	O	(	_	0	SENT_207	[p8l1007t2373r1070b2426],
4	n	NN	O	n	dobj	3	SENT_207	[p8l1007t2373r1070b2426],
5	,	,	O	,	_	0	SENT_207	[p8l1007t2373r1070b2426],
6	%	NN	O	%	appos	4	SENT_207	[p8l1092t2373r1145b2426],
7	)	CD	NUMBER	)	num	8	SENT_207	[p8l1092t2373r1145b2426],
8	Alleles	NNS	O	allele	dep	20	SENT_207	[p8l1612t2372r1782b2416],
9	(	CD	NUMBER	(	num	10	SENT_207	[p8l1806t2373r1868b2426],
10	n	NN	O	n	dep	8	SENT_207	[p8l1806t2373r1868b2426],
11	,	,	O	,	_	0	SENT_207	[p8l1806t2373r1868b2426],
12	%	NN	O	%	nn	14	SENT_207	[p8l1890t2373r1943b2426],
13	)	CD	NUMBER	)	num	14	SENT_207	[p8l1890t2373r1943b2426],
14	TS	NN	O	t	appos	10	SENT_207	[p8l56t2486r115b2528],
15	28bp	JJ	O	28bp	amod	16	SENT_207	[p8l138t2484r266b2538],
16	STR	NN	O	str	dep	20	SENT_207	[p8l289t2486r383b2528],
17	2/2	CD	NUMBER	2/2	number	18	SENT_207	[p8l713t2484r793b2538],
18	2/3	CD	NUMBER	2/3	num	20	SENT_207	[p8l1017t2484r1097b2538],
19	3/3	CD	NUMBER	3/3	number	20	SENT_207	[p8l1317t2484r1398b2538],
20	2	CD	NUMBER	2	dep	4	SENT_207	[p8l1614t2486r1642b2527],
21	3	CD	NUMBER	3	dep	20	SENT_207	[p8l1910t2486r1937b2528],

1	MTHFR	NN	O	mthfr	nn	2	SENT_208	[p8l59t2676r247b2717],
2	C677T	NN	O	c677t	_	0	SENT_208	[p8l267t2676r430b2717],
3	C/C	NN	O	c/c	nn	4	SENT_208	[p8l713t2673r798b2728],
4	C/T	NN	O	c/t	dep	2	SENT_208	[p8l1018t2673r1101b2728],
5	T/T	NN	O	t/t	nn	7	SENT_208	[p8l1316t2673r1400b2728],
6	C	NN	O	c	nn	7	SENT_208	[p8l1615t2676r1645b2717],
7	T	NN	O	t	dep	2	SENT_208	[p8l1909t2676r1940b2717],

1	p53	NN	O	p53	nn	4	SENT_209	[p8l58t2865r151b2917],
2	codon72	NN	O	codon72	nn	4	SENT_209	[p8l176t2863r395b2907],
3	Arg/Arg	NN	O	arg/arg	nn	4	SENT_209	[p8l711t2863r912b2917],
4	Arg/Pro	NN	O	arg/pro	_	0	SENT_209	[p8l1015t2863r1210b2917],
5	Pro/Pro	NNP	O	Pro/Pro	nn	6	SENT_209	[p8l1319t2863r1507b2917],
6	Arg	NN	O	arg	dep	4	SENT_209	[p8l1612t2865r1703b2917],
7	Pro	FW	O	pro	dep	4	SENT_209	[p8l1911t2866r1993b2907],

1	MDR1	NN	O	mdr1	nn	2	SENT_210	[p8l59t3055r208b3096],
2	C3435T	NN	O	c3435t	_	0	SENT_210	[p8l238t3055r433b3096],
3	C/C	NN	O	c/c	nn	4	SENT_210	[p8l713t3052r798b3107],
4	C/T	NN	O	c/t	dep	2	SENT_210	[p8l1018t3052r1101b3107],
5	T/T	NN	O	t/t	nn	7	SENT_210	[p8l1316t3052r1400b3107],
6	C	NN	O	c	nn	7	SENT_210	[p8l1615t3055r1646b3096],
7	T	NN	O	t	dep	2	SENT_210	[p8l1909t3055r1940b3096],

1	adverse	JJ	O	adverse	amod	2	SENT_211	[p9l12t68r258b122],
2	reactions	NNS	O	reaction	nsubjpass	13	SENT_211	[p9l284t69r575b122],
3	and	CC	O	and	_	0	SENT_211	[p9l601t68r717b122],
4	the	DT	O	the	det	7	SENT_211	[p9l743t68r844b122],
5	polymorphisms	NNS	O	polymorphism	nn	7	SENT_211	[p9l869t68r1373b136],
6	MTHFR	NNP	O	MTHFR	nn	7	SENT_211	[p9l1400t72r1636b122],
7	C677T	NN	O	c677t	nsubjpass	13	SENT_211	[p9l1658t71r1861b122],
8	and	CC	O	and	_	0	SENT_211	[p9l1884t68r2000b122],
9	p53	NN	O	p53	nn	10	SENT_211	[p9l2026t71r2142b136],
10	codon	NN	O	codon	nsubjpass	13	SENT_211	[p9l12t155r205b209],
11	72	CD	NUMBER	72	dep	10	SENT_211	[p9l225t158r298b209],
12	was	VBD	O	be	auxpass	13	SENT_211	[p9l317t171r441b209],
13	established	VBN	O	establish	_	0	SENT_211	[p9l462t155r824b209],
14	(	RB	O	(	advmod	13	SENT_211	[p9l843t155r1040b222],
15	Table	NNP	O	Table	prep	13	SENT_211	[p9l843t155r1040b222],
16	4	CD	NUMBER	4	num	17	SENT_211	[p9l1057t155r1136b222],
17	)	CD	NUMBER	)	dep	15	SENT_211	[p9l1057t155r1136b222],
18	.	.	O	.	_	0	SENT_211	[p9l1057t155r1136b222],

1	All	DT	O	all	det	2	SENT_212	[p9l1153t155r1239b209],
2	patients	NNS	O	patient	nsubj	20	SENT_212	[p9l1259t156r1516b223],
3	with	IN	O	with	_	0	SENT_212	[p9l1534t155r1682b209],
4	the	DT	O	the	det	7	SENT_212	[p9l1699t155r1801b209],
5	MTHFR	NNP	O	MTHFR	nn	7	SENT_212	[p9l1820t159r2056b209],
6	TT	NN	O	tt	nn	7	SENT_212	[p9l2068t159r2147b209],
7	variant	NN	O	variant	prep_with	2	SENT_212	[p9l10t243r253b305],
8	,	,	O	,	_	0	SENT_212	[p9l10t243r253b305],
9	as	RB	O	as	_	0	SENT_212	[p9l303t258r366b297],
10	well	RB	O	well	_	0	SENT_212	[p9l415t243r551b297],
11	as	IN	O	as	_	0	SENT_212	[p9l600t258r662b297],
12	all	DT	O	all	det	13	SENT_212	[p9l713t243r787b297],
13	ones	NNS	O	one	conj_and	7	SENT_212	[p9l838t258r982b297],
14	with	IN	O	with	_	0	SENT_212	[p9l1031t243r1179b297],
15	the	DT	O	the	det	18	SENT_212	[p9l1228t242r1329b297],
16	p53	NN	O	p53	nn	18	SENT_212	[p9l1378t245r1494b310],
17	Pro/Pro	NNP	O	Pro/Pro	nn	18	SENT_212	[p9l1548t242r1783b310],
18	genotype	NN	O	genotype	prep_with	13	SENT_212	[p9l1832t251r2145b310],
19	,	,	O	,	_	0	SENT_212	[p9l1832t251r2145b310],
20	developed	VBD	O	develop	_	0	SENT_212	[p9l12t329r341b397],
21	some	DT	O	some	det	22	SENT_212	[p9l368t345r535b383],
22	type	NN	O	type	dobj	20	SENT_212	[p9l559t338r699b397],
23	of	IN	O	of	_	0	SENT_212	[p9l724t329r790b383],
24	adverse	JJ	O	adverse	amod	27	SENT_212	[p9l807t329r1053b383],
25	reaction	NN	O	reaction	nn	27	SENT_212	[p9l1078t330r1339b383],
26	(	NN	O	(	nn	27	SENT_212	[p9l1363t330r1423b397],
27	p	NN	O	p	prep_of	22	SENT_212	[p9l1363t330r1423b397],
28	=	JJ	O	=	amod	27	SENT_212	[p9l1446t352r1479b368],
29	0.018	CD	NUMBER	0.018	tmod	28	SENT_212	[p9l1502t332r1674b384],
30	and	CC	O	and	_	0	SENT_212	[p9l1701t329r1817b383],
31	p	NN	O	p	conj_and	22	SENT_212	[p9l1837t345r1876b397],
32	=	JJ	O	=	amod	31	SENT_212	[p9l1898t352r1931b368],
33	0.022	CD	NUMBER	0.022	tmod	32	SENT_212	[p9l1954t332r2145b392],
34	,	,	O	,	_	0	SENT_212	[p9l1954t332r2145b392],
35	respectively	RB	O	respectively	advmod	36	SENT_212	[p9l12t417r440b484],
36	)	CD	NUMBER	)	rcmod	31	SENT_212	[p9l12t417r440b484],
37	.	.	O	.	_	0	SENT_212	[p9l12t417r440b484],

1	Due	JJ	O	due	_	0	SENT_213	[p9l463t420r587b471],
2	to	TO	O	to	_	0	SENT_213	[p9l606t425r668b471],
3	the	DT	O	the	det	5	SENT_213	[p9l687t417r789b471],
4	short	JJ	O	short	amod	5	SENT_213	[p9l809t417r974b471],
5	number	NN	O	number	prep_due_to	15	SENT_213	[p9l992t417r1247b471],
6	of	IN	O	of	_	0	SENT_213	[p9l1265t417r1331b471],
7	patients	NNS	O	patient	prep_of	5	SENT_213	[p9l1342t418r1616b484],
8	,	,	O	,	_	0	SENT_213	[p9l1342t418r1616b484],
9	MTHFR	NN	O	mthfr	prep_of	5	SENT_213	[p9l1638t420r1873b470],
10	and	CC	O	and	_	0	SENT_213	[p9l1890t417r2006b471],
11	p53	NN	O	p53	prep_of	5	SENT_213	[p9l2026t420r2142b484],
12	polymorphic	JJ	O	polymorphic	amod	13	SENT_213	[p9l12t504r423b571],
13	variants	NNS	O	variant	nsubjpass	15	SENT_213	[p9l451t505r709b558],
14	were	VBD	O	be	auxpass	15	SENT_213	[p9l740t520r899b558],
15	grouped	VBN	O	group	_	0	SENT_213	[p9l930t504r1195b571],
16	to	TO	O	to	aux	17	SENT_213	[p9l1226t512r1288b558],
17	increase	VB	O	increase	xcomp	15	SENT_213	[p9l1319t505r1582b558],
18	the	DT	O	the	det	19	SENT_213	[p9l1612t504r1714b558],
19	reliability	NN	O	reliability	dobj	17	SENT_213	[p9l1746t504r2057b571],
20	of	IN	O	of	_	0	SENT_213	[p9l2087t504r2153b558],
21	the	DT	O	the	det	22	SENT_213	[p9l11t590r113b644],
22	analyses	NNS	O	analysis	prep_of	19	SENT_213	[p9l140t590r426b658],
23	.	.	O	.	_	0	SENT_213	[p9l140t590r426b658],

1	Patients	NNS	O	patient	nsubj	16	SENT_214	[p9l455t591r710b644],
2	with	IN	O	with	_	0	SENT_214	[p9l736t590r884b644],
3	MTHFR	NN	ORGANIZATION	mthfr	nn	4	SENT_214	[p9l911t594r1147b644],
4	CT	NN	O	ct	prep_with	1	SENT_214	[p9l1171t593r1250b644],
5	+	CC	O	+	_	0	SENT_214	[p9l1269t602r1303b636],
6	TT	NN	O	tt	nn	7	SENT_214	[p9l1322t594r1402b644],
7	variants	NNS	O	variant	prep_with	1	SENT_214	[p9l1424t591r1683b644],
8	and	CC	O	and	_	0	SENT_214	[p9l1710t590r1826b644],
9	with	IN	O	with	_	0	SENT_214	[p9l1851t590r2000b644],
10	p53	NN	O	p53	nn	11	SENT_214	[p9l2026t593r2142b658],
11	Arg/Pro	NN	O	arg/pro	conj_and	4	SENT_214	[p9l9t677r253b745],
12	+	CC	O	+	_	0	SENT_214	[p9l275t689r309b722],
13	Pro/Pro	NN	O	pro/pro	nn	14	SENT_214	[p9l332t677r567b745],
14	variants	NNS	O	variant	conj_and	4	SENT_214	[p9l598t678r873b739],
15	,	,	O	,	_	0	SENT_214	[p9l598t678r873b739],
16	suffered	VBD	O	suffer	_	0	SENT_214	[p9l907t677r1166b731],
17	more	RBR	O	more	advmod	18	SENT_214	[p9l1199t693r1364b731],
18	adverse	JJ	O	adverse	amod	19	SENT_214	[p9l1398t677r1643b731],
19	reactions	NNS	O	reaction	dobj	16	SENT_214	[p9l1677t678r1967b731],
20	than	IN	O	than	_	0	SENT_214	[p9l2001t677r2146b731],
21	MTHFR	NNP	O	MTHFR	nn	23	SENT_214	[p9l12t768r248b818],
22	CC	NN	O	cc	nn	23	SENT_214	[p9l294t767r375b818],
23	patients	NNS	O	patient	prep_than	19	SENT_214	[p9l424t765r681b832],
24	and	CC	O	and	_	0	SENT_214	[p9l730t764r847b818],
25	p53	NN	O	p53	nn	27	SENT_214	[p9l896t767r1012b832],
26	Arg/Arg	NN	O	arg/arg	nn	27	SENT_214	[p9l1061t764r1312b832],
27	patients	NNS	O	patient	prep_than	19	SENT_214	[p9l1359t765r1617b832],
28	(	CD	NUMBER	(	num	29	SENT_214	[p9l1667t764r1727b832],
29	p	NN	O	p	dep	40	SENT_214	[p9l1667t764r1727b832],
30	=	JJ	O	=	amod	29	SENT_214	[p9l1749t787r1782b803],
31	0.014	CD	NUMBER	0.014	tmod	30	SENT_214	[p9l1805t767r1980b819],
32	and	CC	O	and	_	0	SENT_214	[p9l2029t764r2145b818],
33	p	NN	O	p	dep	40	SENT_214	[p9l7t867r46b919],
34	=	JJ	O	=	amod	35	SENT_214	[p9l68t874r101b890],
35	0.006	CD	NUMBER	0.006	dep	33	SENT_214	[p9l124t854r314b914],
36	,	,	O	,	_	0	SENT_214	[p9l124t854r314b914],
37	respectively	RB	O	respectively	advmod	33	SENT_214	[p9l351t851r764b919],
38	)	CD	NUMBER	)	dep	40	SENT_214	[p9l351t851r764b919],
39	(	CD	NUMBER	(	num	40	SENT_214	[p9l800t851r997b919],
40	Table	NNP	O	Table	dep	19	SENT_214	[p9l800t851r997b919],
41	4	CD	NUMBER	4	num	40	SENT_214	[p9l1032t851r1111b919],
42	)	CD	NUMBER	)	dep	40	SENT_214	[p9l1032t851r1111b919],
43	.	.	O	.	_	0	SENT_214	[p9l1032t851r1111b919],

1	Regarding	VBG	O	regard	prep	17	SENT_215	[p9l1149t851r1473b919],
2	to	TO	O	to	pcomp	1	SENT_215	[p9l1507t860r1569b905],
3	TSER	NN	O	tser	nn	8	SENT_215	[p9l1602t854r1763b905],
4	and	CC	O	and	_	0	SENT_215	[p9l1796t851r1912b905],
5	MDR1	NN	O	mdr1	nn	8	SENT_215	[p9l1949t854r2137b905],
6	C3435T	NN	O	c3435t	nn	8	SENT_215	[p9l12t942r256b993],
7	gene	NN	O	gene	nn	8	SENT_215	[p9l304t955r454b1006],
8	polymorphisms	NNS	O	polymorphism	pobj	2	SENT_215	[p9l506t939r1026b1006],
9	,	,	O	,	_	0	SENT_215	[p9l506t939r1026b1006],
10	no	DT	O	no	det	12	SENT_215	[p9l1079t955r1155b993],
11	signiﬁcant	JJ	O	signiﬁcant	amod	12	SENT_215	[p9l1208t939r1542b1006],
12	association	NN	O	association	nsubjpass	17	SENT_215	[p9l1592t940r1949b993],
13	with	IN	O	with	_	0	SENT_215	[p9l1998t939r2146b993],
14	adverse	JJ	O	adverse	amod	15	SENT_215	[p9l12t1026r258b1080],
15	reaction	NN	O	reaction	prep_with	12	SENT_215	[p9l283t1027r544b1080],
16	was	VBD	O	be	auxpass	17	SENT_215	[p9l566t1042r690b1080],
17	observed	VBN	O	observe	_	0	SENT_215	[p9l715t1026r1005b1080],
18	(	RB	O	(	advmod	19	SENT_215	[p9l1029t1026r1089b1093],
19	p	NN	O	p	nsubj	22	SENT_215	[p9l1029t1026r1089b1093],
20	>	JJR	O	>	amod	19	SENT_215	[p9l1115t1042r1158b1082],
21	0.05	CD	NUMBER	0.05	num	22	SENT_215	[p9l1183t1026r1358b1093],
22	)	NN	O	)	xcomp	17	SENT_215	[p9l1183t1026r1358b1093],
23	.	.	O	.	_	0	SENT_215	[p9l1183t1026r1358b1093],

1	In	IN	O	in	_	0	SENT_216	[p9l1384t1029r1444b1079],
2	multivariate	JJ	O	multivariate	amod	3	SENT_216	[p9l1469t1026r1865b1080],
3	analysis	NN	O	analysis	prep_in	34	SENT_216	[p9l1889t1026r2144b1093],
4	including	VBG	O	include	_	0	SENT_216	[p9l12t1112r314b1180],
5	age	NN	O	age	prep_including	3	SENT_216	[p9l349t1128r456b1180],
6	at	IN	O	at	_	0	SENT_216	[p9l493t1120r553b1166],
7	the	DT	O	the	det	8	SENT_216	[p9l587t1112r688b1166],
8	time	NN	O	time	prep_at	5	SENT_216	[p9l724t1113r870b1166],
9	of	IN	O	of	_	0	SENT_216	[p9l906t1112r973b1166],
10	diagnosis	NN	O	diagnosis	nn	15	SENT_216	[p9l1002t1112r1317b1180],
11	,	,	O	,	_	0	SENT_216	[p9l1002t1112r1317b1180],
12	BMI	NN	O	bmus	dep	15	SENT_216	[p9l1355t1116r1496b1175],
13	,	,	O	,	_	0	SENT_216	[p9l1355t1116r1496b1175],
14	menopause	NN	O	menopause	dep	15	SENT_216	[p9l1534t1128r1902b1180],
15	status	NN	O	status	prep_of	8	SENT_216	[p9l1940t1120r2145b1175],
16	,	,	O	,	_	0	SENT_216	[p9l1940t1120r2145b1175],
17	tumour	NN	O	tumour	nn	18	SENT_216	[p9l11t1207r255b1253],
18	stage	NN	O	stage	nsubjpass	34	SENT_216	[p9l271t1207r435b1267],
19	and	CC	O	and	_	0	SENT_216	[p9l453t1199r569b1253],
20	type	NN	O	type	conj_and	18	SENT_216	[p9l588t1207r728b1267],
21	of	IN	O	of	_	0	SENT_216	[p9l746t1199r812b1253],
22	chemotherapy	NN	O	chemotherapy	prep_of	18	SENT_216	[p9l822t1199r1308b1267],
23	;	:	O	;	_	0	SENT_216	[p9l822t1199r1308b1267],
24	p53	NN	O	p53	nn	25	SENT_216	[p9l1331t1202r1447b1267],
25	allele	NN	O	allele	nsubjpass	34	SENT_216	[p9l1468t1199r1638b1253],
26	Pro	FW	O	pro	dep	25	SENT_216	[p9l1656t1202r1759b1253],
27	and	CC	O	and	_	0	SENT_216	[p9l1778t1199r1893b1253],
28	MTHFR	NNP	O	MTHFR	nn	31	SENT_216	[p9l1913t1202r2149b1253],
29	allele	NN	O	allele	nn	31	SENT_216	[p9l12t1286r181b1340],
30	T	NN	O	t	nn	31	SENT_216	[p9l218t1290r258b1340],
31	polymorphisms	NNS	O	polymorphism	conj_and	18	SENT_216	[p9l297t1286r800b1354],
32	were	VBD	O	be	auxpass	34	SENT_216	[p9l840t1302r999b1340],
33	strongly	RB	O	strongly	advmod	34	SENT_216	[p9l1040t1286r1303b1354],
34	associated	VBN	O	associate	_	0	SENT_216	[p9l1342t1286r1673b1340],
35	with	IN	O	with	_	0	SENT_216	[p9l1712t1286r1860b1340],
36	adverse	JJ	O	adverse	amod	37	SENT_216	[p9l1899t1286r2145b1340],
37	reaction	NN	O	reaction	prep_with	34	SENT_216	[p9l12t1374r288b1436],
38	,	,	O	,	_	0	SENT_216	[p9l12t1374r288b1436],
39	with	IN	O	with	_	0	SENT_216	[p9l308t1373r457b1427],
40	an	DT	O	a	det	42	SENT_216	[p9l477t1389r552b1427],
41	odds	NNS	O	odds	nn	42	SENT_216	[p9l573t1373r722b1427],
42	ratio	NN	O	ratio	prep_with	34	SENT_216	[p9l745t1374r892b1427],
43	of	IN	O	of	_	0	SENT_216	[p9l913t1373r979b1427],
44	7.0	CD	PERCENT	7.0	num	48	SENT_216	[p9l994t1376r1086b1428],
45	(	CD	PERCENT	(	number	46	SENT_216	[p9l1108t1373r1256b1441],
46	95	CD	PERCENT	95	dep	47	SENT_216	[p9l1108t1373r1256b1441],
47	%	NN	PERCENT	%	dep	48	SENT_216	[p9l1108t1373r1256b1441],
48	CI	NN	O	ci	prep_of	42	SENT_216	[p9l1277t1376r1352b1436],
49	,	,	O	,	_	0	SENT_216	[p9l1277t1376r1352b1436],
50	1.2	CD	NUMBER	1.2	appos	48	SENT_216	[p9l1377t1376r1669b1436],
51	—	CD	NUMBER	—	number	52	SENT_216	[p9l1377t1376r1669b1436],
52	40.5	CD	NUMBER	40.5	dep	50	SENT_216	[p9l1377t1376r1669b1436],
53	;	:	O	;	_	0	SENT_216	[p9l1377t1376r1669b1436],
54	p	NN	O	p	dep	50	SENT_216	[p9l1690t1389r1729b1441],
55	=	JJ	O	=	amod	57	SENT_216	[p9l1751t1396r1784b1412],
56	0.029	CD	NUMBER	0.029	tmod	55	SENT_216	[p9l1807t1374r2008b1441],
57	)	NN	O	)	dep	54	SENT_216	[p9l1807t1374r2008b1441],
58	and	CC	O	and	_	0	SENT_216	[p9l2029t1373r2145b1427],
59	7.1	CD	PERCENT	7.1	num	63	SENT_216	[p9l13t1464r98b1515],
60	(	CD	PERCENT	(	number	61	SENT_216	[p9l149t1461r297b1528],
61	95	CD	PERCENT	95	dep	62	SENT_216	[p9l149t1461r297b1528],
62	%	NN	PERCENT	%	dep	63	SENT_216	[p9l149t1461r297b1528],
63	CI	NN	O	ci	conj_and	54	SENT_216	[p9l339t1464r414b1523],
64	,	,	O	,	_	0	SENT_216	[p9l339t1464r414b1523],
65	1.4	CD	NUMBER	1.4	number	66	SENT_216	[p9l460t1464r752b1523],
66	—	CD	NUMBER	—	num	67	SENT_216	[p9l460t1464r752b1523],
67	36.1	CD	NUMBER	36.1	appos	63	SENT_216	[p9l460t1464r752b1523],
68	;	:	O	;	_	0	SENT_216	[p9l460t1464r752b1523],
69	p	NN	O	p	dep	50	SENT_216	[p9l795t1477r833b1528],
70	=	JJ	O	=	amod	72	SENT_216	[p9l856t1484r889b1500],
71	0.018	CD	NUMBER	0.018	tmod	70	SENT_216	[p9l911t1461r1127b1528],
72	)	NN	O	)	dep	69	SENT_216	[p9l911t1461r1127b1528],
73	,	,	O	,	_	0	SENT_216	[p9l911t1461r1127b1528],
74	respectively	RB	O	respectively	advmod	42	SENT_216	[p9l1171t1461r1559b1528],
75	(	CD	NUMBER	(	num	76	SENT_216	[p9l1599t1461r1796b1528],
76	Table	NNP	O	Table	dep	42	SENT_216	[p9l1599t1461r1796b1528],
77	5	CD	NUMBER	5	num	76	SENT_216	[p9l1840t1461r1916b1528],
78	)	NN	O	)	dep	76	SENT_216	[p9l1840t1461r1916b1528],
79	.	.	O	.	_	0	SENT_216	[p9l1840t1461r1916b1528],

1	Those	DT	O	those	det	2	SENT_217	[p9l1957t1461r2145b1515],
2	results	NNS	O	result	nsubj	3	SENT_217	[p9l12t1548r225b1602],
3	suggest	VBP	O	suggest	_	0	SENT_217	[p9l256t1556r497b1615],
4	a	DT	O	a	det	6	SENT_217	[p9l524t1564r556b1602],
5	potential	JJ	O	potential	amod	6	SENT_217	[p9l585t1548r873b1615],
6	implication	NN	O	implication	dobj	3	SENT_217	[p9l903t1548r1270b1615],
7	of	IN	O	of	_	0	SENT_217	[p9l1298t1548r1364b1602],
8	these	DT	O	these	det	10	SENT_217	[p9l1384t1548r1554b1602],
9	gene	NN	O	gene	nn	10	SENT_217	[p9l1582t1563r1733b1615],
10	polymorphL	NN	O	polymorphl	prep_of	6	SENT_217	[p9l1762t1548r2145b1615, p9l312t1692r352b1713],
11	.	.	O	.	_	0	SENT_217	[p9l1762t1548r2145b1615, p9l312t1692r352b1713],

1	A.	NN	O	a.	_	0	SENT_218	[p9l1762t1548r2145b1615, p9l312t1692r352b1713],

1	Henr1	NN	O	henr1	_	0	SENT_219	[p9l364t1690r630b1718],
2	’	CD	NUMBER	’	num	3	SENT_219	[p9l364t1690r630b1718],
3	quez	NN	O	quez	dep	1	SENT_219	[p9l364t1690r630b1718],
4	.	.	O	.	_	0	SENT_219	[p9l364t1690r630b1718],

1	—	NN	O	—	_	0	SENT_220	[p9l364t1690r630b1718],
2	.	.	O	.	_	0	SENT_220	[p9l364t1690r630b1718],

1	Hemdndez	NNP	O	Hemdndez	_	0	SENT_221	[p9l364t1690r630b1718],
2	et	FW	O	et	nn	3	SENT_221	[p9l640t1694r663b1713],
3	al.	FW	O	al.	dep	1	SENT_221	[p9l672t1691r714b1718],
4	/	:	O	/	punct	1	SENT_221	[p9l672t1691r714b1718],
5	Cancer	NNP	O	Cancer	nn	6	SENT_221	[p9l719t1692r801b1713],
6	Epidemiology	NNP	O	Epidemiology	dep	1	SENT_221	[p9l810t1691r973b1718],
7	34	CD	NUMBER	34	number	8	SENT_221	[p9l982t1692r1012b1713],
8	(	CD	NUMBER	(	num	9	SENT_221	[p9l1023t1691r1103b1718],
9	2010	CD	DATE	2010	dep	6	SENT_221	[p9l1023t1691r1103b1718],
10	)	CD	NUMBER	)	number	11	SENT_221	[p9l1023t1691r1103b1718],
11	634-638 637	CD	NUMBER	634-638 637	num	9	SENT_221	[p9l1804t1692r1848b1713],[p9l1114t1692r1220b1713],

1	Table	NNP	O	Table	nsubj	16	SENT_222	[p9l7t1821r153b1864],
2	4	CD	NUMBER	4	num	1	SENT_222	[p9l173t1823r205b1864],
3	Association	NNP	O	Association	dep	1	SENT_222	[p9l7t1893r303b1936],
4	between	IN	O	between	_	0	SENT_222	[p9l319t1892r541b1936],
5	MTHFR	NNP	O	MTHFR	prep_between	3	SENT_222	[p9l556t1895r746b1935],
6	and	CC	O	and	_	0	SENT_222	[p9l759t1892r852b1936],
7	p53	NN	O	p53	nn	9	SENT_222	[p9l869t1894r962b1946],
8	gene	NN	O	gene	nn	9	SENT_222	[p9l980t1905r1101b1946],
9	polymorphisms	NNS	O	polymorphism	prep_between	3	SENT_222	[p9l1117t1892r1521b1946],
10	and	CC	O	and	_	0	SENT_222	[p9l1538t1892r1631b1936],
11	the	DT	O	the	det	12	SENT_222	[p9l1647t1892r1728b1936],
12	development	NN	O	development	conj_and	1	SENT_222	[p9l1745t1892r2085b1946],
13	of	IN	O	of	_	0	SENT_222	[p9l2100t1892r2153b1936],
14	adverse	JJ	O	adverse	amod	15	SENT_222	[p9l9t1963r206b2007],
15	reactions	NNS	O	reaction	prep_of	12	SENT_222	[p9l229t1964r463b2007],
16	(	VBP	O	(	_	0	SENT_222	[p9l486t1955r567b2018],
17	X2	NN	O	x2	nn	19	SENT_222	[p9l486t1955r567b2018],
18	test	NN	O	test	nn	19	SENT_222	[p9l590t1963r717b2017],
19	)	NN	O	)	dobj	16	SENT_222	[p9l590t1963r717b2017],
20	.	.	O	.	_	0	SENT_222	[p9l590t1963r717b2017],

1	Gene	NNP	O	Gene	_	0	SENT_223	[p9l56t2105r185b2146],
2	Adverse	JJ	O	adverse	amod	4	SENT_223	[p9l783t2103r989b2146],
3	reaction	NN	O	reaction	nn	4	SENT_223	[p9l1013t2103r1222b2146],
4	p	NN	O	p	dep	1	SENT_223	[p9l1951t2115r1982b2157],

1	No	DT	O	no	det	2	SENT_224	[p9l785t2216r854b2257],
2	(	NN	O	(	_	0	SENT_224	[p9l877t2213r939b2267],
3	n	NN	O	n	dep	2	SENT_224	[p9l877t2213r939b2267],
4	,	,	O	,	_	0	SENT_224	[p9l877t2213r939b2267],
5	%	NN	O	%	nn	8	SENT_224	[p9l962t2213r1015b2267],
6	)	CD	NUMBER	)	num	8	SENT_224	[p9l962t2213r1015b2267],
7	grade	NN	O	grade	nn	8	SENT_224	[p9l1036t2213r1179b2268],
8	o	NN	O	o	appos	3	SENT_224	[p9l1202t2215r1231b2257],
9	Yes	UH	O	yes	dep	11	SENT_224	[p9l1468t2216r1555b2257],
10	(	CD	NUMBER	(	num	11	SENT_224	[p9l1578t2213r1640b2267],
11	n	NN	O	n	rcmod	8	SENT_224	[p9l1578t2213r1640b2267],
12	,	,	O	,	_	0	SENT_224	[p9l1578t2213r1640b2267],
13	%	NN	O	%	appos	3	SENT_224	[p9l1663t2213r1716b2267],
14	)	CD	NUMBER	)	num	13	SENT_224	[p9l1663t2213r1716b2267],

1	MTHFR	NN	O	mthfr	nn	2	SENT_225	[p9l57t2355r246b2396],
2	C/Ca	NN	O	c/ca	dep	8	SENT_225	[p9l106t2422r213b2478],
3	8	CD	NUMBER	8	dep	2	SENT_225	[p9l818t2426r845b2467],
4	(	NN	O	(	dep	8	SENT_225	[p9l870t2424r1020b2478],
5	61.5	CD	NUMBER	61.5	num	4	SENT_225	[p9l870t2424r1020b2478],
6	)	CD	NUMBER	)	num	8	SENT_225	[p9l870t2424r1020b2478],
7	8	CD	NUMBER	8	num	8	SENT_225	[p9l1503t2426r1530b2467],
8	(	NN	O	(	dep	14	SENT_225	[p9l1555t2424r1705b2478],
9	21.6	CD	NUMBER	21.6	number	10	SENT_225	[p9l1555t2424r1705b2478],
10	)	CD	NUMBER	)	dep	8	SENT_225	[p9l1555t2424r1705b2478],
11	0.018	CD	NUMBER	0.018	num	12	SENT_225	[p9l1955t2426r2094b2468],
12	C/T	NN	O	c/t	dep	10	SENT_225	[p9l106t2495r189b2549],
13	5	CD	NUMBER	5	num	14	SENT_225	[p9l818t2498r845b2539],
14	(	NN	O	(	dep	27	SENT_225	[p9l870t2495r1020b2549],
15	38.5	CD	NUMBER	38.5	number	16	SENT_225	[p9l870t2495r1020b2549],
16	)	CD	NUMBER	)	dep	14	SENT_225	[p9l870t2495r1020b2549],
17	22	CD	NUMBER	22	num	18	SENT_225	[p9l1470t2497r1530b2538],
18	(	NN	O	(	dep	16	SENT_225	[p9l1555t2495r1705b2549],
19	59.4	CD	NUMBER	59.4	number	20	SENT_225	[p9l1555t2495r1705b2549],
20	)	CD	NUMBER	)	num	25	SENT_225	[p9l1555t2495r1705b2549],
21	T/T	NN	O	t/t	nn	25	SENT_225	[p9l103t2566r187b2621],
22	o	NN	O	o	nn	25	SENT_225	[p9l818t2566r940b2621],
23	(	CD	NUMBER	(	num	25	SENT_225	[p9l818t2566r940b2621],
24	o	NN	O	o	nn	25	SENT_225	[p9l818t2566r940b2621],
25	)	NN	O	)	dep	16	SENT_225	[p9l818t2566r940b2621],
26	7	CD	NUMBER	7	num	27	SENT_225	[p9l1504t2569r1530b2610],
27	(	NN	O	(	dep	34	SENT_225	[p9l1555t2567r1705b2620],
28	19.0	CD	NUMBER	19.0	number	29	SENT_225	[p9l1555t2567r1705b2620],
29	)	CD	NUMBER	)	num	30	SENT_225	[p9l1555t2567r1705b2620],
30	C/T	NN	O	c/t	dep	27	SENT_225	[p9l106t2637r322b2692],
31	+	CC	O	+	_	0	SENT_225	[p9l106t2637r322b2692],
32	T/T	NN	O	t/t	conj_+	30	SENT_225	[p9l106t2637r322b2692],
33	5	CD	NUMBER	5	num	34	SENT_225	[p9l818t2640r845b2681],
34	(	NN	O	(	dep	38	SENT_225	[p9l870t2638r1020b2692],
35	38.5	CD	NUMBER	38.5	number	36	SENT_225	[p9l870t2638r1020b2692],
36	)	CD	NUMBER	)	dep	34	SENT_225	[p9l870t2638r1020b2692],
37	29	CD	NUMBER	29	dep	36	SENT_225	[p9l1470t2640r1531b2681],
38	(	NN	O	(	dep	41	SENT_225	[p9l1555t2638r1705b2692],
39	78.4	CD	NUMBER	78.4	num	38	SENT_225	[p9l1555t2638r1705b2692],
40	)	CD	NUMBER	)	num	41	SENT_225	[p9l1555t2638r1705b2692],
41	0.014	CD	NUMBER	0.014	_	0	SENT_225	[p9l1955t2640r2096b2682],

1	p53	NN	O	p53	nn	2	SENT_226	[p9l56t2758r149b2810],
2	Arg/Arg	NN	O	arg/arg	dep	9	SENT_226	[p9l103t2827r304b2882],
3	3	CD	NUMBER	3	num	4	SENT_226	[p9l325t2826r345b2847],
4	11	CD	NUMBER	11	dep	2	SENT_226	[p9l788t2830r840b2871],
5	(	NN	O	(	dep	9	SENT_226	[p9l870t2828r1020b2882],
6	84.6	CD	NUMBER	84.6	num	5	SENT_226	[p9l870t2828r1020b2882],
7	)	CD	NUMBER	)	num	9	SENT_226	[p9l870t2828r1020b2882],
8	15	CD	NUMBER	15	num	9	SENT_226	[p9l1472t2830r1530b2871],
9	(	NN	O	(	dep	13	SENT_226	[p9l1555t2828r1705b2882],
10	40.5	CD	NUMBER	40.5	number	11	SENT_226	[p9l1555t2828r1705b2882],
11	)	CD	NUMBER	)	dep	9	SENT_226	[p9l1555t2828r1705b2882],
12	0.022	CD	NUMBER	0.022	dep	11	SENT_226	[p9l1955t2830r2094b2872],
13	Arg/Pro	NN	O	arg/pro	dep	17	SENT_226	[p9l103t2899r299b2953],
14	2	CD	NUMBER	2	num	13	SENT_226	[p9l817t2901r845b2942],
15	(	CD	NUMBER	(	num	17	SENT_226	[p9l869t2899r1020b2953],
16	15.4	CD	NUMBER	15.4	num	17	SENT_226	[p9l869t2899r1020b2953],
17	)	NN	O	)	dep	25	SENT_226	[p9l869t2899r1020b2953],
18	19	CD	NUMBER	19	number	19	SENT_226	[p9l1472t2901r1531b2943],
19	(	CD	NUMBER	(	dep	17	SENT_226	[p9l1555t2899r1705b2953],
20	51.4	CD	NUMBER	51.4	num	23	SENT_226	[p9l1555t2899r1705b2953],
21	)	NN	O	)	nn	23	SENT_226	[p9l1555t2899r1705b2953],
22	Pro/Pro	NN	O	pro/pro	nn	23	SENT_226	[p9l106t2970r295b3025],
23	o	NN	O	o	dep	19	SENT_226	[p9l818t2970r940b3025],
24	(	CD	NUMBER	(	num	25	SENT_226	[p9l818t2970r940b3025],
25	o	NN	O	o	dep	37	SENT_226	[p9l818t2970r940b3025],
26	)	CD	NUMBER	)	number	27	SENT_226	[p9l818t2970r940b3025],
27	3	CD	NUMBER	3	num	28	SENT_226	[p9l1502t2973r1529b3014],
28	(	NN	O	(	dep	25	SENT_226	[p9l1555t2971r1672b3024],
29	8.1	CD	NUMBER	8.1	number	30	SENT_226	[p9l1555t2971r1672b3024],
30	)	CD	NUMBER	)	num	31	SENT_226	[p9l1555t2971r1672b3024],
31	Arg/Pro	NN	O	arg/pro	dep	28	SENT_226	[p9l103t3042r541b3096],
32	+	CC	O	+	_	0	SENT_226	[p9l103t3042r541b3096],
33	Pro/Pro	NN	O	pro/pro	conj_+	28	SENT_226	[p9l103t3042r541b3096],
34	2	CD	NUMBER	2	number	35	SENT_226	[p9l817t3044r845b3085],
35	(	CD	NUMBER	(	dep	33	SENT_226	[p9l869t3042r1020b3096],
36	15.4	CD	NUMBER	15.4	num	37	SENT_226	[p9l869t3042r1020b3096],
37	)	NN	O	)	dep	41	SENT_226	[p9l869t3042r1020b3096],
38	22	CD	NUMBER	22	dep	37	SENT_226	[p9l1470t3044r1530b3085],
39	(	CD	NUMBER	(	number	40	SENT_226	[p9l1555t3042r1705b3096],
40	59.5	CD	NUMBER	59.5	dep	38	SENT_226	[p9l1555t3042r1705b3096],
41	)	NN	O	)	_	0	SENT_226	[p9l1555t3042r1705b3096],
42	0.006	CD	NUMBER	0.006	num	41	SENT_226	[p9l1955t3044r2095b3086],

1	3	CD	NUMBER	3	_	0	SENT_227	[p9l59t3184r79b3205],
2	Reference	NNP	O	Reference	nn	3	SENT_227	[p9l114t3185r365b3229],
3	category	NN	O	category	dep	1	SENT_227	[p9l405t3192r637b3240],
4	.	.	O	.	_	0	SENT_227	[p9l405t3192r637b3240],

1	Negative	JJ	O	negative	amod	3	SENT_228	[p9l678t3186r903b3240],
2	adverse	JJ	O	adverse	amod	3	SENT_228	[p9l942t3186r1139b3229],
3	reaction	NN	O	reaction	_	0	SENT_228	[p9l1179t3186r1403b3229],
4	:	:	O	:	_	0	SENT_228	[p9l1179t3186r1403b3229],
5	grade	NN	O	grade	nn	6	SENT_228	[p9l1446t3185r1589b3240],
6	o.	NN	O	o.	dep	3	SENT_228	[p9l1629t3188r1669b3229],
7	Positive	JJ	O	positive	amod	9	SENT_228	[p9l1710t3186r1910b3229],
8	adverse	JJ	O	adverse	amod	9	SENT_228	[p9l1949t3186r2146b3229],
9	reaction	NN	O	reaction	dep	6	SENT_228	[p9l10t3257r234b3301],
10	:	:	O	:	_	0	SENT_228	[p9l10t3257r234b3301],
11	grades	NNS	O	grade	dep	3	SENT_228	[p9l260t3257r428b3311],
12	1-4	CD	NUMBER	1-4	dep	11	SENT_228	[p9l454t3259r559b3301],
13	.	.	O	.	_	0	SENT_228	[p9l454t3259r559b3301],

1	Table	NNP	O	Table	nsubj	19	SENT_229	[p9l7t3465r153b3508],
2	5	CD	NUMBER	5	num	1	SENT_229	[p9l175t3467r204b3508],
3	Association	NNP	O	Association	rcmod	1	SENT_229	[p9l7t3537r303b3579],
4	between	IN	O	between	_	0	SENT_229	[p9l331t3536r553b3579],
5	MTHFR	NNP	O	MTHFR	prep_between	3	SENT_229	[p9l581t3539r770b3579],
6	and	CC	O	and	_	0	SENT_229	[p9l796t3536r889b3579],
7	p53	NN	O	p53	nn	8	SENT_229	[p9l918t3538r1010b3590],
8	variants	NNS	O	variant	prep_between	3	SENT_229	[p9l1040t3537r1247b3579],
9	and	CC	O	and	_	0	SENT_229	[p9l1276t3536r1369b3579],
10	the	DT	O	the	det	11	SENT_229	[p9l1397t3536r1479b3579],
11	development	NN	O	development	rcmod	1	SENT_229	[p9l1507t3536r1847b3590],
12	of	IN	O	of	_	0	SENT_229	[p9l1874t3536r1927b3579],
13	adverse	JJ	O	adverse	amod	14	SENT_229	[p9l1949t3536r2146b3579],
14	reaction	NN	O	reaction	prep_of	11	SENT_229	[p9l10t3608r219b3651],
15	in	IN	O	in	dep	3	SENT_229	[p9l239t3608r286b3650],
16	multivariate	JJ	O	multivariate	amod	17	SENT_229	[p9l306t3607r623b3651],
17	analysis	NN	O	analysis	pobj	15	SENT_229	[p9l643t3607r861b3661],
18	,	,	O	,	_	0	SENT_229	[p9l643t3607r861b3661],
19	adjusted	VBN	O	adjust	_	0	SENT_229	[p9l881t3607r1100b3661],
20	by	IN	O	by	_	0	SENT_229	[p9l1120t3607r1182b3661],
21	age	NN	O	age	prep_by	19	SENT_229	[p9l1200t3620r1299b3662],
22	,	,	O	,	_	0	SENT_229	[p9l1200t3620r1299b3662],
23	BMI	NN	O	bmus	conj_and	21	SENT_229	[p9l1319t3610r1432b3657],
24	,	,	O	,	_	0	SENT_229	[p9l1319t3610r1432b3657],
25	menopause	NN	O	menopause	nn	26	SENT_229	[p9l1453t3620r1749b3662],
26	status	NN	O	status	conj_and	21	SENT_229	[p9l1769t3614r1933b3657],
27	,	,	O	,	_	0	SENT_229	[p9l1769t3614r1933b3657],
28	tumour	NN	O	tumour	nn	29	SENT_229	[p9l1953t3614r2148b3651],
29	stage	NN	O	stage	prep_by	19	SENT_229	[p9l10t3685r141b3733],
30	and	CC	O	and	_	0	SENT_229	[p9l164t3679r257b3722],
31	treatment	NN	O	treatment	prep_by	19	SENT_229	[p9l280t3685r538b3722],
32	(	CD	NUMBER	(	num	37	SENT_229	[p9l560t3679r747b3733],
33	binary	JJ	O	binary	amod	37	SENT_229	[p9l560t3679r747b3733],
34	logistic	JJ	O	logistic	amod	37	SENT_229	[p9l769t3679r952b3733],
35	regression	NN	O	regression	nn	37	SENT_229	[p9l975t3679r1240b3733],
36	test	NN	O	test	nn	37	SENT_229	[p9l1261t3679r1388b3733],
37	)	NN	O	)	dep	31	SENT_229	[p9l1261t3679r1388b3733],
38	.	.	O	.	_	0	SENT_229	[p9l1261t3679r1388b3733],

1	Gene	NNP	O	Gene	nn	3	SENT_230	[p10l60t25r189b66],
2	Odds	NNPS	O	Odds	nn	3	SENT_230	[p10l999t22r1127b66],
3	ratio	NN	O	ratio	_	0	SENT_230	[p10l1151t23r1269b66],
4	(	CD	PERCENT	(	number	5	SENT_230	[p10l1292t23r1411b76],
5	95	CD	PERCENT	95	num	6	SENT_230	[p10l1292t23r1411b76],
6	%	NN	PERCENT	%	dep	3	SENT_230	[p10l1292t23r1411b76],
7	CI	NN	O	ci	nn	9	SENT_230	[p10l1433t23r1502b76],
8	)	NN	O	)	nn	9	SENT_230	[p10l1433t23r1502b76],
9	p	NN	O	p	dep	6	SENT_230	[p10l1951t35r1982b77],

1	MTHFR	NN	O	mthfr	nn	2	SENT_231	[p10l57t136r246b177],
2	C/C	NN	O	c/c	dep	11	SENT_231	[p10l106t205r191b259],
3	1	CD	NUMBER	1	num	4	SENT_231	[p10l1001t207r1021b248],
4	C/T	NN	O	c/t	dep	2	SENT_231	[p10l106t276r189b331],
5	+	CC	O	+	_	0	SENT_231	[p10l201t276r322b331],
6	T/T	NN	O	t/t	dep	2	SENT_231	[p10l201t276r322b331],
7	7.1	CD	NUMBER	7.1	num	6	SENT_231	[p10l999t279r1067b320],
8	(	NN	O	(	dep	11	SENT_231	[p10l1097t276r1141b330],
9	1	CD	NUMBER	1	num	8	SENT_231	[p10l1097t276r1141b330],
10	.4	CD	NUMBER	.4	num	11	SENT_231	[p10l1152t276r1360b330],
11	—	NN	O	—	dep	15	SENT_231	[p10l1152t276r1360b330],
12	36.1	CD	NUMBER	36.1	num	13	SENT_231	[p10l1152t276r1360b330],
13	)	CD	NUMBER	)	dep	11	SENT_231	[p10l1152t276r1360b330],
14	0.01	CD	NUMBER	0.01	num	15	SENT_231	[p10l1955t278r2056b320],
15	8	CD	NUMBER	8	_	0	SENT_231	[p10l2067t278r2094b320],

1	p53	NN	O	p53	nn	2	SENT_232	[p10l56t397r149b449],
2	Arg/Arg	NN	O	arg/arg	dep	12	SENT_232	[p10l103t466r304b520],
3	1	CD	NUMBER	1	num	4	SENT_232	[p10l1001t468r1021b509],
4	Arg	NN	O	arg	dep	2	SENT_232	[p10l103t537r212b592],
5	/	:	O	/	punct	6	SENT_232	[p10l103t537r212b592],
6	Pro	FW	O	pro	dep	4	SENT_232	[p10l217t540r299b581],
7	+	CC	O	+	_	0	SENT_232	[p10l312t547r339b574],
8	Pro/Pro	FW	O	pro/pro	conj_+	6	SENT_232	[p10l353t537r541b592],
9	7.0	CD	NUMBER	7.0	num	10	SENT_232	[p10l999t540r1074b582],
10	(	NN	O	(	dep	12	SENT_232	[p10l1097t538r1140b592],
11	1	CD	NUMBER	1	num	12	SENT_232	[p10l1097t538r1140b592],
12	.2	NN	NUMBER	.2	_	0	SENT_232	[p10l1151t538r1359b592],
13	—	CD	NUMBER	—	number	14	SENT_232	[p10l1151t538r1359b592],
14	40.5	CD	NUMBER	40.5	dep	12	SENT_232	[p10l1151t538r1359b592],
15	)	NN	O	)	dep	14	SENT_232	[p10l1151t538r1359b592],
16	0.029	CD	NUMBER	0.029	num	15	SENT_232	[p10l1955t540r2095b582],

1	CI	NN	O	ci	_	0	SENT_233	[p10l10t681r70b729],
2	,	,	O	,	_	0	SENT_233	[p10l10t681r70b729],
3	conﬁdence	NN	O	conﬁdence	nn	4	SENT_233	[p10l93t678r371b722],
4	interval	NN	O	interval	appos	1	SENT_233	[p10l394t679r604b723],
5	.	.	O	.	_	0	SENT_233	[p10l394t679r604b723],

1	isms	NNS	O	ism	_	0	SENT_234	[p10l10t863r154b917],
2	in	IN	O	in	_	0	SENT_234	[p10l191t863r251b917],
3	toxicity	NN	O	toxicity	prep_in	1	SENT_234	[p10l285t863r530b931],
4	due	JJ	O	due	_	0	SENT_234	[p10l564t862r681b917],
5	to	TO	O	to	_	0	SENT_234	[p10l716t870r778b917],
6	chemotherapy	NN	O	chemotherapy	prep_due_to	1	SENT_234	[p10l813t862r1295b931],
7	.	.	O	.	_	0	SENT_234	[p10l813t862r1295b931],

1	We	PRP	O	we	nsubj	4	SENT_235	[p10l1329t866r1437b917],
2	did	VBD	O	do	aux	4	SENT_235	[p10l1473t862r1573b917],
3	not	RB	O	not	neg	4	SENT_235	[p10l1609t870r1714b917],
4	observe	VB	O	observe	_	0	SENT_235	[p10l1749t862r1997b917],
5	any	DT	O	any	det	6	SENT_235	[p10l2032t878r2148b931],
6	genotype	NN	O	genotype	dobj	4	SENT_235	[p10l9t959r307b1020],
7	in	IN	O	in	_	0	SENT_235	[p10l339t952r398b1005],
8	study	NN	O	study	prep_in	6	SENT_235	[p10l431t951r608b1020],
9	as	IN	O	as	_	0	SENT_235	[p10l639t967r701b1006],
10	a	DT	O	a	det	12	SENT_235	[p10l735t967r767b1006],
11	risk	NN	O	risk	nn	12	SENT_235	[p10l799t951r917b1006],
12	factor	NN	O	factor	prep_as	4	SENT_235	[p10l947t951r1134b1006],
13	for	IN	O	for	_	0	SENT_235	[p10l1164t951r1253b1006],
14	any	DT	O	any	det	17	SENT_235	[p10l1283t967r1398b1020],
15	other	JJ	O	other	amod	17	SENT_235	[p10l1428t951r1600b1006],
16	clinical	JJ	O	clinical	amod	17	SENT_235	[p10l1630t951r1857b1006],
17	variable	JJ	O	variable	prep_for	12	SENT_235	[p10l1888t951r2146b1006],
18	considered	VBN	O	consider	partmod	12	SENT_235	[p10l10t1040r360b1095],
19	(	NN	O	(	nn	20	SENT_235	[p10l389t1040r449b1109],
20	p	NN	O	p	dobj	18	SENT_235	[p10l389t1040r449b1109],
21	>	JJR	O	>	tmod	18	SENT_235	[p10l474t1057r518b1097],
22	0.05	CD	NUMBER	0.05	num	23	SENT_235	[p10l542t1041r717b1109],
23	)	NN	O	)	dep	21	SENT_235	[p10l542t1041r717b1109],
24	.	.	O	.	_	0	SENT_235	[p10l542t1041r717b1109],

1	4	LS	NUMBER	4	_	0	SENT_236	[p10l7t1222r65b1273],
2	.	.	O	.	_	0	SENT_236	[p10l7t1222r65b1273],

1	Discussion	NN	O	discussion	_	0	SENT_237	[p10l104t1219r465b1273],

1	We	PRP	O	we	nsubj	2	SENT_238	[p10l109t1400r217b1451],
2	explored	VBD	O	explore	_	0	SENT_238	[p10l263t1396r544b1465],
3	the	DT	O	the	det	4	SENT_238	[p10l589t1396r691b1451],
4	distribution	NN	O	distribution	dobj	2	SENT_238	[p10l737t1396r1118b1451],
5	of	IN	O	of	_	0	SENT_238	[p10l1163t1396r1230b1451],
6	TSER	NN	O	tser	nn	12	SENT_238	[p10l1265t1399r1438b1460],
7	,	,	O	,	_	0	SENT_238	[p10l1265t1399r1438b1460],
8	MTHFR	NN	O	mthfr	dep	12	SENT_238	[p10l1485t1400r1721b1451],
9	C677T	NN	O	c677t	nn	12	SENT_238	[p10l1764t1399r1980b1460],
10	,	,	O	,	_	0	SENT_238	[p10l1764t1399r1980b1460],
11	p53	NN	O	p53	dep	12	SENT_238	[p10l2027t1399r2143b1465],
12	Arg72Pro	NN	O	arg72pro	prep_of	4	SENT_238	[p10l7t1488r309b1554],
13	and	CC	O	and	_	0	SENT_238	[p10l329t1486r445b1541],
14	MDR1	NN	O	mdr1	nn	18	SENT_238	[p10l467t1489r654b1540],
15	C343	NN	O	c343	nn	18	SENT_238	[p10l684t1488r841b1541],
16	5T	NN	O	5t	nn	18	SENT_238	[p10l851t1489r928b1541],
17	gene	NN	O	gene	nn	18	SENT_238	[p10l944t1501r1095b1554],
18	polymorphisms	NNS	O	polymorphism	conj_and	12	SENT_238	[p10l1116t1486r1621b1554],
19	in	IN	O	in	_	0	SENT_238	[p10l1642t1486r1701b1540],
20	breast	NN	O	breast	nn	22	SENT_238	[p10l1721t1486r1919b1541],
21	cancer	NN	O	cancer	nn	22	SENT_238	[p10l1939t1501r2149b1541],
22	patients	NNS	O	patient	prep_in	2	SENT_238	[p10l10t1575r268b1643],
23	treated	VBN	O	treat	partmod	22	SENT_238	[p10l291t1574r520b1629],
24	with	IN	O	with	_	0	SENT_238	[p10l542t1574r690b1629],
25	neoadjuvant	JJ	O	neoadjuvant	amod	26	SENT_238	[p10l712t1574r1114b1643],
26	chemotherapy	NN	O	chemotherapy	prep_with	23	SENT_238	[p10l1136t1574r1617b1643],
27	.	.	O	.	_	0	SENT_238	[p10l1136t1574r1617b1643],

1	The	DT	O	the	det	2	SENT_239	[p10l1638t1574r1755b1629],
2	appearance	NN	O	appearance	nsubjpass	8	SENT_239	[p10l1778t1590r2146b1643],
3	of	IN	O	of	_	0	SENT_239	[p10l10t1664r76b1719],
4	adverse	JJ	O	adverse	amod	5	SENT_239	[p10l131t1664r377b1719],
5	reactions	NNS	O	reaction	prep_of	2	SENT_239	[p10l441t1665r732b1719],
6	was	VBD	O	be	auxpass	8	SENT_239	[p10l795t1680r919b1719],
7	signiﬁcantly	RB	O	signiﬁcantly	advmod	8	SENT_239	[p10l984t1664r1379b1732],
8	associated	VBN	O	associate	_	0	SENT_239	[p10l1441t1664r1772b1719],
9	with	IN	O	with	_	0	SENT_239	[p10l1834t1664r1982b1719],
10	the	DT	O	the	det	13	SENT_239	[p10l2044t1664r2146b1719],
11	polymorphisms	NNS	O	polymorphism	nn	13	SENT_239	[p10l10t1753r515b1821],
12	MTHFR	NNP	O	MTHFR	nn	13	SENT_239	[p10l549t1756r786b1807],
13	C677T	NN	O	c677t	prep_with	8	SENT_239	[p10l816t1756r1019b1808],
14	and	CC	O	and	_	0	SENT_239	[p10l1051t1753r1167b1808],
15	p53	NN	O	p53	nn	16	SENT_239	[p10l1201t1756r1317b1821],
16	codon	NN	O	codon	conj_and	13	SENT_239	[p10l1355t1753r1548b1808],
17	72	CD	NUMBER	72	dep	16	SENT_239	[p10l1583t1756r1674b1808],
18	.	.	O	.	_	0	SENT_239	[p10l1583t1756r1674b1808],

1	MTHFR	NN	O	mthfr	nn	3	SENT_240	[p10l1710t1756r1946b1807],
2	allele	NN	O	allele	nn	3	SENT_240	[p10l1977t1753r2146b1808],
3	T	NN	O	t	nsubjpass	10	SENT_240	[p10l7t1845r47b1896],
4	and	CC	O	and	_	0	SENT_240	[p10l95t1841r211b1896],
5	p53	NN	O	p53	nn	6	SENT_240	[p10l261t1844r377b1910],
6	allele	NN	O	allele	conj_and	3	SENT_240	[p10l430t1841r600b1896],
7	Pro	FW	O	pro	dep	3	SENT_240	[p10l650t1845r753b1896],
8	were	VBD	O	be	auxpass	10	SENT_240	[p10l801t1857r960b1896],
9	strongly	RB	O	strongly	advmod	10	SENT_240	[p10l1011t1841r1274b1910],
10	associated	VBN	O	associate	_	0	SENT_240	[p10l1322t1841r1654b1896],
11	with	IN	O	with	_	0	SENT_240	[p10l1703t1841r1851b1896],
12	adverse	JJ	O	adverse	amod	13	SENT_240	[p10l1900t1841r2146b1896],
13	reactions	NNS	O	reaction	prep_with	10	SENT_240	[p10l10t1931r318b1986],
14	.	.	O	.	_	0	SENT_240	[p10l10t1931r318b1986],

1	The	DT	O	the	det	3	SENT_241	[p10l358t1930r475b1985],
2	main	JJ	O	main	amod	3	SENT_241	[p10l516t1931r677b1985],
3	handicap	NN	O	handicap	nsubj	12	SENT_241	[p10l718t1930r1010b1999],
4	of	IN	O	of	_	0	SENT_241	[p10l1051t1930r1117b1985],
5	this	DT	O	this	det	6	SENT_241	[p10l1150t1930r1267b1985],
6	study	NN	O	study	prep_of	3	SENT_241	[p10l1309t1930r1486b1999],
7	is	VBZ	O	be	cop	12	SENT_241	[p10l1526t1931r1573b1985],
8	the	DT	O	the	det	12	SENT_241	[p10l1614t1930r1715b1985],
9	sample	NN	O	sample	nn	12	SENT_241	[p10l1757t1930r1985b1999],
10	size	NN	O	size	nn	12	SENT_241	[p10l2027t1931r2146b1985],
11	(	NN	O	(	nn	12	SENT_241	[p10l10t2020r72b2088],
12	n	NN	O	n	_	0	SENT_241	[p10l10t2020r72b2088],
13	=	JJ	O	=	amod	12	SENT_241	[p10l94t2043r127b2059],
14	50	CD	NUMBER	50	number	15	SENT_241	[p10l151t2020r267b2088],
15	)	CD	NUMBER	)	dep	13	SENT_241	[p10l151t2020r267b2088],
16	.	.	O	.	_	0	SENT_241	[p10l151t2020r267b2088],

1	Although	IN	O	although	mark	6	SENT_242	[p10l300t2020r599b2088],
2	other	JJ	O	other	amod	3	SENT_242	[p10l632t2020r804b2075],
3	studies	NNS	O	study	nsubjpass	6	SENT_242	[p10l836t2020r1061b2075],
4	have	VBP	O	have	aux	6	SENT_242	[p10l1097t2020r1246b2075],
5	been	VBN	O	be	auxpass	6	SENT_242	[p10l1279t2020r1433b2075],
6	published	VBN	O	publish	advcl	22	SENT_242	[p10l1467t2020r1783b2088],
7	even	RB	O	even	advmod	6	SENT_242	[p10l1817t2035r1967b2075],
8	with	IN	O	with	_	0	SENT_242	[p10l1998t2020r2147b2075],
9	fewer	JJR	O	fewer	amod	10	SENT_242	[p10l10t2108r193b2163],
10	amounts	NNS	O	amount	prep_with	7	SENT_242	[p10l233t2117r512b2163],
11	of	IN	O	of	_	0	SENT_242	[p10l555t2108r621b2163],
12	patients	NNS	O	patient	prep_of	10	SENT_242	[p10l655t2109r913b2177],
13	[	CD	NUMBER	[	number	14	SENT_242	[p10l959t2108r1199b2177],
14	27,28	CD	NUMBER	27,28	num	15	SENT_242	[p10l959t2108r1199b2177],
15	]	NN	O	]	dobj	6	SENT_242	[p10l959t2108r1199b2177],
16	,	,	O	,	_	0	SENT_242	[p10l959t2108r1199b2177],
17	the	DT	O	the	det	19	SENT_242	[p10l1241t2108r1343b2163],
18	present	JJ	DATE	present	amod	19	SENT_242	[p10l1384t2117r1625b2177],
19	work	NN	O	work	nsubjpass	22	SENT_242	[p10l1664t2108r1831b2163],
20	must	MD	O	must	aux	22	SENT_242	[p10l1870t2117r2033b2163],
21	be	VB	O	be	auxpass	22	SENT_242	[p10l2072t2108r2146b2163],
22	considered	VBN	O	consider	_	0	SENT_242	[p10l10t2198r360b2253],
23	a	DT	O	a	det	26	SENT_242	[p10l380t2214r413b2253],
24	hypothesis	NN	O	hypothesis	nn	26	SENT_242	[p10l434t2198r781b2266],
25	generating	VBG	O	generate	amod	26	SENT_242	[p10l801t2199r1147b2266],
26	study	NN	O	study	dobj	22	SENT_242	[p10l1167t2198r1359b2266],
27	.	.	O	.	_	0	SENT_242	[p10l1167t2198r1359b2266],

1	Anyhow	RB	O	anyhow	advmod	16	SENT_243	[p10l1378t2198r1662b2266],
2	,	,	O	,	_	0	SENT_243	[p10l1378t2198r1662b2266],
3	to	TO	O	to	aux	4	SENT_243	[p10l1682t2206r1744b2253],
4	validate	VB	O	validate	purpcl	16	SENT_243	[p10l1763t2198r2020b2253],
5	our	PRP$	O	we	poss	6	SENT_243	[p10l2040t2214r2148b2253],
6	model	NN	O	model	dobj	4	SENT_243	[p10l10t2287r210b2342],
7	formed	VBN	O	form	partmod	6	SENT_243	[p10l239t2287r470b2342],
8	with	IN	O	with	_	0	SENT_243	[p10l498t2287r646b2342],
9	a	DT	O	a	det	11	SENT_243	[p10l674t2303r707b2342],
10	limited	JJ	O	limited	amod	11	SENT_243	[p10l736t2287r965b2342],
11	number	NN	O	number	prep_with	7	SENT_243	[p10l995t2287r1250b2342],
12	of	IN	O	of	_	0	SENT_243	[p10l1276t2287r1342b2342],
13	cases	NNS	O	case	prep_of	11	SENT_243	[p10l1364t2303r1545b2350],
14	,	,	O	,	_	0	SENT_243	[p10l1364t2303r1545b2350],
15	we	PRP	O	we	nsubj	16	SENT_243	[p10l1573t2303r1667b2342],
16	compared	VBD	O	compare	_	0	SENT_243	[p10l1696t2287r2016b2355],
17	the	DT	O	the	det	20	SENT_243	[p10l2044t2287r2146b2342],
18	gene	NN	O	gene	nn	20	SENT_243	[p10l9t2391r160b2444],
19	polymorphism	NN	O	polymorphism	nn	20	SENT_243	[p10l190t2375r664b2444],
20	frequencies	NNS	O	frequency	dobj	16	SENT_243	[p10l695t2375r1064b2444],
21	of	IN	O	of	_	0	SENT_243	[p10l1095t2375r1161b2430],
22	breast	NN	O	breast	nn	24	SENT_243	[p10l1183t2375r1382b2430],
23	cancer	NN	O	cancer	nn	24	SENT_243	[p10l1411t2391r1621b2430],
24	patients	NNS	O	patient	prep_of	20	SENT_243	[p10l1648t2376r1906b2444],
25	with	IN	O	with	_	0	SENT_243	[p10l1936t2375r2085b2430],
26	a	DT	O	a	det	28	SENT_243	[p10l2114t2391r2146b2430],
27	healthy	JJ	O	healthy	amod	28	SENT_243	[p10l10t2464r252b2533],
28	population	NN	O	population	prep_with	16	SENT_243	[p10l281t2464r631b2533],
29	of	IN	O	of	_	0	SENT_243	[p10l662t2464r728b2519],
30	our	PRP$	O	we	poss	31	SENT_243	[p10l751t2480r859b2519],
31	area	NN	O	area	prep_of	28	SENT_243	[p10l887t2480r1022b2519],
32	and	CC	O	and	_	0	SENT_243	[p10l1052t2464r1168b2519],
33	other	JJ	O	other	amod	35	SENT_243	[p10l1200t2464r1371b2519],
34	world	NN	O	world	nn	35	SENT_243	[p10l1398t2464r1586b2519],
35	regions	NNS	O	region	nsubj	36	SENT_243	[p10l1618t2465r1850b2533],
36	[	VBP	O	[	conj_and	16	SENT_243	[p10l1886t2464r2027b2533],
37	26	CD	NUMBER	26	num	38	SENT_243	[p10l1886t2464r2027b2533],
38	]	CD	NUMBER	]	dobj	36	SENT_243	[p10l1886t2464r2027b2533],
39	.	.	O	.	_	0	SENT_243	[p10l1886t2464r2027b2533],

1	No	DT	O	no	det	3	SENT_244	[p10l2059t2467r2146b2519],
2	signiﬁcant	NN	O	signiﬁcant	nn	3	SENT_244	[p10l11t2553r346b2622],
3	differences	NNS	O	difference	nsubjpass	5	SENT_244	[p10l369t2553r720b2608],
4	were	VBD	O	be	auxpass	5	SENT_244	[p10l744t2569r904b2608],
5	observed	VBN	O	observe	_	0	SENT_244	[p10l928t2553r1233b2609],
6	.	.	O	.	_	0	SENT_244	[p10l928t2553r1233b2609],

1	Large	JJ	O	large	amod	3	SENT_245	[p10l1260t2557r1431b2622],
2	interindividual	JJ	O	interindividual	amod	3	SENT_245	[p10l1456t2553r1935b2608],
3	variation	NN	O	variation	nsubjpass	5	SENT_245	[p10l1959t2554r2146b2608, p10l9t2643r136b2697],
4	is	VBZ	O	be	auxpass	5	SENT_245	[p10l160t2643r207b2697],
5	observed	VBN	O	observe	_	0	SENT_245	[p10l232t2642r522b2697],
6	in	IN	O	in	_	0	SENT_245	[p10l547t2643r607b2697],
7	both	CC	O	both	preconj	9	SENT_245	[p10l630t2642r777b2697],
8	the	DT	O	the	det	9	SENT_245	[p10l800t2642r902b2697],
9	response	NN	O	response	prep_in	5	SENT_245	[p10l927t2658r1211b2711],
10	and	CC	O	and	_	0	SENT_245	[p10l1236t2642r1352b2697],
11	toxicity	NN	O	toxicity	conj_and	9	SENT_245	[p10l1376t2643r1621b2711],
12	associated	VBN	O	associate	partmod	9	SENT_245	[p10l1643t2642r1975b2697],
13	with	IN	O	with	_	0	SENT_245	[p10l1998t2642r2147b2697],
14	anticancer	JJ	O	anticancer	amod	15	SENT_245	[p10l10t2733r347b2787],
15	therapy	NN	O	therapy	prep_with	12	SENT_245	[p10l364t2732r628b2800],
16	.	.	O	.	_	0	SENT_245	[p10l364t2732r628b2800],

1	The	DT	O	the	det	2	SENT_246	[p10l646t2732r763b2787],
2	aetiology	NN	O	aetiology	nsubj	11	SENT_246	[p10l783t2732r1080b2800],
3	of	IN	O	of	_	0	SENT_246	[p10l1098t2732r1164b2787],
4	this	DT	O	this	det	5	SENT_246	[p10l1176t2732r1293b2787],
5	variation	NN	O	variation	prep_of	2	SENT_246	[p10l1312t2733r1601b2787],
6	is	VBZ	O	be	cop	7	SENT_246	[p10l1622t2733r1668b2787],
7	multifactorial	JJ	O	multifactorial	dep	18	SENT_246	[p10l1689t2732r2146b2795],
8	,	,	O	,	_	0	SENT_246	[p10l1689t2732r2146b2795],
9	but	CC	O	but	_	0	SENT_246	[p10l9t2821r117b2876],
10	is	VBZ	O	be	cop	11	SENT_246	[p10l134t2822r180b2876],
11	due	JJ	O	due	conj_but	7	SENT_246	[p10l200t2821r316b2876],
12	in	IN	O	in	_	0	SENT_246	[p10l335t2822r394b2875],
13	part	NN	O	part	prep_in	11	SENT_246	[p10l412t2829r542b2889],
14	to	TO	O	to	_	0	SENT_246	[p10l558t2829r620b2876],
15	host	NN	O	host	prep_to	11	SENT_246	[p10l639t2821r776b2876],
16	genetic	JJ	O	genetic	amod	17	SENT_246	[p10l791t2822r1024b2889],
17	variations	NNS	O	variation	nsubj	18	SENT_246	[p10l1040t2822r1359b2876],
18	[	VBP	O	[	_	0	SENT_246	[p10l1382t2821r1522b2889],
19	10	CD	NUMBER	10	number	20	SENT_246	[p10l1382t2821r1522b2889],
20	]	CD	NUMBER	]	dobj	18	SENT_246	[p10l1382t2821r1522b2889],
21	.	.	O	.	_	0	SENT_246	[p10l1382t2821r1522b2889],

1	Recent	JJ	O	recent	amod	2	SENT_247	[p10l1543t2824r1758b2876],
2	advances	NNS	O	advance	nsubj	7	SENT_247	[p10l1775t2821r2067b2876],
3	in	IN	O	in	_	0	SENT_247	[p10l2087t2822r2146b2875],
4	molecular	JJ	O	molecular	amod	5	SENT_247	[p10l10t2909r334b2964],
5	biology	NN	O	biology	prep_in	2	SENT_247	[p10l361t2909r599b2978],
6	have	VBP	O	have	aux	7	SENT_247	[p10l628t2909r777b2964],
7	provided	VBN	O	provide	_	0	SENT_247	[p10l807t2909r1092b2978],
8	physicians	NNS	O	physician	dobj	7	SENT_247	[p10l1122t2909r1459b2978],
9	with	IN	O	with	_	0	SENT_247	[p10l1489t2909r1637b2964],
10	genetic	JJ	O	genetic	amod	12	SENT_247	[p10l1665t2910r1898b2978],
11	testing	NN	O	testing	nn	12	SENT_247	[p10l1927t2910r2148b2978],
12	strategies	NNS	O	strategy	prep_with	7	SENT_247	[p10l11t2999r319b3067],
13	that	WDT	O	that	nsubjpass	16	SENT_247	[p10l339t2998r469b3053],
14	can	MD	O	can	aux	16	SENT_247	[p10l487t3014r596b3053],
15	be	VB	O	be	auxpass	16	SENT_247	[p10l615t2998r689b3053],
16	used	VBN	O	use	rcmod	12	SENT_247	[p10l709t2998r856b3053],
17	to	TO	O	to	aux	18	SENT_247	[p10l876t3006r938b3053],
18	predict	VB	O	predict	xcomp	16	SENT_247	[p10l958t2998r1185b3067],
19	adverse	JJ	O	adverse	amod	21	SENT_247	[p10l1204t2998r1450b3053],
20	drug	NN	O	drug	nn	21	SENT_247	[p10l1470t2998r1618b3067],
21	reactions	NNS	O	reaction	dobj	18	SENT_247	[p10l1637t2999r1945b3054],
22	.	.	O	.	_	0	SENT_247	[p10l1637t2999r1945b3054],

1	Many	JJ	O	many	nsubjpass	6	SENT_248	[p10l1967t3001r2148b3067],
2	of	IN	O	of	_	0	SENT_248	[p10l10t3087r76b3142],
3	them	PRP	O	they	prep_of	1	SENT_248	[p10l89t3087r257b3142],
4	can	MD	O	can	aux	6	SENT_248	[p10l278t3103r387b3142],
5	be	VB	O	be	auxpass	6	SENT_248	[p10l407t3087r481b3142],
6	linked	VBN	O	link	_	0	SENT_248	[p10l503t3087r700b3142],
7	to	TO	O	to	_	0	SENT_248	[p10l721t3096r783b3142],
8	SNPs	NNS	O	snp	prep_to	6	SENT_248	[p10l806t3090r960b3142],
9	in	IN	O	in	_	0	SENT_248	[p10l983t3088r1042b3142],
10	genes	NNS	O	gene	prep_in	8	SENT_248	[p10l1062t3103r1243b3156],
11	that	WDT	O	that	nsubj	12	SENT_248	[p10l1265t3087r1394b3142],
12	control	VBP	O	control	rcmod	10	SENT_248	[p10l1415t3087r1642b3142],
13	aspects	NNS	O	aspect	dobj	12	SENT_248	[p10l1664t3096r1897b3156],
14	of	IN	O	of	_	0	SENT_248	[p10l1920t3087r1986b3142],
15	drug	NN	O	drug	nn	16	SENT_248	[p10l1999t3087r2148b3156],
16	disposition	NN	O	disposition	prep_of	13	SENT_248	[p10l10t3176r365b3245],
17	[	CD	NUMBER	[	number	18	SENT_248	[p10l399t3176r539b3245],
18	10	CD	NUMBER	10	num	19	SENT_248	[p10l399t3176r539b3245],
19	]	NN	O	]	dep	16	SENT_248	[p10l399t3176r539b3245],
20	.	.	O	.	_	0	SENT_248	[p10l399t3176r539b3245],

1	MTHFR	NN	O	mthfr	nn	2	SENT_249	[p10l571t3180r807b3231],
2	C677T	NN	O	c677t	nsubjpass	5	SENT_249	[p10l835t3179r1038b3231],
3	has	VBZ	O	have	aux	5	SENT_249	[p10l1066t3176r1171b3231],
4	been	VBN	O	be	auxpass	5	SENT_249	[p10l1201t3176r1355b3231],
5	shown	VBN	O	show	_	0	SENT_249	[p10l1386t3176r1598b3231],
6	to	TO	O	to	aux	7	SENT_249	[p10l1627t3185r1689b3231],
7	alter	VB	O	alter	xcomp	5	SENT_249	[p10l1719t3176r1867b3231],
8	enzyme	NN	O	enzyme	nn	9	SENT_249	[p10l1895t3192r2146b3245],
9	activity	NN	O	activity	dobj	7	SENT_249	[p10l10t3267r250b3334],
10	as	RB	O	as	_	0	SENT_249	[p10l310t3282r373b3321],
11	well	RB	O	well	_	0	SENT_249	[p10l433t3266r569b3321],
12	as	IN	O	as	_	0	SENT_249	[p10l631t3282r693b3321],
13	5	CD	NUMBER	5	dobj	7	SENT_249	[p10l757t3269r909b3321],
14	.	.	O	.	_	0	SENT_249	[p10l757t3269r909b3321],

1	—	NN	O	—	_	0	SENT_250	[p10l757t3269r909b3321],
2	.	.	O	.	_	0	SENT_250	[p10l757t3269r909b3321],

1	FU	NN	O	fu	nn	4	SENT_251	[p10l757t3269r909b3321],
2	and	CC	O	and	_	0	SENT_251	[p10l970t3266r1086b3321],
3	MTX	NN	O	mtx	nn	4	SENT_251	[p10l1148t3269r1298b3320],
4	sensitivity	NN	O	sensitivity	_	0	SENT_251	[p10l1358t3267r1691b3334],
5	[	CD	NUMBER	[	number	6	SENT_251	[p10l1754t3266r1953b3334],
6	9,29	CD	NUMBER	9,29	dep	4	SENT_251	[p10l1754t3266r1953b3334],
7	]	NN	O	]	dep	6	SENT_251	[p10l1754t3266r1953b3334],
8	.	.	O	.	_	0	SENT_251	[p10l1754t3266r1953b3334],

1	This	DT	O	this	det	2	SENT_252	[p10l2013t3266r2145b3321],
2	polymorphism	NN	O	polymorphism	nsubj	3	SENT_252	[p10l10t3355r484b3423],
3	increased	VBD	O	increase	_	0	SENT_252	[p10l513t3355r818b3410],
4	the	DT	O	the	det	5	SENT_252	[p10l846t3355r948b3410],
5	risk	NN	O	risk	dobj	3	SENT_252	[p10l977t3355r1095b3410],
6	of	IN	O	of	_	0	SENT_252	[p10l1121t3355r1188b3410],
7	leucopoenia	NN	O	leucopoenia	prep_of	5	SENT_252	[p10l1209t3355r1613b3423],
8	,	,	O	,	_	0	SENT_252	[p10l1209t3355r1613b3423],
9	gastrointestinal	JJ	O	gastrointestinal	amod	10	SENT_252	[p10l1641t3355r2145b3423],
10	toxicity	NN	O	toxicity	prep_of	5	SENT_252	[p10l9t3444r254b3512],
11	and	CC	O	and	_	0	SENT_252	[p10l278t3443r394b3498],
12	hepatotoxicity	NN	O	hepatotoxicity	prep_of	5	SENT_252	[p10l420t3443r888b3512],
13	in	IN	O	in	_	0	SENT_252	[p10l913t3444r972b3498],
14	adult	JJ	O	adult	prep_in	3	SENT_252	[p10l997t3443r1163b3498],
15	and	CC	O	and	_	0	SENT_252	[p10l1187t3443r1303b3498],
16	childhood	NN	O	childhood	conj_and	14	SENT_252	[p10l1329t3443r1649b3498],
17	acute	JJ	O	acute	amod	20	SENT_252	[p10l1675t3451r1846b3498],
18	lymphoblastic	JJ	O	lymphoblastic	amod	20	SENT_252	[p10l1873t3443r2146b3512, p10l9t3532r218b3587],
19	leukemia	NN	O	leukemia	nn	20	SENT_252	[p10l263t3532r558b3587],
20	patients	NNS	O	patient	tmod	3	SENT_252	[p10l603t3533r861b3601],
21	treated	VBN	O	treat	partmod	20	SENT_252	[p10l907t3532r1136b3587],
22	with	IN	O	with	_	0	SENT_252	[p10l1180t3532r1328b3587],
23	MTX	NN	O	mtx	prep_with	21	SENT_252	[p10l1373t3535r1523b3586],
24	[	CD	NUMBER	[	num	23	SENT_252	[p10l1569t3532r1808b3601],
25	28,30	CD	NUMBER	28,30	num	26	SENT_252	[p10l1569t3532r1808b3601],
26	]	NN	O	]	dep	20	SENT_252	[p10l1569t3532r1808b3601],
27	.	.	O	.	_	0	SENT_252	[p10l1569t3532r1808b3601],

1	Common	JJ	O	common	amod	3	SENT_253	[p10l1856t3535r2147b3587],
2	genetic	JJ	O	genetic	amod	3	SENT_253	[p10l9t3622r242b3690],
3	variation	NN	O	variation	nsubj	11	SENT_253	[p10l284t3622r573b3676],
4	in	IN	O	in	_	0	SENT_253	[p10l618t3622r677b3676],
5	MTHFR	NN	O	mthfr	prep_in	3	SENT_253	[p10l721t3625r957b3676],
6	but	CC	O	but	_	0	SENT_253	[p10l998t3621r1105b3676],
7	not	RB	O	not	_	0	SENT_253	[p10l1149t3630r1254b3676],
8	TYMS	NN	O	tym	prep_in	3	SENT_253	[p10l1294t3624r1478b3676],
9	may	MD	O	may	aux	11	SENT_253	[p10l1523t3637r1661b3690],
10	be	VB	O	be	cop	11	SENT_253	[p10l1703t3621r1777b3676],
11	useful	JJ	O	useful	_	0	SENT_253	[p10l1821t3621r2014b3676],
12	for	IN	O	for	_	0	SENT_253	[p10l2059t3621r2148b3676],
13	predicting	VBG	O	predict	prepc_for	11	SENT_253	[p10l10t3710r340b3779],
14	toxicity	NN	O	toxicity	dobj	13	SENT_253	[p10l377t3711r621b3779],
15	in	IN	O	in	_	0	SENT_253	[p10l660t3711r719b3765],
16	patients	NNS	O	patient	prep_in	14	SENT_253	[p10l758t3711r1016b3779],
17	with	IN	O	with	_	0	SENT_253	[p10l1055t3710r1203b3765],
18	advanced	JJ	O	advanced	amod	20	SENT_253	[p10l1242t3710r1545b3765],
19	colorectal	JJ	O	colorectal	amod	20	SENT_253	[p10l1586t3710r1898b3765],
20	cancer	NN	O	cancer	prep_with	13	SENT_253	[p10l1939t3726r2149b3765],
21	treated	VBN	O	treat	partmod	20	SENT_253	[p11l9t17r238b72],
22	with	IN	O	with	_	0	SENT_253	[p11l262t17r410b72],
23	capacitabine	NN	O	capacitabine	prep_with	21	SENT_253	[p11l434t17r838b85],
24	[	CD	NUMBER	[	num	23	SENT_253	[p11l865t17r988b85],
25	31	CD	NUMBER	31	num	26	SENT_253	[p11l865t17r988b85],
26	]	NN	O	]	dep	23	SENT_253	[p11l865t17r988b85],
27	and	CC	O	and	_	0	SENT_253	[p11l1016t17r1132b72],
28	in	IN	O	in	_	0	SENT_253	[p11l1157t18r1216b71],
29	metastatic	JJ	O	metastatic	amod	32	SENT_253	[p11l1240t18r1577b72],
30	colorectal	JJ	O	colorectal	amod	32	SENT_253	[p11l1601t17r1913b72],
31	cancer	NN	O	cancer	nn	32	SENT_253	[p11l1939t33r2148b72],
32	patients	NNS	O	patient	prep_in	13	SENT_253	[p11l10t106r268b174],
33	treated	VBN	O	treat	partmod	32	SENT_253	[p11l296t105r526b160],
34	with	IN	O	with	_	0	SENT_253	[p11l553t105r701b160],
35	FOLFOX	NN	O	folfox	prep_with	33	SENT_253	[p11l729t108r982b160],
36	[	CD	NUMBER	[	number	37	SENT_253	[p11l1011t105r1152b174],
37	32	CD	NUMBER	32	num	38	SENT_253	[p11l1011t105r1152b174],
38	]	NN	O	]	dep	33	SENT_253	[p11l1011t105r1152b174],
39	.	.	O	.	_	0	SENT_253	[p11l1011t105r1152b174],

1	MTHFR	NN	O	mthfr	nn	3	SENT_254	[p11l1182t109r1418b160],
2	C677T	NN	O	c677t	nn	3	SENT_254	[p11l1443t108r1646b160],
3	polymorphism	NN	O	polymorphism	nsubj	4	SENT_254	[p11l1672t105r2147b174],
4	appears	VBZ	O	appear	_	0	SENT_254	[p11l11t211r259b263],
5	to	TO	O	to	aux	9	SENT_254	[p11l310t203r372b250],
6	be	VB	O	be	cop	9	SENT_254	[p11l421t195r495b250],
7	an	DT	O	a	det	9	SENT_254	[p11l545t211r620b250],
8	important	JJ	O	important	amod	9	SENT_254	[p11l670t196r996b263],
9	predictor	NN	O	predictor	xcomp	4	SENT_254	[p11l1045t195r1342b263],
10	of	IN	O	of	_	0	SENT_254	[p11l1389t195r1455b250],
11	CMF	NN	O	cmf	npadvmod	13	SENT_254	[p11l1498t195r1895b250],
12	—	CD	NUMBER	—	num	11	SENT_254	[p11l1498t195r1895b250],
13	related	JJ	O	related	amod	15	SENT_254	[p11l1498t195r1895b250],
14	severe	JJ	O	severe	amod	15	SENT_254	[p11l1946t211r2149b250],
15	toxicity	NN	O	toxicity	prep_of	9	SENT_254	[p11l10t284r269b352],
16	.	.	O	.	_	0	SENT_254	[p11l10t284r269b352],

1	Early	JJ	O	early	amod	4	SENT_255	[p11l305t283r467b352],
2	breast	NN	O	breast	nn	4	SENT_255	[p11l500t283r698b338],
3	cancer	NN	O	cancer	nn	4	SENT_255	[p11l732t299r943b338],
4	patients	NNS	O	patient	nsubj	9	SENT_255	[p11l975t284r1233b352],
5	with	IN	O	with	_	0	SENT_255	[p11l1267t283r1416b338],
6	T/T	NN	O	t/t	nn	8	SENT_255	[p11l1447t283r1551b352],
7	MTHFR	NN	O	mthfr	nn	8	SENT_255	[p11l1585t287r1821b338],
8	genotype	NN	O	genotype	prep_with	4	SENT_255	[p11l1852t291r2150b352],
9	have	VBP	O	have	_	0	SENT_255	[p11l11t372r161b427],
10	an	DT	O	a	det	12	SENT_255	[p11l189t388r264b427],
11	increased	VBN	O	increase	amod	12	SENT_255	[p11l292t372r597b427],
12	risk	NN	O	risk	dobj	9	SENT_255	[p11l627t372r744b427],
13	of	IN	O	of	_	0	SENT_255	[p11l770t372r836b427],
14	developing	VBG	O	develop	prepc_of	12	SENT_255	[p11l857t372r1213b441],
15	severe	JJ	O	severe	amod	24	SENT_255	[p11l1241t388r1444b427],
16	acute	JJ	O	acute	amod	24	SENT_255	[p11l1472t380r1644b427],
17	toxicity	NN	O	toxicity	nn	24	SENT_255	[p11l1672t373r1916b440],
18	due	JJ	O	due	_	0	SENT_255	[p11l1944t372r2060b427],
19	to	TO	O	to	_	0	SENT_255	[p11l2088t380r2149b427],
20	CMF	NN	ORGANIZATION	cmf	nn	21	SENT_255	[p11l11t464r153b516],
21	treatment	NN	O	treatment	prep_due_to	24	SENT_255	[p11l196t470r521b516],
22	[	CD	NUMBER	[	number	23	SENT_255	[p11l569t461r711b530],
23	33	CD	NUMBER	33	dep	21	SENT_255	[p11l569t461r711b530],
24	]	NN	O	]	dobj	14	SENT_255	[p11l569t461r711b530],
25	.	.	O	.	_	0	SENT_255	[p11l569t461r711b530],

1	The	DT	O	the	det	3	SENT_256	[p11l756t461r873b516],
2	C/C	NN	O	c/c	nn	3	SENT_256	[p11l920t461r1026b530],
3	genotype	NN	O	genotype	nsubj	10	SENT_256	[p11l1071t470r1369b530],
4	of	IN	O	of	_	0	SENT_256	[p11l1415t461r1482b516],
5	the	DT	O	the	det	8	SENT_256	[p11l1520t461r1621b516],
6	MTHFR	NN	O	mthfr	nn	8	SENT_256	[p11l1668t465r1905b516],
7	C677T	NN	O	c677t	nn	8	SENT_256	[p11l1949t464r2152b516],
8	polymorphism	NN	O	polymorphism	prep_of	3	SENT_256	[p11l11t550r486b619],
9	was	VBD	O	be	cop	10	SENT_256	[p11l539t566r663b605],
10	protective	JJ	O	protective	_	0	SENT_256	[p11l720t551r1045b619],
11	against	IN	O	against	_	0	SENT_256	[p11l1100t551r1331b619],
12	grade	NN	O	grade	nn	14	SENT_256	[p11l1384t550r1563b619],
13	3-4	CD	NUMBER	3-4	num	14	SENT_256	[p11l1617t553r1738b605],
14	toxicity	NN	O	toxicity	prep_against	10	SENT_256	[p11l1792t551r2036b619],
15	in	IN	O	in	_	0	SENT_256	[p11l2091t551r2150b605],
16	colorectal	JJ	O	colorectal	amod	18	SENT_256	[p11l11t640r324b695],
17	cancer	NN	O	cancer	nn	18	SENT_256	[p11l374t656r584b695],
18	patients	NNS	O	patient	prep_in	10	SENT_256	[p11l631t641r889b708],
19	[	CD	NUMBER	[	number	20	SENT_256	[p11l942t640r1083b708],
20	34	CD	NUMBER	34	num	21	SENT_256	[p11l942t640r1083b708],
21	]	NN	O	]	dep	10	SENT_256	[p11l942t640r1083b708],
22	.	.	O	.	_	0	SENT_256	[p11l942t640r1083b708],

1	Our	PRP$	O	we	poss	2	SENT_257	[p11l1134t643r1254b695],
2	results	NNS	O	result	nsubj	3	SENT_257	[p11l1300t640r1514b695],
3	agree	VBP	O	agree	_	0	SENT_257	[p11l1563t656r1736b708],
4	with	IN	O	with	_	0	SENT_257	[p11l1783t640r1932b695],
5	other	JJ	O	other	amod	7	SENT_257	[p11l1980t640r2152b695],
6	published	VBN	O	publish	amod	7	SENT_257	[p11l11t729r327b797],
7	articles	NNS	O	article	prep_with	3	SENT_257	[p11l356t729r604b784],
8	.	.	O	.	_	0	SENT_257	[p11l356t729r604b784],

1	Nevertheless	RB	O	nevertheless	advmod	8	SENT_258	[p11l635t729r1066b792],
2	,	,	O	,	_	0	SENT_258	[p11l635t729r1066b792],
3	some	DT	O	some	det	5	SENT_258	[p11l1096t744r1264b784],
4	contradictory	JJ	O	contradictory	amod	5	SENT_258	[p11l1293t729r1729b797],
5	results	NNS	O	result	nsubjpass	8	SENT_258	[p11l1757t729r1970b784],
6	have	VBP	O	have	aux	8	SENT_258	[p11l2000t729r2150b784],
7	been	VBN	O	be	auxpass	8	SENT_258	[p11l10t817r164b872],
8	published	VBN	O	publish	_	0	SENT_258	[p11l191t817r524b886],
9	.	.	O	.	_	0	SENT_258	[p11l191t817r524b886],

1	It	PRP	O	it	nsubjpass	4	SENT_259	[p11l554t820r598b872],
2	has	VBZ	O	have	aux	4	SENT_259	[p11l626t817r731b872],
3	been	VBN	O	be	auxpass	4	SENT_259	[p11l759t817r913b872],
4	suggested	VBN	O	suggest	_	0	SENT_259	[p11l941t817r1260b886],
5	that	IN	O	that	complm	14	SENT_259	[p11l1288t817r1418b872],
6	MTHFR	NN	O	mthfr	nn	8	SENT_259	[p11l1445t820r1682b871],
7	A1298C	NN	O	a1298c	nn	8	SENT_259	[p11l1703t819r1956b872],
8	gene	NN	O	gene	nsubj	14	SENT_259	[p11l1982t833r2149b886],
9	,	,	O	,	_	0	SENT_259	[p11l1982t833r2149b886],
10	but	CC	O	but	_	0	SENT_259	[p11l10t906r118b961],
11	not	RB	O	not	_	0	SENT_259	[p11l163t914r268b961],
12	C677T	NN	O	c677t	nn	13	SENT_259	[p11l312t909r515b961],
13	polymorphism	NN	O	polymorphism	conj_negcc	8	SENT_259	[p11l559t906r1034b975],
14	is	VBZ	O	be	ccomp	4	SENT_259	[p11l1080t907r1127b961],
15	associated	VBN	O	associate	dep	14	SENT_259	[p11l1173t906r1506b961],
16	with	IN	O	with	_	0	SENT_259	[p11l1550t906r1698b961],
17	MTX	NN	O	mtx	prep_with	15	SENT_259	[p11l1744t906r2149b961],
18	—	CD	NUMBER	—	num	20	SENT_259	[p11l1744t906r2149b961],
19	related	JJ	O	related	amod	20	SENT_259	[p11l1744t906r2149b961],
20	toxicity	NN	O	toxicity	dobj	15	SENT_259	[p11l10t996r255b1064],
21	in	IN	O	in	_	0	SENT_259	[p11l280t996r339b1050],
22	children	NNS	O	child	prep_in	20	SENT_259	[p11l366t995r631b1050],
23	treated	VBN	O	treat	partmod	22	SENT_259	[p11l657t995r886b1050],
24	for	IN	O	for	_	0	SENT_259	[p11l914t995r1003b1050],
25	acute	JJ	O	acute	amod	27	SENT_259	[p11l1027t1004r1199b1050],
26	lymphoblastic	JJ	O	lymphoblastic	amod	27	SENT_259	[p11l1226t995r1685b1064],
27	leukemia	NN	O	leukemia	prep_for	23	SENT_259	[p11l1711t995r2006b1050],
28	and	CC	O	and	_	0	SENT_259	[p11l2033t995r2149b1050],
29	non	JJ	O	non	conj_and	15	SENT_259	[p11l11t1084r437b1153],
30	.	.	O	.	_	0	SENT_259	[p11l11t1084r437b1153],

1	—	NN	O	—	_	0	SENT_260	[p11l11t1084r437b1153],
2	.	.	O	.	_	0	SENT_260	[p11l11t1084r437b1153],

1	Hodgkin	NN	PERSON	hodgkin	nn	2	SENT_261	[p11l11t1084r437b1153],
2	lymphoma	NN	O	lymphoma	_	0	SENT_261	[p11l457t1084r804b1153],
3	[	CD	NUMBER	[	number	4	SENT_261	[p11l828t1084r969b1153],
4	35	CD	NUMBER	35	dep	2	SENT_261	[p11l828t1084r969b1153],
5	]	NN	O	]	dep	4	SENT_261	[p11l828t1084r969b1153],
6	.	.	O	.	_	0	SENT_261	[p11l828t1084r969b1153],

1	Moreover	RB	O	moreover	advmod	9	SENT_262	[p11l991t1088r1317b1148],
2	,	,	O	,	_	0	SENT_262	[p11l991t1088r1317b1148],
3	the	DT	O	the	det	6	SENT_262	[p11l1337t1084r1439b1139],
4	677	CD	NUMBER	677	num	6	SENT_262	[p11l1460t1087r1576b1139],
5	C/C	NN	O	c/c	nn	6	SENT_262	[p11l1600t1084r1706b1153],
6	genotype	NN	O	genotype	nsubjpass	9	SENT_262	[p11l1725t1093r2023b1153],
7	has	VBZ	O	have	aux	9	SENT_262	[p11l2044t1084r2148b1139],
8	been	VBN	O	be	auxpass	9	SENT_262	[p11l10t1174r164b1229],
9	associated	VBN	O	associate	_	0	SENT_262	[p11l198t1174r530b1229],
10	to	TO	O	to	_	0	SENT_262	[p11l565t1182r627b1229],
11	toxicity	NN	O	toxicity	prep_to	9	SENT_262	[p11l662t1175r907b1242],
12	in	IN	O	in	_	0	SENT_262	[p11l940t1175r999b1228],
13	colorectal	JJ	O	colorectal	amod	15	SENT_262	[p11l1034t1174r1347b1229],
14	cancer	NN	O	cancer	nn	15	SENT_262	[p11l1383t1190r1593b1229],
15	patients	NNS	O	patient	prep_in	9	SENT_262	[p11l1626t1175r1884b1242],
16	treated	VBN	O	treat	partmod	15	SENT_262	[p11l1919t1174r2149b1229],
17	with	IN	O	with	_	0	SENT_262	[p11l9t1263r158b1318],
18	5	CD	NUMBER	5	prep_with	16	SENT_262	[p11l179t1266r330b1318],
19	.	.	O	.	_	0	SENT_262	[p11l179t1266r330b1318],

1	—	NN	O	—	_	0	SENT_263	[p11l179t1266r330b1318],
2	.	.	O	.	_	0	SENT_263	[p11l179t1266r330b1318],

1	FU	NN	LOCATION	fu	nsubj	2	SENT_264	[p11l179t1266r330b1318],
2	based	VBN	O	base	_	0	SENT_264	[p11l351t1263r535b1318],
3	adjuvant	JJ	O	adjuvant	amod	7	SENT_264	[p11l556t1263r840b1331],
4	chemotherapy	NN	O	chemotherapy	nn	7	SENT_264	[p11l860t1263r1328b1331],
5	[	NN	O	[	nn	7	SENT_264	[p11l1351t1262r1493b1331],
6	36	CD	NUMBER	36	num	7	SENT_264	[p11l1351t1262r1493b1331],
7	]	NN	O	]	dobj	2	SENT_264	[p11l1351t1262r1493b1331],
8	.	.	O	.	_	0	SENT_264	[p11l1351t1262r1493b1331],

1	Because	IN	O	because	_	0	SENT_265	[p11l1516t1266r1772b1318],
2	the	DT	O	the	det	3	SENT_265	[p11l1793t1263r1895b1318],
3	MTHFR	NN	MISC	mthfr	prep_because	6	SENT_265	[p11l1916t1266r2153b1317],
4	SNPs	NNS	MISC	snp	nsubj	6	SENT_265	[p11l11t1354r165b1406],
5	are	VBP	O	be	cop	6	SENT_265	[p11l202t1367r300b1406],
6	prevalent	JJ	O	prevalent	_	0	SENT_265	[p11l336t1351r643b1420],
7	and	CC	O	and	_	0	SENT_265	[p11l677t1351r793b1406],
8	MTX	NN	O	mtx	conj_and	6	SENT_265	[p11l831t1354r981b1405],
9	and	CC	O	and	_	0	SENT_265	[p11l1014t1351r1130b1406],
10	5	CD	NUMBER	5	conj_and	8	SENT_265	[p11l1168t1354r1319b1406],
11	.	.	O	.	_	0	SENT_265	[p11l1168t1354r1319b1406],

1	—	NN	O	—	_	0	SENT_266	[p11l1168t1354r1319b1406],
2	.	.	O	.	_	0	SENT_266	[p11l1168t1354r1319b1406],

1	FU	NNP	O	FU	nsubjpass	4	SENT_267	[p11l1168t1354r1319b1406],
2	are	VBP	O	be	auxpass	4	SENT_267	[p11l1355t1367r1452b1406],
3	widely	RB	O	widely	advmod	4	SENT_267	[p11l1487t1351r1706b1419],
4	used	VBN	O	use	ccomp	22	SENT_267	[p11l1741t1351r1889b1406],
5	for	IN	O	for	_	0	SENT_267	[p11l1925t1351r2015b1406],
6	the	DT	O	the	det	7	SENT_267	[p11l2048t1351r2150b1406],
7	treatment	NN	O	treatment	prep_for	4	SENT_267	[p11l10t1448r334b1495],
8	of	IN	O	of	_	0	SENT_267	[p11l365t1440r431b1495],
9	common	JJ	O	common	amod	10	SENT_267	[p11l455t1456r738b1495],
10	cancers	NNS	O	cancer	prep_of	7	SENT_267	[p11l770t1456r1008b1495],
11	and	CC	O	and	_	0	SENT_267	[p11l1041t1440r1158b1495],
12	inﬂammatory	JJ	O	inﬂammatory	amod	13	SENT_267	[p11l1191t1440r1633b1508],
13	conditions	NNS	O	condition	conj_and	10	SENT_267	[p11l1664t1440r2016b1503],
14	,	,	O	,	_	0	SENT_267	[p11l1664t1440r2016b1503],
15	the	DT	O	the	det	17	SENT_267	[p11l2048t1440r2150b1495],
16	pharmacogenetic	JJ	O	pharmacogenetic	amod	17	SENT_267	[p11l11t1529r570b1598],
17	role	NN	O	role	nsubj	22	SENT_267	[p11l599t1529r720b1584],
18	of	IN	O	of	_	0	SENT_267	[p11l751t1529r817b1584],
19	the	DT	O	the	det	21	SENT_267	[p11l838t1529r940b1584],
20	MTHFR	NN	MISC	mthfr	nn	21	SENT_267	[p11l971t1533r1208b1584],
21	SNPs	NNS	MISC	snp	prep_of	17	SENT_267	[p11l1235t1532r1389b1584],
22	has	VBZ	O	have	_	0	SENT_267	[p11l1421t1529r1526b1584],
23	signiﬁcant	JJ	O	signiﬁcant	amod	25	SENT_267	[p11l1558t1529r1893b1598],
24	clinical	JJ	O	clinical	amod	25	SENT_267	[p11l1922t1529r2149b1584],
25	implications	NNS	O	implication	dobj	22	SENT_267	[p11l11t1618r409b1687],
26	[	VBP	O	[	rcmod	25	SENT_267	[p11l432t1618r573b1687],
27	37	CD	NUMBER	37	number	28	SENT_267	[p11l432t1618r573b1687],
28	]	CD	NUMBER	]	dobj	26	SENT_267	[p11l432t1618r573b1687],
29	.	.	O	.	_	0	SENT_267	[p11l432t1618r573b1687],

1	Less	RBR	O	less	dep	3	SENT_268	[p11l594t1622r723b1673],
2	is	VBZ	O	be	auxpass	3	SENT_268	[p11l743t1619r790b1673],
3	known	VBN	O	know	_	0	SENT_268	[p11l810t1618r1030b1673],
4	about	IN	O	about	_	0	SENT_268	[p11l1048t1618r1232b1673],
5	the	DT	O	the	det	6	SENT_268	[p11l1249t1618r1350b1673],
6	role	NN	O	role	prep_about	3	SENT_268	[p11l1369t1618r1490b1673],
7	of	IN	O	of	_	0	SENT_268	[p11l1509t1618r1575b1673],
8	p53	NN	O	p53	nn	9	SENT_268	[p11l1587t1621r1703b1687],
9	codon	NN	O	codon	prep_of	6	SENT_268	[p11l1725t1618r1918b1673],
10	72	CD	NUMBER	72	nsubjpass	3	SENT_268	[p11l1938t1621r2012b1673],
11	and	CC	O	and	_	0	SENT_268	[p11l2033t1618r2149b1673],
12	the	DT	O	the	det	13	SENT_268	[p11l10t1708r112b1763],
13	development	NN	O	development	conj_and	10	SENT_268	[p11l172t1708r596b1776],
14	of	IN	O	of	_	0	SENT_268	[p11l655t1708r721b1763],
15	adverse	JJ	O	adverse	amod	16	SENT_268	[p11l773t1708r1020b1763],
16	reactions	NNS	O	reaction	prep_of	13	SENT_268	[p11l1080t1709r1372b1763],
17	and	CC	O	and	_	0	SENT_268	[p11l1432t1708r1549b1763],
18	toxicity	NN	O	toxicity	conj_and	10	SENT_268	[p11l1609t1709r1854b1776],
19	due	JJ	O	due	_	0	SENT_268	[p11l1912t1708r2028b1763],
20	to	TO	O	to	_	0	SENT_268	[p11l2087t1716r2149b1763],
21	chemotherapy	NN	O	chemotherapy	prep_due_to	18	SENT_268	[p11l11t1797r493b1865],
22	.	.	O	.	_	0	SENT_268	[p11l11t1797r493b1865],

1	It	PRP	O	it	nsubjpass	3	SENT_269	[p11l528t1800r573b1852],
2	is	VBZ	O	be	auxpass	3	SENT_269	[p11l605t1797r652b1852],
3	reported	VBN	O	report	dep	22	SENT_269	[p11l687t1797r963b1865],
4	that	IN	O	that	complm	14	SENT_269	[p11l997t1797r1126b1852],
5	patients	NNS	O	patient	nsubj	14	SENT_269	[p11l1160t1797r1417b1865],
6	carrying	VBG	O	carry	partmod	5	SENT_269	[p11l1453t1797r1719b1865],
7	the	DT	O	the	det	10	SENT_269	[p11l1750t1797r1852b1852],
8	arginine	NN	O	arginine	nn	10	SENT_269	[p11l1885t1797r2150b1865],
9	homozygous	JJ	O	homozygous	amod	10	SENT_269	[p11l11t1885r419b1954],
10	genotype	NN	O	genotype	dobj	6	SENT_269	[p11l441t1893r739b1954],
11	at	IN	O	at	_	0	SENT_269	[p11l761t1893r821b1940],
12	codon	NN	O	codon	prep_at	10	SENT_269	[p11l841t1885r1035b1940],
13	72	CD	NUMBER	72	num	12	SENT_269	[p11l1058t1888r1131b1939],
14	are	VBP	O	be	ccomp	3	SENT_269	[p11l1156t1901r1253b1940],
15	at	IN	O	at	_	0	SENT_269	[p11l1276t1893r1335b1940],
16	risk	NN	O	risk	prep_at	14	SENT_269	[p11l1357t1885r1474b1940],
17	for	IN	O	for	_	0	SENT_269	[p11l1494t1885r1583b1940],
18	the	DT	O	the	det	19	SENT_269	[p11l1602t1885r1704b1940],
19	development	NN	O	development	prep_for	16	SENT_269	[p11l1726t1885r2151b1954],
20	of	IN	O	of	_	0	SENT_269	[p11l11t1974r77b2029],
21	arsenic	NN	O	arsenic	prep_of	19	SENT_269	[p11l98t1975r326b2029],
22	induced	VBD	O	induce	_	0	SENT_269	[p11l355t1974r611b2029],
23	keratosis	NN	O	keratosis	dobj	22	SENT_269	[p11l641t1974r927b2029],
24	[	CD	NUMBER	[	num	23	SENT_269	[p11l962t1974r1103b2043],
25	38	CD	NUMBER	38	num	26	SENT_269	[p11l962t1974r1103b2043],
26	]	NN	O	]	nsubj	22	SENT_269	[p11l962t1974r1103b2043],
27	.	.	O	.	_	0	SENT_269	[p11l962t1974r1103b2043],

1	The	DT	O	the	det	2	SENT_270	[p11l1131t1974r1248b2029],
2	response	NN	O	response	nsubjpass	7	SENT_270	[p11l1279t1990r1563b2043],
3	to	TO	O	to	_	0	SENT_270	[p11l1592t1982r1654b2029],
4	chemotherapy	NN	O	chemotherapy	prep_to	2	SENT_270	[p11l1683t1974r2151b2043],
5	must	MD	O	must	aux	7	SENT_270	[p11l11t2072r174b2118],
6	be	VB	O	be	auxpass	7	SENT_270	[p11l208t2063r282b2118],
7	inﬂuenced	VBN	O	inﬂuenced	_	0	SENT_270	[p11l319t2063r655b2118],
8	by	IN	O	by	_	0	SENT_270	[p11l691t2063r769b2132],
9	the	DT	O	the	det	12	SENT_270	[p11l803t2063r905b2118],
10	p53	NN	O	p53	nn	12	SENT_270	[p11l941t2063r1469b2132],
11	—	NN	O	—	nn	12	SENT_270	[p11l941t2063r1469b2132],
12	modulation	NN	O	modulation	agent	7	SENT_270	[p11l941t2063r1469b2132],
13	of	IN	O	of	_	0	SENT_270	[p11l1504t2063r1570b2118],
14	apoptosis	NN	O	apoptosis	prep_of	12	SENT_270	[p11l1598t2064r1921b2132],
15	.	.	O	.	_	0	SENT_270	[p11l1598t2064r1921b2132],

1	Arg72	NN	O	arg72	nn	2	SENT_271	[p11l1956t2066r2148b2132],
2	form	NN	O	form	nsubj	8	SENT_271	[p11l11t2152r164b2207],
3	of	IN	O	of	_	0	SENT_271	[p11l210t2152r277b2207],
4	wild	JJ	O	wild	amod	7	SENT_271	[p11l313t2152r628b2221],
5	—	NN	O	—	nn	7	SENT_271	[p11l313t2152r628b2221],
6	type	NN	O	type	nn	7	SENT_271	[p11l313t2152r628b2221],
7	p53	NN	O	p53	prep_of	2	SENT_271	[p11l676t2155r791b2221],
8	harbours	VBZ	O	harbour	_	0	SENT_271	[p11l842t2152r1128b2207],
9	a	DT	O	a	det	12	SENT_271	[p11l1176t2168r1208b2207],
10	greater	JJR	O	greater	amod	12	SENT_271	[p11l1254t2161r1485b2221],
11	apoptosis	NN	O	apoptosis	nn	12	SENT_271	[p11l1529t2152r2152b2221],
12	—	NN	O	—	dobj	8	SENT_271	[p11l1529t2152r2152b2221],
13	inducing	VBG	O	induce	xcomp	8	SENT_271	[p11l1529t2152r2152b2221],
14	potential	NN	O	potential	dobj	13	SENT_271	[p11l11t2242r299b2310],
15	than	IN	O	than	_	0	SENT_271	[p11l330t2242r475b2297],
16	the	DT	O	the	det	19	SENT_271	[p11l504t2242r606b2297],
17	Pro72	NN	O	pro72	nn	19	SENT_271	[p11l637t2245r820b2297],
18	variant	JJ	O	variant	amod	19	SENT_271	[p11l851t2243r1081b2297],
19	[	NN	O	[	prep_than	13	SENT_271	[p11l1114t2242r1255b2310],
20	16	CD	NUMBER	16	num	21	SENT_271	[p11l1114t2242r1255b2310],
21	]	NN	O	]	dep	19	SENT_271	[p11l1114t2242r1255b2310],
22	,	,	O	,	_	0	SENT_271	[p11l1114t2242r1255b2310],
23	and	CC	O	and	_	0	SENT_271	[p11l1286t2242r1403b2297],
24	may	MD	O	may	aux	25	SENT_271	[p11l1434t2258r1572b2310],
25	alter	VB	O	alter	conj_and	8	SENT_271	[p11l1600t2242r1748b2297],
26	the	DT	O	the	det	28	SENT_271	[p11l1776t2242r1878b2297],
27	tumour	NN	O	tumour	nn	28	SENT_271	[p11l1908t2250r2152b2297],
28	response	NN	O	response	dobj	25	SENT_271	[p11l11t2346r296b2399],
29	to	TO	O	to	_	0	SENT_271	[p11l324t2339r386b2386],
30	systemic	JJ	O	systemic	amod	31	SENT_271	[p11l417t2331r698b2399],
31	chemotherapy	NN	O	chemotherapy	prep_to	25	SENT_271	[p11l726t2331r1194b2399],
32	by	IN	O	by	_	0	SENT_271	[p11l1220t2331r1298b2399],
33	inﬂuencing	VBG	O	inﬂuencing	prepc_by	25	SENT_271	[p11l1326t2330r1689b2399],
34	the	DT	O	the	det	39	SENT_271	[p11l1715t2331r1817b2386],
35	apoptotic	JJ	O	apoptotic	amod	39	SENT_271	[p11l1846t2331r2151b2399],
36	capacity	NN	O	capacity	nn	39	SENT_271	[p11l11t2420r278b2488],
37	[	NN	O	[	nn	39	SENT_271	[p11l305t2419r447b2488],
38	17	CD	NUMBER	17	num	39	SENT_271	[p11l305t2419r447b2488],
39	]	NN	O	]	dobj	33	SENT_271	[p11l305t2419r447b2488],
40	.	.	O	.	_	0	SENT_271	[p11l305t2419r447b2488],

1	Mutations	NNS	O	mutation	nsubj	15	SENT_272	[p11l474t2420r802b2474],
2	in	IN	O	in	_	0	SENT_272	[p11l831t2420r890b2473],
3	p53	NN	O	p53	prep_in	1	SENT_272	[p11l915t2422r1031b2488],
4	have	VBP	O	have	aux	6	SENT_272	[p11l1061t2419r1210b2474],
5	been	VBN	O	be	auxpass	6	SENT_272	[p11l1236t2419r1390b2474],
6	associated	VBN	O	associate	_	0	SENT_272	[p11l1416t2419r1748b2474],
7	with	IN	O	with	_	0	SENT_272	[p11l1772t2419r1921b2474],
8	a	DT	O	a	det	11	SENT_272	[p11l1946t2435r1979b2474],
9	poor	JJ	O	poor	amod	11	SENT_272	[p11l2005t2435r2152b2488],
10	clinical	JJ	O	clinical	amod	11	SENT_272	[p11l11t2508r238b2563],
11	course	NN	O	course	prep_with	6	SENT_272	[p11l260t2524r469b2563],
12	and	CC	O	and	_	0	SENT_272	[p11l490t2508r607b2563],
13	may	MD	O	may	aux	15	SENT_272	[p11l629t2524r767b2576],
14	be	VB	O	be	cop	15	SENT_272	[p11l787t2508r861b2563],
15	prognostic	JJ	O	prognostic	conj_and	6	SENT_272	[p11l882t2509r1223b2577],
16	of	IN	O	of	_	0	SENT_272	[p11l1244t2508r1310b2563],
17	paclitaxel	NN	O	paclitaxel	nn	23	SENT_272	[p11l1325t2508r1635b2577],
18	resistance	NN	O	resistance	nn	23	SENT_272	[p11l1657t2509r1979b2563],
19	nonsmall	JJ	O	nonsmall	amod	23	SENT_272	[p11l2001t2524r2149b2563, p11l12t2597r182b2652],
20	cell	NN	O	cell	nn	23	SENT_272	[p11l210t2597r318b2652],
21	lung	NN	O	lung	nn	23	SENT_272	[p11l346t2598r487b2666],
22	cancer	NN	O	cancer	nn	23	SENT_272	[p11l513t2613r723b2652],
23	patients	NNS	O	patient	prep_of	15	SENT_272	[p11l748t2598r1006b2666],
24	[	CD	NUMBER	[	num	26	SENT_272	[p11l1038t2597r1180b2666],
25	39	CD	NUMBER	39	num	26	SENT_272	[p11l1038t2597r1180b2666],
26	]	NN	O	]	dobj	6	SENT_272	[p11l1038t2597r1180b2666],
27	.	.	O	.	_	0	SENT_272	[p11l1038t2597r1180b2666],

1	Patients	NNS	O	patient	nsubj	8	SENT_273	[p11l1209t2598r1464b2652],
2	carrying	VBG	O	carry	partmod	1	SENT_273	[p11l1493t2598r1759b2666],
3	the	DT	O	the	det	5	SENT_273	[p11l1784t2597r1886b2652],
4	Pro/Pro	NNP	O	Pro/Pro	nn	5	SENT_273	[p11l1913t2597r2150b2666],
5	variant	NN	O	variant	dobj	2	SENT_273	[p11l9t2687r239b2741],
6	were	VBD	O	be	cop	8	SENT_273	[p11l266t2702r426b2741],
7	less	RBR	O	less	advmod	8	SENT_273	[p11l457t2686r572b2741],
8	sensitive	JJ	O	sensitive	_	0	SENT_273	[p11l604t2687r886b2741],
9	to	TO	O	to	_	0	SENT_273	[p11l917t2695r978b2741],
10	cyclophosphamide	NN	O	cyclophosphamide	nn	11	SENT_273	[p11l1009t2686r1832b2755],
11	—	NN	O	—	prep_to	8	SENT_273	[p11l1009t2686r1832b2755],
12	based	VBN	O	base	partmod	11	SENT_273	[p11l1009t2686r1832b2755],
13	neoadju	NN	O	neoadju	nn	16	SENT_273	[p11l1864t2686r2149b2755],
14	—	NN	O	—	nn	16	SENT_273	[p11l1864t2686r2149b2755],
15	vant	NN	O	vant	nn	16	SENT_273	[p11l9t2784r152b2831],
16	therapy	NN	O	therapy	dobj	12	SENT_273	[p11l169t2776r419b2844],
17	and	CC	O	and	_	0	SENT_273	[p11l437t2776r554b2831],
18	displayed	VBD	O	display	conj_and	8	SENT_273	[p11l574t2776r882b2844],
19	a	DT	O	a	det	25	SENT_273	[p11l902t2792r935b2831],
20	more	RBR	O	more	advmod	21	SENT_273	[p11l955t2792r1120b2831],
21	frequently	RB	O	frequently	advmod	22	SENT_273	[p11l1141t2776r1477b2844],
22	positive	JJ	O	positive	amod	25	SENT_273	[p11l1495t2777r1747b2844],
23	lymph	NN	O	lymph	nn	25	SENT_273	[p11l1768t2776r1974b2844],
24	node	NN	O	node	nn	25	SENT_273	[p11l1994t2776r2150b2831],
25	status	NN	O	status	dobj	18	SENT_273	[p11l12t2873r200b2920],
26	[	CD	NUMBER	[	number	27	SENT_273	[p11l233t2865r374b2933],
27	17	CD	NUMBER	17	num	28	SENT_273	[p11l233t2865r374b2933],
28	]	NN	O	]	dobj	8	SENT_273	[p11l233t2865r374b2933],
29	.	.	O	.	_	0	SENT_273	[p11l233t2865r374b2933],

1	We	PRP	O	we	nsubj	2	SENT_274	[p11l401t2868r509b2920],
2	observed	VBD	O	observe	_	0	SENT_274	[p11l538t2865r827b2920],
3	a	DT	O	a	det	5	SENT_274	[p11l856t2881r888b2920],
4	marginal	JJ	O	marginal	amod	5	SENT_274	[p11l917t2865r1202b2933],
5	association	NN	O	association	dobj	2	SENT_274	[p11l1230t2866r1589b2920],
6	of	IN	O	of	_	0	SENT_274	[p11l1617t2865r1683b2920],
7	p53	NN	O	p53	nn	8	SENT_274	[p11l1704t2868r1819b2933],
8	codon	NN	O	codon	prep_of	5	SENT_274	[p11l1851t2865r2045b2920],
9	72	CD	NUMBER	72	num	8	SENT_274	[p11l2074t2868r2147b2919],
10	and	CC	O	and	_	0	SENT_274	[p11l11t2953r127b3008],
11	response	NN	O	response	conj_and	5	SENT_274	[p11l158t2969r443b3022],
12	to	TO	O	to	_	0	SENT_274	[p11l472t2961r534b3008],
13	5	CD	NUMBER	5	prep_to	11	SENT_274	[p11l566t2957r717b3008],
14	.	.	O	.	_	0	SENT_274	[p11l566t2957r717b3008],

1	—	NN	O	—	_	0	SENT_275	[p11l566t2957r717b3008],
2	.	.	O	.	_	0	SENT_275	[p11l566t2957r717b3008],

1	FU	NN	O	fu	nn	4	SENT_276	[p11l566t2957r717b3008],
2	and	CC	O	and	_	0	SENT_276	[p11l747t2953r863b3008],
3	cyclophosphamide	NN	O	cyclophosphamide	conj_and	1	SENT_276	[p11l894t2953r1717b3022],
4	—	NN	O	—	nsubj	15	SENT_276	[p11l894t2953r1717b3022],
5	based	VBN	O	base	partmod	4	SENT_276	[p11l894t2953r1717b3022],
6	neoadjuvant	JJ	O	neoadjuvant	amod	9	SENT_276	[p11l1749t2953r2151b3022],
7	therapy	NN	O	therapy	nn	9	SENT_276	[p11l10t3042r260b3111],
8	(	NN	O	(	nn	9	SENT_276	[p11l289t3042r349b3111],
9	p	NN	O	p	dobj	5	SENT_276	[p11l289t3042r349b3111],
10	=	JJ	O	=	amod	9	SENT_276	[p11l372t3065r405b3081],
11	0.083	CD	NUMBER	0.083	num	12	SENT_276	[p11l427t3042r644b3110],
12	)	NN	O	)	dep	10	SENT_276	[p11l427t3042r644b3110],
13	,	,	O	,	_	0	SENT_276	[p11l427t3042r644b3110],
14	possibly	RB	O	possibly	advmod	15	SENT_276	[p11l675t3042r940b3111],
15	explained	VBN	O	explain	_	0	SENT_276	[p11l969t3042r1282b3111],
16	by	IN	O	by	_	0	SENT_276	[p11l1312t3042r1390b3111],
17	the	DT	O	the	det	20	SENT_276	[p11l1418t3042r1520b3097],
18	small	JJ	O	small	amod	20	SENT_276	[p11l1551t3042r1722b3097],
19	sample	NN	O	sample	nn	20	SENT_276	[p11l1753t3042r1982b3111],
20	size	NN	O	size	prep_by	15	SENT_276	[p11l2013t3043r2148b3098],
21	.	.	O	.	_	0	SENT_276	[p11l2013t3043r2148b3098],

1	Mutations	NNS	O	mutation	nsubj	5	SENT_277	[p11l11t3132r339b3186],
2	in	IN	O	in	_	0	SENT_277	[p11l363t3132r423b3186],
3	p53	NN	O	p53	prep_in	1	SENT_277	[p11l446t3134r562b3200],
4	can	MD	O	can	aux	5	SENT_277	[p11l588t3147r697b3186],
5	increase	VB	O	increase	_	0	SENT_277	[p11l721t3132r985b3186],
6	resistance	NN	O	resistance	dobj	5	SENT_277	[p11l1008t3132r1329b3186],
7	to	TO	O	to	_	0	SENT_277	[p11l1352t3140r1414b3186],
8	ionizing	VBG	O	ionize	prepc_to	5	SENT_277	[p11l1438t3132r1697b3200],
9	radiation	NN	O	radiation	nn	13	SENT_277	[p11l1719t3131r2011b3186],
10	and	CC	O	and	_	0	SENT_277	[p11l2033t3131r2149b3186],
11	other	JJ	O	other	conj_and	9	SENT_277	[p11l11t3221r183b3276],
12	DNA	NN	MISC	dna	nn	13	SENT_277	[p11l244t3221r740b3289],
13	—	NN	O	—	dobj	8	SENT_277	[p11l244t3221r740b3289],
14	damaging	VBG	O	damage	partmod	13	SENT_277	[p11l244t3221r740b3289],
15	agents	NNS	O	agent	dobj	14	SENT_277	[p11l801t3229r1008b3289],
16	in	FW	O	in	nn	17	SENT_277	[p11l1073t3222r1132b3275],
17	vivo	FW	O	vivo	dep	15	SENT_277	[p11l1193t3222r1328b3276],
18	and	CC	O	and	_	0	SENT_277	[p11l1390t3221r1507b3276],
19	in	FW	O	in	conj_and	17	SENT_277	[p11l1571t3222r1630b3275],
20	vitro	FW	O	vitro	nn	21	SENT_277	[p11l1691t3222r1842b3276],
21	[	FW	O	[	pobj	19	SENT_277	[p11l1909t3221r2148b3289],
22	40,41	CD	NUMBER	40,41	num	23	SENT_277	[p11l1909t3221r2148b3289],
23	]	NN	O	]	dep	14	SENT_277	[p11l1909t3221r2148b3289],
24	.	.	O	.	_	0	SENT_277	[p11l1909t3221r2148b3289],

1	Inactivation	NN	O	inactivation	nsubj	7	SENT_278	[p11l11t3311r395b3365],
2	of	IN	O	of	_	0	SENT_278	[p11l458t3310r524b3365],
3	p53	NN	O	p53	prep_of	1	SENT_278	[p11l579t3313r695b3378],
4	by	IN	O	by	_	0	SENT_278	[p11l761t3310r838b3378],
5	mutations	NNS	O	mutation	prep_by	3	SENT_278	[p11l901t3311r1228b3365],
6	can	MD	O	can	aux	7	SENT_278	[p11l1292t3326r1401b3365],
7	cause	VB	O	cause	_	0	SENT_278	[p11l1463t3326r1640b3365],
8	resistance	NN	O	resistance	dobj	7	SENT_278	[p11l1704t3311r2025b3365],
9	to	TO	O	to	_	0	SENT_278	[p11l2087t3318r2149b3365],
10	doxorubicin	NN	O	doxorubicin	nn	14	SENT_278	[p11l11t3398r399b3453],
11	and	CC	O	and	_	0	SENT_278	[p11l441t3398r557b3453],
12	gamma	NN	O	gamma	nn	14	SENT_278	[p11l599t3414r839b3467],
13	radiation	NN	O	radiation	nn	14	SENT_278	[p11l882t3398r1173b3453],
14	treatments	NNS	O	treatment	prep_to	7	SENT_278	[p11l1215t3406r1568b3453],
15	in	FW	O	in	nn	16	SENT_278	[p11l1612t3399r1672b3453],
16	vivo	FW	O	vivo	advmod	7	SENT_278	[p11l1711t3399r1846b3453],
17	and	CC	O	and	_	0	SENT_278	[p11l1889t3398r2005b3453],
18	the	DT	O	the	det	20	SENT_278	[p11l2048t3398r2150b3453],
19	mutational	JJ	O	mutational	amod	20	SENT_278	[p11l11t3487r365b3542],
20	status	NN	O	status	nsubjpass	25	SENT_278	[p11l389t3495r578b3542],
21	of	IN	O	of	_	0	SENT_278	[p11l602t3487r668b3542],
22	p53	NN	O	p53	prep_of	20	SENT_278	[p11l684t3490r800b3556],
23	might	MD	O	might	aux	25	SENT_278	[p11l827t3487r1017b3556],
24	be	VB	O	be	auxpass	25	SENT_278	[p11l1037t3487r1111b3542],
25	associated	VBN	O	associate	conj_and	7	SENT_278	[p11l1134t3487r1466b3542],
26	with	IN	O	with	_	0	SENT_278	[p11l1488t3487r1636b3542],
27	drug	NN	O	drug	nn	28	SENT_278	[p11l1658t3487r1807b3556],
28	resistance	NN	O	resistance	prep_with	25	SENT_278	[p11l1828t3488r2150b3542],
29	in	IN	O	in	_	0	SENT_278	[p11l11t3577r71b3630],
30	human	JJ	O	human	amod	31	SENT_278	[p11l94t3577r321b3631],
31	tumours	NNS	O	tumour	prep_in	28	SENT_278	[p11l343t3585r632b3631],
32	.	.	O	.	_	0	SENT_278	[p11l343t3585r632b3631],

1	Those	DT	O	those	det	2	SENT_279	[p11l655t3577r843b3631],
2	studies	NNS	O	study	nsubjpass	4	SENT_279	[p11l868t3577r1094b3631],
3	were	VBD	O	be	auxpass	4	SENT_279	[p11l1118t3592r1277b3631],
4	made	VBN	O	make	_	0	SENT_279	[p11l1302t3577r1478b3631],
5	in	FW	O	in	nn	6	SENT_279	[p11l1502t3577r1562b3630],
6	vitro	FW	O	vitro	dep	4	SENT_279	[p11l1583t3577r1735b3631],
7	or	CC	O	or	_	0	SENT_279	[p11l1759t3592r1825b3631],
8	in	IN	O	in	conj_or	6	SENT_279	[p11l1847t3577r1906b3630],
9	animal	NN	O	animal	nn	10	SENT_279	[p11l1929t3577r2149b3631],
10	models	NNS	O	model	pobj	8	SENT_279	[p11l11t3664r258b3720],
11	.	.	O	.	_	0	SENT_279	[p11l11t3664r258b3720],

1	Severe	JJ	O	severe	amod	2	SENT_280	[p11l281t3667r491b3719],
2	neutropenia	NN	O	neutropenia	dep	4	SENT_280	[p11l513t3665r905b3733],
3	was	VBD	O	be	auxpass	4	SENT_280	[p11l925t3680r1049b3719],
4	associated	VBN	O	associate	_	0	SENT_280	[p11l1071t3664r1403b3719],
5	with	IN	O	with	_	0	SENT_280	[p11l1424t3664r1572b3719],
6	the	DT	O	the	det	8	SENT_280	[p11l1593t3664r1695b3719],
7	p53	NN	O	p53	nn	8	SENT_280	[p11l1716t3667r1832b3733],
8	codon	NN	O	codon	prep_with	4	SENT_280	[p11l1857t3664r2051b3719],
9	72	CD	NUMBER	72	nsubjpass	4	SENT_280	[p11l2074t3667r2147b3719],

1	Pro/Pro	NNP	O	Pro/Pro	nn	2	SENT_281	[p12l11t17r247b85],
2	genotype	NN	O	genotype	nsubj	7	SENT_281	[p12l266t25r565b85],
3	in	IN	O	in	_	0	SENT_281	[p12l585t18r645b71],
4	ovarian	JJ	O	ovarian	amod	6	SENT_281	[p12l665t18r904b72],
5	cancer	NN	O	cancer	nn	6	SENT_281	[p12l924t33r1135b72],
6	patients	NNS	O	patient	prep_in	2	SENT_281	[p12l1153t18r1411b85],
7	treated	VBN	O	treat	_	0	SENT_281	[p12l1431t17r1661b72],
8	with	IN	O	with	_	0	SENT_281	[p12l1680t17r1829b72],
9	cisplatin	NN	O	cisplatin	nn	10	SENT_281	[p12l1848t17r2149b85],
10	—	NN	O	—	prep_with	7	SENT_281	[p12l1848t17r2149b85],
11	based	VBN	O	base	partmod	10	SENT_281	[p12l10t106r194b161],
12	chemotherapy	NN	O	chemotherapy	dobj	11	SENT_281	[p12l217t106r685b174],
13	[	CD	NUMBER	[	num	12	SENT_281	[p12l708t106r850b174],
14	42	CD	NUMBER	42	num	15	SENT_281	[p12l708t106r850b174],
15	]	NN	O	]	dep	12	SENT_281	[p12l708t106r850b174],
16	.	.	O	.	_	0	SENT_281	[p12l708t106r850b174],

1	Nonetheless	RB	O	nonetheless	advmod	7	SENT_282	[p12l874t106r1283b169],
2	,	,	O	,	_	0	SENT_282	[p12l874t106r1283b169],
3	contradictory	JJ	O	contradictory	amod	4	SENT_282	[p12l1306t106r1743b174],
4	results	NNS	O	result	nsubjpass	7	SENT_282	[p12l1764t106r1977b161],
5	have	VBP	O	have	aux	7	SENT_282	[p12l2000t106r2150b161],
6	been	VBN	O	be	auxpass	7	SENT_282	[p12l10t194r164b249],
7	reported	VBN	O	report	_	0	SENT_282	[p12l193t194r469b263],
8	in	FW	O	in	prep	7	SENT_282	[p12l500t195r559b249],
9	vitro	FW	O	vitro	nn	10	SENT_282	[p12l586t195r737b249],
10	[	FW	O	[	pobj	8	SENT_282	[p12l771t194r893b263],
11	43	CD	NUMBER	43	num	12	SENT_282	[p12l771t194r893b263],
12	]	NN	O	]	dep	10	SENT_282	[p12l771t194r893b263],
13	and	CC	O	and	_	0	SENT_282	[p12l926t194r1042b249],
14	in	FW	O	in	dep	10	SENT_282	[p12l1073t195r1132b249],
15	vivo	FW	O	vivo	nn	16	SENT_282	[p12l1160t195r1294b249],
16	[	FW	O	[	pobj	14	SENT_282	[p12l1328t194r1469b263],
17	44	CD	NUMBER	44	num	18	SENT_282	[p12l1328t194r1469b263],
18	]	NN	O	]	dobj	7	SENT_282	[p12l1328t194r1469b263],
19	.	.	O	.	_	0	SENT_282	[p12l1328t194r1469b263],

1	We	PRP	O	we	nsubj	2	SENT_283	[p12l1497t198r1606b249],
2	present	VBP	DATE	present	_	0	SENT_283	[p12l1635t202r1877b263],
3	here	RB	O	here	advmod	2	SENT_283	[p12l1906t194r2046b249],
4	an	DT	O	a	det	5	SENT_283	[p12l2075t210r2150b249],
5	association	NN	O	association	dobj	2	SENT_283	[p12l11t284r369b338],
6	between	IN	O	between	_	0	SENT_283	[p12l401t283r679b338],
7	p53	NN	O	p53	nn	8	SENT_283	[p12l713t286r829b352],
8	codon	NN	O	codon	prep_between	5	SENT_283	[p12l866t283r1060b338],
9	72	CD	NUMBER	72	num	11	SENT_283	[p12l1095t286r1169b337],
10	gene	NN	O	gene	nn	11	SENT_283	[p12l1204t299r1355b352],
11	polymorphism	NN	O	polymorphism	dep	8	SENT_283	[p12l1389t283r1864b352],
12	and	CC	O	and	_	0	SENT_283	[p12l1898t283r2014b338],
13	the	DT	O	the	det	15	SENT_283	[p12l2048t283r2150b338],
14	relative	JJ	O	relative	amod	15	SENT_283	[p12l11t372r252b427],
15	risk	NN	O	risk	prep_between	5	SENT_283	[p12l310t372r427b427],
16	to	TO	O	to	aux	17	SENT_283	[p12l482t381r543b427],
17	develop	VB	O	develop	infmod	15	SENT_283	[p12l601t372r853b441],
18	adverse	JJ	O	adverse	amod	19	SENT_283	[p12l910t372r1156b427],
19	reaction	NN	O	reaction	nsubj	20	SENT_283	[p12l1214t373r1476b427],
20	due	JJ	O	due	xcomp	17	SENT_283	[p12l1532t372r1649b427],
21	to	TO	O	to	_	0	SENT_283	[p12l1705t381r1767b427],
22	5	CD	NUMBER	5	prep_to	20	SENT_283	[p12l1825t376r1976b427],
23	.	.	O	.	_	0	SENT_283	[p12l1825t376r1976b427],

1	—	NN	O	—	_	0	SENT_284	[p12l1825t376r1976b427],
2	.	.	O	.	_	0	SENT_284	[p12l1825t376r1976b427],

1	FU	NN	O	fu	nn	4	SENT_285	[p12l1825t376r1976b427],
2	and	CC	O	and	_	0	SENT_285	[p12l2033t372r2149b427],
3	cyclophosphamide	NN	O	cyclophosphamide	nn	4	SENT_285	[p12l11t461r833b530],
4	—	NN	O	—	nsubj	5	SENT_285	[p12l11t461r833b530],
5	based	VBN	O	base	_	0	SENT_285	[p12l11t461r833b530],
6	neoadjuvant	JJ	O	neoadjuvant	amod	7	SENT_285	[p12l877t461r1280b530],
7	therapy	NN	O	therapy	dobj	5	SENT_285	[p12l1321t461r1584b530],
8	.	.	O	.	_	0	SENT_285	[p12l1321t461r1584b530],

1	Taken	VBN	O	take	partmod	8	SENT_286	[p12l1626t461r1820b516],
2	together	RB	O	together	advmod	1	SENT_286	[p12l1862t461r2149b530],
3	,	,	O	,	_	0	SENT_286	[p12l1862t461r2149b530],
4	patients	NNS	O	patient	nsubj	19	SENT_286	[p12l11t552r269b619],
5	with	IN	O	with	_	0	SENT_286	[p12l291t551r439b606],
6	Pro	FW	O	pro	prep_with	4	SENT_286	[p12l462t554r565b606],
7	allele	NN	O	allele	dep	6	SENT_286	[p12l587t551r757b606],
8	seem	VBP	O	seem	_	0	SENT_286	[p12l781t567r946b606],
9	to	TO	O	to	aux	12	SENT_286	[p12l967t559r1029b606],
10	be	VB	O	be	cop	12	SENT_286	[p12l1051t551r1125b606],
11	less	RBR	O	less	advmod	12	SENT_286	[p12l1148t551r1264b606],
12	sensitive	JJ	O	sensitive	xcomp	8	SENT_286	[p12l1288t552r1569b606],
13	to	TO	O	to	_	0	SENT_286	[p12l1591t559r1653b606],
14	treatment	NN	O	treatment	nn	15	SENT_286	[p12l1675t559r1999b606],
15	[	NN	O	[	prep_to	12	SENT_286	[p12l2024t551r2146b619],
16	17	CD	NUMBER	17	num	17	SENT_286	[p12l2024t551r2146b619],
17	]	NN	O	]	dep	15	SENT_286	[p12l2024t551r2146b619],
18	and	CC	O	and	_	0	SENT_286	[p12l11t640r127b695],
19	seem	VBP	O	seem	conj_and	8	SENT_286	[p12l148t656r313b695],
20	to	TO	O	to	aux	21	SENT_286	[p12l332t648r394b695],
21	develop	VB	O	develop	xcomp	19	SENT_286	[p12l413t640r665b708],
22	more	JJR	O	more	amod	23	SENT_286	[p12l685t656r851b695],
23	toxicity	NN	O	toxicity	dobj	21	SENT_286	[p12l870t641r1114b708],
24	than	IN	O	than	_	0	SENT_286	[p12l1132t640r1277b695],
25	those	DT	O	those	prep_than	21	SENT_286	[p12l1295t640r1468b695],
26	with	IN	O	with	_	0	SENT_286	[p12l1486t640r1634b695],
27	Arg	NN	O	arg	nn	28	SENT_286	[p12l1651t642r1764b708],
28	variant	NN	O	variant	prep_with	25	SENT_286	[p12l1779t641r2023b695],
29	.	.	O	.	_	0	SENT_286	[p12l1779t641r2023b695],

1	We	PRP	O	we	nsubj	2	SENT_287	[p12l2041t643r2150b695],
2	introduced	VBD	O	introduce	_	0	SENT_287	[p12l11t728r362b783],
3	new	JJ	O	new	amod	4	SENT_287	[p12l382t744r518b783],
4	data	NNS	O	datum	dobj	2	SENT_287	[p12l535t728r672b783],
5	related	VBN	O	relate	partmod	4	SENT_287	[p12l691t728r914b783],
6	to	TO	O	to	_	0	SENT_287	[p12l933t736r995b783],
7	the	DT	O	the	det	8	SENT_287	[p12l1013t728r1115b783],
8	role	NN	O	role	prep_to	5	SENT_287	[p12l1134t728r1256b783],
9	of	IN	O	of	_	0	SENT_287	[p12l1275t728r1341b783],
10	TSER	NN	O	tser	prep_of	8	SENT_287	[p12l1348t731r1522b792],
11	,	,	O	,	_	0	SENT_287	[p12l1348t731r1522b792],
12	MTHFR	NN	O	mthfr	nn	13	SENT_287	[p12l1542t732r1779b783],
13	C677T	NN	O	c677t	conj_and	10	SENT_287	[p12l1794t731r2011b792],
14	,	,	O	,	_	0	SENT_287	[p12l1794t731r2011b792],
15	p53	NN	O	p53	nn	16	SENT_287	[p12l2030t731r2146b797],
16	codon	NN	O	codon	conj_and	10	SENT_287	[p12l11t817r204b872],
17	72	CD	NUMBER	72	dep	16	SENT_287	[p12l226t820r300b871],
18	and	CC	O	and	_	0	SENT_287	[p12l324t817r440b872],
19	MDR1	NN	O	mdr1	nn	20	SENT_287	[p12l462t820r650b871],
20	C343	NN	O	c343	conj_and	10	SENT_287	[p12l680t820r838b872],
21	ST	JJ	O	st	amod	20	SENT_287	[p12l848t820r925b872],
22	in	IN	O	in	_	0	SENT_287	[p12l945t818r1004b871],
23	patients	NNS	O	patient	prep_in	21	SENT_287	[p12l1025t818r1283b886],
24	with	IN	O	with	_	0	SENT_287	[p12l1303t817r1452b872],
25	breast	NN	O	breast	nn	26	SENT_287	[p12l1472t817r1671b872],
26	cancer	NN	O	cancer	prep_with	23	SENT_287	[p12l1691t833r1901b872],
27	treated	VBN	O	treat	partmod	26	SENT_287	[p12l1919t817r2149b872],
28	with	IN	O	with	_	0	SENT_287	[p12l9t906r158b961],
29	neoadjuvant	JJ	O	neoadjuvant	amod	30	SENT_287	[p12l200t906r603b975],
30	chemotherapy	NN	O	chemotherapy	prep_with	27	SENT_287	[p12l644t906r1126b975],
31	.	.	O	.	_	0	SENT_287	[p12l644t906r1126b975],

1	Because	IN	O	because	mark	5	SENT_288	[p12l1170t910r1426b961],
2	any	DT	O	any	det	3	SENT_288	[p12l1469t922r1584b975],
3	association	NN	O	association	nsubjpass	5	SENT_288	[p12l1625t907r1983b961],
4	was	VBD	O	be	auxpass	5	SENT_288	[p12l2024t922r2148b961],
5	observed	VBN	O	observe	advcl	16	SENT_288	[p12l11t995r300b1050],
6	between	IN	O	between	_	0	SENT_288	[p12l351t995r629b1050],
7	response	NN	O	response	nn	8	SENT_288	[p12l680t1011r964b1064],
8	rates	NNS	O	rate	prep_between	5	SENT_288	[p12l1016t1004r1170b1050],
9	and	CC	O	and	_	0	SENT_288	[p12l1222t995r1338b1050],
10	toxicity	NN	O	toxicity	nn	11	SENT_288	[p12l1389t996r1634b1064],
11	reactions	NNS	O	reaction	prep_between	5	SENT_288	[p12l1683t996r1992b1059],
12	,	,	O	,	_	0	SENT_288	[p12l1683t996r1992b1059],
13	our	PRP$	O	we	poss	14	SENT_288	[p12l2043t1011r2152b1050],
14	ﬁndings	NNS	O	ﬁndings	nsubj	16	SENT_288	[p12l11t1085r268b1153],
15	would	MD	O	would	aux	16	SENT_288	[p12l296t1085r499b1140],
16	provide	VB	O	provide	_	0	SENT_288	[p12l528t1085r772b1153],
17	useful	JJ	O	useful	amod	18	SENT_288	[p12l801t1085r994b1140],
18	information	NN	O	information	dobj	16	SENT_288	[p12l1025t1085r1409b1140],
19	for	IN	O	for	_	0	SENT_288	[p12l1437t1085r1527b1140],
20	selecting	VBG	O	select	prepc_for	16	SENT_288	[p12l1554t1085r1839b1153],
21	the	DT	O	the	det	23	SENT_288	[p12l1866t1085r1968b1140],
22	right	JJ	O	right	amod	23	SENT_288	[p12l1998t1085r2151b1153],
23	candidates	NNS	O	candidate	dobj	20	SENT_288	[p12l11t1174r355b1229],
24	for	IN	O	for	_	0	SENT_288	[p12l399t1174r488b1229],
25	5	CD	NUMBER	5	prep_for	23	SENT_288	[p12l529t1177r681b1229],
26	.	.	O	.	_	0	SENT_288	[p12l529t1177r681b1229],

1	—	NN	O	—	_	0	SENT_289	[p12l529t1177r681b1229],
2	.	.	O	.	_	0	SENT_289	[p12l529t1177r681b1229],

1	FU	NN	O	fu	nn	4	SENT_290	[p12l529t1177r681b1229],
2	and	CC	O	and	_	0	SENT_290	[p12l723t1174r839b1229],
3	cyclophosphamide	NN	O	cyclophosphamide	nn	4	SENT_290	[p12l882t1174r1705b1242],
4	—	NN	O	—	nsubj	5	SENT_290	[p12l882t1174r1705b1242],
5	based	VBN	O	base	_	0	SENT_290	[p12l882t1174r1705b1242],
6	neoadjuvant	JJ	O	neoadjuvant	amod	7	SENT_290	[p12l1749t1174r2151b1242],
7	chemotherapy	NN	O	chemotherapy	dobj	5	SENT_290	[p12l11t1262r493b1331],
8	.	.	O	.	_	0	SENT_290	[p12l11t1262r493b1331],

1	Further	JJ	O	further	amod	2	SENT_291	[p12l514t1262r753b1317],
2	experiments	NNS	O	experiment	nsubjpass	13	SENT_291	[p12l770t1263r1172b1331],
3	in	IN	O	in	_	0	SENT_291	[p12l1193t1263r1252b1317],
4	larger	JJR	O	larger	amod	5	SENT_291	[p12l1271t1262r1459b1331],
5	series	NN	O	series	prep_in	2	SENT_291	[p12l1476t1263r1656b1317],
6	of	IN	O	of	_	0	SENT_291	[p12l1677t1262r1743b1317],
7	patients	NNS	O	patient	prep_of	5	SENT_291	[p12l1755t1263r2013b1331],
8	and	CC	O	and	_	0	SENT_291	[p12l2033t1262r2149b1317],
9	longer	JJR	O	longer	advmod	10	SENT_291	[p12l11t1351r216b1420],
10	follow	VB	O	follow	prep_of	5	SENT_291	[p12l242t1351r445b1406],
11	up	RP	O	up	prt	10	SENT_291	[p12l472t1367r551b1420],
12	are	VBP	O	be	auxpass	13	SENT_291	[p12l580t1367r678b1406],
13	needed	VBN	O	need	_	0	SENT_291	[p12l707t1351r938b1406],
14	to	TO	O	to	aux	15	SENT_291	[p12l966t1359r1028b1406],
15	validate	VB	O	validate	xcomp	13	SENT_291	[p12l1054t1351r1312b1406],
16	these	DT	O	these	det	17	SENT_291	[p12l1339t1351r1510b1406],
17	results	NNS	O	result	dobj	15	SENT_291	[p12l1538t1351r1768b1406],
18	.	.	O	.	_	0	SENT_291	[p12l1538t1351r1768b1406],

1	Conﬂict	NN	O	conﬂict	_	0	SENT_292	[p12l10t1529r273b1583],
2	of	IN	O	of	_	0	SENT_292	[p12l297t1529r369b1583],
3	interest	NN	O	interest	nn	4	SENT_292	[p12l390t1529r654b1583],
4	statement	NN	O	statement	prep_of	1	SENT_292	[p12l680t1537r1026b1584],

1	The	DT	O	the	det	2	SENT_293	[p12l110t1708r227b1763],
2	authors	NNS	O	author	nsubj	3	SENT_293	[p12l255t1708r498b1763],
3	declare	VBP	O	declare	_	0	SENT_293	[p12l526t1708r758b1763],
4	that	IN	O	that	complm	6	SENT_293	[p12l785t1708r915b1763],
5	there	EX	O	there	expl	6	SENT_293	[p12l940t1708r1108b1763],
6	is	VBZ	O	be	ccomp	3	SENT_293	[p12l1136t1709r1182b1763],
7	no	DT	O	no	det	9	SENT_293	[p12l1212t1724r1289b1763],
8	competing	VBG	O	compete	amod	9	SENT_293	[p12l1317t1709r1660b1776],
9	interest	NN	O	interest	nsubj	6	SENT_293	[p12l1687t1709r1934b1763],
10	for	IN	O	for	_	0	SENT_293	[p12l1961t1708r2050b1763],
11	all	DT	O	all	det	12	SENT_293	[p12l2075t1708r2149b1763],
12	authors	NNS	O	author	prep_for	9	SENT_293	[p12l11t1797r271b1852],
13	.	.	O	.	_	0	SENT_293	[p12l11t1797r271b1852],

1	Acknowledgements	NNS	O	acknowledgement	_	0	SENT_294	[p12l7t1973r654b2041],

1	We	PRP	O	we	nsubj	2	SENT_295	[p12l110t2156r218b2207],
2	thank	VBP	O	thank	_	0	SENT_295	[p12l243t2153r428b2207],
3	Fatima	NNP	PERSON	Fatima	nn	4	SENT_295	[p12l451t2150r670b2207],
4	Gillén	NNP	PERSON	Gillén	dobj	2	SENT_295	[p12l694t2150r884b2207],
5	and	CC	O	and	_	0	SENT_295	[p12l908t2153r1024b2207],
6	Elia	NNP	PERSON	Elia	nn	7	SENT_295	[p12l1050t2153r1164b2207],
7	Garcia	NNP	PERSON	Garcia	conj_and	4	SENT_295	[p12l1189t2150r1392b2207],
8	for	IN	O	for	_	0	SENT_295	[p12l1417t2153r1506b2207],
9	their	PRP$	O	they	poss	11	SENT_295	[p12l1529t2153r1683b2207],
10	crucial	JJ	O	crucial	amod	11	SENT_295	[p12l1705t2153r1919b2207],
11	role	NN	O	role	prep_for	4	SENT_295	[p12l1945t2153r2066b2207],
12	in	IN	O	in	_	0	SENT_295	[p12l2091t2154r2150b2206],
13	sample	NN	O	sample	nn	16	SENT_295	[p12l12t2241r240b2310],
14	and	CC	O	and	_	0	SENT_295	[p12l270t2241r386b2296],
15	questionnaire	NN	O	questionnaire	nn	16	SENT_295	[p12l417t2242r862b2310],
16	recollection	NN	O	recollection	prep_in	11	SENT_295	[p12l892t2241r1289b2305],
17	;	:	O	;	_	0	SENT_295	[p12l892t2241r1289b2305],
18	Dr.	NNP	O	Dr.	nn	21	SENT_295	[p12l1325t2245r1415b2297],
19	Jesus	NNP	PERSON	Jesus	nn	21	SENT_295	[p12l1438t2238r1606b2310],
20	Garcia	NNP	PERSON	Garcia	nn	21	SENT_295	[p12l1637t2238r1840b2296],
21	Foncillas	NNP	PERSON	Foncillas	dep	4	SENT_295	[p12l1870t2241r2149b2296],

1	638	CD	NUMBER	638	_	0	SENT_296	[p12l312t2387r356b2408],
2	LA.	NN	O	la.	dep	1	SENT_296	[p12l940t2387r981b2408],
3	.	.	O	.	_	0	SENT_296	[p12l940t2387r981b2408],

1	Henrz	JJ	PERSON	henrz	amod	2	SENT_297	[p12l992t2385r1258b2413],
2	’	NN	O	’	_	0	SENT_297	[p12l992t2385r1258b2413],
3	quez	NN	O	quez	dep	2	SENT_297	[p12l992t2385r1258b2413],
4	.	.	O	.	_	0	SENT_297	[p12l992t2385r1258b2413],

1	—	NN	O	—	_	0	SENT_298	[p12l992t2385r1258b2413],
2	.	.	O	.	_	0	SENT_298	[p12l992t2385r1258b2413],

1	Hermindez	NNP	O	Hermindez	_	0	SENT_299	[p12l992t2385r1258b2413],
2	et	FW	O	et	nn	3	SENT_299	[p12l1268t2389r1291b2408],
3	al.	FW	O	al.	dep	1	SENT_299	[p12l1301t2386r1430b2413],
4	/	:	O	/	punct	1	SENT_299	[p12l1301t2386r1430b2413],
5	Cancer	NNP	O	Cancer	nn	6	SENT_299	[p12l1301t2386r1430b2413],
6	Epidemiology	NNP	O	Epidemiology	dep	1	SENT_299	[p12l1438t2386r1601b2413],
7	34	CD	NUMBER	34	number	8	SENT_299	[p12l1610t2387r1640b2408],
8	(	CD	NUMBER	(	num	9	SENT_299	[p12l1651t2386r1731b2413],
9	2010	CD	DATE	2010	dep	6	SENT_299	[p12l1651t2386r1731b2413],
10	)	CD	NUMBER	)	number	11	SENT_299	[p12l1651t2386r1731b2413],
11	634-638	CD	NUMBER	634-638	num	9	SENT_299	[p12l1742t2387r1848b2408],

1	and	CC	O	and	dep	4	SENT_300	[p12l7t2521r123b2576],
2	Dr.	NNP	O	Dr.	nn	4	SENT_300	[p12l149t2524r239b2576],
3	Ruth	NNP	PERSON	Ruth	nn	4	SENT_300	[p12l265t2521r415b2576],
4	Zarate	NNP	PERSON	Zarate	_	0	SENT_300	[p12l438t2518r640b2576],
5	for	IN	O	for	_	0	SENT_300	[p12l665t2521r754b2576],
6	technical	JJ	O	technical	amod	7	SENT_300	[p12l775t2521r1067b2576],
7	support	NN	O	support	prep_for	4	SENT_300	[p12l1092t2529r1341b2589],
8	and	CC	O	and	_	0	SENT_300	[p12l1364t2521r1481b2576],
9	protocol	NN	O	protocol	nn	10	SENT_300	[p12l1505t2521r1771b2589],
10	assistance	NN	O	assistance	prep_for	4	SENT_300	[p12l1796t2522r2141b2584],
11	;	:	O	;	_	0	SENT_300	[p12l1796t2522r2141b2584],
12	and	CC	O	and	_	0	SENT_300	[p12l7t2608r123b2663],
13	Marta	NNP	PERSON	Marta	nn	15	SENT_300	[p12l152t2612r342b2663],
14	Rodriguez	NNP	PERSON	Rodriguez	nn	15	SENT_300	[p12l370t2605r693b2677],
15	Pérez	NNP	PERSON	Pérez	dep	4	SENT_300	[p12l721t2605r893b2663],
16	for	IN	O	for	_	0	SENT_300	[p12l922t2608r1011b2663],
17	the	DT	O	the	det	18	SENT_300	[p12l1036t2608r1137b2663],
18	management	NN	O	management	prep_for	15	SENT_300	[p12l1165t2616r1590b2677],
19	of	IN	O	of	_	0	SENT_300	[p12l1616t2608r1682b2663],
20	questionnaire	NN	O	questionnaire	prep_of	18	SENT_300	[p12l1702t2609r2147b2677],
21	and	CC	O	and	_	0	SENT_300	[p12l7t2697r123b2752],
22	creation	NN	O	creation	dep	4	SENT_300	[p12l148t2698r410b2752],
23	of	IN	O	of	_	0	SENT_300	[p12l434t2697r500b2752],
24	the	DT	O	the	det	25	SENT_300	[p12l516t2697r618b2752],
25	database	NN	O	database	prep_of	22	SENT_300	[p12l642t2697r941b2752],
26	.	.	O	.	_	0	SENT_300	[p12l642t2697r941b2752],

1	This	DT	O	this	det	2	SENT_301	[p12l964t2697r1097b2752],
2	study	NN	O	study	nsubjpass	4	SENT_301	[p12l1123t2697r1300b2766],
3	was	VBD	O	be	auxpass	4	SENT_301	[p12l1321t2713r1446b2752],
4	supported	VBN	O	support	_	0	SENT_301	[p12l1472t2697r1798b2766],
5	by	IN	O	by	_	0	SENT_301	[p12l1822t2697r1900b2766],
6	a	DT	O	a	det	7	SENT_301	[p12l1922t2713r1954b2752],
7	grant	NN	O	grant	agent	4	SENT_301	[p12l1977t2705r2148b2766],
8	from	IN	O	from	_	0	SENT_301	[p12l8t2786r160b2841],
9	the	DT	O	the	det	10	SENT_301	[p12l190t2786r292b2841],
10	Foundation	NNP	O	Foundation	prep_from	4	SENT_301	[p12l323t2786r689b2841],
11	of	IN	O	of	_	0	SENT_301	[p12l719t2786r785b2841],
12	the	DT	O	the	det	14	SENT_301	[p12l807t2786r909b2841],
13	Canary	NNP	ORGANIZATION	Canary	nn	14	SENT_301	[p12l940t2789r1164b2855],
14	Institute	NNP	ORGANIZATION	Institute	prep_of	10	SENT_301	[p12l1193t2787r1465b2841],
15	for	IN	ORGANIZATION	for	_	0	SENT_301	[p12l1496t2786r1585b2841],
16	Cancer	NNP	ORGANIZATION	Cancer	nn	17	SENT_301	[p12l1613t2789r1832b2841],
17	Research	NNP	ORGANIZATION	Research	prep_for	4	SENT_301	[p12l1861t2786r2147b2841],
18	(	CD	NUMBER	(	num	19	SENT_301	[p12l7t2874r236b2943],
19	FICIC	NNP	O	FICIC	dep	17	SENT_301	[p12l7t2874r236b2943],
20	)	CD	NUMBER	)	num	19	SENT_301	[p12l7t2874r236b2943],
21	.	.	O	.	_	0	SENT_301	[p12l7t2874r236b2943],

1	Henriquez	NNP	PERSON	Henriquez	_	0	SENT_302	[p12l263t2871r980b2943],
2	.	.	O	.	_	0	SENT_302	[p12l263t2871r980b2943],

1	—	NN	O	—	_	0	SENT_303	[p12l263t2871r980b2943],
2	.	.	O	.	_	0	SENT_303	[p12l263t2871r980b2943],

1	Hernandez	NNP	PERSON	Hernandez	nn	2	SENT_304	[p12l263t2871r980b2943],
2	LA	NNP	O	LA	nsubjpass	4	SENT_304	[p12l1006t2877r1085b2929],
3	was	VBD	O	be	auxpass	4	SENT_304	[p12l1106t2890r1231b2929],
4	supported	VBN	O	support	_	0	SENT_304	[p12l1258t2874r1584b2943],
5	by	IN	O	by	_	0	SENT_304	[p12l1609t2874r1687b2943],
6	a	DT	O	a	det	7	SENT_304	[p12l1711t2890r1743b2929],
7	grant	NN	O	grant	agent	4	SENT_304	[p12l1767t2883r1938b2943],
8	of	IN	O	of	_	0	SENT_304	[p12l1962t2874r2028b2929],
9	the	DT	O	the	det	12	SENT_304	[p12l2045t2874r2147b2929],
10	Consejeria	NNP	O	Consejeria	nn	12	SENT_304	[p12l8t2961r341b3032],
11	de	IN	O	de	amod	12	SENT_304	[p12l384t2964r458b3019],
12	Industria	NNP	O	Industria	prep_of	7	SENT_304	[p12l502t2964r791b3019],
13	from	IN	O	from	_	0	SENT_304	[p12l835t2964r987b3019],
14	the	DT	O	the	det	16	SENT_304	[p12l1030t2964r1131b3019],
15	Canary	NNP	O	Canary	nn	16	SENT_304	[p12l1175t2967r1398b3032],
16	Government	NNP	O	Government	prep_from	12	SENT_304	[p12l1440t2967r1844b3019],
17	and	CC	O	and	_	0	SENT_304	[p12l1885t2964r2002b3019],
18	the	DT	O	the	det	20	SENT_304	[p12l2045t2964r2147b3019],
19	Canary	NNP	ORGANIZATION	Canary	nn	20	SENT_304	[p12l8t3056r231b3121],
20	Foundation	NNP	ORGANIZATION	Foundation	conj_and	12	SENT_304	[p12l273t3053r639b3108],
21	for	IN	ORGANIZATION	for	_	0	SENT_304	[p12l682t3053r772b3108],
22	Investigation	NNP	ORGANIZATION	Investigation	prep_for	20	SENT_304	[p12l813t3054r1234b3121],
23	and	CC	ORGANIZATION	and	_	0	SENT_304	[p12l1276t3053r1392b3108],
24	Health	NNP	ORGANIZATION	Health	prep_for	20	SENT_304	[p12l1437t3053r1649b3108],
25	(	CD	NUMBER	(	num	26	SENT_304	[p12l1693t3053r1996b3121],
26	FUNCIS	NNP	O	FUNCIS	dep	20	SENT_304	[p12l1693t3053r1996b3121],
27	)	CD	NUMBER	)	num	26	SENT_304	[p12l1693t3053r1996b3121],
28	.	.	O	.	_	0	SENT_304	[p12l1693t3053r1996b3121],

1	We	PRP	O	we	nsubj	2	SENT_305	[p12l2038t3056r2147b3108],
2	appreciate	VBP	O	appreciate	_	0	SENT_305	[p12l7t3142r344b3210],
3	the	DT	O	the	det	4	SENT_305	[p12l372t3141r474b3196],
4	support	NN	O	support	dobj	2	SENT_305	[p12l503t3149r752b3210],
5	of	IN	O	of	_	0	SENT_305	[p12l780t3141r846b3196],
6	Obra	NNP	ORGANIZATION	Obra	nn	10	SENT_305	[p12l866t3141r1019b3196],
7	Social	NNP	ORGANIZATION	Social	nn	10	SENT_305	[p12l1047t3141r1232b3196],
8	de	IN	ORGANIZATION	de	amod	10	SENT_305	[p12l1261t3141r1334b3196],
9	La	NNP	ORGANIZATION	La	nn	10	SENT_305	[p12l1364t3145r1431b3196],
10	Caja	NNP	ORGANIZATION	Caja	prep_of	4	SENT_305	[p12l1459t3142r1592b3210],
11	de	IN	ORGANIZATION	de	_	0	SENT_305	[p12l1620t3141r1694b3196],
12	Canarias	NNP	ORGANIZATION	Canarias	prep_de	4	SENT_305	[p12l1723t3142r2011b3197],
13	.	.	O	.	_	0	SENT_305	[p12l1723t3142r2011b3197],

1	References	NNS	O	reference	_	0	SENT_306	[p12l6t3299r375b3353],

1	[	NN	O	[	_	0	SENT_307	[p12l38t3465r103b3520],
2	1	CD	NUMBER	1	num	1	SENT_307	[p12l38t3465r103b3520],
3	]	CD	NUMBER	]	num	5	SENT_307	[p12l38t3465r103b3520],
4	Kamangar	NNP	PERSON	Kamangar	nn	5	SENT_307	[p12l138t3468r401b3520],
5	F	NN	PERSON	f	dep	1	SENT_307	[p12l418t3468r455b3516],
6	,	,	O	,	_	0	SENT_307	[p12l418t3468r455b3516],
7	Dores	NNP	ORGANIZATION	Dores	nn	8	SENT_307	[p12l474t3468r619b3509],
8	GM	NNP	ORGANIZATION	GM	appos	5	SENT_307	[p12l638t3468r740b3516],
9	,	,	O	,	_	0	SENT_307	[p12l638t3468r740b3516],
10	Anderson	NNP	PERSON	Anderson	nn	11	SENT_307	[p12l756t3466r1004b3509],
11	WF	NNP	PERSON	WF	appos	5	SENT_307	[p12l1019t3468r1118b3510],
12	.	.	O	.	_	0	SENT_307	[p12l1019t3468r1118b3510],

1	Patterns	NN	O	pattern	_	0	SENT_308	[p12l1137t3468r1348b3509],
2	of	IN	O	of	_	0	SENT_308	[p12l1367t3465r1420b3509],
3	cancer	NN	O	cancer	nn	4	SENT_308	[p12l1432t3478r1601b3509],
4	incidence	NN	O	incidence	prep_of	1	SENT_308	[p12l1617t3466r1874b3516],
5	,	,	O	,	_	0	SENT_308	[p12l1617t3466r1874b3516],
6	mortality	NN	O	mortality	prep_of	1	SENT_308	[p12l1894t3466r2147b3520],
7	,	,	O	,	_	0	SENT_308	[p12l1894t3466r2147b3520],
8	and	CC	O	and	_	0	SENT_308	[p12l138t3532r231b3575],
9	prevalence	NN	O	prevalence	conj_and	4	SENT_308	[p12l260t3532r539b3586],
10	across	IN	O	across	_	0	SENT_308	[p12l568t3544r726b3575],
11	ﬁve	NN	O	ﬁve	nn	12	SENT_308	[p12l756t3532r847b3575],
12	continents	NNS	O	continent	prep_across	9	SENT_308	[p12l876t3533r1164b3576],
13	:	:	O	:	_	0	SENT_308	[p12l876t3533r1164b3576],
14	deﬁning	VBG	O	deﬁning	dep	32	SENT_308	[p12l1197t3532r1409b3586],
15	priorities	NNS	O	priority	dobj	14	SENT_308	[p12l1437t3533r1671b3586],
16	to	TO	O	to	aux	17	SENT_308	[p12l1700t3538r1750b3575],
17	reduce	VB	O	reduce	xcomp	14	SENT_308	[p12l1779t3532r1951b3575],
18	cancer	NN	O	cancer	nn	19	SENT_308	[p12l1981t3544r2149b3575],
19	disparities	NNS	O	disparity	dobj	17	SENT_308	[p12l138t3597r405b3652],
20	in	IN	O	in	_	0	SENT_308	[p12l426t3598r474b3641],
21	different	JJ	O	different	amod	23	SENT_308	[p12l493t3597r716b3641],
22	geographic	JJ	O	geographic	amod	23	SENT_308	[p12l734t3597r1019b3652],
23	regions	NNS	O	region	prep_in	17	SENT_308	[p12l1038t3598r1224b3652],
24	of	IN	O	of	_	0	SENT_308	[p12l1245t3597r1298b3641],
25	the	DT	O	the	det	26	SENT_308	[p12l1311t3598r1393b3641],
26	world	NN	O	world	prep_of	23	SENT_308	[p12l1411t3597r1609b3652],
27	]	CD	NUMBER	]	num	29	SENT_308	[p12l1411t3597r1609b3652],
28	Clin	NNP	O	Clin	nn	29	SENT_308	[p12l1629t3597r1728b3641],
29	Oncol	NNP	O	Oncol	dep	26	SENT_308	[p12l1747t3598r1894b3641],
30	2006	CD	DATE	2006	num	29	SENT_308	[p12l1913t3600r2142b3648],
31	;	:	O	;	_	0	SENT_308	[p12l1913t3600r2142b3648],
32	24	CD	NUMBER	24	dep	1	SENT_308	[p12l1913t3600r2142b3648],
33	:	:	O	:	_	0	SENT_308	[p12l1913t3600r2142b3648],
34	2137-50	CD	NUMBER	2137-50	dep	32	SENT_308	[p12l138t3667r377b3709],
35	.	.	O	.	_	0	SENT_308	[p12l138t3667r377b3709],

1	[	NN	O	[	_	0	SENT_309	[p13l38t18r103b73],
2	2	CD	NUMBER	2	number	3	SENT_309	[p13l38t18r103b73],
3	]	CD	NUMBER	]	dep	1	SENT_309	[p13l38t18r103b73],
4	Sachelarie	NN	O	sachelarie	dep	3	SENT_309	[p13l138t18r400b62],
5	I	PRP	O	I	dep	1	SENT_309	[p13l433t21r459b68],
6	,	,	O	,	_	0	SENT_309	[p13l433t21r459b68],
7	Grossbard	NNP	PERSON	Grossbard	nn	8	SENT_309	[p13l494t18r754b62],
8	ML	NNP	O	ML	appos	5	SENT_309	[p13l788t21r877b69],
9	,	,	O	,	_	0	SENT_309	[p13l788t21r877b69],
10	Chadha	NNP	PERSON	Chadha	nn	11	SENT_309	[p13l911t18r1103b62],
11	M	NNP	O	M	appos	5	SENT_309	[p13l1136t21r1197b68],
12	,	,	O	,	_	0	SENT_309	[p13l1136t21r1197b68],
13	Feldman	NNP	PERSON	Feldman	nn	14	SENT_309	[p13l1231t18r1453b62],
14	S	NNP	O	S	appos	5	SENT_309	[p13l1486t20r1524b68],
15	,	,	O	,	_	0	SENT_309	[p13l1486t20r1524b68],
16	Ghesani	NNP	O	Ghesani	nn	17	SENT_309	[p13l1558t18r1763b62],
17	M	NNP	O	M	appos	5	SENT_309	[p13l1797t21r1859b68],
18	,	,	O	,	_	0	SENT_309	[p13l1797t21r1859b68],
19	Blum	NNP	PERSON	Blum	nn	20	SENT_309	[p13l1893t18r2027b62],
20	RH	NNP	O	RH	appos	5	SENT_309	[p13l2060t21r2146b62],
21	.	.	O	.	_	0	SENT_309	[p13l2060t21r2146b62],

1	Primary	JJ	O	primary	amod	3	SENT_310	[p13l138t85r343b138],
2	systemic	JJ	O	systemic	amod	3	SENT_310	[p13l366t85r591b138],
3	therapy	NN	O	therapy	_	0	SENT_310	[p13l612t84r812b138],
4	of	IN	O	of	_	0	SENT_310	[p13l834t84r887b127],
5	breast	NN	O	breast	nn	6	SENT_310	[p13l903t84r1063b127],
6	cancer	NN	O	cancer	prep_of	3	SENT_310	[p13l1084t96r1263b128],
7	.	.	O	.	_	0	SENT_310	[p13l1084t96r1263b128],

1	Oncologist	NN	O	oncologist	_	0	SENT_311	[p13l1287t84r1561b138],
2	2006	CD	DATE	2006	num	1	SENT_311	[p13l1582t86r2026b134],
3	;	:	O	;	_	0	SENT_311	[p13l1582t86r2026b134],
4	11:574	CD	NUMBER	11:574	number	5	SENT_311	[p13l1582t86r2026b134],
5	—	CD	NUMBER	—	dep	1	SENT_311	[p13l1582t86r2026b134],
6	89	CD	NUMBER	89	dep	5	SENT_311	[p13l1582t86r2026b134],
7	.	.	O	.	_	0	SENT_311	[p13l1582t86r2026b134],

1	[	NN	O	[	nn	3	SENT_312	[p13l38t150r103b204],
2	3	CD	NUMBER	3	num	3	SENT_312	[p13l38t150r103b204],
3	]	NN	O	]	_	0	SENT_312	[p13l38t150r103b204],
4	Fisher	NNP	PERSON	Fisher	nn	5	SENT_312	[p13l138t150r294b194],
5	B	NNP	PERSON	B	dep	3	SENT_312	[p13l314t153r357b200],
6	,	,	O	,	_	0	SENT_312	[p13l314t153r357b200],
7	Brown	NNP	PERSON	Brown	nn	8	SENT_312	[p13l380t153r548b194],
8	A	NNP	O	A	appos	5	SENT_312	[p13l568t152r616b200],
9	,	,	O	,	_	0	SENT_312	[p13l568t152r616b200],
10	Mamounas	NNP	O	Mamounas	nn	11	SENT_312	[p13l639t153r924b194],
11	E	NNP	O	E	appos	5	SENT_312	[p13l948t153r988b200],
12	,	,	O	,	_	0	SENT_312	[p13l948t153r988b200],
13	Wieand	NNP	O	Wieand	nn	14	SENT_312	[p13l1008t150r1209b194],
14	S	NNP	O	S	appos	5	SENT_312	[p13l1232t152r1270b200],
15	,	,	O	,	_	0	SENT_312	[p13l1232t152r1270b200],
16	Robidoux	NNP	PERSON	Robidoux	nn	17	SENT_312	[p13l1293t150r1538b194],
17	A	NNP	O	A	appos	5	SENT_312	[p13l1556t152r1605b200],
18	,	,	O	,	_	0	SENT_312	[p13l1556t152r1605b200],
19	Margolese	NNP	PERSON	Margolese	nn	20	SENT_312	[p13l1627t150r1893b204],
20	RG	NNP	O	RG	appos	5	SENT_312	[p13l1915t152r1998b200],
21	,	,	O	,	_	0	SENT_312	[p13l1915t152r1998b200],
22	et	FW	O	et	nn	23	SENT_312	[p13l2022t157r2069b194],
23	al.	FW	O	al.	appos	5	SENT_312	[p13l2091t150r2146b194],
24	.	.	O	.	_	0	SENT_312	[p13l2091t150r2146b194],

1	Effect	NN	O	effect	_	0	SENT_313	[p13l138t215r282b259],
2	of	IN	O	of	_	0	SENT_313	[p13l299t215r352b259],
3	preoperative	JJ	O	preoperative	amod	4	SENT_313	[p13l363t216r691b270],
4	chemotherapy	NN	O	chemotherapy	prep_of	1	SENT_313	[p13l709t216r1083b270],
5	on	IN	O	on	_	0	SENT_313	[p13l1100t228r1162b259],
6	local-regional	JJ	O	local-regional	amod	7	SENT_313	[p13l1179t216r1533b270],
7	disease	NN	O	disease	prep_on	1	SENT_313	[p13l1551t216r1737b259],
8	in	IN	O	in	dep	1	SENT_313	[p13l1755t216r1803b259],
9	women	NNS	O	woman	pobj	8	SENT_313	[p13l1819t228r2013b259],
10	with	IN	O	with	dep	1	SENT_313	[p13l2029t216r2147b259],
11	operable	JJ	O	operable	amod	13	SENT_313	[p13l138t282r361b337],
12	breast	NN	O	breast	nn	13	SENT_313	[p13l383t282r542b326],
13	cancer	NN	O	cancer	pobj	10	SENT_313	[p13l564t295r746b326],
14	:	:	O	:	_	0	SENT_313	[p13l564t295r746b326],
15	ﬁndings	NNS	O	ﬁndings	dep	13	SENT_313	[p13l773t282r979b337],
16	from	IN	O	from	_	0	SENT_313	[p13l1003t282r1125b326],
17	National	NNP	O	National	nn	18	SENT_313	[p13l1148t282r1365b326],
18	Surgical	NNP	O	Surgical	prep_from	15	SENT_313	[p13l1389t282r1593b337],
19	Adjuvant	JJ	O	adjuvant	amod	20	SENT_313	[p13l1613t282r1850b337],
20	Breast	NN	O	breast	dep	25	SENT_313	[p13l1872t285r2032b326],
21	and	CC	O	and	_	0	SENT_313	[p13l2053t282r2147b326],
22	Bowel	NN	O	bowel	nn	24	SENT_313	[p13l138t348r294b392],
23	Project	NN	O	project	nn	24	SENT_313	[p13l318t349r496b403],
24	B	NN	O	b	conj_and	20	SENT_313	[p13l518t350r688b403],
25	—	CD	NUMBER	—	dep	15	SENT_313	[p13l518t350r688b403],
26	18	CD	NUMBER	18	dep	25	SENT_313	[p13l518t350r688b403],
27	.	.	O	.	_	0	SENT_313	[p13l518t350r688b403],
28	]	SYM	O	]	dep	15	SENT_313	[p13l518t350r688b403],

1	Clin	NNP	O	Clin	nn	2	SENT_314	[p13l710t348r810b392],
2	Oncol	NNP	O	Oncol	_	0	SENT_314	[p13l832t348r978b392],
3	1997	CD	DATE	1997	num	2	SENT_314	[p13l1004t350r1479b398],
4	;	:	O	;	_	0	SENT_314	[p13l1004t350r1479b398],
5	15:2483	CD	NUMBER	15:2483	number	6	SENT_314	[p13l1004t350r1479b398],
6	—	CD	NUMBER	—	dep	2	SENT_314	[p13l1004t350r1479b398],
7	93	CD	NUMBER	93	dep	6	SENT_314	[p13l1004t350r1479b398],
8	.	.	O	.	_	0	SENT_314	[p13l1004t350r1479b398],

1	[	NN	O	[	_	0	SENT_315	[p13l38t414r103b468],
2	4	CD	NUMBER	4	number	3	SENT_315	[p13l38t414r103b468],
3	]	CD	NUMBER	]	num	5	SENT_315	[p13l38t414r103b468],
4	Sharp	JJ	PERSON	sharp	amod	5	SENT_315	[p13l138t414r284b468],
5	L	NN	PERSON	l	dep	1	SENT_315	[p13l308t417r344b464],
6	,	,	O	,	_	0	SENT_315	[p13l308t417r344b464],
7	Little	JJ	O	little	amod	8	SENT_315	[p13l369t414r549b468],
8	]	NN	O	]	appos	5	SENT_315	[p13l369t414r549b468],
9	.	.	O	.	_	0	SENT_315	[p13l369t414r549b468],

1	Polymorphisms	NNS	O	polymorphism	_	0	SENT_316	[p13l574t414r976b468],
2	in	IN	O	in	_	0	SENT_316	[p13l1001t415r1049b457],
3	genes	NNS	O	gene	prep_in	1	SENT_316	[p13l1071t426r1216b468],
4	involved	VBN	O	involve	partmod	3	SENT_316	[p13l1241t414r1461b457],
5	in	IN	O	in	_	0	SENT_316	[p13l1486t415r1533b457],
6	folate	JJ	O	folate	amod	7	SENT_316	[p13l1557t414r1700b457],
7	metabolism	NN	O	metabolism	prep_in	4	SENT_316	[p13l1725t414r2030b457],
8	and	CC	O	and	_	0	SENT_316	[p13l2053t414r2147b457],
9	colorectal	JJ	O	colorectal	amod	10	SENT_316	[p13l138t480r389b524],
10	neoplasia	NN	O	neoplasium	prep_in	4	SENT_316	[p13l412t480r671b534],
11	:	:	O	:	_	0	SENT_316	[p13l412t480r671b534],
12	a	DT	O	a	det	13	SENT_316	[p13l698t493r724b524],
13	HuGE	NN	O	huge	dep	1	SENT_316	[p13l747t482r892b524],
14	review	NN	O	review	dep	13	SENT_316	[p13l915t481r1101b524],
15	.	.	O	.	_	0	SENT_316	[p13l915t481r1101b524],

1	Am	VBP	O	be	dep	3	SENT_317	[p13l1122t482r1247b534],
2	]	CD	NUMBER	]	num	3	SENT_317	[p13l1122t482r1247b534],
3	Epidemiol	NNP	O	Epidemiol	_	0	SENT_317	[p13l1270t480r1529b534],
4	2004	CD	DATE	2004	num	3	SENT_317	[p13l1552t482r2029b530],
5	;	:	O	;	_	0	SENT_317	[p13l1552t482r2029b530],
6	159:423	CD	NUMBER	159:423	dep	3	SENT_317	[p13l1552t482r2029b530],
7	—	CD	NUMBER	—	num	8	SENT_317	[p13l1552t482r2029b530],
8	43	CD	NUMBER	43	dep	6	SENT_317	[p13l1552t482r2029b530],
9	.	.	O	.	_	0	SENT_317	[p13l1552t482r2029b530],

1	[	NN	O	[	_	0	SENT_318	[p13l38t545r103b600],
2	5	CD	NUMBER	5	num	1	SENT_318	[p13l38t545r103b600],
3	]	CD	NUMBER	]	num	5	SENT_318	[p13l38t545r103b600],
4	Marsh	NNP	O	Marsh	nn	5	SENT_318	[p13l138t546r299b589],
5	S	NN	O	s	dep	1	SENT_318	[p13l326t548r363b596],
6	,	,	O	,	_	0	SENT_318	[p13l326t548r363b596],
7	McLeod	NNP	PERSON	McLeod	nn	8	SENT_318	[p13l390t546r589b589],
8	HL	NNS	O	hl	appos	5	SENT_318	[p13l616t548r695b590],
9	.	.	O	.	_	0	SENT_318	[p13l616t548r695b590],

1	Pharmacogenomics	NNS	O	pharmacogenomic	_	0	SENT_319	[p13l723t546r1242b600],
2	:	:	O	:	_	0	SENT_319	[p13l723t546r1242b600],
3	from	IN	O	from	_	0	SENT_319	[p13l1273t545r1395b589],
4	bedside	NN	O	bedside	prep_from	1	SENT_319	[p13l1420t546r1618b589],
5	to	TO	O	to	_	0	SENT_319	[p13l1644t552r1694b589],
6	clinical	JJ	O	clinical	amod	7	SENT_319	[p13l1721t546r1902b589],
7	practice	NN	O	practice	prep_to	4	SENT_319	[p13l1929t546r2146b600],
8	.	.	O	.	_	0	SENT_319	[p13l1929t546r2146b600],

1	Hum	NNP	O	Hum	nn	3	SENT_320	[p13l138t615r263b655],
2	Mol	NNP	O	Mol	nn	3	SENT_320	[p13l286t612r383b655],
3	Genet	NNP	O	Genet	_	0	SENT_320	[p13l407t614r558b655],
4	2006	CD	DATE	2006	dep	3	SENT_320	[p13l580t612r934b666],
5	;	:	O	;	_	0	SENT_320	[p13l580t612r934b666],
6	15	CD	NUMBER	15	num	7	SENT_320	[p13l580t612r934b666],
7	(	NN	O	(	dep	3	SENT_320	[p13l580t612r934b666],
8	Spec	NNP	O	Spec	nn	9	SENT_320	[p13l580t612r934b666],
9	No.	NNP	O	No.	dep	7	SENT_320	[p13l957t615r1039b656],
10	1	CD	NUMBER	1	number	11	SENT_320	[p13l1065t612r1345b666],
11	)	CD	NUMBER	)	dep	9	SENT_320	[p13l1065t612r1345b666],
12	:	:	O	:	_	0	SENT_320	[p13l1065t612r1345b666],
13	R89	CD	NUMBER	r89	number	14	SENT_320	[p13l1065t612r1345b666],
14	—	CD	NUMBER	—	dep	3	SENT_320	[p13l1065t612r1345b666],
15	93	CD	NUMBER	93	dep	14	SENT_320	[p13l1065t612r1345b666],
16	.	.	O	.	_	0	SENT_320	[p13l1065t612r1345b666],

1	[	NN	O	[	nn	5	SENT_321	[p13l38t677r103b732],
2	6	CD	NUMBER	6	num	5	SENT_321	[p13l38t677r103b732],
3	]	CD	NUMBER	]	num	5	SENT_321	[p13l38t677r103b732],
4	Kawakami	NNP	PERSON	Kawakami	nn	5	SENT_321	[p13l138t677r408b721],
5	K	NNP	PERSON	K	nsubjpass	24	SENT_321	[p13l427t680r471b728],
6	,	,	O	,	_	0	SENT_321	[p13l427t680r471b728],
7	Omura	NNP	PERSON	Omura	nn	8	SENT_321	[p13l490t680r666b721],
8	K	NNP	PERSON	K	appos	5	SENT_321	[p13l685t680r730b728],
9	,	,	O	,	_	0	SENT_321	[p13l685t680r730b728],
10	Kanehira	NNP	O	Kanehira	nn	11	SENT_321	[p13l749t678r979b721],
11	E	NNP	O	E	appos	5	SENT_321	[p13l997t680r1037b728],
12	,	,	O	,	_	0	SENT_321	[p13l997t680r1037b728],
13	Watanabe	NNP	PERSON	Watanabe	nn	14	SENT_321	[p13l1053t677r1317b721],
14	Y.	NNP	O	Y.	appos	5	SENT_321	[p13l1334t680r1379b721],
15	Polymorphic	JJ	O	polymorphic	amod	17	SENT_321	[p13l1399t677r1727b732],
16	tandem	JJ	O	tandem	amod	17	SENT_321	[p13l1744t677r1941b721],
17	repeats	NNS	O	repeat	dep	14	SENT_321	[p13l1959t684r2146b732],
18	in	IN	O	in	_	0	SENT_321	[p13l138t745r186b787],
19	the	DT	O	the	det	22	SENT_321	[p13l205t744r287b788],
20	thymidylate	NN	O	thymidylate	nn	22	SENT_321	[p13l307t744r622b798],
21	synthase	NN	O	synthase	nn	22	SENT_321	[p13l643t744r869b798],
22	gene	NN	O	gene	prep_in	17	SENT_321	[p13l889t757r1010b798],
23	is	VBZ	O	be	auxpass	24	SENT_321	[p13l1031t745r1068b788],
24	associated	VBN	O	associate	_	0	SENT_321	[p13l1090t744r1356b788],
25	with	IN	O	with	_	0	SENT_321	[p13l1375t744r1494b788],
26	its	PRP$	O	its	poss	28	SENT_321	[p13l1514t745r1573b788],
27	protein	NN	O	protein	nn	28	SENT_321	[p13l1595t745r1782b798],
28	expression	NN	O	expression	prep_with	24	SENT_321	[p13l1802t745r2079b798],
29	in	IN	O	in	_	0	SENT_321	[p13l2100t745r2148b787],
30	human	JJ	O	human	amod	32	SENT_321	[p13l138t810r319b854],
31	gastrointestinal	JJ	O	gastrointestinal	amod	32	SENT_321	[p13l340t810r744b865],
32	cancers	NNS	O	cancer	prep_in	24	SENT_321	[p13l768t823r973b854],
33	.	.	O	.	_	0	SENT_321	[p13l768t823r973b854],

1	Anticancer	JJ	O	anticancer	amod	2	SENT_322	[p13l994t811r1274b854],
2	Res	NNP	O	Res	_	0	SENT_322	[p13l1295t813r1380b854],
3	1999	CD	DATE	1999	dep	2	SENT_322	[p13l1406t812r1881b860],
4	;	:	O	;	_	0	SENT_322	[p13l1406t812r1881b860],
5	19:3249	CD	NUMBER	19:3249	number	6	SENT_322	[p13l1406t812r1881b860],
6	—	CD	NUMBER	—	dep	2	SENT_322	[p13l1406t812r1881b860],
7	52	CD	NUMBER	52	dep	6	SENT_322	[p13l1406t812r1881b860],
8	.	.	O	.	_	0	SENT_322	[p13l1406t812r1881b860],

1	[	NN	O	[	nn	5	SENT_323	[p13l38t876r103b930],
2	7	CD	NUMBER	7	num	5	SENT_323	[p13l38t876r103b930],
3	]	CD	NUMBER	]	num	5	SENT_323	[p13l38t876r103b930],
4	Russo	NNP	PERSON	Russo	nn	5	SENT_323	[p13l138t879r285b919],
5	A	NNP	O	A	_	0	SENT_323	[p13l303t878r351b926],
6	,	,	O	,	_	0	SENT_323	[p13l303t878r351b926],
7	Corsale	NNP	ORGANIZATION	Corsale	nn	8	SENT_323	[p13l371t876r557b919],
8	S	NNP	ORGANIZATION	S	appos	5	SENT_323	[p13l576t878r614b926],
9	,	,	O	,	_	0	SENT_323	[p13l576t878r614b926],
10	Cammareri	NNP	ORGANIZATION	Cammareri	nn	11	SENT_323	[p13l634t877r920b919],
11	P	NN	ORGANIZATION	p	appos	8	SENT_323	[p13l940t879r981b926],
12	,	,	O	,	_	0	SENT_323	[p13l940t879r981b926],
13	Agnese	NNP	PERSON	Agnese	nn	14	SENT_323	[p13l998t878r1183b930],
14	V	NNP	PERSON	V	appos	8	SENT_323	[p13l1200t879r1249b926],
15	,	,	O	,	_	0	SENT_323	[p13l1200t879r1249b926],
16	Cascio	NNP	PERSON	Cascio	nn	17	SENT_323	[p13l1268t877r1429b919],
17	S	NNP	O	S	appos	8	SENT_323	[p13l1449t878r1487b926],
18	,	,	O	,	_	0	SENT_323	[p13l1449t878r1487b926],
19	Di	NNP	PERSON	Di	nn	21	SENT_323	[p13l1507t877r1560b919],
20	Fede	NNP	PERSON	Fede	nn	21	SENT_323	[p13l1580t876r1698b919],
21	G	NNP	O	G	appos	8	SENT_323	[p13l1717t878r1766b926],
22	,	,	O	,	_	0	SENT_323	[p13l1717t878r1766b926],
23	et	FW	O	et	nn	24	SENT_323	[p13l1786t882r1834b919],
24	al.	FW	O	al.	appos	8	SENT_323	[p13l1852t876r1907b920],
25	.	.	O	.	_	0	SENT_323	[p13l1852t876r1907b920],

1	Pharmacogenomics	NNS	MISC	pharmacogenomic	_	0	SENT_324	[p13l1927t876r2146b919, p13l138t943r440b996],
2	in	IN	O	in	_	0	SENT_324	[p13l475t943r523b985],
3	colorectal	JJ	O	colorectal	amod	4	SENT_324	[p13l557t942r808b986],
4	carcinomas	NNS	O	carcinoma	prep_in	1	SENT_324	[p13l842t943r1151b986],
5	:	:	O	:	_	0	SENT_324	[p13l842t943r1151b986],
6	future	JJ	DATE	future	amod	7	SENT_324	[p13l1190t942r1347b986],
7	perspectives	NNS	O	perspective	dep	4	SENT_324	[p13l1381t943r1701b996],
8	in	IN	O	in	prep	7	SENT_324	[p13l1737t943r1784b985],
9	personalized	JJ	O	personalized	amod	10	SENT_324	[p13l1819t942r2146b996],
10	therapy	NN	O	therapy	dep	8	SENT_324	[p13l137t1008r386b1062],
11	.	.	O	.	_	0	SENT_324	[p13l137t1008r386b1062],
12	]	SYM	O	]	dep	7	SENT_324	[p13l137t1008r386b1062],

1	Cell	NN	O	cell	_	0	SENT_325	[p13l409t1008r502b1051],
2	Physiol	NNP	O	Physiol	dep	1	SENT_325	[p13l526t1008r710b1062],
3	2005	CD	DATE	2005	num	2	SENT_325	[p13l733t1010r1176b1058],
4	;	:	O	;	_	0	SENT_325	[p13l733t1010r1176b1058],
5	204:742	CD	NUMBER	204:742	number	6	SENT_325	[p13l733t1010r1176b1058],
6	—	CD	NUMBER	—	dep	1	SENT_325	[p13l733t1010r1176b1058],
7	9	CD	NUMBER	9	dep	6	SENT_325	[p13l733t1010r1176b1058],
8	.	.	O	.	_	0	SENT_325	[p13l733t1010r1176b1058],

1	[	NN	O	[	nn	6	SENT_326	[p13l38t1074r103b1129],
2	8	CD	NUMBER	8	num	6	SENT_326	[p13l38t1074r103b1129],
3	]	CD	NUMBER	]	num	6	SENT_326	[p13l38t1074r103b1129],
4	Marsh	NNP	O	Marsh	nn	6	SENT_326	[p13l138t1074r299b1118],
5	S.	NNP	O	S.	nn	6	SENT_326	[p13l323t1076r361b1118],
6	Impact	NNP	O	Impact	_	0	SENT_326	[p13l386t1077r565b1129],
7	of	IN	O	of	_	0	SENT_326	[p13l588t1074r641b1118],
8	pharmacogenomics	NNS	O	pharmacogenomic	prep_of	6	SENT_326	[p13l659t1074r1163b1129],
9	on	IN	O	on	_	0	SENT_326	[p13l1187t1087r1250b1118],
10	clinical	JJ	O	clinical	amod	11	SENT_326	[p13l1274t1074r1455b1118],
11	practice	NN	O	practice	prep_on	8	SENT_326	[p13l1480t1075r1684b1129],
12	in	IN	O	in	_	0	SENT_326	[p13l1708t1075r1756b1117],
13	oncology	NN	O	oncology	prep_in	6	SENT_326	[p13l1780t1074r2024b1129],
14	.	.	O	.	_	0	SENT_326	[p13l1780t1074r2024b1129],

1	Mol	NNP	O	Mol	_	0	SENT_327	[p13l2049t1074r2146b1118],

1	Diagn	NNP	O	Diagn	nn	2	SENT_328	[p13l138t1141r287b1195],
2	Ther	NNP	O	Ther	_	0	SENT_328	[p13l306t1140r425b1184],
3	2007	CD	DATE	2007	num	2	SENT_328	[p13l446t1142r857b1190],
4	;	:	O	;	_	0	SENT_328	[p13l446t1142r857b1190],
5	11:79	CD	NUMBER	11:79	number	6	SENT_328	[p13l446t1142r857b1190],
6	—	CD	NUMBER	—	dep	2	SENT_328	[p13l446t1142r857b1190],
7	82	CD	NUMBER	82	dep	6	SENT_328	[p13l446t1142r857b1190],
8	.	.	O	.	_	0	SENT_328	[p13l446t1142r857b1190],

1	[	NN	O	[	nn	4	SENT_329	[p13l38t1206r103b1260],
2	9	CD	NUMBER	9	num	4	SENT_329	[p13l38t1206r103b1260],
3	]	NN	O	]	nn	4	SENT_329	[p13l38t1206r103b1260],
4	Etienne-Grimaldi	NN	O	etienne-grimaldus	_	0	SENT_329	[p13l138t1206r584b1249],
5	MC	NNP	O	MC	dep	4	SENT_329	[p13l609t1208r705b1256],
6	,	,	O	,	_	0	SENT_329	[p13l609t1208r705b1256],
7	Francoual	JJ	O	francoual	amod	8	SENT_329	[p13l730t1206r981b1249],
8	M	NN	O	m	dep	4	SENT_329	[p13l1006t1209r1068b1256],
9	,	,	O	,	_	0	SENT_329	[p13l1006t1209r1068b1256],
10	Formento	NNP	PERSON	Formento	nn	12	SENT_329	[p13l1093t1209r1341b1249],
11	]	CD	NUMBER	]	num	12	SENT_329	[p13l1360t1209r1421b1260],
12	L	NN	O	l	conj_and	5	SENT_329	[p13l1360t1209r1421b1260],
13	,	,	O	,	_	0	SENT_329	[p13l1360t1209r1421b1260],
14	Milano	NNP	PERSON	Milano	nn	19	SENT_329	[p13l1446t1206r1624b1249],
15	G.	NNP	PERSON	G.	nn	19	SENT_329	[p13l1650t1208r1698b1250],
16	Methylenetetrahydrofolate	NNP	PERSON	Methylenetetrahydrofolate	nn	19	SENT_329	[p13l1724t1206r2146b1260, p13l138t1272r436b1326],
17	reductase	NN	O	reductase	nn	19	SENT_329	[p13l454t1272r703b1316],
18	(	CD	NUMBER	(	num	19	SENT_329	[p13l721t1272r951b1326],
19	MTHFR	NN	O	mthfr	dep	4	SENT_329	[p13l721t1272r951b1326],
20	)	CD	NUMBER	)	num	21	SENT_329	[p13l721t1272r951b1326],
21	variants	NNS	O	variant	dep	19	SENT_329	[p13l968t1273r1174b1316],
22	and	CC	O	and	_	0	SENT_329	[p13l1194t1272r1287b1316],
23	ﬂuorouracil-based	JJ	O	ﬂuorouracil-based	amod	24	SENT_329	[p13l1306t1272r1779b1316],
24	treatments	NNS	O	treatment	conj_and	5	SENT_329	[p13l1797t1279r2080b1316],
25	in	IN	O	in	_	0	SENT_329	[p13l2100t1273r2147b1315],
26	colorectal	JJ	O	colorectal	amod	27	SENT_329	[p13l138t1338r389b1381],
27	cancer	NN	O	cancer	prep_in	4	SENT_329	[p13l412t1350r591b1382],
28	.	.	O	.	_	0	SENT_329	[p13l412t1350r591b1382],

1	Pharmacogenomics	NNS	O	pharmacogenomic	_	0	SENT_330	[p13l615t1338r1117b1392],
2	2007	CD	DATE	2007	num	1	SENT_330	[p13l1141t1340r1552b1388],
3	;	:	O	;	_	0	SENT_330	[p13l1141t1340r1552b1388],
4	8:1561	CD	NUMBER	8:1561	number	5	SENT_330	[p13l1141t1340r1552b1388],
5	—	CD	NUMBER	—	dep	1	SENT_330	[p13l1141t1340r1552b1388],
6	6	CD	NUMBER	6	dep	5	SENT_330	[p13l1141t1340r1552b1388],
7	.	.	O	.	_	0	SENT_330	[p13l1141t1340r1552b1388],

1	[	NN	O	[	_	0	SENT_331	[p13l9t1404r106b1458],
2	10	CD	NUMBER	10	num	1	SENT_331	[p13l9t1404r106b1458],
3	]	CD	NUMBER	]	num	5	SENT_331	[p13l9t1404r106b1458],
4	Huang	NNP	ORGANIZATION	Huang	nn	5	SENT_331	[p13l142t1407r310b1458],
5	RS	NN	ORGANIZATION	r	dep	1	SENT_331	[p13l327t1406r399b1454],
6	,	,	O	,	_	0	SENT_331	[p13l327t1406r399b1454],
7	Ratain	NN	O	ratain	nn	9	SENT_331	[p13l417t1405r579b1447],
8	M	NN	O	m	nn	9	SENT_331	[p13l597t1407r676b1458],
9	]	NN	O	]	appos	5	SENT_331	[p13l597t1407r676b1458],
10	.	.	O	.	_	0	SENT_331	[p13l597t1407r676b1458],

1	Pharmacogenetics	NNS	MISC	pharmacogenetic	_	0	SENT_332	[p13l694t1404r1163b1458],
2	and	CC	O	and	_	0	SENT_332	[p13l1181t1404r1274b1447],
3	pharmacogenomics	NNS	O	pharmacogenomic	conj_and	1	SENT_332	[p13l1292t1404r1796b1458],
4	of	IN	O	of	_	0	SENT_332	[p13l1815t1404r1867b1447],
5	anticancer	JJ	O	anticancer	amod	6	SENT_332	[p13l1878t1405r2149b1447],
6	agents	NNS	O	agent	prep_of	1	SENT_332	[p13l141t1476r321b1524],
7	.	.	O	.	_	0	SENT_332	[p13l141t1476r321b1524],

1	CA	NNP	O	CA	nn	2	SENT_333	[p13l345t1471r414b1513],
2	Cancer	NNP	O	Cancer	nsubj	3	SENT_333	[p13l435t1472r645b1524],
3	]	VBD	O	]	_	0	SENT_333	[p13l435t1472r645b1524],
4	Clin	NNP	O	Clin	dobj	3	SENT_333	[p13l668t1469r767b1513],
5	2009	CD	DATE	2009	num	4	SENT_333	[p13l789t1472r1200b1520],
6	;	:	O	;	_	0	SENT_333	[p13l789t1472r1200b1520],
7	59:42	CD	NUMBER	59:42	number	8	SENT_333	[p13l789t1472r1200b1520],
8	—	CD	NUMBER	—	dep	4	SENT_333	[p13l789t1472r1200b1520],
9	55	CD	NUMBER	55	dep	8	SENT_333	[p13l789t1472r1200b1520],
10	.	.	O	.	_	0	SENT_333	[p13l789t1472r1200b1520],

1	[	RB	O	[	advmod	28	SENT_334	[p13l9t1536r107b1590],
2	11	CD	NUMBER	11	number	3	SENT_334	[p13l9t1536r107b1590],
3	]	CD	NUMBER	]	num	5	SENT_334	[p13l9t1536r107b1590],
4	Akoglu	NN	O	akoglu	nn	5	SENT_334	[p13l140t1536r321b1590],
5	B	NN	O	b	nsubj	28	SENT_334	[p13l341t1539r383b1586],
6	,	,	O	,	_	0	SENT_334	[p13l341t1539r383b1586],
7	Kindl	NNP	ORGANIZATION	Kindl	nn	8	SENT_334	[p13l404t1536r538b1580],
8	P	NN	ORGANIZATION	p	appos	5	SENT_334	[p13l559t1539r599b1586],
9	,	,	O	,	_	0	SENT_334	[p13l559t1539r599b1586],
10	Weber	NNP	ORGANIZATION	Weber	nn	11	SENT_334	[p13l617t1536r791b1580],
11	N	NNP	ORGANIZATION	N	appos	8	SENT_334	[p13l810t1539r860b1586],
12	,	,	O	,	_	0	SENT_334	[p13l810t1539r860b1586],
13	Trojan	NNP	MISC	Trojan	nn	14	SENT_334	[p13l878t1537r1091b1590],
14	]	NNP	O	]	appos	8	SENT_334	[p13l878t1537r1091b1590],
15	,	,	O	,	_	0	SENT_334	[p13l878t1537r1091b1590],
16	Caspary	NNP	ORGANIZATION	Caspary	nn	17	SENT_334	[p13l1111t1538r1314b1590],
17	WF	NNP	ORGANIZATION	WF	appos	8	SENT_334	[p13l1331t1539r1430b1586],
18	,	,	O	,	_	0	SENT_334	[p13l1331t1539r1430b1586],
19	Faust	NNP	PERSON	Faust	nn	21	SENT_334	[p13l1451t1539r1587b1580],
20	D.	NNP	PERSON	D.	nn	21	SENT_334	[p13l1606t1539r1655b1580],
21	Polymorphisms	NNP	PERSON	Polymorphisms	appos	8	SENT_334	[p13l1676t1536r2078b1590],
22	in	IN	O	in	_	0	SENT_334	[p13l2100t1537r2147b1579],
23	the	DT	O	the	det	26	SENT_334	[p13l142t1602r224b1646],
24	methylenetetrahydrofolate	JJ	O	methylenetetrahydrofolate	amod	26	SENT_334	[p13l248t1602r949b1657],
25	reductase	NN	O	reductase	nn	26	SENT_334	[p13l974t1602r1222b1646],
26	gene	NN	O	gene	prep_in	21	SENT_334	[p13l1246t1615r1367b1657],
27	are	VBP	O	be	cop	28	SENT_334	[p13l1392t1615r1470b1646],
28	determinant	NN	O	determinant	_	0	SENT_334	[p13l1494t1602r1817b1646],
29	for	IN	O	for	_	0	SENT_334	[p13l1840t1602r1912b1646],
30	vascular	JJ	O	vascular	amod	31	SENT_334	[p13l1933t1602r2149b1646],
31	complications	NNS	O	complication	prep_for	28	SENT_334	[p13l143t1668r503b1722],
32	after	IN	O	after	_	0	SENT_334	[p13l526t1668r647b1711],
33	liver	NN	O	liver	nn	34	SENT_334	[p13l668t1668r783b1711],
34	transplantation	NN	O	transplantation	prep_after	28	SENT_334	[p13l803t1668r1215b1722],
35	.	.	O	.	_	0	SENT_334	[p13l803t1668r1215b1722],

1	Eur	NNP	O	Eur	nn	4	SENT_335	[p13l1239t1671r1360b1722],
2	]	NNP	O	]	nn	4	SENT_335	[p13l1239t1671r1360b1722],
3	Clin	NNP	O	Clin	nn	4	SENT_335	[p13l1384t1668r1483b1711],
4	Nutr	NNP	O	Nutr	_	0	SENT_335	[p13l1505t1670r1623b1711],
5	2008	CD	DATE	2008	num	4	SENT_335	[p13l1644t1670r2054b1718],
6	;	:	O	;	_	0	SENT_335	[p13l1644t1670r2054b1718],
7	62:430	CD	NUMBER	62:430	number	8	SENT_335	[p13l1644t1670r2054b1718],
8	—	CD	NUMBER	—	dep	4	SENT_335	[p13l1644t1670r2054b1718],
9	5	CD	NUMBER	5	dep	8	SENT_335	[p13l1644t1670r2054b1718],
10	.	.	O	.	_	0	SENT_335	[p13l1644t1670r2054b1718],

1	[	NN	O	[	_	0	SENT_336	[p13l9t1734r107b1788],
2	12	CD	NUMBER	12	number	3	SENT_336	[p13l9t1734r107b1788],
3	]	CD	NUMBER	]	num	7	SENT_336	[p13l9t1734r107b1788],
4	Przekop	NNP	O	Przekop	nn	7	SENT_336	[p13l141t1734r343b1788],
5	]	CD	NUMBER	]	num	7	SENT_336	[p13l369t1737r414b1788],
6	r	NN	O	r	nn	7	SENT_336	[p13l369t1737r414b1788],
7	PR	NN	O	pr	dep	1	SENT_336	[p13l444t1737r518b1784],
8	,	,	O	,	_	0	SENT_336	[p13l444t1737r518b1784],
9	Tulgan	NN	PERSON	tulgan	nn	10	SENT_336	[p13l549t1734r723b1788],
10	H	NN	PERSON	h	appos	7	SENT_336	[p13l754t1737r805b1784],
11	,	,	O	,	_	0	SENT_336	[p13l754t1737r805b1784],
12	Przekop	NNP	ORGANIZATION	Przekop	nn	13	SENT_336	[p13l838t1734r1040b1788],
13	AA	NNP	ORGANIZATION	AA	appos	10	SENT_336	[p13l1070t1736r1154b1784],
14	,	,	O	,	_	0	SENT_336	[p13l1070t1736r1154b1784],
15	Glantz	NNP	PERSON	Glantz	nn	19	SENT_336	[p13l1187t1734r1351b1778],
16	M.	NNP	O	M.	nn	19	SENT_336	[p13l1383t1737r1445b1778],
17	Adverse	JJ	O	adverse	amod	19	SENT_336	[p13l1475t1734r1680b1778],
18	drug	NN	O	drug	nn	19	SENT_336	[p13l1712t1734r1829b1788],
19	reaction	NN	O	reaction	appos	13	SENT_336	[p13l1860t1735r2066b1778],
20	to	TO	O	to	_	0	SENT_336	[p13l2098t1741r2147b1778],
21	methotrexate	NN	O	methotrexate	prep_to	19	SENT_336	[p13l143t1800r503b1844],
22	:	:	O	:	_	0	SENT_336	[p13l143t1800r503b1844],
23	pharmacogenetic	JJ	O	pharmacogenetic	amod	24	SENT_336	[p13l522t1800r962b1854],
24	origin	NN	O	origin	dep	21	SENT_336	[p13l976t1800r1165b1854],
25	.	.	O	.	_	0	SENT_336	[p13l976t1800r1165b1854],
26	]	SYM	O	]	dep	19	SENT_336	[p13l976t1800r1165b1854],

1	Am	VBP	O	be	dep	3	SENT_337	[p13l1178t1802r1266b1843],
2	Osteopath	NNP	O	Osteopath	nn	3	SENT_337	[p13l1281t1800r1541b1854],
3	Assoc	NNP	O	Assoc	_	0	SENT_337	[p13l1553t1801r1696b1843],
4	2006	CD	DATE	2006	num	3	SENT_337	[p13l1710t1802r1852b1850],
5	;	:	O	;	_	0	SENT_337	[p13l1710t1802r1852b1850],
6	106:706	CD	NUMBER	106:706	num	7	SENT_337	[p13l1863t1802r2146b1844],
7	—	NN	O	—	dep	3	SENT_337	[p13l1863t1802r2146b1844],
8	7	CD	NUMBER	7	dep	7	SENT_337	[p13l1863t1802r2146b1844],
9	.	.	O	.	_	0	SENT_337	[p13l1863t1802r2146b1844],

1	[	RB	O	[	advmod	2	SENT_338	[p13l9t1866r107b1921],
2	13	CD	NUMBER	13	_	0	SENT_338	[p13l9t1866r107b1921],
3	]	CD	NUMBER	]	num	5	SENT_338	[p13l9t1866r107b1921],
4	Gemmati	NN	O	gemmatus	nn	5	SENT_338	[p13l143t1867r380b1910],
5	D	NN	O	d	dep	2	SENT_338	[p13l414t1869r463b1916],
6	,	,	O	,	_	0	SENT_338	[p13l414t1869r463b1916],
7	Ongaro	NNP	O	Ongaro	nn	8	SENT_338	[p13l497t1868r682b1921],
8	A	NNP	O	A	appos	5	SENT_338	[p13l713t1868r761b1916],
9	,	,	O	,	_	0	SENT_338	[p13l713t1868r761b1916],
10	Tognazzo	NNP	O	Tognazzo	nn	11	SENT_338	[p13l792t1869r1037b1921],
11	S	NNP	O	S	appos	5	SENT_338	[p13l1070t1868r1108b1916],
12	,	,	O	,	_	0	SENT_338	[p13l1070t1868r1108b1916],
13	Catozzi	NNP	ORGANIZATION	Catozzi	nn	14	SENT_338	[p13l1141t1867r1327b1910],
14	L	NNP	ORGANIZATION	L	appos	5	SENT_338	[p13l1361t1869r1398b1916],
15	,	,	O	,	_	0	SENT_338	[p13l1361t1869r1398b1916],
16	Federici	NNP	PERSON	Federici	nn	17	SENT_338	[p13l1431t1866r1632b1910],
17	F	NN	O	f	appos	5	SENT_338	[p13l1666t1869r1703b1917],
18	,	,	O	,	_	0	SENT_338	[p13l1666t1869r1703b1917],
19	Mauro	NNP	PERSON	Mauro	nn	20	SENT_338	[p13l1737t1869r1904b1910],
20	E	NNP	PERSON	E	appos	5	SENT_338	[p13l1937t1869r1977b1916],
21	,	,	O	,	_	0	SENT_338	[p13l1937t1869r1977b1916],
22	et	FW	O	et	nn	23	SENT_338	[p13l2011t1873r2059b1910],
23	al.	FW	O	al.	appos	5	SENT_338	[p13l2090t1866r2146b1910],
24	.	.	O	.	_	0	SENT_338	[p13l2090t1866r2146b1910],

1	Methylenetetrahydrofolate	NNP	O	Methylenetetrahydrofolate	nn	3	SENT_339	[p13l143t1932r844b1987],
2	reductase	NN	O	reductase	nn	3	SENT_339	[p13l877t1932r1125b1976],
3	C677T	NN	O	c677t	_	0	SENT_339	[p13l1158t1934r1321b1976],
4	and	CC	O	and	_	0	SENT_339	[p13l1351t1932r1444b1976],
5	A1298C	NN	O	a1298c	nn	7	SENT_339	[p13l1475t1934r1677b1976],
6	gene	NN	O	gene	nn	7	SENT_339	[p13l1707t1945r1828b1987],
7	variants	NNS	O	variant	conj_and	3	SENT_339	[p13l1860t1933r2066b1976],
8	in	IN	O	in	_	0	SENT_339	[p13l2100t1933r2147b1975],
9	adult	JJ	O	adult	amod	10	SENT_339	[p13l142t1998r276b2041],
10	non-Hodgkin	JJ	O	non-hodgkin	poss	13	SENT_339	[p13l299t1998r676b2052],
11	's	POS	O	's	_	0	SENT_339	[p13l299t1998r676b2052],
12	lymphoma	NN	O	lymphoma	nn	13	SENT_339	[p13l702t1998r981b2052],
13	patients	NNS	O	patient	prep_in	7	SENT_339	[p13l1005t1999r1228b2052],
14	:	:	O	:	_	0	SENT_339	[p13l1005t1999r1228b2052],
15	association	NN	O	association	dep	3	SENT_339	[p13l1256t1999r1543b2041],
16	with	IN	O	with	_	0	SENT_339	[p13l1566t1998r1685b2041],
17	toxicity	NN	O	toxicity	prep_with	15	SENT_339	[p13l1708t1999r1904b2052],
18	and	CC	O	and	_	0	SENT_339	[p13l1927t1998r2021b2041],
19	survival	NN	O	survival	conj_and	17	SENT_339	[p13l2046t2010r2147b2041, p13l141t2064r276b2108],
20	.	.	O	.	_	0	SENT_339	[p13l2046t2010r2147b2041, p13l141t2064r276b2108],

1	Haematologica	NNP	O	Haematologica	_	0	SENT_340	[p13l300t2064r686b2118],
2	2007	CD	DATE	2007	num	1	SENT_340	[p13l709t2066r1152b2114],
3	;	:	O	;	_	0	SENT_340	[p13l709t2066r1152b2114],
4	92:478	CD	NUMBER	92:478	number	5	SENT_340	[p13l709t2066r1152b2114],
5	—	CD	NUMBER	—	dep	1	SENT_340	[p13l709t2066r1152b2114],
6	85	CD	NUMBER	85	dep	5	SENT_340	[p13l709t2066r1152b2114],
7	.	.	O	.	_	0	SENT_340	[p13l709t2066r1152b2114],

1	[	RB	O	[	advmod	2	SENT_341	[p13l9t2129r107b2184],
2	14	CD	NUMBER	14	_	0	SENT_341	[p13l9t2129r107b2184],
3	]	CD	NUMBER	]	dep	2	SENT_341	[p13l9t2129r107b2184],
4	Borresen-Dale	NNP	O	Borresen-Dale	nn	5	SENT_341	[p13l143t2130r509b2173],
5	AL.	NNP	O	AL.	dep	3	SENT_341	[p13l529t2132r606b2174],
6	.	.	O	.	_	0	SENT_341	[p13l529t2132r606b2174],

1	TP53	NN	O	tp53	_	0	SENT_342	[p13l627t2132r752b2173],
2	and	CC	O	and	_	0	SENT_342	[p13l778t2130r871b2173],
3	breast	NN	O	breast	conj_and	1	SENT_342	[p13l893t2130r1053b2173],
4	cancer	NN	O	cancer	dep	1	SENT_342	[p13l1075t2142r1254b2174],
5	.	.	O	.	_	0	SENT_342	[p13l1075t2142r1254b2174],

1	Hum	NNP	O	Hum	nn	2	SENT_343	[p13l1278t2132r1403b2173],
2	Mutat	NNP	O	Mutat	_	0	SENT_343	[p13l1425t2132r1582b2173],
3	2003	CD	DATE	2003	num	2	SENT_343	[p13l1603t2132r2079b2180],
4	;	:	O	;	_	0	SENT_343	[p13l1603t2132r2079b2180],
5	21:292	CD	NUMBER	21:292	number	6	SENT_343	[p13l1603t2132r2079b2180],
6	-300	CD	NUMBER	-300	dep	2	SENT_343	[p13l1603t2132r2079b2180],
7	.	.	O	.	_	0	SENT_343	[p13l1603t2132r2079b2180],

1	[	RB	O	[	advmod	5	SENT_344	[p13l9t2196r107b2250],
2	15	CD	NUMBER	15	num	5	SENT_344	[p13l9t2196r107b2250],
3	]	CD	NUMBER	]	num	5	SENT_344	[p13l9t2196r107b2250],
4	Papadakis	NNP	PERSON	Papadakis	nn	5	SENT_344	[p13l143t2196r399b2250],
5	EN	NNP	PERSON	EN	_	0	SENT_344	[p13l416t2199r497b2246],
6	,	,	O	,	_	0	SENT_344	[p13l416t2199r497b2246],
7	Dokianakis	NNP	O	Dokianakis	nn	11	SENT_344	[p13l513t2196r796b2239],
8	DN	JJ	O	dn	amod	11	SENT_344	[p13l812t2199r903b2246],
9	,	,	O	,	_	0	SENT_344	[p13l812t2199r903b2246],
10	Spandidos	NNP	O	Spandidos	dep	11	SENT_344	[p13l919t2196r1183b2250],
11	DA	NNP	O	DA	appos	5	SENT_344	[p13l1199t2198r1285b2240],
12	.	.	O	.	_	0	SENT_344	[p13l1199t2198r1285b2240],

1	p53	NN	O	p53	nn	2	SENT_345	[p13l1302t2198r1395b2250],
2	codon	NN	O	codon	_	0	SENT_345	[p13l1413t2196r1568b2239],
3	72	CD	NUMBER	72	num	4	SENT_345	[p13l1583t2198r1643b2239],
4	polymorphism	NN	O	polymorphism	dep	2	SENT_345	[p13l1660t2196r2040b2250],
5	as	IN	O	as	_	0	SENT_345	[p13l2055t2208r2105b2239],
6	a	DT	O	a	det	8	SENT_345	[p13l2121t2208r2147b2239],
7	risk	NN	O	risk	nn	8	SENT_345	[p13l143t2261r237b2305],
8	factor	NN	O	factor	prep_as	4	SENT_345	[p13l261t2261r410b2305],
9	in	IN	O	in	_	0	SENT_345	[p13l433t2262r481b2305],
10	the	DT	O	the	det	11	SENT_345	[p13l505t2261r587b2305],
11	development	NN	O	development	prep_in	8	SENT_345	[p13l612t2261r953b2316],
12	of	IN	O	of	_	0	SENT_345	[p13l976t2261r1029b2305],
13	breast	NN	O	breast	nn	14	SENT_345	[p13l1048t2261r1207b2305],
14	cancer	NN	O	cancer	prep_of	11	SENT_345	[p13l1232t2274r1410b2305],
15	.	.	O	.	_	0	SENT_345	[p13l1232t2274r1410b2305],

1	Mol	NNP	ORGANIZATION	Mol	nn	5	SENT_346	[p13l1437t2261r1534b2305],
2	Cell	NNP	ORGANIZATION	Cell	nn	5	SENT_346	[p13l1560t2261r1653b2305],
3	Biol	NNP	ORGANIZATION	Biol	nn	5	SENT_346	[p13l1679t2261r1775b2305],
4	Res	NNP	ORGANIZATION	Res	nn	5	SENT_346	[p13l1801t2264r1885b2305],
5	Commun	NNP	ORGANIZATION	Commun	_	0	SENT_346	[p13l1911t2264r2147b2305],
6	2000	CD	DATE	2000	num	5	SENT_346	[p13l142t2330r553b2378],
7	;	:	O	;	_	0	SENT_346	[p13l142t2330r553b2378],
8	3:389	CD	NUMBER	3:389	number	9	SENT_346	[p13l142t2330r553b2378],
9	-92	CD	NUMBER	-92	dep	5	SENT_346	[p13l142t2330r553b2378],
10	.	.	O	.	_	0	SENT_346	[p13l142t2330r553b2378],

1	[	RB	O	[	advmod	3	SENT_347	[p13l9t2394r107b2449],
2	16	CD	NUMBER	16	number	3	SENT_347	[p13l9t2394r107b2449],
3	]	CD	NUMBER	]	ccomp	13	SENT_347	[p13l9t2394r107b2449],
4	Dumont	NNP	PERSON	Dumont	nn	5	SENT_347	[p13l143t2397r355b2438],
5	P	NN	PERSON	p	dep	3	SENT_347	[p13l378t2397r418b2444],
6	,	,	O	,	_	0	SENT_347	[p13l378t2397r418b2444],
7	Leu	NN	O	leu	appos	3	SENT_347	[p13l443t2397r531b2438],
8	]	CD	NUMBER	]	num	7	SENT_347	[p13l549t2397r599b2449],
9	I	PRP	O	I	dep	7	SENT_347	[p13l549t2397r599b2449],
10	,	,	O	,	_	0	SENT_347	[p13l549t2397r599b2449],
11	Della	NNP	PERSON	Della	nn	12	SENT_347	[p13l624t2394r754b2438],
12	Pietra	NNP	PERSON	Pietra	nsubj	13	SENT_347	[p13l779t2395r927b2438],
13	3rd	VBD	ORDINAL	3rd	_	0	SENT_347	[p13l950t2394r1036b2438],
14	AC	NN	O	ac	nsubj	28	SENT_347	[p13l1059t2396r1141b2444],
15	,	,	O	,	_	0	SENT_347	[p13l1059t2396r1141b2444],
16	George	NNP	PERSON	George	nn	17	SENT_347	[p13l1166t2396r1346b2449],
17	DL	NNP	PERSON	DL	appos	14	SENT_347	[p13l1371t2397r1448b2444],
18	,	,	O	,	_	0	SENT_347	[p13l1371t2397r1448b2444],
19	Murphy	NNP	PERSON	Murphy	nn	25	SENT_347	[p13l1473t2394r1680b2449],
20	M.	NNP	O	M.	nn	25	SENT_347	[p13l1703t2397r1764b2438],
21	The	NNP	O	The	nn	25	SENT_347	[p13l1787t2394r1881b2438],
22	codon	NN	O	codon	npadvmod	24	SENT_347	[p13l1906t2394r2061b2438],
23	72	CD	NUMBER	72	num	22	SENT_347	[p13l2085t2396r2145b2437],
24	polymorphic	JJ	O	polymorphic	amod	25	SENT_347	[p13l143t2460r472b2514],
25	variants	NNS	O	variant	appos	14	SENT_347	[p13l488t2460r695b2503],
26	of	IN	O	of	_	0	SENT_347	[p13l714t2460r768b2503],
27	p53	NN	O	p53	prep_of	25	SENT_347	[p13l780t2462r873b2514],
28	have	VBP	O	have	ccomp	13	SENT_347	[p13l894t2460r1014b2503],
29	markedly	RB	O	markedly	advmod	30	SENT_347	[p13l1032t2460r1277b2514],
30	different	JJ	O	different	amod	32	SENT_347	[p13l1293t2460r1517b2503],
31	apoptotic	JJ	O	apoptotic	amod	32	SENT_347	[p13l1534t2461r1777b2514],
32	potential	NN	O	potential	dobj	28	SENT_347	[p13l1795t2460r2039b2514],
33	.	.	O	.	_	0	SENT_347	[p13l1795t2460r2039b2514],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_348	[p13l2059t2463r2148b2503],
2	Genet	NNP	PERSON	Genet	_	0	SENT_348	[p13l143t2528r294b2569],
3	2003	CD	DATE	2003	num	2	SENT_348	[p13l316t2528r759b2576],
4	;	:	O	;	_	0	SENT_348	[p13l316t2528r759b2576],
5	33:357	CD	NUMBER	33:357	number	6	SENT_348	[p13l316t2528r759b2576],
6	—	CD	NUMBER	—	dep	2	SENT_348	[p13l316t2528r759b2576],
7	65	CD	NUMBER	65	dep	6	SENT_348	[p13l316t2528r759b2576],
8	.	.	O	.	_	0	SENT_348	[p13l316t2528r759b2576],

1	[	NN	O	[	nsubj	28	SENT_349	[p13l9t2591r107b2646],
2	17	CD	NUMBER	17	dep	1	SENT_349	[p13l9t2591r107b2646],
3	]	CD	NUMBER	]	num	5	SENT_349	[p13l9t2591r107b2646],
4	Xu	NNP	O	Xu	nn	5	SENT_349	[p13l141t2594r210b2635],
5	Y	NN	O	y	dep	1	SENT_349	[p13l228t2594r274b2642],
6	,	,	O	,	_	0	SENT_349	[p13l228t2594r274b2642],
7	Yao	NNP	PERSON	Yao	nn	8	SENT_349	[p13l292t2594r386b2635],
8	L	NNP	PERSON	L	appos	5	SENT_349	[p13l406t2594r442b2642],
9	,	,	O	,	_	0	SENT_349	[p13l406t2594r442b2642],
10	Ouyang	NNP	ORGANIZATION	Ouyang	nn	11	SENT_349	[p13l463t2594r660b2646],
11	T	NN	ORGANIZATION	t	appos	5	SENT_349	[p13l677t2594r719b2642],
12	,	,	O	,	_	0	SENT_349	[p13l677t2594r719b2642],
13	Li	NNP	PERSON	Li	nn	14	SENT_349	[p13l740t2592r827b2646],
14	]	NNP	O	]	appos	5	SENT_349	[p13l740t2592r827b2646],
15	,	,	O	,	_	0	SENT_349	[p13l740t2592r827b2646],
16	Wang	NNP	PERSON	Wang	nn	17	SENT_349	[p13l845t2594r998b2646],
17	T	NN	PERSON	t	appos	5	SENT_349	[p13l1014t2594r1057b2642],
18	,	,	O	,	_	0	SENT_349	[p13l1014t2594r1057b2642],
19	Fan	NN	O	fan	nn	20	SENT_349	[p13l1077t2594r1166b2635],
20	Z	NN	O	z	appos	5	SENT_349	[p13l1184t2594r1225b2642],
21	,	,	O	,	_	0	SENT_349	[p13l1184t2594r1225b2642],
22	et	FW	O	et	nn	24	SENT_349	[p13l1246t2598r1294b2635],
23	al.	FW	O	al.	nn	24	SENT_349	[p13l1312t2592r1367b2636],
24	p53	NN	O	p53	appos	5	SENT_349	[p13l1388t2594r1481b2646],
25	Codon	NNP	ORGANIZATION	Codon	nn	27	SENT_349	[p13l1504t2592r1666b2635],
26	72	CD	NUMBER	72	num	27	SENT_349	[p13l1686t2594r1745b2635],
27	polymorphism	NN	O	polymorphism	dep	24	SENT_349	[p13l1767t2592r2147b2646],
28	predicts	VBZ	O	predict	_	0	SENT_349	[p13l143t2658r348b2713],
29	the	DT	O	the	det	31	SENT_349	[p13l376t2658r457b2702],
30	pathologic	JJ	O	pathologic	amod	31	SENT_349	[p13l485t2658r756b2713],
31	response	NN	O	response	dobj	28	SENT_349	[p13l783t2671r1011b2713],
32	to	TO	O	to	_	0	SENT_349	[p13l1038t2665r1087b2702],
33	neoadjuvant	JJ	O	neoadjuvant	amod	34	SENT_349	[p13l1115t2658r1437b2713],
34	chemotherapy	NN	O	chemotherapy	prep_to	28	SENT_349	[p13l1463t2658r1838b2713],
35	in	IN	O	in	_	0	SENT_349	[p13l1865t2659r1912b2701],
36	patients	NNS	O	patient	prep_in	34	SENT_349	[p13l1940t2659r2146b2713],
37	with	IN	O	with	_	0	SENT_349	[p13l141t2724r260b2768],
38	breast	NN	O	breast	nn	39	SENT_349	[p13l281t2724r441b2768],
39	cancer	NN	O	cancer	prep_with	36	SENT_349	[p13l463t2737r642b2768],
40	.	.	O	.	_	0	SENT_349	[p13l463t2737r642b2768],

1	Clin	NNP	O	Clin	nn	3	SENT_350	[p13l666t2724r765b2768],
2	Cancer	NNP	O	Cancer	nn	3	SENT_350	[p13l787t2726r962b2768],
3	Res	NNP	O	Res	_	0	SENT_350	[p13l983t2727r1068b2768],
4	2005	CD	DATE	2005	num	3	SENT_350	[p13l1091t2726r1568b2774],
5	;	:	O	;	_	0	SENT_350	[p13l1091t2726r1568b2774],
6	11:7328	CD	NUMBER	11:7328	number	7	SENT_350	[p13l1091t2726r1568b2774],
7	—	CD	NUMBER	—	dep	3	SENT_350	[p13l1091t2726r1568b2774],
8	33	CD	NUMBER	33	dep	7	SENT_350	[p13l1091t2726r1568b2774],
9	.	.	O	.	_	0	SENT_350	[p13l1091t2726r1568b2774],

1	[	NN	O	[	nn	4	SENT_351	[p13l9t2790r107b2844],
2	18	CD	NUMBER	18	num	4	SENT_351	[p13l9t2790r107b2844],
3	]	NN	O	]	nn	4	SENT_351	[p13l9t2790r107b2844],
4	Leonessa	NN	PERSON	leonessa	_	0	SENT_351	[p13l143t2793r372b2833],
5	F	NN	PERSON	f	dep	4	SENT_351	[p13l391t2793r428b2840],
6	,	,	O	,	_	0	SENT_351	[p13l391t2793r428b2840],
7	Clarke	NNP	PERSON	Clarke	nn	8	SENT_351	[p13l447t2790r607b2833],
8	R.	NNP	O	R.	appos	5	SENT_351	[p13l626t2793r669b2834],
9	ATP	NN	O	atp	nn	12	SENT_351	[p13l686t2792r786b2833],
10	binding	NN	O	binding	nn	12	SENT_351	[p13l803t2790r1001b2844],
11	cassette	NN	O	cassette	nn	12	SENT_351	[p13l1017t2796r1222b2833],
12	transporters	NNS	O	transporter	dep	4	SENT_351	[p13l1240t2796r1557b2844],
13	and	CC	O	and	_	0	SENT_351	[p13l1576t2790r1669b2833],
14	drug	NN	O	drug	nn	15	SENT_351	[p13l1688t2790r1807b2844],
15	resistance	NN	O	resistance	dep	4	SENT_351	[p13l1824t2791r2081b2833],
16	in	IN	O	in	_	0	SENT_351	[p13l2100t2791r2147b2833],
17	breast	NN	O	breast	nn	18	SENT_351	[p13l142t2856r301b2900],
18	cancer	NN	O	cancer	prep_in	12	SENT_351	[p13l323t2869r502b2900],
19	.	.	O	.	_	0	SENT_351	[p13l323t2869r502b2900],

1	Endocr	NNP	MISC	Endocr	nn	3	SENT_352	[p13l526t2856r705b2900],
2	Relat	NNP	MISC	Relat	nn	3	SENT_352	[p13l726t2856r855b2900],
3	Cancer	NNP	O	Cancer	_	0	SENT_352	[p13l877t2858r1053b2900],
4	2003	CD	DATE	2003	num	3	SENT_352	[p13l1073t2858r1483b2906],
5	;	:	O	;	_	0	SENT_352	[p13l1073t2858r1483b2906],
6	10:43	CD	TIME	10:43	number	7	SENT_352	[p13l1073t2858r1483b2906],
7	—	CD	NUMBER	—	dep	3	SENT_352	[p13l1073t2858r1483b2906],
8	73	CD	NUMBER	73	dep	7	SENT_352	[p13l1073t2858r1483b2906],
9	.	.	O	.	_	0	SENT_352	[p13l1073t2858r1483b2906],

1	[	NN	O	[	_	0	SENT_353	[p13l9t2921r107b2976],
2	19	CD	NUMBER	19	num	1	SENT_353	[p13l9t2921r107b2976],
3	]	CD	NUMBER	]	num	5	SENT_353	[p13l9t2921r107b2976],
4	Hoffmeyer	NNP	PERSON	Hoffmeyer	nn	5	SENT_353	[p13l143t2921r418b2976],
5	S	NN	O	s	dep	1	SENT_353	[p13l438t2924r476b2972],
6	,	,	O	,	_	0	SENT_353	[p13l438t2924r476b2972],
7	Burk	NNP	PERSON	Burk	nn	8	SENT_353	[p13l499t2922r619b2965],
8	o	NN	O	o	appos	5	SENT_353	[p13l639t2924r689b2972],
9	,	,	O	,	_	0	SENT_353	[p13l639t2924r689b2972],
10	von	NNP	PERSON	von	nn	12	SENT_353	[p13l710t2934r804b2965],
11	Richter	NNP	PERSON	Richter	nn	12	SENT_353	[p13l826t2922r1011b2965],
12	o	NN	O	o	appos	5	SENT_353	[p13l1031t2924r1080b2972],
13	,	,	O	,	_	0	SENT_353	[p13l1031t2924r1080b2972],
14	Arnold	NNP	ORGANIZATION	Arnold	nn	15	SENT_353	[p13l1100t2922r1275b2965],
15	HP	NNP	ORGANIZATION	HP	appos	5	SENT_353	[p13l1298t2924r1381b2972],
16	,	,	O	,	_	0	SENT_353	[p13l1298t2924r1381b2972],
17	Brockmoller	NNP	PERSON	Brockmoller	appos	5	SENT_353	[p13l1403t2922r1719b2965],
18	]	CD	NUMBER	]	num	17	SENT_353	[p13l1733t2924r1766b2976],
19	,	,	O	,	_	0	SENT_353	[p13l1733t2924r1766b2976],
20	]	CD	NUMBER	]	num	22	SENT_353	[p13l1782t2922r1932b2976],
21	ohne	NN	O	ohne	nn	22	SENT_353	[p13l1782t2922r1932b2976],
22	A	NN	O	a	appos	5	SENT_353	[p13l1952t2924r1999b2972],
23	,	,	O	,	_	0	SENT_353	[p13l1952t2924r1999b2972],
24	et	FW	O	et	nn	25	SENT_353	[p13l2022t2928r2070b2965],
25	al.	FW	O	al.	appos	5	SENT_353	[p13l2091t2922r2146b2966],
26	.	.	O	.	_	0	SENT_353	[p13l2091t2922r2146b2966],

1	Functional	JJ	O	functional	amod	2	SENT_354	[p13l143t2988r413b3031],
2	polymorphisms	NNS	O	polymorphism	_	0	SENT_354	[p13l431t2988r835b3042],
3	of	IN	O	of	_	0	SENT_354	[p13l852t2988r906b3031],
4	the	DT	O	the	det	9	SENT_354	[p13l915t2988r997b3031],
5	human	JJ	O	human	amod	9	SENT_354	[p13l1014t2988r1195b3031],
6	multidrug	JJ	O	multidrug	amod	9	SENT_354	[p13l1211t2988r1755b3042],
7	—	NN	O	—	nn	9	SENT_354	[p13l1211t2988r1755b3042],
8	resistance	NN	O	resistance	nn	9	SENT_354	[p13l1211t2988r1755b3042],
9	gene	NN	O	gene	prep_of	2	SENT_354	[p13l1771t3000r1907b3042],
10	:	:	O	:	_	0	SENT_354	[p13l1771t3000r1907b3042],
11	multiple	JJ	O	multiple	amod	13	SENT_354	[p13l1929t2988r2147b3042],
12	sequence	NN	O	sequence	nn	13	SENT_354	[p13l143t3066r381b3108],
13	variations	NNS	O	variation	dep	2	SENT_354	[p13l398t3054r655b3097],
14	and	CC	O	and	_	0	SENT_354	[p13l675t3053r768b3097],
15	correlation	NN	O	correlation	dep	2	SENT_354	[p13l788t3053r1070b3097],
16	of	IN	O	of	_	0	SENT_354	[p13l1089t3053r1142b3097],
17	one	CD	NUMBER	one	num	18	SENT_354	[p13l1155t3066r1246b3097],
18	allele	NN	O	allele	prep_of	15	SENT_354	[p13l1265t3053r1401b3097],
19	with	IN	O	with	_	0	SENT_354	[p13l1419t3053r1538b3097],
20	P-glycoprotein	NN	MISC	p-glycoprotein	nn	21	SENT_354	[p13l1557t3053r1937b3108],
21	expression	NN	O	expression	prep_with	18	SENT_354	[p13l1956t3066r2147b3108, p13l143t3121r248b3164],
22	and	CC	O	and	_	0	SENT_354	[p13l270t3120r363b3164],
23	activity	NN	O	activity	conj_and	21	SENT_354	[p13l385t3121r578b3174],
24	in	FW	O	in	prep	15	SENT_354	[p13l600t3121r648b3163],
25	vivo	FW	O	vivo	pobj	24	SENT_354	[p13l668t3121r789b3164],
26	.	.	O	.	_	0	SENT_354	[p13l668t3121r789b3164],

1	Proc	NNP	ORGANIZATION	Proc	nn	7	SENT_355	[p13l813t3123r923b3164],
2	Natl	NNP	ORGANIZATION	Natl	nn	7	SENT_355	[p13l946t3120r1050b3164],
3	Acad	NNP	ORGANIZATION	Acad	nn	7	SENT_355	[p13l1072t3120r1197b3164],
4	Sci	NNP	ORGANIZATION	Sci	nn	7	SENT_355	[p13l1221t3121r1290b3164],
5	U	NNP	ORGANIZATION	U	nn	7	SENT_355	[p13l1312t3123r1350b3164],
6	S	NNP	ORGANIZATION	S	nn	7	SENT_355	[p13l1373t3122r1398b3164],
7	A	NNP	O	A	_	0	SENT_355	[p13l1418t3122r1456b3163],
8	2000	CD	DATE	2000	num	7	SENT_355	[p13l1476t3122r1919b3170],
9	;	:	O	;	_	0	SENT_355	[p13l1476t3122r1919b3170],
10	97:3473	CD	NUMBER	97:3473	number	11	SENT_355	[p13l1476t3122r1919b3170],
11	—	CD	NUMBER	—	dep	7	SENT_355	[p13l1476t3122r1919b3170],
12	8	CD	NUMBER	8	dep	11	SENT_355	[p13l1476t3122r1919b3170],
13	.	.	O	.	_	0	SENT_355	[p13l1476t3122r1919b3170],

1	[	RB	O	[	dep	5	SENT_356	[p13l9t3186r106b3241],
2	20	CD	NUMBER	20	num	5	SENT_356	[p13l9t3186r106b3241],
3	]	CD	NUMBER	]	num	5	SENT_356	[p13l9t3186r106b3241],
4	Sauna	NNP	O	Sauna	nn	5	SENT_356	[p13l142t3188r295b3230],
5	ZE	NNP	O	ZE	_	0	SENT_356	[p13l311t3189r384b3237],
6	,	,	O	,	_	0	SENT_356	[p13l311t3189r384b3237],
7	Kimchi-Sarfaty	NNP	O	Kimchi-Sarfaty	nn	8	SENT_356	[p13l402t3186r789b3240],
8	C	NNP	O	C	appos	5	SENT_356	[p13l805t3188r848b3236],
9	,	,	O	,	_	0	SENT_356	[p13l805t3188r848b3236],
10	Ambudkar	NNP	O	Ambudkar	nn	11	SENT_356	[p13l863t3186r1138b3230],
11	SV	NNP	O	SV	appos	5	SENT_356	[p13l1153t3188r1228b3236],
12	,	,	O	,	_	0	SENT_356	[p13l1153t3188r1228b3236],
13	Gottesman	NNP	PERSON	Gottesman	nn	14	SENT_356	[p13l1246t3188r1528b3230],
14	MM	NN	O	mm	appos	11	SENT_356	[p13l1545t3189r1659b3230],
15	.	.	O	.	_	0	SENT_356	[p13l1545t3189r1659b3230],

1	Silent	JJ	O	silent	amod	2	SENT_357	[p13l1677t3186r1823b3230],
2	polymorphisms	NNS	O	polymorphism	nsubj	3	SENT_357	[p13l1839t3186r2147b3241, p13l142t3253r257b3295],
3	speak	VBP	O	speak	_	0	SENT_357	[p13l278t3252r439b3306],
4	:	:	O	:	_	0	SENT_357	[p13l278t3252r439b3306],
5	how	WRB	O	how	advmod	7	SENT_357	[p13l463t3252r575b3295],
6	they	PRP	O	they	nsubj	7	SENT_357	[p13l592t3252r706b3306],
7	affect	VBP	O	affect	ccomp	3	SENT_357	[p13l724t3252r866b3295],
8	pharmacogenomics	NNS	O	pharmacogenomic	dobj	7	SENT_357	[p13l885t3252r1390b3306],
9	and	CC	O	and	_	0	SENT_357	[p13l1410t3252r1503b3295],
10	the	DT	O	the	det	11	SENT_357	[p13l1523t3252r1604b3295],
11	treatment	NN	O	treatment	conj_and	8	SENT_357	[p13l1623t3258r1882b3295],
12	of	IN	O	of	_	0	SENT_357	[p13l1901t3252r1954b3295],
13	cancer	NN	O	cancer	prep_of	11	SENT_357	[p13l1967t3264r2146b3296],
14	.	.	O	.	_	0	SENT_357	[p13l1967t3264r2146b3296],

1	Cancer	NN	O	cancer	_	0	SENT_358	[p13l142t3320r317b3361],
2	Res	NNP	O	Res	dep	1	SENT_358	[p13l339t3320r423b3361],
3	2007	CD	DATE	2007	num	2	SENT_358	[p13l447t3320r923b3368],
4	;	:	O	;	_	0	SENT_358	[p13l447t3320r923b3368],
5	67:9609	CD	NUMBER	67:9609	number	6	SENT_358	[p13l447t3320r923b3368],
6	—	CD	NUMBER	—	dep	1	SENT_358	[p13l447t3320r923b3368],
7	12	CD	NUMBER	12	dep	6	SENT_358	[p13l447t3320r923b3368],
8	.	.	O	.	_	0	SENT_358	[p13l447t3320r923b3368],

1	[	NN	O	[	nn	4	SENT_359	[p13l9t3383r107b3438],
2	21	CD	NUMBER	21	num	4	SENT_359	[p13l9t3383r107b3438],
3	]	NN	O	]	nn	4	SENT_359	[p13l9t3383r107b3438],
4	Zubor	NN	O	zubor	_	0	SENT_359	[p13l141t3384r295b3427],
5	P	NN	O	p	dep	4	SENT_359	[p13l310t3386r350b3434],
6	,	,	O	,	_	0	SENT_359	[p13l310t3386r350b3434],
7	Lasabova	NN	LOCATION	lasabova	nn	8	SENT_359	[p13l368t3384r601b3427],
8	Z	NN	LOCATION	z	appos	5	SENT_359	[p13l617t3386r658b3434],
9	,	,	O	,	_	0	SENT_359	[p13l617t3386r658b3434],
10	Hatok	NNP	PERSON	Hatok	nn	11	SENT_359	[p13l676t3384r872b3438],
11	]	NNP	O	]	appos	5	SENT_359	[p13l676t3384r872b3438],
12	,	,	O	,	_	0	SENT_359	[p13l676t3384r872b3438],
13	Stanclova	NNP	O	Stanclova	nn	14	SENT_359	[p13l890t3384r1136b3427],
14	A	NNP	O	A	appos	5	SENT_359	[p13l1151t3386r1199b3434],
15	,	,	O	,	_	0	SENT_359	[p13l1151t3386r1199b3434],
16	Danko	NNP	PERSON	Danko	nn	17	SENT_359	[p13l1217t3384r1380b3427],
17	]	NNP	O	]	appos	5	SENT_359	[p13l1390t3386r1423b3438],
18	.	.	O	.	_	0	SENT_359	[p13l1390t3386r1423b3438],

1	A	DT	O	a	det	3	SENT_360	[p13l1440t3386r1477b3427],
2	polymorphism	NN	O	polymorphism	nn	3	SENT_360	[p13l1492t3384r1872b3438],
3	C3435T	NN	O	c3435t	nsubj	16	SENT_360	[p13l1889t3386r2085b3427],
4	of	IN	O	of	_	0	SENT_360	[p13l2100t3383r2153b3427],
5	the	DT	O	the	det	7	SENT_360	[p13l142t3450r224b3494],
6	MDR-1	NN	MISC	mdr-1	nn	7	SENT_360	[p13l244t3453r418b3493],
7	gene	NN	O	gene	prep_of	3	SENT_360	[p13l444t3463r565b3505],
8	associated	VBN	O	associate	partmod	7	SENT_360	[p13l585t3450r851b3494],
9	with	IN	O	with	_	0	SENT_360	[p13l871t3450r989b3494],
10	smoking	NN	O	smoking	prep_with	8	SENT_360	[p13l1010t3450r1230b3505],
11	or	CC	O	or	_	0	SENT_360	[p13l1249t3463r1302b3494],
12	high	JJ	O	high	amod	15	SENT_360	[p13l1321t3450r1433b3505],
13	body	NN	O	body	nn	15	SENT_360	[p13l1452t3450r1580b3505],
14	mass	NN	O	mass	nn	15	SENT_360	[p13l1599t3463r1727b3494],
15	index	NN	O	index	conj_or	10	SENT_360	[p13l1748t3450r1892b3494],
16	increases	VBZ	O	increase	_	0	SENT_360	[p13l1911t3451r2146b3494],
17	the	DT	O	the	det	18	SENT_360	[p13l142t3516r224b3560],
18	risk	NN	O	risk	dobj	16	SENT_360	[p13l247t3516r341b3560],
19	of	IN	O	of	_	0	SENT_360	[p13l362t3516r415b3560],
20	sporadic	JJ	O	sporadic	amod	22	SENT_360	[p13l432t3516r649b3571],
21	breast	NN	O	breast	nn	22	SENT_360	[p13l671t3516r830b3560],
22	cancer	NN	O	cancer	prep_of	18	SENT_360	[p13l851t3529r1020b3560],
23	in	IN	O	in	_	0	SENT_360	[p13l1041t3517r1089b3559],
24	women	NNS	O	woman	prep_in	22	SENT_360	[p13l1110t3529r1316b3560],
25	.	.	O	.	_	0	SENT_360	[p13l1110t3529r1316b3560],

1	Oncol	NNP	MISC	Oncol	nn	2	SENT_361	[p13l1340t3516r1486b3560],
2	Rep	NNP	MISC	Rep	_	0	SENT_361	[p13l1510t3519r1603b3571],
3	2007	CD	DATE	2007	num	2	SENT_361	[p13l1626t3518r2037b3566],
4	;	:	O	;	_	0	SENT_361	[p13l1626t3518r2037b3566],
5	18:211	CD	NUMBER	18:211	num	6	SENT_361	[p13l1626t3518r2037b3566],
6	—	NN	O	—	dep	2	SENT_361	[p13l1626t3518r2037b3566],
7	7	CD	NUMBER	7	dep	6	SENT_361	[p13l1626t3518r2037b3566],
8	.	.	O	.	_	0	SENT_361	[p13l1626t3518r2037b3566],

1	[	NN	O	[	dep	7	SENT_362	[p13l9t3582r107b3636],
2	22	CD	NUMBER	22	dep	1	SENT_362	[p13l9t3582r107b3636],
3	]	CD	NUMBER	]	dep	7	SENT_362	[p13l9t3582r107b3636],
4	Cabrera	NNP	PERSON	Cabrera	nn	7	SENT_362	[p13l143t3582r340b3625],
5	de	IN	PERSON	de	amod	7	SENT_362	[p13l360t3582r419b3625],
6	Leon	NNP	PERSON	Leon	nn	7	SENT_362	[p13l439t3585r560b3625],
7	A	NNP	O	A	dep	33	SENT_362	[p13l577t3584r625b3632],
8	,	,	O	,	_	0	SENT_362	[p13l577t3584r625b3632],
9	Rodriguez	NNP	PERSON	Rodriguez	nn	12	SENT_362	[p13l645t3582r904b3636],
10	Perez	NNP	PERSON	Perez	nn	12	SENT_362	[p13l925t3585r1062b3625],
11	Mdel	NNP	PERSON	Mdel	nn	12	SENT_362	[p13l1083t3582r1211b3625],
12	C	NNP	O	C	appos	7	SENT_362	[p13l1232t3584r1275b3632],
13	,	,	O	,	_	0	SENT_362	[p13l1232t3584r1275b3632],
14	Almeida	NNP	PERSON	Almeida	nn	16	SENT_362	[p13l1293t3582r1508b3625],
15	Gonzalez	NNP	PERSON	Gonzalez	nn	16	SENT_362	[p13l1528t3582r1762b3625],
16	D	NNP	O	D	appos	7	SENT_362	[p13l1783t3585r1831b3632],
17	,	,	O	,	_	0	SENT_362	[p13l1783t3585r1831b3632],
18	Dominguez	NNP	PERSON	Dominguez	nn	20	SENT_362	[p13l1852t3583r2147b3636],
19	Coello	NNP	PERSON	Coello	nn	20	SENT_362	[p13l143t3648r300b3692],
20	S	NN	PERSON	s	appos	7	SENT_362	[p13l328t3650r366b3698],
21	,	,	O	,	_	0	SENT_362	[p13l328t3650r366b3698],
22	Aguirre	NNP	PERSON	Aguirre	nn	24	SENT_362	[p13l391t3649r584b3702],
23	Jaime	NNP	PERSON	Jaime	nn	24	SENT_362	[p13l605t3649r753b3702],
24	A	NNP	O	A	appos	7	SENT_362	[p13l779t3650r827b3698],
25	,	,	O	,	_	0	SENT_362	[p13l779t3650r827b3698],
26	Brito	NNP	PERSON	Brito	nn	28	SENT_362	[p13l855t3649r978b3692],
27	Diaz	NNP	PERSON	Diaz	nn	28	SENT_362	[p13l1006t3649r1117b3692],
28	B	NNP	O	B	appos	7	SENT_362	[p13l1144t3651r1187b3698],
29	,	,	O	,	_	0	SENT_362	[p13l1144t3651r1187b3698],
30	et	FW	O	et	appos	7	SENT_362	[p13l1215t3655r1263b3692],
31	al.	FW	O	al.	nn	33	SENT_362	[p13l1289t3648r1345b3692],
32	[	FW	O	[	nn	33	SENT_362	[p13l1375t3648r1719b3702],
33	Presentation	NN	O	presentation	dep	41	SENT_362	[p13l1375t3648r1719b3702],
34	of	IN	O	of	_	0	SENT_362	[p13l1746t3648r1799b3692],
35	the	DT	O	the	det	39	SENT_362	[p13l1819t3648r1901b3692],
36	“	CD	NUMBER	“	num	39	SENT_362	[p13l1929t3650r2061b3692],
37	CDC	NNP	ORGANIZATION	CDC	nn	39	SENT_362	[p13l1929t3650r2061b3692],
38	de	IN	O	de	amod	39	SENT_362	[p13l2088t3648r2147b3692],
39	Canarias	NNP	O	Canarias	prep_of	33	SENT_362	[p13l139t3715r384b3759],
40	”	CD	NUMBER	”	num	41	SENT_362	[p13l139t3715r384b3759],
41	cohort	NN	O	cohort	dep	49	SENT_362	[p13l408t3714r590b3759],
42	:	:	O	:	_	0	SENT_362	[p13l408t3714r590b3759],
43	objectives	NNS	O	objective	nn	45	SENT_362	[p13l619t3714r890b3770],
44	,	,	O	,	_	0	SENT_362	[p13l619t3714r890b3770],
45	design	NN	O	design	nn	48	SENT_362	[p13l915t3714r1083b3770],
46	and	CC	O	and	_	0	SENT_362	[p13l1106t3714r1199b3759],
47	preliminary	JJ	O	preliminary	nn	48	SENT_362	[p13l1224t3714r1530b3770],
48	results	NNS	O	result	nsubj	49	SENT_362	[p13l1553t3714r1758b3770],
49	]	VBP	O	]	_	0	SENT_362	[p13l1553t3714r1758b3770],
50	.	.	O	.	_	0	SENT_362	[p13l1553t3714r1758b3770],

1	Rev	NN	O	rev	_	0	SENT_363	[p13l1784t3717r1876b3759],
2	Esp	NNP	O	Esp	nn	4	SENT_363	[p13l1899t3717r1986b3770],
3	Salud	NNP	O	Salud	nn	4	SENT_363	[p13l2010t3714r2150b3759],
4	Publica	NNP	O	Publica	dep	1	SENT_363	[p13l139t3781r326b3825],
5	2008	CD	DATE	2008	num	4	SENT_363	[p13l348t3783r794b3831],
6	;	:	O	;	_	0	SENT_363	[p13l348t3783r794b3831],
7	82:519	CD	NUMBER	82:519	number	8	SENT_363	[p13l348t3783r794b3831],
8	—	CD	NUMBER	—	dep	1	SENT_363	[p13l348t3783r794b3831],
9	34	CD	NUMBER	34	dep	8	SENT_363	[p13l348t3783r794b3831],
10	.	.	O	.	_	0	SENT_363	[p13l348t3783r794b3831],

1	[	NN	O	[	_	0	SENT_364	[p14l6t21r104b75],
2	23	CD	NUMBER	23	num	1	SENT_364	[p14l6t21r104b75],
3	]	CD	NUMBER	]	num	5	SENT_364	[p14l6t21r104b75],
4	Nilsson	NN	O	nilsson	nn	5	SENT_364	[p14l139t21r329b65],
5	G	NN	O	g	dep	1	SENT_364	[p14l344t23r393b71],
6	,	,	O	,	_	0	SENT_364	[p14l344t23r393b71],
7	Skytting	NN	O	skytting	nn	8	SENT_364	[p14l409t21r623b75],
8	B	NN	O	b	appos	5	SENT_364	[p14l638t24r681b71],
9	,	,	O	,	_	0	SENT_364	[p14l638t24r681b71],
10	Xie	NNP	O	Xie	nn	11	SENT_364	[p14l695t22r777b65],
11	Y	NN	O	y	appos	5	SENT_364	[p14l790t24r836b71],
12	,	,	O	,	_	0	SENT_364	[p14l790t24r836b71],
13	Brodin	NN	PERSON	brodin	nn	14	SENT_364	[p14l852t21r1023b65],
14	B	NN	PERSON	b	appos	5	SENT_364	[p14l1038t24r1081b71],
15	,	,	O	,	_	0	SENT_364	[p14l1038t24r1081b71],
16	Perfekt	NNP	ORGANIZATION	Perfekt	nn	17	SENT_364	[p14l1097t21r1280b65],
17	R	NNP	ORGANIZATION	R	appos	5	SENT_364	[p14l1294t24r1338b71],
18	,	,	O	,	_	0	SENT_364	[p14l1294t24r1338b71],
19	Mandahl	NNP	ORGANIZATION	Mandahl	nn	20	SENT_364	[p14l1354t21r1581b65],
20	N	NNP	ORGANIZATION	N	appos	5	SENT_364	[p14l1597t24r1648b71],
21	,	,	O	,	_	0	SENT_364	[p14l1597t24r1648b71],
22	et	FW	O	et	nn	23	SENT_364	[p14l1664t28r1712b65],
23	al.	FW	O	al.	appos	5	SENT_364	[p14l1725t21r1781b65],
24	.	.	O	.	_	0	SENT_364	[p14l1725t21r1781b65],

1	The	DT	O	the	det	3	SENT_365	[p14l1795t21r1890b65],
2	SYT-SSX1	NN	O	syt-ssx1	nn	3	SENT_365	[p14l1905t23r2144b65],
3	variant	NN	O	variant	nsubjpass	8	SENT_365	[p14l138t87r322b131],
4	of	IN	O	of	_	0	SENT_365	[p14l354t86r408b131],
5	synovial	JJ	O	synovial	amod	6	SENT_365	[p14l435t87r648b142],
6	sarcoma	NN	O	sarcoma	prep_of	3	SENT_365	[p14l682t99r897b131],
7	is	VBZ	O	be	auxpass	8	SENT_365	[p14l931t87r968b131],
8	associated	VBN	O	associate	_	0	SENT_365	[p14l1002t87r1269b131],
9	with	IN	O	with	_	0	SENT_365	[p14l1301t87r1420b131],
10	a	DT	O	a	det	12	SENT_365	[p14l1453t99r1479b131],
11	high	JJ	O	high	amod	12	SENT_365	[p14l1512t87r1625b142],
12	rate	NN	O	rate	prep_with	8	SENT_365	[p14l1658t93r1757b131],
13	of	IN	O	of	_	0	SENT_365	[p14l1791t86r1844b131],
14	tumor	NN	O	tumor	nn	16	SENT_365	[p14l1870t93r2032b131],
15	cell	NN	O	cell	nn	16	SENT_365	[p14l2063t87r2150b131],
16	proliferation	NN	O	proliferation	prep_of	12	SENT_365	[p14l139t154r465b208],
17	and	CC	O	and	_	0	SENT_365	[p14l487t154r581b197],
18	poor	JJ	O	poor	amod	20	SENT_365	[p14l604t166r722b208],
19	clinical	JJ	O	clinical	amod	20	SENT_365	[p14l743t154r926b197],
20	outcome	NN	O	outcome	prep_of	12	SENT_365	[p14l949t160r1187b198],
21	.	.	O	.	_	0	SENT_365	[p14l949t160r1187b198],

1	Cancer	NNP	O	Cancer	nn	2	SENT_366	[p14l1211t156r1387b197],
2	Res	NNP	O	Res	_	0	SENT_366	[p14l1408t157r1493b197],
3	1999	CD	DATE	1999	num	2	SENT_366	[p14l1519t156r1962b204],
4	;	:	O	;	_	0	SENT_366	[p14l1519t156r1962b204],
5	59:3180	CD	NUMBER	59:3180	number	6	SENT_366	[p14l1519t156r1962b204],
6	—	CD	NUMBER	—	dep	2	SENT_366	[p14l1519t156r1962b204],
7	4	CD	NUMBER	4	dep	6	SENT_366	[p14l1519t156r1962b204],
8	.	.	O	.	_	0	SENT_366	[p14l1519t156r1962b204],

1	[	NN	O	[	_	0	SENT_367	[p14l6t219r104b275],
2	24	CD	NUMBER	24	num	1	SENT_367	[p14l6t219r104b275],
3	]	CD	NUMBER	]	num	5	SENT_367	[p14l6t219r104b275],
4	Hayes	NNP	PERSON	Hayes	nn	5	SENT_367	[p14l140t222r293b275],
5	DF	NN	O	df	dep	1	SENT_367	[p14l323t222r401b271],
6	,	,	O	,	_	0	SENT_367	[p14l323t222r401b271],
7	Thor	NNP	PERSON	Thor	nn	8	SENT_367	[p14l427t219r549b264],
8	AD	NN	O	ad	appos	5	SENT_367	[p14l573t221r662b264],
9	.	.	O	.	_	0	SENT_367	[p14l573t221r662b264],

1	c	NN	O	c	nn	4	SENT_368	[p14l692t219r912b264],
2	—	CD	NUMBER	—	num	4	SENT_368	[p14l692t219r912b264],
3	erbB	NN	O	erbb	nn	4	SENT_368	[p14l692t219r912b264],
4	—	NN	O	—	_	0	SENT_368	[p14l692t219r912b264],
5	2	CD	NUMBER	2	dep	4	SENT_368	[p14l692t219r912b264],
6	in	IN	O	in	_	0	SENT_368	[p14l943t220r991b263],
7	breast	NN	O	breast	nn	8	SENT_368	[p14l1018t219r1178b264],
8	cancer	NN	O	cancer	prep_in	5	SENT_368	[p14l1206t232r1388b264],
9	:	:	O	:	_	0	SENT_368	[p14l1206t232r1388b264],
10	development	NN	O	development	dep	4	SENT_368	[p14l1421t219r1762b275],
11	of	IN	O	of	_	0	SENT_368	[p14l1790t219r1843b264],
12	a	DT	O	a	det	15	SENT_368	[p14l1865t232r1891b264],
13	clinically	RB	O	clinically	advmod	14	SENT_368	[p14l1919t219r2152b275],
14	useful	JJ	O	useful	amod	15	SENT_368	[p14l139t287r295b331],
15	marker	NN	O	marker	prep_of	10	SENT_368	[p14l318t287r516b331],
16	.	.	O	.	_	0	SENT_368	[p14l318t287r516b331],

1	Semin	NNP	O	Semin	nn	2	SENT_369	[p14l540t288r700b331],
2	Oncol	NNP	O	Oncol	_	0	SENT_369	[p14l722t287r869b331],
3	2002	CD	DATE	2002	num	2	SENT_369	[p14l892t289r1337b337],
4	;	:	O	;	_	0	SENT_369	[p14l892t289r1337b337],
5	29:231	CD	NUMBER	29:231	number	6	SENT_369	[p14l892t289r1337b337],
6	—	CD	NUMBER	—	dep	2	SENT_369	[p14l892t289r1337b337],
7	45	CD	NUMBER	45	dep	6	SENT_369	[p14l892t289r1337b337],
8	.	.	O	.	_	0	SENT_369	[p14l892t289r1337b337],

1	[	NN	O	[	nn	5	SENT_370	[p14l6t353r104b409],
2	25	CD	NUMBER	25	num	5	SENT_370	[p14l6t353r104b409],
3	]	CD	NUMBER	]	num	5	SENT_370	[p14l6t353r104b409],
4	Miller	NNP	ORGANIZATION	Miller	nn	5	SENT_370	[p14l140t353r295b398],
5	AB	NNP	ORGANIZATION	AB	nsubj	16	SENT_370	[p14l315t355r397b404],
6	,	,	O	,	_	0	SENT_370	[p14l315t355r397b404],
7	Hoogstraten	NNP	PERSON	Hoogstraten	nn	8	SENT_370	[p14l422t356r740b409],
8	B	NNP	PERSON	B	appos	5	SENT_370	[p14l764t356r806b404],
9	,	,	O	,	_	0	SENT_370	[p14l764t356r806b404],
10	Staquet	NNP	O	Staquet	nn	11	SENT_370	[p14l831t355r1027b409],
11	M	NNP	O	M	appos	5	SENT_370	[p14l1051t356r1112b404],
12	,	,	O	,	_	0	SENT_370	[p14l1051t356r1112b404],
13	Winkler	NNP	PERSON	Winkler	nn	15	SENT_370	[p14l1134t353r1347b398],
14	A.	NNP	O	A.	nn	15	SENT_370	[p14l1366t355r1414b398],
15	Reporting	NNP	O	Reporting	appos	5	SENT_370	[p14l1439t354r1693b409],
16	results	VBZ	O	result	_	0	SENT_370	[p14l1717t353r1887b398],
17	of	IN	O	of	_	0	SENT_370	[p14l1912t353r1966b398],
18	cancer	NN	O	cancer	nn	19	SENT_370	[p14l1984t366r2153b398],
19	treatment	NN	O	treatment	prep_of	16	SENT_370	[p14l139t426r410b464],
20	.	.	O	.	_	0	SENT_370	[p14l139t426r410b464],

1	Cancer	NN	O	cancer	_	0	SENT_371	[p14l435t422r611b463],
2	1981	CD	DATE	1981	num	1	SENT_371	[p14l634t422r753b463],
3	;	:	O	;	_	0	SENT_371	[p14l768t422r1077b470],
4	47:207	CD	NUMBER	47:207	number	5	SENT_371	[p14l768t422r1077b470],
5	—	CD	NUMBER	—	dep	1	SENT_371	[p14l768t422r1077b470],
6	14	CD	NUMBER	14	dep	5	SENT_371	[p14l768t422r1077b470],
7	.	.	O	.	_	0	SENT_371	[p14l768t422r1077b470],

1	[	NN	O	[	nn	5	SENT_372	[p14l6t486r104b540],
2	26	CD	NUMBER	26	num	5	SENT_372	[p14l6t486r104b540],
3	]	CD	NUMBER	]	num	5	SENT_372	[p14l6t486r104b540],
4	Henriquez-Hernandez	NNP	O	Henriquez-Hernandez	nn	5	SENT_372	[p14l139t486r715b540],
5	LA	NNP	O	LA	_	0	SENT_372	[p14l738t488r812b536],
6	,	,	O	,	_	0	SENT_372	[p14l738t488r812b536],
7	Murias-Rosales	NNP	O	Murias-Rosales	nn	8	SENT_372	[p14l835t486r1230b530],
8	A	NNP	O	A	appos	5	SENT_372	[p14l1251t488r1300b536],
9	,	,	O	,	_	0	SENT_372	[p14l1251t488r1300b536],
10	Hernandez	NNP	PERSON	Hernandez	nn	12	SENT_372	[p14l1322t486r1603b530],
11	Gonzalez	NNP	PERSON	Gonzalez	nn	12	SENT_372	[p14l1626t486r1861b530],
12	A	NNP	O	A	appos	8	SENT_372	[p14l1881t488r1929b536],
13	,	,	O	,	_	0	SENT_372	[p14l1881t488r1929b536],
14	Cabrera	NNP	PERSON	Cabrera	nn	17	SENT_372	[p14l1952t486r2151b530],
15	De	NNP	PERSON	De	nn	17	SENT_372	[p14l140t554r206b595],
16	Leon	NNP	PERSON	Leon	nn	17	SENT_372	[p14l226t554r346b595],
17	A	NNP	O	A	appos	8	SENT_372	[p14l363t554r411b602],
18	,	,	O	,	_	0	SENT_372	[p14l363t554r411b602],
19	Diaz-Chico	NNP	O	Diaz-Chico	nn	20	SENT_372	[p14l431t552r711b595],
20	BN	NNP	O	BN	appos	8	SENT_372	[p14l731t554r816b602],
21	,	,	O	,	_	0	SENT_372	[p14l731t554r816b602],
22	Mori	NNP	PERSON	Mori	nn	25	SENT_372	[p14l836t552r956b595],
23	De	NNP	PERSON	De	nn	25	SENT_372	[p14l977t554r1044b595],
24	Santiago	NNP	PERSON	Santiago	nn	25	SENT_372	[p14l1063t552r1283b606],
25	M	NN	PERSON	m	appos	8	SENT_372	[p14l1303t554r1365b602],
26	,	,	O	,	_	0	SENT_372	[p14l1303t554r1365b602],
27	et	FW	O	et	nn	28	SENT_372	[p14l1385t558r1433b595],
28	al.	FW	O	al.	appos	8	SENT_372	[p14l1451t552r1507b596],
29	.	.	O	.	_	0	SENT_372	[p14l1451t552r1507b596],

1	Gene	NNP	PERSON	Gene	nn	2	SENT_373	[p14l1528t554r1657b595],
2	polymorphisms	NNS	O	polymorphism	_	0	SENT_373	[p14l1677t552r2082b606],
3	in	IN	O	in	_	0	SENT_373	[p14l2104t552r2151b595],
4	TYMS	NNS	O	tym	prep_in	2	SENT_373	[p14l137t620r297b669],
5	,	,	O	,	_	0	SENT_373	[p14l137t620r297b669],
6	MTHFR	NN	LOCATION	mthfr	appos	4	SENT_373	[p14l317t621r517b669],
7	,	,	O	,	_	0	SENT_373	[p14l317t621r517b669],
8	p53	NN	O	p53	conj_and	6	SENT_373	[p14l537t620r630b674],
9	and	CC	O	and	_	0	SENT_373	[p14l652t618r745b663],
10	MDR1	NN	O	mdr1	conj_and	6	SENT_373	[p14l765t621r916b662],
11	as	IN	O	as	_	0	SENT_373	[p14l941t631r991b663],
12	risk	NN	O	risk	nn	13	SENT_373	[p14l1012t618r1106b663],
13	factors	NNS	O	factor	prep_as	6	SENT_373	[p14l1124t618r1296b663],
14	for	IN	O	for	_	0	SENT_373	[p14l1316t618r1388b663],
15	breast	NN	O	breast	nn	16	SENT_373	[p14l1404t618r1564b663],
16	cancer	NN	O	cancer	prep_for	13	SENT_373	[p14l1582t631r1765b663],
17	:	:	O	:	_	0	SENT_373	[p14l1582t631r1765b663],
18	a	DT	O	a	det	19	SENT_373	[p14l1788t631r1814b663],
19	case	NN	O	case	dep	2	SENT_373	[p14l1833t618r2150b663],
20	—	CD	NUMBER	—	num	22	SENT_373	[p14l1833t618r2150b663],
21	control	NN	O	control	nn	22	SENT_373	[p14l1833t618r2150b663],
22	study	NN	O	study	dep	19	SENT_373	[p14l140t685r294b741],
23	.	.	O	.	_	0	SENT_373	[p14l140t685r294b741],

1	Oncol	NNP	MISC	Oncol	nn	2	SENT_374	[p14l318t685r465b730],
2	Rep	NNP	MISC	Rep	_	0	SENT_374	[p14l489t688r583b741],
3	2009	CD	DATE	2009	num	2	SENT_374	[p14l605t687r1084b736],
4	;	:	O	;	_	0	SENT_374	[p14l605t687r1084b736],
5	22:1425	CD	NUMBER	22:1425	number	6	SENT_374	[p14l605t687r1084b736],
6	—	CD	NUMBER	—	dep	2	SENT_374	[p14l605t687r1084b736],
7	33	CD	NUMBER	33	dep	6	SENT_374	[p14l605t687r1084b736],
8	.	.	O	.	_	0	SENT_374	[p14l605t687r1084b736],

1	[	NN	O	[	nn	5	SENT_375	[p14l6t752r104b806],
2	27	CD	NUMBER	27	num	5	SENT_375	[p14l6t752r104b806],
3	]	CD	NUMBER	]	num	5	SENT_375	[p14l6t752r104b806],
4	Nogueira	NNP	O	Nogueira	nn	5	SENT_375	[p14l139t753r374b806],
5	JA	NNP	O	JA	nsubj	17	SENT_375	[p14l384t754r455b806],
6	,	,	O	,	_	0	SENT_375	[p14l384t754r455b806],
7	Ono-Nita	NNP	O	Ono-Nita	nn	8	SENT_375	[p14l472t753r708b796],
8	SK	NNP	O	SK	appos	5	SENT_375	[p14l725t754r800b802],
9	,	,	O	,	_	0	SENT_375	[p14l725t754r800b802],
10	Nita	NNP	PERSON	Nita	nn	11	SENT_375	[p14l818t753r923b796],
11	ME	NNP	O	ME	appos	8	SENT_375	[p14l940t755r1034b802],
12	,	,	O	,	_	0	SENT_375	[p14l940t755r1034b802],
13	de	FW	O	de	dep	8	SENT_375	[p14l1052t752r1111b796],
14	Souza	NNP	O	Souza	nn	15	SENT_375	[p14l1128t754r1278b796],
15	MM	NN	O	mm	dep	8	SENT_375	[p14l1295t755r1410b802],
16	,	,	O	,	_	0	SENT_375	[p14l1295t755r1410b802],
17	do	VBP	O	do	_	0	SENT_375	[p14l1428t752r1489b796],
18	Carmo	NNP	O	Carmo	nn	19	SENT_375	[p14l1506t754r1674b796],
19	EP	NNP	O	EP	dobj	17	SENT_375	[p14l1691t755r1763b802],
20	,	,	O	,	_	0	SENT_375	[p14l1691t755r1763b802],
21	Mello	NNP	ORGANIZATION	Mello	nn	22	SENT_375	[p14l1781t752r1926b796],
22	ES	NN	ORGANIZATION	e	appos	19	SENT_375	[p14l1943t754r2013b802],
23	,	,	O	,	_	0	SENT_375	[p14l1943t754r2013b802],
24	et	FW	O	et	nn	25	SENT_375	[p14l2030t759r2078b796],
25	al.	FW	O	al.	appos	22	SENT_375	[p14l2094t752r2149b796],
26	249	CD	NUMBER	249	num	28	SENT_375	[p14l139t820r234b862],
27	TP53	NN	O	tp53	nn	28	SENT_375	[p14l261t820r387b862],
28	mutation	NN	O	mutation	nsubjpass	34	SENT_375	[p14l419t819r658b862],
29	has	VBZ	O	have	rcmod	25	SENT_375	[p14l687t818r771b862],
30	high	JJ	O	high	amod	31	SENT_375	[p14l801t818r913b872],
31	prevalence	NN	O	prevalence	dobj	29	SENT_375	[p14l942t818r1222b872],
32	and	CC	O	and	_	0	SENT_375	[p14l1251t818r1345b862],
33	is	VBZ	O	be	auxpass	34	SENT_375	[p14l1374t819r1412b862],
34	correlated	VBN	O	correlate	rcmod	25	SENT_375	[p14l1442t818r1704b862],
35	with	IN	O	with	_	0	SENT_375	[p14l1731t818r1851b862],
36	larger	JJR	O	larger	prep_with	34	SENT_375	[p14l1879t818r2030b872],
37	and	CC	O	and	_	0	SENT_375	[p14l2057t818r2150b862],
38	poorly	RB	O	poorly	advmod	34	SENT_375	[p14l140t884r306b939],
39	differentiated	VBN	O	differentiate	conj_and	34	SENT_375	[p14l327t883r681b928],
40	HCC	NNP	ORGANIZATION	HCC	dobj	39	SENT_375	[p14l705t886r812b928],
41	in	IN	O	in	_	0	SENT_375	[p14l835t884r882b928],
42	Brazilian	JJ	MISC	brazilian	amod	43	SENT_375	[p14l905t884r1132b928],
43	patients	NNS	O	patient	prep_in	40	SENT_375	[p14l1155t884r1376b939],
44	.	.	O	.	_	0	SENT_375	[p14l1155t884r1376b939],

1	BMC	NNP	O	BMC	nn	2	SENT_376	[p14l1400t886r1518b928],
2	Cancer	NNP	O	Cancer	_	0	SENT_376	[p14l1540t886r1716b928],
3	2009	CD	DATE	2009	num	2	SENT_376	[p14l1737t886r2049b935],
4	;	:	O	;	_	0	SENT_376	[p14l1737t886r2049b935],
5	9:204	CD	NUMBER	9:204	dep	2	SENT_376	[p14l1737t886r2049b935],
6	.	.	O	.	_	0	SENT_376	[p14l1737t886r2049b935],

1	[	NN	O	[	nn	4	SENT_377	[p14l6t951r104b1005],
2	28	CD	NUMBER	28	num	4	SENT_377	[p14l6t951r104b1005],
3	]	NN	O	]	nn	4	SENT_377	[p14l6t951r104b1005],
4	Shimasaki	NN	ORGANIZATION	shimasakus	_	0	SENT_377	[p14l139t951r401b994],
5	N	NN	ORGANIZATION	n	dep	4	SENT_377	[p14l421t954r472b1001],
6	,	,	O	,	_	0	SENT_377	[p14l421t954r472b1001],
7	Mori	NN	LOCATION	morus	nn	8	SENT_377	[p14l491t952r612b994],
8	T	NN	LOCATION	t	appos	5	SENT_377	[p14l629t954r671b1001],
9	,	,	O	,	_	0	SENT_377	[p14l629t954r671b1001],
10	Torii	NNP	PERSON	Torii	nn	11	SENT_377	[p14l689t952r807b994],
11	C	NNP	PERSON	C	appos	5	SENT_377	[p14l827t953r870b1001],
12	,	,	O	,	_	0	SENT_377	[p14l827t953r870b1001],
13	Sato	NNP	PERSON	Sato	nn	14	SENT_377	[p14l889t953r997b994],
14	R	NNP	O	R	appos	5	SENT_377	[p14l1016t954r1060b1001],
15	,	,	O	,	_	0	SENT_377	[p14l1016t954r1060b1001],
16	Shimada	NNP	PERSON	Shimada	nn	17	SENT_377	[p14l1079t951r1302b994],
17	H	NNP	O	H	appos	5	SENT_377	[p14l1320t954r1371b1001],
18	,	,	O	,	_	0	SENT_377	[p14l1320t954r1371b1001],
19	Tanigawara	NNP	O	Tanigawara	nn	20	SENT_377	[p14l1388t951r1690b1005],
20	Y	NN	O	y	appos	5	SENT_377	[p14l1707t954r1753b1001],
21	,	,	O	,	_	0	SENT_377	[p14l1707t954r1753b1001],
22	et	FW	O	et	nn	23	SENT_377	[p14l1772t957r1820b994],
23	al.	FW	O	al.	appos	5	SENT_377	[p14l1837t951r1893b995],
24	.	.	O	.	_	0	SENT_377	[p14l1837t951r1893b995],

1	Inﬂuence	NN	O	inﬂuence	_	0	SENT_378	[p14l1913t951r2151b994],
2	of	IN	O	of	_	0	SENT_378	[p14l139t1016r192b1061],
3	MTHFR	NN	O	mthfr	nn	6	SENT_378	[p14l213t1019r403b1060],
4	and	CC	O	and	_	0	SENT_378	[p14l426t1016r519b1061],
5	RFC1	NN	O	rfc1	conj_and	3	SENT_378	[p14l547t1019r667b1061],
6	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_378	[p14l700t1016r1105b1072],
7	on	IN	O	on	_	0	SENT_378	[p14l1133t1029r1196b1061],
8	toxicities	NNS	O	toxicity	prep_on	1	SENT_378	[p14l1220t1017r1456b1061],
9	during	IN	O	during	_	0	SENT_378	[p14l1483t1016r1654b1072],
10	maintenance	NN	O	maintenance	nn	11	SENT_378	[p14l1679t1017r2014b1061],
11	chemotherapy	NN	O	chemotherapy	prep_during	8	SENT_378	[p14l2041t1016r2151b1061, p14l140t1084r424b1138],
12	for	IN	O	for	_	0	SENT_378	[p14l460t1084r532b1128],
13	childhood	NN	O	childhood	nn	16	SENT_378	[p14l568t1084r825b1128],
14	acute	JJ	O	acute	amod	16	SENT_378	[p14l862t1091r1001b1128],
15	lymphoblastic	JJ	O	lymphoblastic	amod	16	SENT_378	[p14l1038t1084r1407b1138],
16	leukemia	NN	O	leukemia	prep_for	1	SENT_378	[p14l1443t1084r1680b1128],
17	or	CC	O	or	_	0	SENT_378	[p14l1718t1097r1771b1128],
18	lymphoma	NN	O	lymphoma	prep_for	1	SENT_378	[p14l1807t1084r2098b1138],
19	.	.	O	.	_	0	SENT_378	[p14l1807t1084r2098b1138],

1	J	NNP	O	J	nn	4	SENT_379	[p14l2130t1087r2151b1138],
2	Pediatr	NNP	O	Pediatr	nn	4	SENT_379	[p14l140t1150r324b1194],
3	Hematol	NNP	O	Hematol	nn	4	SENT_379	[p14l345t1150r565b1194],
4	Oncol	NNP	O	Oncol	_	0	SENT_379	[p14l588t1150r735b1194],
5	2008	CD	DATE	2008	num	4	SENT_379	[p14l758t1152r1203b1200],
6	;	:	O	;	_	0	SENT_379	[p14l758t1152r1203b1200],
7	30:347	CD	NUMBER	30:347	number	8	SENT_379	[p14l758t1152r1203b1200],
8	—	CD	NUMBER	—	dep	4	SENT_379	[p14l758t1152r1203b1200],
9	52	CD	NUMBER	52	dep	8	SENT_379	[p14l758t1152r1203b1200],
10	.	.	O	.	_	0	SENT_379	[p14l758t1152r1203b1200],

1	[	NN	O	[	_	0	SENT_380	[p14l6t1216r104b1270],
2	29	CD	NUMBER	29	num	1	SENT_380	[p14l6t1216r104b1270],
3	]	CD	NUMBER	]	num	5	SENT_380	[p14l6t1216r104b1270],
4	Zarate	NNP	PERSON	Zarate	nn	5	SENT_380	[p14l138t1219r300b1259],
5	R	NN	PERSON	r	dep	1	SENT_380	[p14l316t1219r359b1266],
6	,	,	O	,	_	0	SENT_380	[p14l316t1219r359b1266],
7	Gonzalez	NNP	PERSON	Gonzalez	appos	5	SENT_380	[p14l375t1216r828b1270],
8	.	.	O	.	_	0	SENT_380	[p14l375t1216r828b1270],

1	—	NN	O	—	_	0	SENT_381	[p14l375t1216r828b1270],
2	.	.	O	.	_	0	SENT_381	[p14l375t1216r828b1270],

1	Santigo	NNP	O	Santigo	nn	2	SENT_382	[p14l375t1216r828b1270],
2	S	NNP	O	S	_	0	SENT_382	[p14l844t1218r882b1266],
3	,	,	O	,	_	0	SENT_382	[p14l844t1218r882b1266],
4	de	FW	O	de	nn	6	SENT_382	[p14l897t1216r957b1259],
5	la	FW	O	la	nn	6	SENT_382	[p14l972t1216r1015b1259],
6	HabaJ	NN	O	habaj	appos	2	SENT_382	[p14l1030t1216r1203b1270],
7	,	,	O	,	_	0	SENT_382	[p14l1030t1216r1203b1270],
8	Bandres	NNPS	ORGANIZATION	Bandres	nn	9	SENT_382	[p14l1218t1216r1423b1259],
9	E	NNP	ORGANIZATION	E	appos	6	SENT_382	[p14l1440t1219r1480b1266],
10	,	,	O	,	_	0	SENT_382	[p14l1440t1219r1480b1266],
11	Morales	NNP	PERSON	Morales	nn	12	SENT_382	[p14l1496t1216r1701b1259],
12	R	NNP	O	R	appos	6	SENT_382	[p14l1717t1219r1760b1266],
13	,	,	O	,	_	0	SENT_382	[p14l1717t1219r1760b1266],
14	SalgadoJ	NNP	O	SalgadoJ	appos	6	SENT_382	[p14l1776t1216r2016b1270],
15	,	,	O	,	_	0	SENT_382	[p14l1776t1216r2016b1270],
16	et	FW	O	et	nn	17	SENT_382	[p14l2032t1222r2080b1259],
17	al.	FW	O	al.	appos	6	SENT_382	[p14l2094t1216r2149b1260],
18	.	.	O	.	_	0	SENT_382	[p14l2094t1216r2149b1260],

1	GSTP1	NN	O	gstp1	nn	4	SENT_383	[p14l139t1284r295b1326],
2	and	CC	O	and	_	0	SENT_383	[p14l324t1282r417b1326],
3	MTHFR	NN	O	mthfr	nn	4	SENT_383	[p14l440t1285r630b1325],
4	polymorphisms	NNS	O	polymorphism	nsubjpass	6	SENT_383	[p14l649t1282r1055b1336],
5	are	VBP	O	be	auxpass	6	SENT_383	[p14l1077t1295r1156b1326],
6	related	VBN	O	relate	_	0	SENT_383	[p14l1178t1282r1357b1326],
7	with	IN	O	with	_	0	SENT_383	[p14l1378t1282r1497b1326],
8	toxicity	NN	O	toxicity	prep_with	6	SENT_383	[p14l1517t1283r1714b1336],
9	in	IN	O	in	_	0	SENT_383	[p14l1735t1283r1783b1325],
10	breast	NN	O	breast	nn	11	SENT_383	[p14l1803t1282r1963b1326],
11	cancer	NN	O	cancer	prep_in	6	SENT_383	[p14l1984t1295r2153b1326],
12	adjuvant	JJ	O	adjuvant	amod	14	SENT_383	[p14l139t1348r367b1402],
13	anthracycline-based	JJ	O	anthracycline-based	amod	14	SENT_383	[p14l389t1348r915b1402],
14	treatment	NN	O	treatment	dep	11	SENT_383	[p14l938t1354r1209b1392],
15	.	.	O	.	_	0	SENT_383	[p14l938t1354r1209b1392],

1	Curr	NNP	MISC	Curr	nn	3	SENT_384	[p14l1234t1350r1347b1391],
2	Drug	NNP	MISC	Drug	nn	3	SENT_384	[p14l1367t1350r1494b1402],
3	Metab	NNP	MISC	Metab	_	0	SENT_384	[p14l1516t1348r1678b1391],
4	2007	CD	DATE	2007	num	3	SENT_384	[p14l1701t1350r2080b1398],
5	;	:	O	;	_	0	SENT_384	[p14l1701t1350r2080b1398],
6	8:481	CD	NUMBER	8:481	number	7	SENT_384	[p14l1701t1350r2080b1398],
7	—	CD	NUMBER	—	dep	3	SENT_384	[p14l1701t1350r2080b1398],
8	6	CD	NUMBER	6	dep	7	SENT_384	[p14l1701t1350r2080b1398],
9	.	.	O	.	_	0	SENT_384	[p14l1701t1350r2080b1398],

1	[	RB	O	[	dep	5	SENT_385	[p14l6t1414r103b1470],
2	30	CD	NUMBER	30	num	5	SENT_385	[p14l6t1414r103b1470],
3	]	CD	NUMBER	]	num	5	SENT_385	[p14l6t1414r103b1470],
4	Ongaro	NNP	MISC	Ongaro	nn	5	SENT_385	[p14l139t1416r325b1470],
5	A	NNP	MISC	A	_	0	SENT_385	[p14l340t1416r388b1465],
6	,	,	O	,	_	0	SENT_385	[p14l340t1416r388b1465],
7	De	NNP	PERSON	De	nn	9	SENT_385	[p14l406t1417r472b1459],
8	Mattei	NNP	PERSON	Mattei	nn	9	SENT_385	[p14l490t1415r657b1459],
9	M	NN	O	m	appos	5	SENT_385	[p14l675t1417r737b1465],
10	,	,	O	,	_	0	SENT_385	[p14l675t1417r737b1465],
11	Della	NNP	PERSON	Della	nn	13	SENT_385	[p14l754t1414r885b1459],
12	Porta	NNP	PERSON	Porta	nn	13	SENT_385	[p14l902t1417r1036b1459],
13	MG	NN	O	mg	appos	5	SENT_385	[p14l1054t1416r1155b1465],
14	,	,	O	,	_	0	SENT_385	[p14l1054t1416r1155b1465],
15	Rigolin	NNP	O	Rigolin	nn	16	SENT_385	[p14l1173t1414r1352b1470],
16	G	NNP	O	G	appos	13	SENT_385	[p14l1369t1416r1418b1465],
17	,	,	O	,	_	0	SENT_385	[p14l1369t1416r1418b1465],
18	Ambrosio	NNP	PERSON	Ambrosio	nn	19	SENT_385	[p14l1434t1414r1684b1459],
19	C	NNP	O	C	appos	13	SENT_385	[p14l1701t1416r1744b1465],
20	,	,	O	,	_	0	SENT_385	[p14l1701t1416r1744b1465],
21	Di	NNP	PERSON	Di	nn	23	SENT_385	[p14l1762t1415r1815b1458],
22	Raimondo	NNP	PERSON	Raimondo	nn	23	SENT_385	[p14l1833t1414r2095b1459],
23	F	NN	PERSON	f	appos	13	SENT_385	[p14l2113t1417r2150b1465],
24	,	,	O	,	_	0	SENT_385	[p14l2113t1417r2150b1465],
25	et	FW	O	et	nn	26	SENT_385	[p14l139t1488r187b1526],
26	al.	FW	O	al.	appos	13	SENT_385	[p14l216t1481r271b1526],
27	.	.	O	.	_	0	SENT_385	[p14l216t1481r271b1526],

1	Gene	NNP	PERSON	Gene	nn	2	SENT_386	[p14l302t1483r431b1526],
2	polymorphisms	NNS	O	polymorphism	_	0	SENT_386	[p14l461t1481r867b1537],
3	in	IN	O	in	_	0	SENT_386	[p14l897t1482r945b1525],
4	folate	JJ	O	folate	amod	6	SENT_386	[p14l974t1481r1119b1526],
5	metabolizing	VBG	O	metabolize	amod	6	SENT_386	[p14l1149t1481r1489b1537],
6	enzymes	NNS	O	enzyme	prep_in	2	SENT_386	[p14l1517t1494r1744b1537],
7	in	IN	O	in	_	0	SENT_386	[p14l1774t1482r1822b1525],
8	adult	JJ	O	adult	amod	11	SENT_386	[p14l1850t1481r1984b1526],
9	acute	JJ	O	acute	amod	11	SENT_386	[p14l2012t1488r2151b1526],
10	lymphoblastic	JJ	O	lymphoblastic	amod	11	SENT_386	[p14l139t1548r508b1602],
11	leukemia	NN	O	leukemia	prep_in	6	SENT_386	[p14l526t1548r778b1592],
12	:	:	O	:	_	0	SENT_386	[p14l526t1548r778b1592],
13	effects	NNS	O	effect	dep	2	SENT_386	[p14l801t1548r968b1591],
14	on	IN	O	on	_	0	SENT_386	[p14l987t1560r1050b1591],
15	methotrexate	NN	O	methotrexate	nn	16	SENT_386	[p14l1068t1548r1626b1591],
16	—	NN	O	—	prep_on	13	SENT_386	[p14l1068t1548r1626b1591],
17	related	JJ	O	related	amod	18	SENT_386	[p14l1068t1548r1626b1591],
18	toxicity	NN	O	toxicity	dep	13	SENT_386	[p14l1644t1549r1841b1602],
19	and	CC	O	and	_	0	SENT_386	[p14l1858t1548r1951b1591],
20	survival	NN	O	survival	dep	13	SENT_386	[p14l1971t1549r2150b1591, p14l138t1614r194b1658],
21	.	.	O	.	_	0	SENT_386	[p14l1971t1549r2150b1591, p14l138t1614r194b1658],

1	Haematologica	NNP	O	Haematologica	_	0	SENT_387	[p14l218t1614r605b1668],
2	2009	CD	DATE	2009	num	1	SENT_387	[p14l628t1616r1073b1664],
3	;	:	O	;	_	0	SENT_387	[p14l628t1616r1073b1664],
4	94:1391	CD	NUMBER	94:1391	number	5	SENT_387	[p14l628t1616r1073b1664],
5	—	CD	NUMBER	—	dep	1	SENT_387	[p14l628t1616r1073b1664],
6	8	CD	NUMBER	8	dep	5	SENT_387	[p14l628t1616r1073b1664],
7	.	.	O	.	_	0	SENT_387	[p14l628t1616r1073b1664],

1	[	NN	O	[	_	0	SENT_388	[p14l6t1679r104b1735],
2	31	CD	NUMBER	31	number	3	SENT_388	[p14l6t1679r104b1735],
3	]	CD	NUMBER	]	dep	1	SENT_388	[p14l6t1679r104b1735],
4	Sharma	FW	PERSON	sharma	dep	3	SENT_388	[p14l140t1680r334b1724],
5	R	NN	PERSON	r	dep	1	SENT_388	[p14l367t1682r410b1731],
6	,	,	O	,	_	0	SENT_388	[p14l367t1682r410b1731],
7	Hoskins	NNP	ORGANIZATION	Hoskins	nn	8	SENT_388	[p14l444t1680r647b1724],
8	JM	NN	ORGANIZATION	jm	appos	5	SENT_388	[p14l673t1682r760b1735],
9	,	,	O	,	_	0	SENT_388	[p14l673t1682r760b1735],
10	Rivory	NNP	ORGANIZATION	Rivory	nn	11	SENT_388	[p14l793t1680r959b1735],
11	LP	NN	ORGANIZATION	lp	appos	5	SENT_388	[p14l991t1682r1059b1731],
12	,	,	O	,	_	0	SENT_388	[p14l991t1682r1059b1731],
13	Zucknick	NN	O	zucknick	nn	14	SENT_388	[p14l1091t1680r1325b1724],
14	M	NN	O	m	appos	5	SENT_388	[p14l1356t1682r1417b1731],
15	,	,	O	,	_	0	SENT_388	[p14l1356t1682r1417b1731],
16	London	NNP	LOCATION	London	nn	17	SENT_388	[p14l1451t1680r1642b1724],
17	R	NN	O	r	appos	5	SENT_388	[p14l1674t1682r1717b1731],
18	,	,	O	,	_	0	SENT_388	[p14l1674t1682r1717b1731],
19	Liddle	NNP	ORGANIZATION	Liddle	nn	20	SENT_388	[p14l1751t1680r1906b1724],
20	C	NNP	ORGANIZATION	C	appos	5	SENT_388	[p14l1939t1682r1981b1731],
21	,	,	O	,	_	0	SENT_388	[p14l1939t1682r1981b1731],
22	et	FW	O	et	nn	23	SENT_388	[p14l2015t1686r2063b1724],
23	al.	FW	O	al.	appos	5	SENT_388	[p14l2094t1680r2149b1725],
24	.	.	O	.	_	0	SENT_388	[p14l2094t1680r2149b1725],

1	Thymidylate	NNP	O	Thymidylate	nn	2	SENT_389	[p14l137t1747r466b1801],
2	synthase	NN	O	synthase	_	0	SENT_389	[p14l493t1747r719b1801],
3	and	CC	O	and	_	0	SENT_389	[p14l745t1747r838b1790],
4	methylenetetrahydrofolate	NN	O	methylenetetrahydrofolate	nn	5	SENT_389	[p14l865t1747r1568b1801],
5	reductase	NN	O	reductase	conj_and	2	SENT_389	[p14l1595t1747r1844b1790],
6	gene	NN	O	gene	nn	7	SENT_389	[p14l1870t1759r1992b1801],
7	polymorphisms	NNS	O	polymorphism	dep	2	SENT_389	[p14l2017t1747r2150b1801, p14l140t1812r431b1868],
8	and	CC	O	and	_	0	SENT_389	[p14l475t1813r568b1857],
9	toxicity	NN	O	toxicity	dep	2	SENT_389	[p14l611t1813r807b1868],
10	to	TO	O	to	_	0	SENT_389	[p14l849t1819r899b1857],
11	capecitabine	NN	O	capecitabine	prep_to	7	SENT_389	[p14l942t1812r1267b1868],
12	in	IN	O	in	_	0	SENT_389	[p14l1311t1813r1358b1856],
13	advanced	JJ	O	advanced	amod	16	SENT_389	[p14l1401t1812r1645b1857],
14	colorectal	JJ	O	colorectal	amod	16	SENT_389	[p14l1688t1812r1940b1857],
15	cancer	NN	O	cancer	nn	16	SENT_389	[p14l1984t1825r2153b1857],
16	patients	NNS	O	patient	prep_in	11	SENT_389	[p14l139t1881r360b1934],
17	.	.	O	.	_	0	SENT_389	[p14l139t1881r360b1934],

1	Clin	NNP	O	Clin	nn	3	SENT_390	[p14l384t1880r484b1924],
2	Cancer	NNP	O	Cancer	nn	3	SENT_390	[p14l506t1882r682b1924],
3	Res	NNP	O	Res	_	0	SENT_390	[p14l703t1883r788b1924],
4	2008	CD	DATE	2008	num	3	SENT_390	[p14l812t1882r1257b1930],
5	;	:	O	;	_	0	SENT_390	[p14l812t1882r1257b1930],
6	14:817	CD	NUMBER	14:817	number	7	SENT_390	[p14l812t1882r1257b1930],
7	—	CD	NUMBER	—	dep	3	SENT_390	[p14l812t1882r1257b1930],
8	25	CD	NUMBER	25	dep	7	SENT_390	[p14l812t1882r1257b1930],
9	.	.	O	.	_	0	SENT_390	[p14l812t1882r1257b1930],

1	[	NN	O	[	nn	5	SENT_391	[p14l6t1946r104b2002],
2	32	CD	NUMBER	32	num	5	SENT_391	[p14l6t1946r104b2002],
3	]	CD	NUMBER	]	num	5	SENT_391	[p14l6t1946r104b2002],
4	Chua	NNP	PERSON	Chua	nn	5	SENT_391	[p14l139t1946r268b1991],
5	W	NNP	PERSON	W	_	0	SENT_391	[p14l282t1949r352b1997],
6	,	,	O	,	_	0	SENT_391	[p14l282t1949r352b1997],
7	Goldstein	NNP	PERSON	Goldstein	nn	8	SENT_391	[p14l369t1946r616b1991],
8	D	NNP	PERSON	D	appos	5	SENT_391	[p14l633t1949r682b1997],
9	,	,	O	,	_	0	SENT_391	[p14l633t1949r682b1997],
10	Lee	NNP	LOCATION	Lee	nn	11	SENT_391	[p14l699t1949r782b1991],
11	CK	NNP	LOCATION	CK	appos	8	SENT_391	[p14l799t1948r878b1997],
12	,	,	O	,	_	0	SENT_391	[p14l799t1948r878b1997],
13	Dhillon	NNP	PERSON	Dhillon	nn	14	SENT_391	[p14l895t1946r1085b1991],
14	H	NNP	PERSON	H	appos	8	SENT_391	[p14l1101t1949r1152b1997],
15	,	,	O	,	_	0	SENT_391	[p14l1101t1949r1152b1997],
16	Michael	NNP	PERSON	Michael	nn	17	SENT_391	[p14l1169t1946r1372b1991],
17	M	NNP	PERSON	M	appos	8	SENT_391	[p14l1390t1949r1451b1997],
18	,	,	O	,	_	0	SENT_391	[p14l1390t1949r1451b1997],
19	Mitchell	NNP	PERSON	Mitchell	nn	20	SENT_391	[p14l1468t1946r1680b1991],
20	P	NN	O	p	appos	8	SENT_391	[p14l1698t1949r1738b1997],
21	,	,	O	,	_	0	SENT_391	[p14l1698t1949r1738b1997],
22	et	FW	O	et	nn	23	SENT_391	[p14l1755t1953r1803b1991],
23	al.	FW	O	al.	appos	8	SENT_391	[p14l1819t1946r1874b1991],
24	.	.	O	.	_	0	SENT_391	[p14l1819t1946r1874b1991],

1	Molecular	JJ	O	molecular	amod	2	SENT_392	[p14l1892t1946r2153b1991],
2	markers	NNS	O	marker	_	0	SENT_392	[p14l140t2013r349b2056],
3	of	IN	O	of	_	0	SENT_392	[p14l383t2013r436b2056],
4	response	NN	O	response	prep_of	2	SENT_392	[p14l462t2025r691b2067],
5	and	CC	O	and	_	0	SENT_392	[p14l723t2013r817b2056],
6	toxicity	NN	O	toxicity	conj_and	4	SENT_392	[p14l849t2014r1046b2067],
7	to	TO	O	to	_	0	SENT_392	[p14l1076t2019r1126b2056],
8	FOLFOX	NNP	O	FOLFOX	nn	9	SENT_392	[p14l1158t2015r1362b2056],
9	chemotherapy	NN	O	chemotherapy	prep_to	2	SENT_392	[p14l1393t2013r1769b2067],
10	in	IN	O	in	_	0	SENT_392	[p14l1800t2014r1848b2056],
11	metastatic	JJ	O	metastatic	amod	13	SENT_392	[p14l1880t2013r2151b2056],
12	colorectal	JJ	O	colorectal	amod	13	SENT_392	[p14l139t2079r391b2123],
13	cancer	NN	O	cancer	prep_in	2	SENT_392	[p14l414t2092r594b2123],
14	.	.	O	.	_	0	SENT_392	[p14l414t2092r594b2123],

1	BrJ	NN	O	brj	nn	2	SENT_393	[p14l618t2082r708b2133],
2	Cancer	NN	O	cancer	_	0	SENT_393	[p14l731t2081r907b2123],
3	2009	CD	DATE	2009	dep	2	SENT_393	[p14l927t2081r1470b2129],
4	;	:	O	;	_	0	SENT_393	[p14l927t2081r1470b2129],
5	101:998	CD	NUMBER	101:998	number	6	SENT_393	[p14l927t2081r1470b2129],
6	—	CD	NUMBER	—	dep	2	SENT_393	[p14l927t2081r1470b2129],
7	1004	CD	DATE	1004	dep	6	SENT_393	[p14l927t2081r1470b2129],
8	.	.	O	.	_	0	SENT_393	[p14l927t2081r1470b2129],

1	[	NN	O	[	nsubj	3	SENT_394	[p14l6t2144r104b2200],
2	33	CD	NUMBER	33	num	3	SENT_394	[p14l6t2144r104b2200],
3	]	CD	NUMBER	]	_	0	SENT_394	[p14l6t2144r104b2200],
4	Toffoli	NNP	O	Toffoli	nn	5	SENT_394	[p14l137t2144r308b2189],
5	G	NNP	O	G	dobj	3	SENT_394	[p14l332t2147r381b2196],
6	,	,	O	,	_	0	SENT_394	[p14l332t2147r381b2196],
7	Veronesi	NNP	PERSON	Veronesi	nn	8	SENT_394	[p14l402t2145r635b2189],
8	A	NNP	O	A	dobj	3	SENT_394	[p14l656t2147r705b2196],
9	,	,	O	,	_	0	SENT_394	[p14l656t2147r705b2196],
10	Boiocchi	NNP	O	Boiocchi	nn	11	SENT_394	[p14l729t2145r951b2189],
11	M	NNP	O	M	dobj	3	SENT_394	[p14l975t2147r1037b2196],
12	,	,	O	,	_	0	SENT_394	[p14l975t2147r1037b2196],
13	Crivellari	NNP	PERSON	Crivellari	nn	17	SENT_394	[p14l1061t2145r1303b2189],
14	D.	NNP	PERSON	D.	nn	17	SENT_394	[p14l1326t2147r1377b2189],
15	MTHFR	NNP	PERSON	MTHFR	nn	17	SENT_394	[p14l1401t2147r1594b2189],
16	gene	NN	O	gene	nn	17	SENT_394	[p14l1614t2157r1738b2200],
17	polymorphism	NN	O	polymorphism	dobj	3	SENT_394	[p14l1760t2145r2151b2200],
18	and	CC	O	and	_	0	SENT_394	[p14l139t2212r234b2257],
19	severe	JJ	O	severe	amod	20	SENT_394	[p14l260t2225r427b2257],
20	toxicity	NN	O	toxicity	dobj	3	SENT_394	[p14l451t2213r654b2268],
21	during	IN	O	during	_	0	SENT_394	[p14l677t2212r852b2268],
22	adjuvant	JJ	O	adjuvant	amod	23	SENT_394	[p14l875t2212r1109b2268],
23	treatment	NN	O	treatment	prep_during	3	SENT_394	[p14l1131t2219r1398b2257],
24	of	IN	O	of	_	0	SENT_394	[p14l1422t2212r1476b2257],
25	early	JJ	O	early	amod	27	SENT_394	[p14l1494t2212r1625b2268],
26	breast	NN	O	breast	nn	27	SENT_394	[p14l1648t2212r1812b2257],
27	cancer	NN	O	cancer	prep_of	23	SENT_394	[p14l1835t2225r2008b2257],
28	with	IN	O	with	_	0	SENT_394	[p14l2029t2212r2151b2257],
29	cyclophosphamide	NN	O	cyclophosphamide	prep_with	27	SENT_394	[p14l139t2279r652b2335],
30	,	,	O	,	_	0	SENT_394	[p14l139t2279r652b2335],
31	methotrexate	NN	O	methotrexate	prep_with	27	SENT_394	[p14l701t2279r1075b2330],
32	,	,	O	,	_	0	SENT_394	[p14l701t2279r1075b2330],
33	and	CC	O	and	_	0	SENT_394	[p14l1125t2279r1220b2324],
34	ﬂuorouracil	NN	O	ﬂuorouracil	nn	37	SENT_394	[p14l1269t2279r1576b2324],
35	(	CD	NUMBER	(	num	37	SENT_394	[p14l1626t2279r1798b2334],
36	CMF	NN	ORGANIZATION	cmf	nn	37	SENT_394	[p14l1626t2279r1798b2334],
37	)	NN	O	)	prep_with	27	SENT_394	[p14l1626t2279r1798b2334],
38	.	.	O	.	_	0	SENT_394	[p14l1626t2279r1798b2334],

1	Ann	NNP	PERSON	Ann	nn	2	SENT_395	[p14l1845t2281r1951b2323],
2	Oncol	NNP	PERSON	Oncol	_	0	SENT_395	[p14l2000t2279r2149b2324],
3	2000	CD	DATE	2000	num	2	SENT_395	[p14l139t2348r285b2396],
4	;	:	O	;	_	0	SENT_395	[p14l139t2348r285b2396],
5	1	CD	NUMBER	1	number	6	SENT_395	[p14l297t2348r317b2389],
6	1	CD	NUMBER	1	dep	2	SENT_395	[p14l331t2348r350b2389],
7	:373	CD	NUMBER	:373	num	8	SENT_395	[p14l366t2348r562b2390],
8	—	NN	O	—	dep	6	SENT_395	[p14l366t2348r562b2390],
9	4	CD	NUMBER	4	dep	6	SENT_395	[p14l366t2348r562b2390],
10	.	.	O	.	_	0	SENT_395	[p14l366t2348r562b2390],

1	[	NN	O	[	_	0	SENT_396	[p14l6t2412r104b2466],
2	34	CD	NUMBER	34	num	1	SENT_396	[p14l6t2412r104b2466],
3	]	CD	NUMBER	]	num	5	SENT_396	[p14l6t2412r104b2466],
4	Gusella	NNP	PERSON	Gusella	nn	5	SENT_396	[p14l139t2412r329b2456],
5	M	NN	PERSON	m	dep	1	SENT_396	[p14l363t2415r425b2462],
6	,	,	O	,	_	0	SENT_396	[p14l363t2415r425b2462],
7	Frigo	NNP	ORGANIZATION	Frigo	nn	8	SENT_396	[p14l459t2413r587b2466],
8	AC	NN	ORGANIZATION	ac	appos	5	SENT_396	[p14l619t2414r701b2462],
9	,	,	O	,	_	0	SENT_396	[p14l619t2414r701b2462],
10	Bolzonella	NN	PERSON	bolzonellum	nn	11	SENT_396	[p14l736t2412r1004b2456],
11	C	NN	PERSON	c	appos	5	SENT_396	[p14l1037t2414r1080b2462],
12	,	,	O	,	_	0	SENT_396	[p14l1037t2414r1080b2462],
13	Marinelli	NNP	PERSON	Marinelli	nn	14	SENT_396	[p14l1115t2412r1348b2456],
14	R	NNP	O	R	appos	5	SENT_396	[p14l1383t2415r1426b2462],
15	,	,	O	,	_	0	SENT_396	[p14l1383t2415r1426b2462],
16	Barile	NNP	PERSON	Barile	nn	17	SENT_396	[p14l1461t2412r1607b2456],
17	C	NNP	O	C	appos	5	SENT_396	[p14l1642t2414r1685b2462],
18	,	,	O	,	_	0	SENT_396	[p14l1642t2414r1685b2462],
19	Bononi	NNP	PERSON	Bononi	nn	20	SENT_396	[p14l1719t2413r1898b2456],
20	A	NNP	O	A	appos	5	SENT_396	[p14l1931t2414r1979b2462],
21	,	,	O	,	_	0	SENT_396	[p14l1931t2414r1979b2462],
22	et	FW	O	et	nn	23	SENT_396	[p14l2013t2419r2062b2456],
23	al.	FW	O	al.	appos	5	SENT_396	[p14l2094t2412r2149b2456],
24	.	.	O	.	_	0	SENT_396	[p14l2094t2412r2149b2456],

1	Predictors	NNS	O	predictor	_	0	SENT_397	[p14l140t2478r399b2522],
2	of	IN	O	of	_	0	SENT_397	[p14l427t2477r480b2522],
3	survival	NN	O	survival	prep_of	1	SENT_397	[p14l501t2478r704b2522],
4	and	CC	O	and	_	0	SENT_397	[p14l732t2478r826b2522],
5	toxicity	NN	O	toxicity	prep_of	1	SENT_397	[p14l852t2478r1049b2533],
6	in	IN	O	in	_	0	SENT_397	[p14l1075t2478r1123b2522],
7	patients	NNS	O	patient	prep_in	1	SENT_397	[p14l1149t2478r1356b2533],
8	on	IN	O	on	_	0	SENT_397	[p14l1385t2490r1448b2522],
9	adjuvant	JJ	O	adjuvant	amod	10	SENT_397	[p14l1474t2478r1702b2533],
10	therapy	NN	O	therapy	prep_on	7	SENT_397	[p14l1727t2478r1928b2533],
11	with	IN	O	with	_	0	SENT_397	[p14l1953t2478r2072b2522],
12	5ﬂuorouracil	NN	O	5ﬂuorouracil	prep_with	10	SENT_397	[p14l2099t2480r2150b2522, p14l140t2545r439b2588],
13	for	IN	O	for	_	0	SENT_397	[p14l463t2545r535b2588],
14	colorectal	JJ	O	colorectal	amod	15	SENT_397	[p14l556t2545r807b2588],
15	cancer	NN	O	cancer	prep_for	1	SENT_397	[p14l831t2557r1011b2589],
16	.	.	O	.	_	0	SENT_397	[p14l831t2557r1011b2589],

1	BrJ	NN	O	brj	nn	2	SENT_398	[p14l1035t2548r1125b2599],
2	Cancer	NN	O	cancer	_	0	SENT_398	[p14l1147t2547r1323b2588],
3	2009	CD	DATE	2009	dep	2	SENT_398	[p14l1344t2547r1855b2595],
4	;	:	O	;	_	0	SENT_398	[p14l1344t2547r1855b2595],
5	100:1549	CD	NUMBER	100:1549	number	6	SENT_398	[p14l1344t2547r1855b2595],
6	—	CD	NUMBER	—	dep	2	SENT_398	[p14l1344t2547r1855b2595],
7	57	CD	NUMBER	57	dep	6	SENT_398	[p14l1344t2547r1855b2595],
8	.	.	O	.	_	0	SENT_398	[p14l1344t2547r1855b2595],

1	[	NN	O	[	nn	4	SENT_399	[p14l6t2610r104b2666],
2	35	CD	NUMBER	35	num	4	SENT_399	[p14l6t2610r104b2666],
3	]	NN	O	]	nn	4	SENT_399	[p14l6t2610r104b2666],
4	Kantar	NN	O	kantar	_	0	SENT_399	[p14l140t2613r312b2655],
5	M	NN	O	m	dep	4	SENT_399	[p14l333t2613r394b2662],
6	,	,	O	,	_	0	SENT_399	[p14l333t2613r394b2662],
7	Kosova	NN	PERSON	kosova	nn	8	SENT_399	[p14l418t2613r600b2655],
8	B	NN	PERSON	b	appos	5	SENT_399	[p14l622t2613r664b2662],
9	,	,	O	,	_	0	SENT_399	[p14l622t2613r664b2662],
10	Cetingul	NNP	ORGANIZATION	Cetingul	nn	11	SENT_399	[p14l687t2610r902b2666],
11	N	NNP	ORGANIZATION	N	appos	5	SENT_399	[p14l925t2613r975b2661],
12	,	,	O	,	_	0	SENT_399	[p14l925t2613r975b2661],
13	Gumus	NNP	O	Gumus	nn	14	SENT_399	[p14l998t2613r1180b2655],
14	S	NNP	O	S	appos	5	SENT_399	[p14l1204t2613r1242b2662],
15	,	,	O	,	_	0	SENT_399	[p14l1204t2613r1242b2662],
16	Toroslu	NNP	O	Toroslu	nn	17	SENT_399	[p14l1262t2610r1456b2655],
17	E	NNP	O	E	appos	5	SENT_399	[p14l1479t2613r1519b2662],
18	,	,	O	,	_	0	SENT_399	[p14l1479t2613r1519b2662],
19	Zafer	NNP	PERSON	Zafer	nn	20	SENT_399	[p14l1541t2610r1673b2655],
20	N	NNP	PERSON	N	appos	5	SENT_399	[p14l1694t2613r1744b2662],
21	,	,	O	,	_	0	SENT_399	[p14l1694t2613r1744b2662],
22	et	FW	O	et	nn	23	SENT_399	[p14l1767t2617r1815b2655],
23	al.	FW	O	al.	appos	5	SENT_399	[p14l1836t2611r1891b2655],
24	.	.	O	.	_	0	SENT_399	[p14l1836t2611r1891b2655],

1	Methylenetetrahydrofolate	NNP	O	Methylenetetrahydrofolate	nn	3	SENT_400	[p14l1915t2610r2150b2666, p14l140t2678r627b2732],
2	reductase	NN	O	reductase	nn	3	SENT_400	[p14l656t2678r905b2722],
3	C677T	NN	O	c677t	nsubj	11	SENT_400	[p14l934t2680r1097b2722],
4	and	CC	O	and	_	0	SENT_400	[p14l1123t2678r1217b2722],
5	A1298C	NN	O	a1298c	nn	7	SENT_400	[p14l1243t2680r1446b2722],
6	gene	NN	O	gene	nn	7	SENT_400	[p14l1472t2691r1594b2732],
7	polymorphisms	NNS	O	polymorphism	conj_and	3	SENT_400	[p14l1622t2678r2028b2732],
8	and	CC	O	and	_	0	SENT_400	[p14l2057t2678r2150b2722],
9	therapy	NN	O	therapy	nn	10	SENT_400	[p14l139t2744r545b2800],
10	—	NN	O	—	conj_and	3	SENT_400	[p14l139t2744r545b2800],
11	related	JJ	O	related	_	0	SENT_400	[p14l139t2744r545b2800],
12	toxicity	NN	O	toxicity	dobj	11	SENT_400	[p14l564t2745r761b2800],
13	in	IN	O	in	_	0	SENT_400	[p14l779t2745r827b2788],
14	children	NNS	O	child	prep_in	12	SENT_400	[p14l845t2744r1058b2789],
15	treated	VBN	O	treat	partmod	14	SENT_400	[p14l1076t2744r1261b2789],
16	for	IN	O	for	_	0	SENT_400	[p14l1280t2744r1352b2789],
17	acute	JJ	O	acute	amod	19	SENT_400	[p14l1368t2751r1507b2789],
18	lymphoblastic	JJ	O	lymphoblastic	amod	19	SENT_400	[p14l1527t2744r1895b2800],
19	leukemia	NN	O	leukemia	prep_for	15	SENT_400	[p14l1914t2744r2151b2789],
20	and	CC	O	and	_	0	SENT_400	[p14l139t2811r232b2854],
21	non-Hodgkin	JJ	MISC	non-hodgkin	amod	22	SENT_400	[p14l256t2811r598b2865],
22	lymphoma	NN	O	lymphoma	prep_for	15	SENT_400	[p14l621t2811r912b2865],
23	.	.	O	.	_	0	SENT_400	[p14l621t2811r912b2865],

1	Leuk	NNP	O	Leuk	nn	2	SENT_401	[p14l936t2811r1057b2854],
2	Lymphoma	NNP	O	Lymphoma	_	0	SENT_401	[p14l1079t2811r1370b2865],
3	2009	CD	DATE	2009	num	2	SENT_401	[p14l1392t2813r1804b2861],
4	;	:	O	;	_	0	SENT_401	[p14l1392t2813r1804b2861],
5	50:912	CD	NUMBER	50:912	num	6	SENT_401	[p14l1392t2813r1804b2861],
6	—	NN	O	—	dep	2	SENT_401	[p14l1392t2813r1804b2861],
7	7	CD	NUMBER	7	dep	6	SENT_401	[p14l1392t2813r1804b2861],
8	.	.	O	.	_	0	SENT_401	[p14l1392t2813r1804b2861],

1	[	NN	O	[	_	0	SENT_402	[p14l6t2877r104b2931],
2	36	CD	NUMBER	36	num	1	SENT_402	[p14l6t2877r104b2931],
3	]	CD	NUMBER	]	num	5	SENT_402	[p14l6t2877r104b2931],
4	Afzal	NNP	PERSON	Afzal	nn	5	SENT_402	[p14l137t2877r266b2921],
5	S	NN	PERSON	s	dep	1	SENT_402	[p14l293t2879r331b2927],
6	,	,	O	,	_	0	SENT_402	[p14l293t2879r331b2927],
7	Jensen	NNP	ORGANIZATION	Jensen	nn	8	SENT_402	[p14l351t2880r525b2931],
8	SA	NNP	ORGANIZATION	SA	appos	5	SENT_402	[p14l551t2879r626b2927],
9	,	,	O	,	_	0	SENT_402	[p14l551t2879r626b2927],
10	Vainer	NNP	PERSON	Vainer	nn	11	SENT_402	[p14l650t2878r822b2921],
11	B	NNP	PERSON	B	appos	5	SENT_402	[p14l846t2880r889b2927],
12	,	,	O	,	_	0	SENT_402	[p14l846t2880r889b2927],
13	Vogel	NNP	ORGANIZATION	Vogel	nn	14	SENT_402	[p14l913t2877r1058b2931],
14	U	NNP	ORGANIZATION	U	appos	5	SENT_402	[p14l1084t2880r1134b2927],
15	,	,	O	,	_	0	SENT_402	[p14l1084t2880r1134b2927],
16	Matsen	NNP	PERSON	Matsen	nn	17	SENT_402	[p14l1161t2880r1350b2921],
17	JP	NNP	O	JP	appos	5	SENT_402	[p14l1369t2880r1434b2931],
18	,	,	O	,	_	0	SENT_402	[p14l1369t2880r1434b2931],
19	Sorensen	NNP	PERSON	Sorensen	nn	20	SENT_402	[p14l1461t2879r1695b2921],
20	JB	NNP	O	JB	appos	5	SENT_402	[p14l1714t2880r1781b2931],
21	,	,	O	,	_	0	SENT_402	[p14l1714t2880r1781b2931],
22	et	FW	O	et	nn	23	SENT_402	[p14l1807t2884r1856b2921],
23	al.	FW	O	al.	appos	5	SENT_402	[p14l1880t2877r1936b2921],
24	.	.	O	.	_	0	SENT_402	[p14l1880t2877r1936b2921],

1	MTHFR	NN	O	mthfr	_	0	SENT_403	[p14l1963t2880r2153b2920],
2	polymorphisms	NNS	O	polymorphism	dep	1	SENT_403	[p14l140t2943r545b2997],
3	and	CC	O	and	_	0	SENT_403	[p14l565t2943r658b2986],
4	5-FU-based	JJ	O	5-fu-based	amod	6	SENT_403	[p14l678t2943r974b2986],
5	adjuvant	JJ	O	adjuvant	amod	6	SENT_403	[p14l993t2943r1221b2997],
6	chemotherapy	NN	O	chemotherapy	dep	1	SENT_403	[p14l1239t2943r1614b2997],
7	in	IN	O	in	_	0	SENT_403	[p14l1633t2943r1680b2986],
8	colorectal	JJ	O	colorectal	amod	9	SENT_403	[p14l1699t2943r1951b2986],
9	cancer	NN	O	cancer	prep_in	1	SENT_403	[p14l1970t2955r2150b2987],
10	.	.	O	.	_	0	SENT_403	[p14l1970t2955r2150b2987],

1	Ann	NNP	O	Ann	nn	2	SENT_404	[p14l137t3011r242b3052],
2	Oncol	NNP	O	Oncol	_	0	SENT_404	[p14l264t3009r411b3053],
3	2009	CD	DATE	2009	num	2	SENT_404	[p14l435t3011r878b3059],
4	;	:	O	;	_	0	SENT_404	[p14l435t3011r878b3059],
5	20:1660	CD	NUMBER	20:1660	number	6	SENT_404	[p14l435t3011r878b3059],
6	—	CD	NUMBER	—	dep	2	SENT_404	[p14l435t3011r878b3059],
7	6	CD	NUMBER	6	dep	6	SENT_404	[p14l435t3011r878b3059],
8	.	.	O	.	_	0	SENT_404	[p14l435t3011r878b3059],

1	[	NN	O	[	_	0	SENT_405	[p14l6t3075r104b3131],
2	37	CD	NUMBER	37	number	3	SENT_405	[p14l6t3075r104b3131],
3	]	CD	NUMBER	]	dep	1	SENT_405	[p14l6t3075r104b3131],
4	Kim	NNP	PERSON	Kim	nn	5	SENT_405	[p14l140t3076r242b3119],
5	YI	NNP	PERSON	YI	dep	3	SENT_405	[p14l266t3078r329b3120],
6	.	.	O	.	_	0	SENT_405	[p14l266t3078r329b3120],

1	Role	NN	O	role	_	0	SENT_406	[p14l356t3075r466b3120],
2	of	IN	O	of	_	0	SENT_406	[p14l491t3075r545b3120],
3	the	DT	O	the	det	5	SENT_406	[p14l564t3075r646b3120],
4	MTHFR	NN	O	mthfr	nn	5	SENT_406	[p14l671t3078r862b3119],
5	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_406	[p14l885t3075r1290b3131],
6	in	IN	O	in	_	0	SENT_406	[p14l1318t3076r1365b3119],
7	cancer	NN	O	cancer	nn	9	SENT_406	[p14l1391t3088r1560b3120],
8	risk	NN	O	risk	nn	9	SENT_406	[p14l1584t3075r1678b3120],
9	modiﬁcation	NN	O	modiﬁcation	prep_in	1	SENT_406	[p14l1703t3075r2032b3120],
10	and	CC	O	and	_	0	SENT_406	[p14l2057t3075r2150b3120],
11	treatment	NN	O	treatment	conj_and	9	SENT_406	[p14l139t3149r410b3186],
12	.	.	O	.	_	0	SENT_406	[p14l139t3149r410b3186],

1	Future	JJ	DATE	future	amod	2	SENT_407	[p14l435t3145r602b3186],
2	Oncol	NN	DATE	oncol	_	0	SENT_407	[p14l625t3142r772b3186],
3	2009	CD	DATE	2009	num	2	SENT_407	[p14l795t3144r1207b3192],
4	;	:	O	;	_	0	SENT_407	[p14l795t3144r1207b3192],
5	5:523	CD	NUMBER	5:523	number	6	SENT_407	[p14l795t3144r1207b3192],
6	—	CD	NUMBER	—	dep	2	SENT_407	[p14l795t3144r1207b3192],
7	42	CD	NUMBER	42	dep	6	SENT_407	[p14l795t3144r1207b3192],
8	.	.	O	.	_	0	SENT_407	[p14l795t3144r1207b3192],

1	[	NN	O	[	nn	5	SENT_408	[p14l6t3208r104b3264],
2	38	CD	NUMBER	38	num	5	SENT_408	[p14l6t3208r104b3264],
3	]	CD	NUMBER	]	num	5	SENT_408	[p14l6t3208r104b3264],
4	De	NNP	PERSON	De	nn	5	SENT_408	[p14l140t3211r206b3253],
5	Chaudhuri	NNP	PERSON	Chaudhuri	_	0	SENT_408	[p14l240t3208r511b3253],
6	S	NN	O	s	dep	5	SENT_408	[p14l546t3210r583b3259],
7	,	,	O	,	_	0	SENT_408	[p14l546t3210r583b3259],
8	Mahata	NNP	PERSON	Mahata	nn	9	SENT_408	[p14l619t3208r812b3253],
9	J	NNP	PERSON	J	appos	6	SENT_408	[p14l840t3211r872b3264],
10	,	,	O	,	_	0	SENT_408	[p14l840t3211r872b3264],
11	Das	NNP	O	Das	nn	12	SENT_408	[p14l908t3211r998b3253],
12	JK	NNP	O	JK	appos	6	SENT_408	[p14l1027t3211r1096b3264],
13	,	,	O	,	_	0	SENT_408	[p14l1027t3211r1096b3264],
14	Mukherjee	NNP	PERSON	Mukherjee	nn	15	SENT_408	[p14l1132t3208r1410b3264],
15	A	NNP	O	A	appos	6	SENT_408	[p14l1441t3210r1489b3259],
16	,	,	O	,	_	0	SENT_408	[p14l1441t3210r1489b3259],
17	Ghosh	NNP	PERSON	Ghosh	nn	18	SENT_408	[p14l1524t3208r1687b3253],
18	P	NN	O	p	appos	6	SENT_408	[p14l1721t3211r1761b3260],
19	,	,	O	,	_	0	SENT_408	[p14l1721t3211r1761b3260],
20	Sau	NNP	PERSON	Sau	nn	21	SENT_408	[p14l1796t3211r1886b3253],
21	TJ	NNP	PERSON	TJ	appos	6	SENT_408	[p14l1918t3211r1978b3264],
22	,	,	O	,	_	0	SENT_408	[p14l1918t3211r1978b3264],
23	et	FW	O	et	nn	24	SENT_408	[p14l2013t3215r2061b3253],
24	al.	FW	O	al.	appos	6	SENT_408	[p14l2094t3208r2149b3253],
25	.	.	O	.	_	0	SENT_408	[p14l2094t3208r2149b3253],

1	Association	NNP	O	Association	nsubj	10	SENT_409	[p14l137t3276r434b3318],
2	of	IN	O	of	_	0	SENT_409	[p14l471t3275r524b3318],
3	speciﬁc	NN	O	speciﬁc	nn	5	SENT_409	[p14l555t3275r747b3329],
4	p53	NN	O	p53	nn	5	SENT_409	[p14l783t3277r876b3329],
5	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_409	[p14l916t3275r1321b3329],
6	with	IN	O	with	_	0	SENT_409	[p14l1357t3275r1476b3318],
7	keratosis	NN	O	keratosis	prep_with	5	SENT_409	[p14l1513t3275r1742b3318],
8	in	IN	O	in	_	0	SENT_409	[p14l1780t3275r1828b3318],
9	individuals	NNS	O	individual	prep_in	7	SENT_409	[p14l1864t3275r2149b3318],
10	exposed	VBN	O	expose	_	0	SENT_409	[p14l139t3341r350b3396],
11	to	TO	O	to	_	0	SENT_409	[p14l383t3347r433b3385],
12	arsenic	NN	O	arsenic	prep_to	10	SENT_409	[p14l467t3341r650b3385],
13	through	IN	O	through	_	0	SENT_409	[p14l682t3340r889b3396],
14	drinking	NN	O	drinking	nn	15	SENT_409	[p14l922t3340r1142b3396],
15	water	NN	O	water	prep_through	10	SENT_409	[p14l1172t3347r1324b3385],
16	in	IN	O	in	_	0	SENT_409	[p14l1356t3341r1403b3384],
17	West	NNP	LOCATION	West	nn	18	SENT_409	[p14l1433t3343r1568b3385],
18	Bengal	NNP	LOCATION	Bengal	prep_in	10	SENT_409	[p14l1601t3341r1785b3396],
19	,	,	O	,	_	0	SENT_409	[p14l1601t3341r1785b3396],
20	India	NNP	LOCATION	India	appos	18	SENT_409	[p14l1820t3340r1960b3385],
21	.	.	O	.	_	0	SENT_409	[p14l1820t3340r1960b3385],

1	Mutat	NNP	O	Mutat	nn	2	SENT_410	[p14l1995t3343r2151b3385],
2	Res	NNP	O	Res	_	0	SENT_410	[p14l140t3410r224b3451],
3	2006	CD	DATE	2006	num	2	SENT_410	[p14l248t3410r725b3458],
4	;	:	O	;	_	0	SENT_410	[p14l248t3410r725b3458],
5	601:102	CD	NUMBER	601:102	number	6	SENT_410	[p14l248t3410r725b3458],
6	—	CD	NUMBER	—	dep	2	SENT_410	[p14l248t3410r725b3458],
7	12	CD	NUMBER	12	dep	6	SENT_410	[p14l248t3410r725b3458],
8	.	.	O	.	_	0	SENT_410	[p14l248t3410r725b3458],

1	[	NN	O	[	_	0	SENT_411	[p14l6t3474r104b3530],
2	39	CD	NUMBER	39	num	1	SENT_411	[p14l6t3474r104b3530],
3	]	CD	NUMBER	]	num	5	SENT_411	[p14l6t3474r104b3530],
4	Rosell	NNP	PERSON	Rosell	nn	5	SENT_411	[p14l140t3474r291b3519],
5	R	NN	PERSON	r	dep	1	SENT_411	[p14l313t3477r357b3525],
6	,	,	O	,	_	0	SENT_411	[p14l313t3477r357b3525],
7	Gonzalez	NNP	PERSON	Gonzalez	appos	5	SENT_411	[p14l379t3474r822b3519],
8	.	.	O	.	_	0	SENT_411	[p14l379t3474r822b3519],

1	—	NN	O	—	_	0	SENT_412	[p14l379t3474r822b3519],
2	.	.	O	.	_	0	SENT_412	[p14l379t3474r822b3519],

1	Larriba	NNP	O	Larriba	nn	2	SENT_413	[p14l379t3474r822b3519],
2	JL	NNP	O	JL	_	0	SENT_413	[p14l837t3477r898b3530],
3	,	,	O	,	_	0	SENT_413	[p14l837t3477r898b3530],
4	Alberola	NNP	O	Alberola	nn	5	SENT_413	[p14l918t3474r1135b3519],
5	V	NNP	O	V	appos	2	SENT_413	[p14l1154t3477r1203b3525],
6	,	,	O	,	_	0	SENT_413	[p14l1154t3477r1203b3525],
7	Molina	NNP	PERSON	Molina	nn	8	SENT_413	[p14l1226t3474r1405b3519],
8	F	NN	O	f	appos	5	SENT_413	[p14l1427t3477r1464b3525],
9	,	,	O	,	_	0	SENT_413	[p14l1427t3477r1464b3525],
10	Monzo	NNP	O	Monzo	nn	11	SENT_413	[p14l1487t3477r1662b3519],
11	M	NNP	O	M	appos	5	SENT_413	[p14l1684t3477r1745b3525],
12	,	,	O	,	_	0	SENT_413	[p14l1684t3477r1745b3525],
13	Benito	NNP	PERSON	Benito	nn	14	SENT_413	[p14l1768t3475r1932b3519],
14	D	NNP	PERSON	D	appos	5	SENT_413	[p14l1954t3477r2003b3525],
15	,	,	O	,	_	0	SENT_413	[p14l1954t3477r2003b3525],
16	et	FW	O	et	nn	17	SENT_413	[p14l2025t3481r2074b3519],
17	al.	FW	O	al.	appos	5	SENT_413	[p14l2094t3474r2149b3519],
18	.	.	O	.	_	0	SENT_413	[p14l2094t3474r2149b3519],

1	Single	JJ	O	single	amod	4	SENT_414	[p14l140t3541r464b3597],
2	—	JJ	O	—	amod	4	SENT_414	[p14l140t3541r464b3597],
3	agent	NN	O	agent	nn	4	SENT_414	[p14l140t3541r464b3597],
4	paclitaxel	NN	O	paclitaxel	_	0	SENT_414	[p14l484t3541r733b3597],
5	by	IN	O	by	_	0	SENT_414	[p14l754t3541r816b3597],
6	3-hour	JJ	DURATION	3-hour	amod	7	SENT_414	[p14l835t3541r1013b3586],
7	infusion	NN	O	infusion	prep_by	4	SENT_414	[p14l1033t3541r1243b3586],
8	in	IN	O	in	_	0	SENT_414	[p14l1263t3542r1311b3585],
9	the	DT	O	the	det	10	SENT_414	[p14l1331t3541r1413b3586],
10	treatment	NN	O	treatment	prep_in	7	SENT_414	[p14l1433t3548r1693b3586],
11	of	IN	O	of	_	0	SENT_414	[p14l1713t3541r1766b3586],
12	non	JJ	O	non	amod	17	SENT_414	[p14l1781t3541r2042b3586],
13	—	JJ	O	—	amod	17	SENT_414	[p14l1781t3541r2042b3586],
14	small	JJ	O	small	amod	17	SENT_414	[p14l1781t3541r2042b3586],
15	cell	NN	O	cell	nn	17	SENT_414	[p14l2063t3541r2150b3586],
16	lung	NN	O	lung	nn	17	SENT_414	[p14l140t3608r253b3662],
17	cancer	NN	O	cancer	prep_of	10	SENT_414	[p14l274t3621r457b3652],
18	:	:	O	:	_	0	SENT_414	[p14l274t3621r457b3652],
19	links	NNS	O	link	dep	4	SENT_414	[p14l483t3608r604b3652],
20	between	IN	O	between	_	0	SENT_414	[p14l626t3608r849b3652],
21	p53	NN	O	p53	nn	25	SENT_414	[p14l871t3610r964b3662],
22	and	CC	O	and	_	0	SENT_414	[p14l989t3608r1082b3652],
23	K-ras	JJ	O	k-ras	nn	25	SENT_414	[p14l1105t3611r1238b3652],
24	gene	NN	O	gene	nn	25	SENT_414	[p14l1260t3621r1381b3662],
25	status	NN	O	status	prep_between	19	SENT_414	[p14l1404t3615r1556b3652],
26	and	CC	O	and	_	0	SENT_414	[p14l1578t3608r1672b3652],
27	chemosensitivity	NN	O	chemosensitivity	prep_between	19	SENT_414	[p14l1694t3608r2149b3662],
28	.	.	O	.	_	0	SENT_414	[p14l1694t3608r2149b3662],

1	Semin	NNP	O	Semin	nn	2	SENT_415	[p14l140t3675r299b3718],
2	Oncol	NNP	O	Oncol	_	0	SENT_415	[p14l322t3674r468b3718],
3	1995	CD	DATE	1995	num	2	SENT_415	[p14l495t3676r872b3724],
4	;	:	O	;	_	0	SENT_415	[p14l495t3676r872b3724],
5	22:12	CD	TIME	22:12	number	6	SENT_415	[p14l495t3676r872b3724],
6	—	CD	NUMBER	—	dep	2	SENT_415	[p14l495t3676r872b3724],
7	8	CD	NUMBER	8	dep	6	SENT_415	[p14l495t3676r872b3724],
8	.	.	O	.	_	0	SENT_415	[p14l495t3676r872b3724],

1	[	RB	O	[	advmod	11	SENT_416	[p14l6t3739r103b3795],
2	40	CD	NUMBER	40	nsubj	11	SENT_416	[p14l6t3739r103b3795],
3	]	CD	NUMBER	]	num	10	SENT_416	[p14l6t3739r103b3795],
4	Lee	NNP	PERSON	Lee	nn	10	SENT_416	[p14l139t3742r222b3784],
5	JM	NN	PERSON	jm	nn	10	SENT_416	[p14l238t3742r324b3795],
6	,	,	O	,	_	0	SENT_416	[p14l238t3742r324b3795],
7	Bernstein	NNP	PERSON	Bernstein	dep	10	SENT_416	[p14l347t3740r592b3784],
8	A.	NNP	O	A.	nn	10	SENT_416	[p14l612t3742r660b3785],
9	p53	NN	O	p53	nn	10	SENT_416	[p14l683t3742r776b3795],
10	mutations	NNS	O	mutation	dep	2	SENT_416	[p14l802t3740r1064b3784],
11	increase	VBP	O	increase	_	0	SENT_416	[p14l1088t3740r1300b3784],
12	resistance	NN	O	resistance	dobj	11	SENT_416	[p14l1322t3740r1580b3784],
13	to	TO	O	to	_	0	SENT_416	[p14l1602t3746r1652b3784],
14	ionizing	VBG	O	ionize	prepc_to	11	SENT_416	[p14l1675t3740r1883b3795],
15	radiation	NN	O	radiation	dobj	14	SENT_416	[p14l1904t3740r2149b3785],
16	.	.	O	.	_	0	SENT_416	[p14l1904t3740r2149b3785],

1	Proc	NNP	ORGANIZATION	Proc	nn	7	SENT_417	[p15l139t16r250b57],
2	Natl	NNP	ORGANIZATION	Natl	nn	7	SENT_417	[p15l272t13r377b57],
3	Acad	NNP	ORGANIZATION	Acad	nn	7	SENT_417	[p15l399t13r524b57],
4	Sci	NNP	ORGANIZATION	Sci	nn	7	SENT_417	[p15l548t14r617b57],
5	U	NNP	ORGANIZATION	U	nn	7	SENT_417	[p15l640t16r678b57],
6	S	NNP	ORGANIZATION	S	nn	7	SENT_417	[p15l701t15r726b57],
7	A	NNP	O	A	_	0	SENT_417	[p15l746t15r785b56],
8	1993	CD	DATE	1993	num	7	SENT_417	[p15l808t15r1250b63],
9	;	:	O	;	_	0	SENT_417	[p15l808t15r1250b63],
10	90:5742	CD	NUMBER	90:5742	number	11	SENT_417	[p15l808t15r1250b63],
11	—	CD	NUMBER	—	dep	7	SENT_417	[p15l808t15r1250b63],
12	6	CD	NUMBER	6	dep	11	SENT_417	[p15l808t15r1250b63],
13	.	.	O	.	_	0	SENT_417	[p15l808t15r1250b63],

1	[	NN	O	[	nn	5	SENT_418	[p15l6t78r104b134],
2	41	CD	NUMBER	41	num	5	SENT_418	[p15l6t78r104b134],
3	]	CD	NUMBER	]	num	5	SENT_418	[p15l6t78r104b134],
4	Lowe	NNP	PERSON	Lowe	nn	5	SENT_418	[p15l140t81r277b123],
5	SW	NNP	O	SW	_	0	SENT_418	[p15l302t81r400b130],
6	,	,	O	,	_	0	SENT_418	[p15l302t81r400b130],
7	Bodis	NNP	PERSON	Bodis	nn	8	SENT_418	[p15l427t78r568b123],
8	S	NNP	O	S	appos	5	SENT_418	[p15l594t81r632b130],
9	,	,	O	,	_	0	SENT_418	[p15l594t81r632b130],
10	McClatchey	NNP	PERSON	McClatchey	nn	11	SENT_418	[p15l659t78r969b134],
11	A	NNP	O	A	appos	5	SENT_418	[p15l991t80r1039b130],
12	,	,	O	,	_	0	SENT_418	[p15l991t80r1039b130],
13	Remington	NNP	ORGANIZATION	Remington	nn	14	SENT_418	[p15l1066t79r1355b134],
14	L	NNP	ORGANIZATION	L	appos	5	SENT_418	[p15l1381t81r1418b130],
15	,	,	O	,	_	0	SENT_418	[p15l1381t81r1418b130],
16	Ruley	NNP	PERSON	Ruley	appos	5	SENT_418	[p15l1444t78r1592b134],
17	HE	PRP	O	he	dep	16	SENT_418	[p15l1616t81r1701b130],
18	,	,	O	,	_	0	SENT_418	[p15l1616t81r1701b130],
19	Fisher	NNP	PERSON	Fisher	nn	20	SENT_418	[p15l1727t78r1887b123],
20	DE	NN	O	de	appos	5	SENT_418	[p15l1911t81r1994b130],
21	,	,	O	,	_	0	SENT_418	[p15l1911t81r1994b130],
22	et	FW	O	et	nn	25	SENT_418	[p15l2019t85r2068b123],
23	al.	FW	O	al.	nn	25	SENT_418	[p15l2092t78r2150b123],
24	p53	NN	O	p53	nn	25	SENT_418	[p15l139t148r234b200],
25	status	NN	O	status	appos	5	SENT_418	[p15l266t153r422b190],
26	and	CC	O	and	_	0	SENT_418	[p15l451t146r547b190],
27	the	DT	O	the	det	28	SENT_418	[p15l575t146r658b190],
28	efﬁcacy	NN	O	efﬁcacy	appos	5	SENT_418	[p15l687t146r888b200],
29	of	IN	O	of	_	0	SENT_418	[p15l915t146r969b190],
30	cancer	NN	O	cancer	nn	31	SENT_418	[p15l991t159r1165b190],
31	therapy	NN	O	therapy	prep_of	28	SENT_418	[p15l1190t146r1396b200],
32	in	FW	O	in	prep	31	SENT_418	[p15l1424t147r1472b189],
33	vivo	FW	O	vivo	pobj	32	SENT_418	[p15l1498t147r1623b190],
34	.	.	O	.	_	0	SENT_418	[p15l1498t147r1623b190],

1	Science	NNP	O	Science	_	0	SENT_419	[p15l1652t147r1847b190],
2	1994:2665	CD	NUMBER	1994:2665	num	1	SENT_419	[p15l1878t148r2146b196],
3	:	:	O	:	_	0	SENT_419	[p15l1878t148r2146b196],
4	807-10	CD	NUMBER	807-10	dep	1	SENT_419	[p15l140t215r350b257],
5	.	.	O	.	_	0	SENT_419	[p15l140t215r350b257],

1	[	NN	O	[	nn	4	SENT_420	[p15l6t279r104b333],
2	42	CD	NUMBER	42	num	4	SENT_420	[p15l6t279r104b333],
3	]	NN	O	]	nn	4	SENT_420	[p15l6t279r104b333],
4	Khrunin	NN	O	khrunin	nsubj	25	SENT_420	[p15l139t279r350b322],
5	AV	NN	O	av	dep	4	SENT_420	[p15l368t281r454b329],
6	,	,	O	,	_	0	SENT_420	[p15l368t281r454b329],
7	Moisseev	NNP	O	Moisseev	nn	8	SENT_420	[p15l476t280r717b322],
8	A	NNP	O	A	dep	4	SENT_420	[p15l734t281r782b329],
9	,	,	O	,	_	0	SENT_420	[p15l734t281r782b329],
10	Gorbunova	NNP	O	Gorbunova	nn	11	SENT_420	[p15l804t279r1089b322],
11	V	NNP	O	V	dep	4	SENT_420	[p15l1107t282r1156b329],
12	,	,	O	,	_	0	SENT_420	[p15l1107t282r1156b329],
13	Limborska	NNP	LOCATION	Limborska	nn	16	SENT_420	[p15l1178t279r1447b322],
14	S.	NNP	O	S.	nn	16	SENT_420	[p15l1468t281r1505b323],
15	Genetic	NNP	O	Genetic	nn	16	SENT_420	[p15l1528t280r1723b322],
16	polymorphisms	NNS	O	polymorphism	dep	4	SENT_420	[p15l1745t279r2150b333],
17	and	CC	O	and	_	0	SENT_420	[p15l139t344r232b389],
18	the	DT	O	the	det	19	SENT_420	[p15l266t344r347b389],
19	efﬁcacy	NN	O	efﬁcacy	dep	4	SENT_420	[p15l380t344r577b400],
20	and	CC	O	and	_	0	SENT_420	[p15l609t344r702b389],
21	toxicity	NN	O	toxicity	conj_and	4	SENT_420	[p15l735t345r931b400],
22	of	IN	O	of	_	0	SENT_420	[p15l963t344r1016b389],
23	cisplatin	NN	O	cisplatin	nn	24	SENT_420	[p15l1043t344r1436b400],
24	—	NN	O	—	prep_of	21	SENT_420	[p15l1043t344r1436b400],
25	based	VBN	O	base	_	0	SENT_420	[p15l1043t344r1436b400],
26	chemotherapy	NN	O	chemotherapy	dobj	25	SENT_420	[p15l1470t344r1846b400],
27	in	IN	O	in	_	0	SENT_420	[p15l1878t345r1925b388],
28	ovarian	JJ	O	ovarian	amod	30	SENT_420	[p15l1958t345r2151b389],
29	cancer	NN	O	cancer	nn	30	SENT_420	[p15l139t424r308b455],
30	patients	NNS	O	patient	prep_in	26	SENT_420	[p15l330t412r550b466],
31	.	.	O	.	_	0	SENT_420	[p15l330t412r550b466],

1	Pharmacogenomics	NNS	O	pharmacogenomic	nsubj	2	SENT_421	[p15l574t412r1116b466],
2	]	VBP	O	]	_	0	SENT_421	[p15l574t412r1116b466],
3	2010	CD	DATE	2010	dobj	2	SENT_421	[p15l1139t414r1550b462],
4	;	:	O	;	_	0	SENT_421	[p15l1139t414r1550b462],
5	10:54	CD	TIME	10:54	number	6	SENT_421	[p15l1139t414r1550b462],
6	—	CD	NUMBER	—	dep	3	SENT_421	[p15l1139t414r1550b462],
7	61	CD	NUMBER	61	dep	6	SENT_421	[p15l1139t414r1550b462],
8	.	.	O	.	_	0	SENT_421	[p15l1139t414r1550b462],

1	[	NN	O	[	_	0	SENT_422	[p15l6t478r104b534],
2	43	CD	NUMBER	43	num	1	SENT_422	[p15l6t478r104b534],
3	]	CD	NUMBER	]	num	4	SENT_422	[p15l6t478r104b534],
4	BrodyJR	NN	O	brodyjr	dep	1	SENT_422	[p15l140t478r366b534],
5	,	,	O	,	_	0	SENT_422	[p15l140t478r366b534],
6	Hucl	NN	PERSON	hucl	nn	7	SENT_422	[p15l382t478r499b523],
7	T	NN	PERSON	t	appos	4	SENT_422	[p15l512t481r555b529],
8	,	,	O	,	_	0	SENT_422	[p15l512t481r555b529],
9	Costantino	NNP	ORGANIZATION	Costantino	nn	10	SENT_422	[p15l570t479r848b523],
10	CL	NN	ORGANIZATION	cl	appos	4	SENT_422	[p15l863t481r934b529],
11	,	,	O	,	_	0	SENT_422	[p15l863t481r934b529],
12	Eshleman	NNP	PERSON	Eshleman	nn	13	SENT_422	[p15l950t478r1201b523],
13	JR	NNP	O	JR	appos	4	SENT_422	[p15l1209t481r1277b534],
14	,	,	O	,	_	0	SENT_422	[p15l1209t481r1277b534],
15	Gallmeier	NNP	O	Gallmeier	nn	16	SENT_422	[p15l1293t478r1547b523],
16	E	NNP	O	E	appos	4	SENT_422	[p15l1561t481r1601b529],
17	,	,	O	,	_	0	SENT_422	[p15l1561t481r1601b529],
18	Zhu	NNP	PERSON	Zhu	nn	19	SENT_422	[p15l1615t478r1713b523],
19	H	NNP	O	H	appos	4	SENT_422	[p15l1728t481r1779b529],
20	,	,	O	,	_	0	SENT_422	[p15l1728t481r1779b529],
21	et	FW	O	et	nn	22	SENT_422	[p15l1795t485r1843b523],
22	al.	FW	O	al.	appos	4	SENT_422	[p15l1856t478r1912b523],
23	.	.	O	.	_	0	SENT_422	[p15l1856t478r1912b523],

1	Limits	NNS	O	limit	nsubj	3	SENT_423	[p15l1928t479r2085b523],
2	to	TO	O	to	aux	3	SENT_423	[p15l2101t485r2151b523],
3	thymidylate	VB	O	thymidylate	_	0	SENT_423	[p15l139t545r455b601],
4	synthase	NN	O	synthase	nn	7	SENT_423	[p15l481t545r708b601],
5	and	CC	O	and	_	0	SENT_423	[p15l733t545r827b590],
6	TP53	NN	O	tp53	nn	7	SENT_423	[p15l851t547r976b590],
7	genes	NNS	O	gene	dobj	3	SENT_423	[p15l1004t558r1150b601],
8	as	IN	O	as	_	0	SENT_423	[p15l1176t558r1227b590],
9	predictive	JJ	O	predictive	amod	10	SENT_423	[p15l1253t545r1513b601],
10	determinants	NNS	O	determinant	prep_as	3	SENT_423	[p15l1538t545r1885b590],
11	for	IN	O	for	_	0	SENT_423	[p15l1912t545r1983b590],
12	ﬂuoropyrimidine	NN	O	ﬂuoropyrimidine	nn	13	SENT_423	[p15l2007t545r2150b590, p15l139t612r457b666],
13	sensitivity	NN	O	sensitivity	prep_for	10	SENT_423	[p15l473t612r740b666],
14	and	CC	O	and	_	0	SENT_423	[p15l753t612r847b655],
15	further	JJ	O	further	amod	16	SENT_423	[p15l862t612r1045b655],
16	evidence	NN	O	evidence	prep_as	3	SENT_423	[p15l1058t612r1285b655],
17	for	IN	O	for	_	0	SENT_423	[p15l1300t612r1372b655],
18	RNA-based	JJ	MISC	rna-based	amod	19	SENT_423	[p15l1385t612r1669b655],
19	toxicity	NN	O	toxicity	prep_for	16	SENT_423	[p15l1684t613r1881b666],
20	as	IN	O	as	_	0	SENT_423	[p15l1894t624r1944b655],
21	a	DT	O	a	det	23	SENT_423	[p15l1960t624r1986b655],
22	major	JJ	O	major	amod	23	SENT_423	[p15l2001t613r2153b666],
23	inﬂuence	NN	O	inﬂuence	prep_as	3	SENT_423	[p15l139t678r389b722],
24	.	.	O	.	_	0	SENT_423	[p15l139t678r389b722],

1	Cancer	NNP	O	Cancer	nn	2	SENT_424	[p15l413t680r589b722],
2	Res	NNP	O	Res	_	0	SENT_424	[p15l611t681r695b722],
3	2009	CD	DATE	2009	num	2	SENT_424	[p15l719t680r1164b728],
4	;	:	O	;	_	0	SENT_424	[p15l719t680r1164b728],
5	69:984	CD	NUMBER	69:984	number	6	SENT_424	[p15l719t680r1164b728],
6	—	CD	NUMBER	—	dep	2	SENT_424	[p15l719t680r1164b728],
7	91	CD	NUMBER	91	dep	6	SENT_424	[p15l719t680r1164b728],
8	.	.	O	.	_	0	SENT_424	[p15l719t680r1164b728],

1	[	NN	O	[	_	0	SENT_425	[p15l6t743r104b799],
2	44	CD	NUMBER	44	num	1	SENT_425	[p15l6t743r104b799],
3	]	CD	NUMBER	]	num	5	SENT_425	[p15l6t743r104b799],
4	Marsh	NNP	PERSON	Marsh	nn	5	SENT_425	[p15l140t744r301b788],
5	S	NN	PERSON	s	dep	1	SENT_425	[p15l328t746r365b795],
6	,	,	O	,	_	0	SENT_425	[p15l328t746r365b795],
7	Paul	NNP	PERSON	Paul	nn	8	SENT_425	[p15l392t744r500b788],
8	J	NNP	PERSON	J	appos	5	SENT_425	[p15l520t746r553b799],
9	,	,	O	,	_	0	SENT_425	[p15l520t746r553b799],
10	King	NNP	O	King	nn	11	SENT_425	[p15l580t744r696b799],
11	CR	NN	O	cr	appos	5	SENT_425	[p15l721t746r799b795],
12	,	,	O	,	_	0	SENT_425	[p15l721t746r799b795],
13	Gifford	NNP	PERSON	Gifford	nn	14	SENT_425	[p15l826t743r1005b788],
14	G	NNP	PERSON	G	appos	5	SENT_425	[p15l1032t746r1081b795],
15	,	,	O	,	_	0	SENT_425	[p15l1032t746r1081b795],
16	McLeod	NNP	PERSON	McLeod	nn	17	SENT_425	[p15l1107t744r1307b788],
17	HL	NNS	O	hl	appos	5	SENT_425	[p15l1334t746r1413b795],
18	,	,	O	,	_	0	SENT_425	[p15l1334t746r1413b795],
19	Brown	NNP	PERSON	Brown	nn	21	SENT_425	[p15l1440t746r1608b788],
20	R.	NNP	PERSON	R.	nn	21	SENT_425	[p15l1634t746r1677b788],
21	Pharmacogenetic	NNP	PERSON	Pharmacogenetic	appos	5	SENT_425	[p15l1705t744r2151b799],
22	assessment	NN	O	assessment	dep	21	SENT_425	[p15l139t818r435b856],
23	of	IN	O	of	_	0	SENT_425	[p15l451t811r504b856],
24	toxicity	NN	O	toxicity	prep_of	22	SENT_425	[p15l514t812r710b867],
25	and	CC	O	and	_	0	SENT_425	[p15l725t811r818b856],
26	outcome	NN	O	outcome	prep_of	22	SENT_425	[p15l836t818r1060b856],
27	after	IN	O	after	mark	28	SENT_425	[p15l1077t811r1197b856],
28	platinum	NN	O	platinum	dep	24	SENT_425	[p15l1212t811r1448b867],
29	plus	CC	O	plus	prep	28	SENT_425	[p15l1465t811r1570b867],
30	taxane	NN	O	taxane	nn	31	SENT_425	[p15l1587t818r1759b856],
31	chemotherapy	NN	O	chemotherapy	dep	29	SENT_425	[p15l1776t811r2152b867],
32	in	IN	O	in	_	0	SENT_425	[p15l140t878r187b922],
33	ovarian	JJ	O	ovarian	amod	34	SENT_425	[p15l216t878r408b922],
34	cancer	NN	O	cancer	prep_in	31	SENT_425	[p15l437t890r619b922],
35	:	:	O	:	_	0	SENT_425	[p15l437t890r619b922],
36	the	DT	O	the	det	39	SENT_425	[p15l652t877r734b922],
37	Scottish	JJ	MISC	scottish	amod	39	SENT_425	[p15l763t877r967b922],
38	Randomised	JJ	MISC	randomised	amod	39	SENT_425	[p15l996t877r1314b922],
39	Trial	NN	MISC	trial	dep	28	SENT_425	[p15l1341t877r1457b922],
40	in	IN	MISC	in	_	0	SENT_425	[p15l1487t878r1535b922],
41	Ovarian	JJ	MISC	ovarian	amod	42	SENT_425	[p15l1563t878r1764b922],
42	Cancer	NN	MISC	cancer	prep_in	39	SENT_425	[p15l1793t880r2023b933],
43	.	.	O	.	_	0	SENT_425	[p15l1793t880r2023b933],
44	]	SYM	O	]	dep	22	SENT_425	[p15l1793t880r2023b933],

1	Clin	NNP	O	Clin	nn	2	SENT_426	[p15l2052t877r2151b922],
2	Oncol	NNP	O	Oncol	_	0	SENT_426	[p15l139t945r286b989],
3	2007	CD	DATE	2007	num	2	SENT_426	[p15l310t947r788b994],
4	;	:	O	;	_	0	SENT_426	[p15l310t947r788b994],
5	25:4528	CD	NUMBER	25:4528	number	6	SENT_426	[p15l310t947r788b994],
6	—	CD	NUMBER	—	dep	2	SENT_426	[p15l310t947r788b994],
7	35	CD	NUMBER	35	dep	6	SENT_426	[p15l310t947r788b994],
8	.	.	O	.	_	0	SENT_426	[p15l310t947r788b994],

